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Abstract 
 
Asymmetric alkene halofunctionalisation is a vibrant and rapidly expanding field.  
Several promising organocatalysts have emerged based on privileged binaphthyl 
phosphoric acid and cinchona alkaloid scaffolds.  However, there is still significant 
potential for improvement.  Many catalyst systems are limited in substrate scope and 
mechanistic understanding. 
 
In this thesis we describe the development of asymmetric bromolactonisation 
reactions catalysed by bis-cinchona alkaloid, (DHQD)2PHAL, as modified by added 
carboxylic acids.  This combination delivers bromolactones with enantioselectivity at 
a comparable level to bespoke organocatalysts previously optimised for particular 
substrate classes.  The utility of our system is based on the commercial availability of 
all reagents and the ability to tune the performance of (DHQD)2PHAL with reaction 
additives.   
 
The mode of substrate activation and the role of the carboxylic acid additive are 
investigated.  Asymmetric induction is strongly influenced by the concentration and 
the stereoelectronic properties of the additive, and enantioselectivity deteriorates with 
reaction conversion in its absence.  Interactions between carboxylic acids and 
(DHQD)2PHAL are characterised by crystallographic and equilibrium 
1H NMR 
analysis.  2D-NOESY experiments indicate that acids significantly restrict the 
rotational flexibility of (DHQD)2PHAL in solution.  We propose that catalyst rigidity 
is essential for maximisation of enantioselectivity.  This hypothesis leads to the 
development of conformationally constrained catalyst derivatives which catalyse 
bromolactonisation with greater enantioselectivity than (DHQD)2PHAL.  
 
The relative stereoselectivities of successive alkene bromination and cyclisation steps, 
and the configurational stability of intermediate bromonium ions are elucidated.  An 
unusual scenario is encountered whereby product e.r. is also determined by the 
regioselectivity of lactonisation.  Finally, a unifying model for asymmetric induction 
is proposed which accounts for the absolute product configurations observed. 
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1 Introduction 
1.1 The Applications of Alkene Halofunctionalisation 
The halofunctionalisation of olefins is an important and widely used reaction in 
organic chemistry.1  The reaction involves the addition of an electrophilic halogen and 
a nucleophile across a carbon-carbon double bond in a single step.  The widespread 
utility of the reaction derives from the variety of nucleophiles which can be added and 
the high chemo-, regio-, and diastereoselectivity that can be obtained under well-
established conditions.2  However, despite rapid advances in asymmetric catalysis, a 
reagent controlled enantioselective variant of this reaction eluded the synthetic 
community until 2010.3   
Research into this reaction has been driven primarily by the need for efficient 
enantioselective synthesis of halogenated natural products and medicinally active 
compounds.  Over 4000 halogenated natural products have been isolated, displaying 
an extraordinary diversity of structure and biological activity.4,5 A large subclass is 
composed of secondary metabolites which are biosynthetically derived from alkene 
halogenation, particularly of terpene and unsaturated fatty acid chains.  Representative 
examples are given in figure 1.1.6,7  
 
 
Figure 1.1: Halogenated natural products. 
To date only napyradomycin (figure 1) has been synthesised via enantioselective 
alkene halogenation.8  Novel catalysts for this reaction have generally been developed 
  
12 
with simpler systems.  However, the methodology now exists for the efficient 
formation of many highly functionalised heterocycles through halocyclisation 
reactions.  The inherent reactivity of the carbon-halogen bond can also be exploited to 
form a range of enantiomerically pure compounds, difficult to access by other 
methods.  This has been demonstrated by several examples in the recent literature: 
Yeung9 and Shi10 showed that the halogen atom may be substituted 
enantiospecifically with a variety of nucleophiles such as azide, acetates and thiolates 
(scheme 1.1).  A two-step sequence can also convert bromo-oxazolidinone 1 into the 
highly functionalised enantiopure terminal epoxide 2, a challenging target via direct 
epoxidation methods (scheme 1.1).11 
Scheme 1.1: Substitution of bromide and further reactions of heterocycles generated 
by asymmetric halocyclisation. 
Other reported reactions include ring-contractions12 and expansions,13 elimination13 
and radical dehalogenation14 (scheme 1.2).   
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Scheme 1.2: Ring contraction, expansion and elimination reactions of brominated 
heterocycles. 
Several groups have developed enantioselective halocyclisation methods in order to 
generate advanced intermediates towards natural product targets, such as (+)-
tanikolide15 and (+)-myriocin16 (scheme 1.3). 
 
Scheme 1.3: Fujioka’s synthesis of (+)-tanikolide15 and Kan’s studies towards (+)-
myriocin.16 
Enantioselective alkene halofunctionalisation is a rapidly expanding field and its 
potential utility in organic synthesis is beginning to be realised.  In the following 
sections a historical account of the development of this class of reactions will be 
given, followed by a review of current methods. 
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1.2 Historical Progress towards the Development of 
Asymmetric Halofunctionalisation 
The stereochemical course of alkene halogenation reactions has been studied for over 
a century.  In 1912, McKenzie first demonstrated that the bromination and 
chlorination of fumarate and maleate esters proceed with predominantly 1,2-anti 
addition across the carbon-carbon double bond.17  However, in some cases such as the 
bromination of stilbenes, the syn-addition product or a mixture of diastereomers were 
obtained.  In order to rationalise these observations, Ingold18 postulated an 
intermediate carbocation, which is formed by attack of the alkene -system onto the 
electrophilic halogen.  Carbenium ions were known to be configurationally unstable 
by C-C bond rotation,19 so consequently it was suggested that the stereoselectivity of 
halogenation depends on the rate of nucleophilic capture of the carbenium ion before 
C-C bond rotation can occur.  This unsatisfying solution was accepted until 1937 
when Roberts and Kimball proposed that the intermediate cation in bromination 
reactions could be drawn with the positive charge on the bromine atom, due to the 
availability of the halogen lone pairs, forming a 3-membered ring termed a 
bromonium ion (scheme 1.4).20  In terms of the relative ionisation potentials of carbon 
and bromine, the two resonance forms are indistinguishable.  However, the new 
structure could explain the common anti-addition selectivity, as the nucleophile opens 
the bromonium ion with inversion of configuration. 
 
Scheme 1.4:  Bromonium ion formation was proposed by Roberts and Kimball to 
account for stereoselectivity of alkene bromination.20 
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In the intervening years, Wilson and Lucas had observed that the bromination of 
racemic dl-diacetate 3 in fuming hydrobromic acid gave the meso-dibromide 4 
(scheme 1.5).21  This was indicative of overall one inversion of configuration, rather 
than the two expected from nucleophilic substitution at each carbon.  Similarly, the 
meso-diacetate was converted to dl-dibromide 5 exclusively.  The relative 
configurations of 4 and 5 were inferred by comparison of their refractive indices, 
boiling points and densities to known pure literature samples. 
 
Scheme 1.5: Reaction of 2,3-butanediacetates with hydrobromic acid.21 
These observations were only explicable in the light of Roberts’ and Kimball’s 
hypothesis;22 that a bromonium ion was formed after an initial acetate substitution, 
and subsequently ring-opened with overall three ‘Walden inversions’ (scheme 1.6).  
 
Scheme 1.6: Roberts and Kimball mechanism for dibromination of dl-2,3-
butanediacetate.22 
1.2.1 Spectroscopic Observation of Halonium Ions 
The reactivity of halonium ions precluded their direct observation for several decades, 
and evidence for their existence was solely based on the stereoselectivity of certain 
alkene halogenation reactions.  However, Olah and Bollinger discovered that 
halonium ions could be generated and studied spectroscopically using low 
temperature 1H NMR.23 The bridged halonium ions (X = I, Br and Cl) were generated 
in situ by antimony pentafluoride (SbF5) mediated fluoride abstraction from -
fluoroalkanes 6, and found to be stable in liquid SO2 between – 80 ◦C and – 60 ◦C.  
  
16 
Besides confirming the existence of halonium ions under certain conditions, these 
experiments highlighted several contrasting chemical properties of the halogens. 
Bromonium and iodonium ions were consistently formed from a range of -
fluoroalkanes (scheme 1.7).  Of particular note is the generation of 1,1-dimethyl 
halonium ions 7 (X = I, Br) despite the expected stability of the carbocation resonance 
form.  The cyclic ion 7-Br was characterised by two singlets at 3.32 ppm (6H) and 
5.55 ppm (2H).  The properties of iodine and bromine diverged only in the halonium 
ions generated from diastereomeric 2-halo-3-fluorobutanes.  In this case syn-8-I gave 
the cis-iodonium ion, and anti-8-I formed the trans-iodonium ion exclusively.  In 
contrast, both diastereomers of 2-bromo-3-fluorobutane (8-Br) formed an equilibrium 
70:30 mixture of trans:cis bromonium ions.  These results suggest that iodonium ion 
formation is irreversible under the reaction conditions, whereas bromonium ions may 
interconvert via the carbenium ion.23a  
 
Scheme 1.7: Bromonium and iodonium ions observed by Olah et al. using 1H NMR at 
low temperature in the presence of Lewis acidic antimony pentafluoride.23 
Chloronium ions were observed only from symmetric tetra-substituted precursor 9 
(scheme 1.8).  1,1-Dimethyl-1-chloro-2-fluoroethane (10) was clearly observed to 
form the t-butyl cation, characterised by long-range coupling between the methylene 
and methyl groups (4J = 5 Hz).  This cation can also be formed via rearrangements of 
the chloronium ion from 8-Cl.23a  
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Scheme 1.8: Chloronium and -chlorocarbenium ions observed by 1H NMR at low 
temperature in the presence of Lewis acidic antimony pentafluoride.23a 
The fluoronium ion was not generated in any system, and the 1H NMR spectra 
suggested a rapidly interconverting mixture of -fluorocarbenium ions.24  With these 
experiments, Olah elegantly demonstrated that a system’s propensity towards 
halonium ion formation is dependent on both the halogen atom and the substrate.  The 
halogen’s ability to bridge a carbon-carbon bond is determined by its electronegativity 
and atomic radius.  However, the halonium ion/carbenium ion equilibrium can also be 
significantly altered if energetically favourable for the system as a whole (e.g. by 
release of strain, as in 8-Br).  Brown has studied this effect in detail, with particular 
focus on the stereoselectivity of stilbene bromination.25 
 
1.2.2 X-Ray Characterisation of Stable Halonium Ions and 
Investigation of their Alkene Transfer Properties 
Conclusive proof of the existence of iodonium and bromonium ions was finally 
obtained by the initial isolation26 and subsequent X-ray crystal structure27 of the stable 
halonium ions of adamantylidene adamantane (Ad=Ad, 11).  Figure 1.2 shows the 
asymmetric unit cell of Brown’s crystal structure27b of the bromonium ion 11-Br with 
a triflate counterion.  The carbon-bromine bond lengths are not exactly equivalent 
(2.118 and 2.136 Å) due to interactions with triflate, and this asymmetry increases 
with the tribromide counterion. 
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Figure 1.2: X-ray crystal structure of stable adamantylidene adamantane bromonium 
ion (11-Br).27b 
The isolation of stable halonium ions not only confirmed their structure and existence 
as intermediates,28 but also facilitated subsequent detailed physiochemical studies and 
mechanistic investigations of olefin halogenation reactions.  Several unexpected 
properties were discovered which strongly influenced later strategies towards 
enantioselective halofunctionalisation.   
In particular, it was found that the halonium ion can be transferred to other alkenes in 
a degenerate bi-molecular process.  Brown and co-workers27b first observed that the 
addition of small quantities of Ad=Ad (11) to a solution of the bromonium ion 11-Br 
at - 80 ◦C led to the coalescence of resonances in the 13C NMR spectrum of 11-Br.  In 
the absence of alkene the signals for 8, 8’, 10 and 10’ appeared downfield to 4, 4’, 9 
and 9’, whereas the peaks coalesced towards a broad singlet as Ad=Ad was added 
(scheme 1.9).  This suggested a rapid transfer of the bromonium ion between olefin 
faces.  Kinetic studies indicated that this process is first order in added 11, implicating 
bromonium ion exchange between olefins.   
 
Scheme 1.9: Bimolecular mechanism of alkene-bromonium ion transfer.27b 
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Ab initio calculations of the transfer of Br+ between two ethylene molecules 
suggested that the reaction proceeds via a D2d symmetrical transition state (scheme 
1.10).27b 
 
Scheme 1.10: Transition state calculated by Brown for alkene-alkene bromonium ion 
exchange.27b 
Furthermore, the activation energy barrier is very low (‡ = 1.8 kcal/mol,S‡ = -21 
cal/(K∙mol)), suggesting that the rate is limited only by diffusion through the solvent 
and the stringent orientation requirement for reactive encounters.29 Similar 
experiments with 11-I indicated that iodonium ions have equivalent properties. 
Brown subsequently investigated the effect of halonium ion exchange on the kinetics 
of halocyclisation reactions.30 It was discovered that addition of alkene 11 
significantly suppressed the rate of bromo-etherification and bromolactonisation of 
1,-alkenols and alkenoic acids.  In some cases the rate asymptotically approaches 
zero at high concentration of alkene 11.  This could be rationalised by a pre-
equilibrium (K1 and K2) involving fast bromonium ion transfer between substrate and 
11 (scheme 1.11).  At high concentrations of added 11, the equilibrium is shifted 
towards the starting materials depressing the reaction rate.  In contrast, added 11 has 
no effect of iodocyclisation.  Iodonium ion opening is faster than the corresponding 
bromonium ion capture31 and consequently exchange processes are no longer 
competitive.
 
Scheme 1.11: Competitive halonium ion exchange in halolactonisation reactions.30 
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1.2.3 General Propensity of All Alkenes Towards Halonium Ion 
Exchange 
Rodebaugh and Fraser-Reid demonstrated that halonium ion exchange between 
olefins is not a particular property of 11, the halonium ion of which 11-X also 
functions as the initial source of electrophilic halogen.  In fact the process is general 
to all alkenes with NBS.32     
The system chosen for study was the reaction of n-pentenyl- and n-hexenyl-tetra-O-
benzyl--D-glucopyranose with NBS in 1% H2O/MeCN solution (scheme 1.12).  
Complete conversion of substrate 12 was observed within 2.3 h to give the hydrolysed 
glycoside and bromo-ether 14, whereas the slower rate of cyclisation for substrate 13 
resulted in a mixture of bromohydrin regioisomers within 5.2 h.  Initial rate 
experiments quantitatively determined that krel = k12/k13 = 2.6.  However, when 
alkenes 12 and 13 were allowed to compete for a single equivalent of NBS (at 25 
mM), the ratio of recovered 12:13 was 1:23.  The ratio was concentration dependent 
and eventually decreased to 1:2.6, as predicted by krel, at 0.2 mM.   
 
Scheme 1.12: Reaction of -alkene glycosides with NBS in 1% H2O:MeCN; S = 
2,3,4,6-tetra-O-benzyl--D-glucopyranosyl.32 
The observations were interpreted on the basis of Brown’s work30 (see above).  A fast, 
reversible bromine transfer equilibrium is set-up prior to bromonium ion capture.  The 
authors point out that this must involve bromonium ion-alkene exchange; transfer 
with NBS is unfavourable relative to succinimide formation in the protic 
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environment.33  The fast cyclisation of the pentenyl bromonium ion to give product 14 
shifts the equilibrium to the right (scheme 1.13), generating a higher concentration of 
bromonium ions.  However, before the less-reactive hexenyl bromonium ion can be 
captured it exchanges with a molecule of 12 to return substrate 13 and reactive 
bromonium ion 12-Br.  This significantly amplifies the proportion of product 14.  
Importantly, bimolecular exchange processes can be suppressed at high dilution. 
 
Scheme 1.13: Mechanism of bromonium ion transfer; S = 2,3,4,6-tetra-O-benzyl--
D-glucopyranosyl.32 
The elegant experiments of Fraser-Reid, Brown and co-workers proved that the rate 
and product distribution of halogenation reactions can be significantly affected when 
halogen transfer is competitive with product forming steps.  This work also had 
important implications in the future development of enantioselective 
halofunctionalisation reactions, as fast exchange processes could be envisaged to 
racemise an intermediate scalemic halonium ion.34 In order to test this assertion it was 
necessary to generate an enantiopure halonium ion and measure its configurational 
stability in the presence and absence of added alkene. 
 
1.2.4 Configurational Stability and Exchange Processes of 
Enantiopure Halonium Ions 
In 2009, Braddock and co-workers reported a new milestone in the history of 
halonium ions with the first generation and in situ trapping of an enantiopure 
bromonium ion.35  They discovered that enantiopure bromonium ions could be opened 
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enantiospecifically by an intermolecular nucleophile in the absence of alkenes, 
demonstrating their stereochemical stability under these conditions.  The enantiopure 
bromonium ions studied were formed from bromohydrin precursors, with the 
hydroxyl group protected as a sulfonate ester.  A 70:30 mixture of bromo-tosylate 
diastereomers 16 and 17 (scheme 1.14) were treated with titanium tetrachloride to 
give a mixture of bromo-chlorides 18 and 19 with the same diastereomer ratio.  The 
product regiochemistry confirmed that the reaction proceeded via a bromonium ion, 
and chiral HPLC analysis of the product mixture confirmed that the reaction was 
enantiospecific. 
 
 
Scheme 1.14: Generation and trapping of enantiopure bromonium ion in the absence 
of alkenes.35 
The following year Denmark extended this work by studying the configurational 
stability of enantiopure bromonium and chloronium ions in the presence of added 
alkene.36 In this case racemisation was observed, but the extent was strongly 
dependent on the halogen, the trapping nucleophile and alkene concentration.  
Acetolysis of (4R,5S)-bromotosylate 20 with sodium or tetrabutylammonium acetate 
in the presence of one equivalent of 4-octene afforded (4R,5S)-bromoacetate 21 with a 
diminished enantiomer ratio (figure 1.3).  Racemisation could be reduced by 
decreasing the concentration of alkene, or increasing the nucleophilicity of the acetate 
anion (compare n-Bu4NOAc and NaOAc, figure 1.3).  These results are consistent 
with previous observations that bromonium ion exchange may be suppressed by 
increasing the relative rate of nucleophilic capture.30 
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Figure 1.3: Configurational stability of bromonium ions in the presence of alkenes.36 
Conversely, chloronium ions were trapped enantiospecifically with acetate, formate 
and methanol nucleophiles but in low yields (32-42%).  These results are also 
consistent with Olah’s observation of the carbocation character of chloronium ions23a 
which leads to slower exchange but increased propensity towards reactions typical of 
carbocations e.g. solvolysis and Wagner-Meerwein rearrangements.36 
At this point, the challenges towards development of enantioselective 
halofunctionalisation reactions using each halogen could be delineated: fluorination 
reactions do not proceed via a fluoronium ion but through a rapid equilibrium of -
fluorocarbocations.24 This makes stereoselective capture impossible unless the 
equilibrium is biased by the presence of a cation-stabilising group, and to date all 
substrates for asymmetric fluorination possess adjacent electron-donating groups (see 
section 1.3.1).  Chlorination processes appear the most promising: they possess the 
stereospecific properties of chloronium ions but do not undergo exchange.  The major 
hurdle towards asymmetric bromination and iodination methods is the suppression of 
racemising halonium ion exchange without resorting to high substrate dilution. 
 
1.2.5 Lewis Base Catalysis of Halofunctionalisation Reactions 
A possible strategy for prevention of halonium ion transfer was developed by 
Braddock and co-workers, who found that simple Lewis bases containing nitrogen 
atoms such as dimethyl acetamide (22) and tetramethylguanidine (23),37 or an iodine 
atom (24)38 can efficiently catalyse the bromolactonisation reaction (figure 1.4).  The 
catalyst was postulated to facilitate the transfer of bromine from NBS to the alkene by 
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formation of an intermediate N- or I-brominated adduct.39  The I-Br adduct of catalyst 
24 could also be isolated from a mixture of 24 and NBS, and characterised by X-ray 
crystallography.40 
                  
Entry Catalyst Time (h) Conversion (%) 
1 - 15 20 
2 22 0.5 100 
3 23 0.5 100 
4 24 15 100 
Figure 1.4: Lewis base catalysed bromolactonisation studied by Braddock et al.39 
Recent work has cast doubt on this mechanism, particularly for the nitrogen-
containing catalysts as these are also strong Bronsted bases.41 It is unclear whether 
catalyst bromination can compete with protonation by the carboxylic acid group of the 
substrate (see section 1.4 for further discussion).  However, Denmark recognised that 
if a bulky Lewis basic catalyst retains some interaction to the halogen atom upon 
formation of the intermediate halonium ion it could prevent close approach of other 
alkenes, and thereby perhaps suppress halonium ion exchange (scheme 1.15).42  In the 
absence of chiral catalysts at the time, this hypothesis was tested by a systematic 
screening of Lewis (but not Bronsted) base catalysts for the bromo- and iodo-
lactonisation of (E)-5-phenyl-4-pentenoic acid (25).  The reaction proceeds with the 
formation of two constitutional isomers arising from lactonisation in a 5-exo (26-exo) 
or 6-endo (26-endo) fashion.  It was postulated that the catalyst should alter the 
isomer ratio if it remains associated to the halogen during the stereochemistry 
determining step (scheme 1.15). 
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Scheme 1.15: Denmark’s Proposed mechanism for Lewis base catalysed 
bromolactonisation.42 
An extensive screening of sulfur, phosphorus and selenium Lewis bases showed that 
these catalysts significantly accelerated the rate and altered the regioselectivity of 
halolactonisation.  In all cases perfect diastereoselectivity was obtained, proving that 
lactonisation is the stereo-determining step (table 1.1). 
Table 1.1: Catalyst survey for Lewis base catalysed halolactonisation.  t1/2 refers to 
time required for 50% conversion.42 
 
X = 
Br 
Catalyst 
t1/2 
(min) 
endo: 
exo 
X = I Catalyst 
t1/2 
(min) 
endo: 
exo 
 - >180 25:1  - >180 9.5:1 
 (Me2N)3P=Se <0.5 8.1:1  (Me2N)3P=Se 4 4.6:1 
 n-(Bu3)P <0.5 38:1  n-(Bu3)P 52 5.1:1 
 (Me2N)3P=S <0.5 3.4:1  (Me2N)3P=S 4 2.5:1 
 
 
  
26 
These results suggested that the Lewis base is associated with the intermediate 
halonium ion during cyclisation, and may consequently be able to prevent halonium 
ion exchange.  Since the development of enantioselective methods for 
halofunctionalisation, Denmark’s discovery proved to be crucial in the design of new 
catalyst systems.  These will be discussed in the following sections. 
 
1.3 Catalytic Enantioselective Halofunctionalisation 
Although the halogenation of alkenes has been known since the 19th century,43 and its 
mechanism under various catalytic conditions studied extensively, highly asymmetric 
variants have only been reported since 2010.  Since this time, over thirty catalyst 
systems have been described making this a dynamic and interesting field to work in.  
Several excellent reviews summarise the current state of the art methods.34, 44 Of 
particular note is the 2012 review by Denmark, Kuester and Burk45 which categorises 
the wide array of reported systems by mode of catalysis and strategy for asymmetric 
induction.  An important distinction is made between these two sub-categories, as 
many catalysts are bi-functional and although a particular functional group may 
accelerate the catalysed reaction, it may not directly confer enantioselectivity.  
However, in general there is considerable overlap between the two.45 
In this section, a review of enantioselective methods for olefin halogenation up to 
October 2013 will be given, and catalyst systems discussed in terms of the strategy 
employed for effecting asymmetric induction.  The main methods for catalysis of 
halofunctionalisation reactions have been described in the previous section.  
Obtaining high and synthetically useful enantioselectivities has proven to be a more 
difficult challenge, although it has now been achieved for all four natural halogens (I, 
Br, Cl, F) within a limited substrate range.  Each halogen presents individual 
challenges related to the propensity of its enantiopure halonium ion to undergo 
racemisation by alkene exchange and to the relative rates of halonium ion formation 
and nucleophilic capture (see section 1.2.3). 
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Denmark et al. identified four major strategies for asymmetric induction used in the 
literature, and categorised each reported system on this basis (figure 1.5).45  In many 
cases, mechanistic information is limited and several possible modes are consistent 
with the data.  In this review, the same useful classification will be employed although 
in some cases we have assigned the major strategy differently, as will be discussed 
below. 
 
Figure 1.5: Four strategies for asymmetric induction. 
The first two strategies directly attempt to suppress halonium ion exchange between 
alkenes by association of a Lewis base (type I) or a chiral anion (type II) to the 
intermediate halonium ion.  In type I, a bulky Lewis basic catalyst (containing S, Se, 
N or P atoms) coordinates the halonium ion datively, whereas in type II this 
interaction is electrostatic.  It is essential that the anion is non-nucleophilic to prevent 
ring-opening of the halonium ion and consequently phosphate groups have been used 
with success (figure 1.6).  For both types the steric hindrance of the catalysts protects 
the halonium from bi-molecular exchange. 
 
Figure 1.6: Common catalyst functional groups for type I and II strategies. 
Types III and IV are characterised by a strong association between the catalyst and the 
trapping nucleophile at the expense of halonium ion interactions.  Type III is 
distinguished by hydrogen bonding between the basic catalyst and a H-bond donor 
group of the substrate (such as a carboxylic acid).  Consequently, this catalytic type is 
frequently used for asymmetric halolactonisation reaction (figure 1.7).  Alternatively, 
H-bond donor groups within the catalyst, such as ureas, sulfonamides and phenols can 
increase association of carbonyl groups (e.g. of NBS) to the catalyst.  Type IV 
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includes the increasing number of organometallic Lewis acid catalysed 
halofunctionalisation reactions.  These function in the same way as type III except 
that the nucleophilic group is coordinated to the metal centre, which is surrounded by 
a chiral ligand (figure 1.7).  This strategy has been used with great success in the first 
reported enantioselective dibromination of allylic alcohols.46  Here asymmetric 
induction is ensured by coordination of Br+, the bromide nucleophile and allylic 
hydroxyl group to a single chiral titanium centre. 
 
Figure 1.7: Catalyst functional groups in type III and IV catalysis. 
 
1.3.1 Type I Catalysis 
Historically, early attempts at enantioselective halofunctionalisation employed 
stoichiometric pre-formed Lewis base-halogen complexes (typically chiral N-halo 
amines) as the source of electrophilic halogen.  This strategy was successful for 
fluorination reactions where the tertiary amine-F adduct is stable and often isolable.47  
In 2001, Shibata and co-workers reported the enantioselective formation of 2-
fluoroindanones (30) mediated by stoichiometric N-fluoro cinchona alkaloids with up 
to 94.5:5.5 e.r.48  The catalysts were prepared by transfer fluorination from 
SelectFluor (28) and studied in detail using 1H NMR spectroscopy and even X-ray 
crystallography (shown for quinine, figure 1.8).  The major obstacle towards catalysis 
was the slow fluorine transfer from 28 to the chiral promoter relative to the rate of 
background reaction.  
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Figure 1.8: Stoichiometric N-Fluoro cinchona alkaloid system for enantioselective 
fluorination, and X-ray crystal structure of quinine N-fluoro adduct.48 
Gouverneur’s group achieved a catalytic variant in 2011, describing the 
fluorocyclisation of indole derivatives, 31, with good enantioselectivity using the 
dimeric quinidine catalyst (DHQ)2PHAL (32) (20 mol%), N-
fluorobenzenesulfonimide (NFSI, 33) as the electrophilic fluorine source (scheme 
1.16) and excess potassium carbonate.49 
 
Scheme 1.16: Gouverneur’s system for catalytic enantioselective fluorocyclisation.49 
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The stoichiometric base (K2CO3) is thought to be required for anion exchange 
between sulfonimide and carbonate, preventing reversibility of transfer fluorination 
(catalytic cycle in scheme 1.16).47 
High enantioselectivities were maintained for a range of trapping nucleophiles e.g. 
XH = OH, NHTs and NHCOMe (34a-d).  This can be seen as supporting evidence for 
type I catalysis over type III. In the latter mechanism, asymmetric induction is 
determined by the ability of the catalyst to direct the nucleophile towards one 
enantiotopic alkene face,45 and should therefore be influenced by the strength of the 
H-bond between the XH group and the catalyst’s quinuclidine nitrogen, which is not 
the case. 
Tertiary amine adducts with other halogens are invoked as intermediates in several 
chloro- and bromo-lactonisation reactions.  However, these adducts are weaker50 and 
must therefore compete with other catalyst:substrate interactions making the 
mechanism more ambiguous.  These systems will be discussed in section 1.4 on type 
III catalysis. 
As discussed in section 1.2.5, Denmark and Burk demonstrated that sulfur, selenium 
and phosphorus Lewis bases can catalyse halocyclisation reactions.42 Since this 
publication several groups have developed chiral analogues for enantioselective 
halofunctionalisation.  Snyder and co-workers synthesised the C2-symmetric 
bromosulfonium salt 35,51 a variant of their popular reagent BDSB which is used to 
promote polyene cyclisations in polar media.52 However, the attempted cation- 
cyclisation of an aryl terminated geranyl chain gave the tri-cyclic product as a 
racemate (scheme 1.17). 
 
Scheme 1.17: Attempted enantioselective polyene cyclisation by Snyder et al.51 
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The first successful system for iodonium-induced polyene cyclisation was developed 
by Ishihara in 2007.53 The reaction is promoted by stoichiometric quantities of a chiral 
phosphoramidite 36a (scheme 1.18).  Geranyl and farnesyl chains afforded tri- and 
tetra-cycles, respectively, in good yields and excellent diastereo- and 
enantioselectivities following initial cyclisation mediated by NIS and 36a and 
subsequent treatment with chlorosulfonic acid.    
 
Scheme 1.18: Successful polyene cyclisation promoted by chiral Lewis basic 
phosphoramidite.53 
The stereochemistry of the catalyst’s secondary amine appeared to be more important 
than the axial chirality of the BINOL-scaffold as the reaction would not proceed with 
diastereomeric catalyst 36b.  The proposed mechanism invokes formation of a strong 
phosphorus iodine bond and partial deprotonation of the secondary amine which 
prevents rotation around the P-N bond and thus delivers iodine to the alkene 
enantioselectively (scheme 1.19). 
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Scheme 1.19: Proposed association of NIS to chiral promoter 36a.53 
In his review,45 Denmark disputes that iodonium ion formation is irreversible and 
stereo-determining citing the presence of internal alkenes which are weak 
nucleophiles but could rapidly racemise the iodonium ion via exchange processes.  
However, Braddock and Marklew have proven that the cation-π cyclisation of geranyl 
bromonium ion 37 proceeds enantiospecifically under certain conditions (scheme 
1.20).54  
 
Scheme 1.20: Enantiospecific polyene cyclisation.54 
Yeung developed a C2-symmetric selenide catalyst on a mannitol-based scaffold, 38, 
for enantioselective bromoaminocyclisation of olefinic sulfonamides (39) (scheme 
1.21).13 The reaction was optimised using N-bromophthalimide as the source of 
electrophilic bromine at – 78 ◦C.  Unexpectedly, the substrate amines specifically 
required 3-nitrobenzenesulfonamide (3-Ns) protection, as 2-Ns and 4-Ns groups gave 
significantly reduced e.r.  The reaction time was sensitive to substitution at the 
terminus olefin carbon, increasing from 12 h with R = H (39a) to five days with R = t-
Bu (39c).  Enantioselectivities, however, remained similar for a range of alkyl 
substituents (40a-c) and in all cases the 5-exo cyclisation product was obtained 
exclusively.  Strongly electron-donating and withdrawing aryl groups (scheme 1.21) 
were not tolerated, giving much reduced enantioselectivities and yields.  These results 
are unusual compared to type II and type III mechanisms, where electron-donating 
substituents typically increase the nucleophilicity of the alkene and consequently the 
reaction rate.  Inductively withdrawing groups are generally beneficial to 
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enantioselectivity as they destabilise the carbenium resonance form of the bromonium 
ion (section 1.2.1).25  
 
Scheme 1.21: C2-Symmetric selenide catalyst for enantioselective 
bromoaminocyclisation.13 
The postulated mechanism involves bromine transfer to selenium forming an ion-pair 
with the phthalimide anion.  Selenium remains loosely coordinated to the bromonium 
ion preventing exchange processes.  It is likely that the sulfonamide nucleophile is 
deprotonated by phthalimide before cyclisation.42,13  
Braddock exploited the Lewis basicity of iodine atoms (+1, +3 oxidation states) in the 
development of an achiral hypervalent iodine catalyst for bromolactonisation (section 
1.2.5).38 Borhan and co-workers attempted to induce enantioselectivity with this 
strategy by incorporating a 2-iodobenzoic functionality within peptide chains, 
synthesised on solid support.55 Although a variety of amino-acid side chains and 
secondary peptide structures were tested, the highest enantioselectivity obtained for 
the bromolactonisation of 4-phenyl-4-pentenoic acid (41) was only 62:38 e.r. with 
catalyst 42 (scheme 1.22). 
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Scheme 1.22: Chiral bromo-periodinane catalyst for asymmetric 
bromolactonisation.55 
The authors attribute the poor results to a fast background reaction and a weak 
association between NBS and 42.55 It may be added that the catalyst’s chiral sites are 
not in proximity to the bromine atom. 
 
1.3.2 Type II Catalysis 
Type II catalysis represents a much larger class of catalyst systems for asymmetric 
alkene halofunctionalisation than type I, but is conceptually similar.  In the type II 
mechanism halonium ion racemisation is suppressed by the close association of a 
chiral anion to the halonium ion intermediate.  Large axially chiral phosphate 
catalysts are popular. 
The first validation of this strategy for asymmetric halogenation was reported by 
Hennecke and co-workers in early 2011.  The axially chiral BINOL phosphate (43a) 
catalyst44a promoted the bromo-cycloetherification of in situ generated meso-
halonium ions (scheme 1.23). 
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Scheme 1.23: Asymmetric ring-opening of meso-halonium ions reported by 
Hennecke.44a 
The iodo-etherification of 4-octene diol (45a) proceeded to the tetrahydrofuran 
product (46a) in high yield and enantioselectivity.  Substitution  to the alcohol by a 
phenyl group (45b) further increased e.r. to 85.5:14.5, presumably due to an increased 
rate of cyclisation as expected by the Thorpe-Ingold effect.56 However, substitution - 
to the alcohol resulted in a marked loss of e.r. (46c).  The corresponding bromo-
cyclisation reactions were also generally successful giving similar yields and e.r. 
(46d).  A side product of this latter reaction is the 6-endo bromo-tetrahydropyran 
product, but application of the reaction conditions to 5-decene-1,10-diol (6-exo) gave 
very low enantioselectivity (58.5:41.5) (scheme 1.24). 
 
Scheme 1.24: Iodo-etherification of 5-decene-1,10-diol.44a 
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Because the intermediate meso-halonium ions are necessarily achiral, asymmetry 
must be induced via an enantioselective etherification step.  1H NMR evidence 
suggests that the catalyst activates N-iodopyrrolidinone (44) by coordination to the 
iodine atom.57  Subsequently, the chiral catalyst controls the facial selectivity of 
cyclisation.  It is not known whether iodonium ion transfer is suppressed by 
coordination of 43a.  The reaction is intolerant of acid, as both phosphoric acid 
catalyst (43b) and the analogous iodolactonisation reaction (scheme 1.25) decrease 
the enantioselectivity.  In both cases protonation of the catalyst may result in loss of 
coordination to the iodonium ion.34  
 
Scheme 1.25: Iodolactonisation using axially chiral catalyst 43a gave racemic 
products.44a 
In late 2011, Shi58 and Denmark59 independently reported related chiral phosphate 
catalyst systems for asymmetric alkene bromo-functionalisation reactions.  Shi 
described the bromocyclisation of -hydroxy and -amino alkenes catalysed by 
BINOL phosphoric acid catalyst 47 and mediated by NBS in CH2Cl2 (scheme 1.26).  
5-(Z)-alkyl-5-pentenols cyclised with high enantioselectivity to give THF products 
(49).  The (E)-isomers also afforded small quantities of the 6-endo constitutional 
isomer (50-endo) which was always isolated with lower e.r. than the exo-product.  
This difference was most pronounced in the single example of an aryl substituent 
(50b) which gave a 1:5 exo:endo mixture and only 59:41 e.r. for the endo-product.  
Changing the substrate to sulfonamide protected (Z)--amino alkenes gave pyrrolidine 
products (e.g. 51) with similar levels of asymmetric induction (90:10 to 95:5 e.r.) 
relative to the bromo-ethers, but higher than their (E)-isomers (78:22 to 85:15 e.r.) 
which also afforded small quantities of endo-bromopiperidines.  The proposed stereo-
determining transition state 48 invokes a ternary complex between the catalyst, NBS 
and substrate.  NBS and the substrate nucleophilic group are activated by H-bonding 
to the phosphoric acid (type III), while the succinimide conjugate base remains 
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coordinated to the bromonium ion.  This could be indicative of a type I or II 
mechanism depending on whether this interaction is considered dative or electrostatic. 
 
Scheme 1.26: Substrate scope and mechanism of chiral phosphoric acid catalysed 
bromo-cyclisation.58 
Denmark’s system differs simply by the inclusion of co-catalytic triphenylphosphine 
sulfide and a solvent exchange from CH2Cl2 to toluene.
59  His paper focuses primarily 
on 5-aryl-pentenols which cyclise to give mixtures of 5-exo and 6-endo bromoethers 
(scheme 1.27). 
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Scheme 1.27: The substrate scope of chiral phosphoric acid/Lewis base co-catalysed 
bromocycloetherification.59 
The precise ratio is strongly dependent on the electronic properties of the aryl 
substituent and alkene geometry.  (E)-alkenes with electron-donating groups (55b) 
favour endo-cyclisation and vice versa for electron-withdrawing substituents (55c).  
(Z)-Alkenes (52) are consistently exo-selective and enantioselectivity is less sensitive 
to electronic effects.  As in Shi’s system,58 higher e.r.’s are always for the 5-exo 
products (53 and 56 relative to 54 and 57). 
The authors suggest a reason for the differences in cyclisation regioselectivity 
between (Z)- and (E)-alkene substrates based on whether the large phenyl substituent 
must take a pseudo-axial or equatorial conformation in the transition state (scheme 
1.28). 
 
Scheme 1.28: Transition state structures for 6-endo and 5-exo cyclisations.59 
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For (E)-alkenes, the phenyl ring adopts an equatorial position for both exo and endo 
cyclisations (A), whereas 1,3-diaxial strain disfavours 6-endo cyclisation of (Z)-
alkenes (B).59  Without this bias, the site selectivity of (E)-alkene cyclisation is much 
more sensitive to other factors. 
It is noteworthy that the Denmark and Shi catalyst systems give different 
regioselectivity and e.r. for the same substrate (compare 50b and 56a:57a).  This may 
be due to solvent effects or an interaction between the substrate bromonium ion and 
Lewis base in the cyclisation step, a conclusion previously drawn by Denmark for 
racemic Lewis base catalysed bromo-cyclisations.42 However, this is not accounted 
for in the present system.  Instead, the role of the Lewis base is proposed to accelerate 
the reaction by assisting transfer of bromine from NBS to the phosphate anion, which 
must proceed with concurrent catalyst deprotonation by the succinimide anion 
(scheme 1.29).  This removes the catalyst’s ability to act as a H-bond donor, and 
consequently the enantio-determining transition state is a binary complex between 47 
and the substrate with a coulombic association between the bromonium ion and 
phosphate counter ion (58).  Unlike Hennecke’s system,44a the halonium ion is formed 
enantioselectively and is configurationally stable to racemisation by the bulky 
catalyst. 
 
Scheme 1.29: Mechanism of Lewis base/phosphate ion catalysed 
bromocycloetherification.59 
The low enantioselectivity of endo-bromoethers is rationalised on the basis that the 
regioselectivity of cyclisation differs for the major and minor bromonium ions (see 
section 4.10).  Denmark and Shi’s mechanistic hypotheses diverge on the presence of 
succinimide in the TS.  However, Denmark concedes in his review that the many 
similarities between the two systems suggest that only one mechanism is operative.45 
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Toste applied a structurally related phosphate catalyst to the enantioselective synthesis 
of bromo- and iodo-benzoxazines 62 and 63, respectively via 6-endo cyclisation of 
aryl amides, 61 (scheme 1.30).60 Excellent enantioselectivities were obtained for a 
wide range of alkene substituents.  The addition of excess Na3PO4 in the reaction 
mixture indicates that the phosphate anion of 59 was designed as the active catalyst, 
and a control experiment in the absence of Na3PO4 showed a marked reduction in rate 
and e.r.   
 
Scheme 1.30: Enantioselective halocyclisation using tri-cationic bromine source 
tailored for phase transfer reactions.60    
The major advance of this work is the choice of halogen source.61  The tricationic(bis-
DABCO) bromine(I) reagent (60a) is insoluble in the non-polar solvent mixture but 
moves into solution upon electrostatic association with the phosphate anion.  In this 
way, the background reaction is completely suppressed.  The precise structure of the 
ion-pair is not speculated.  However, 2:1 amine:bromine complexes are known to 
dissociate slowly to the 1:1 adduct in solution,62 from which direct bromine transfer to 
the catalyst is possible (scheme 1.31).  This gives the active phosphate hypobromite 
reagent 64 postulated by Denmark (scheme 1.29). 
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Scheme 1.31: Mechanism of bromine transfer to generate phosphate hypobromite.60 
The extension of this type of catalyst system to reactions with an intermolecular 
nucleophile is strongly dependent on whether the catalyst:bromonium ion association 
is sufficiently strong to prevent racemisation and other side reactions within the 
timescale of nucleophilic capture. 
Tang and co-workers demonstrated, and to a certain extent overcame, these 
challenges with the first report of an asymmetric bromoesterification reaction using 
chiral phosphate catalyst 65b (scheme 1.32).63  The reaction of benzoic acid, 
cyclohexene and NBS was strongly influenced by the structure of the catalyst’s aryl 
substituent (65a-b) and the pKa of the acidic proton (65b, 66).  Selected phenyl acetic 
acids gave bromoesters with up to 85:15 e.r., but reaction yields were consistently low 
due to bromonium ion trapping by the phosphate anion.  Catalysts which can activate 
the carboxylic acid by hydrogen bonding, such as cinchona alkaloids gave much 
improved yields but racemic products.  It appears that a bifunctional catalyst is 
required which can associate strongly with benzoic acid but retain a phosphate anion. 
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Scheme 1.32: Enantioselective bromoesterification reported by Tang et al.63 
 
1.4 Type III Catalysis 
As defined by Denmark, Kuester and Burk,45 type III catalysis is characterised by 
hydrogen bonding between the catalyst and the nucleophilic halonium ion-capturing 
functional group of the substrate.  This strategy has been commonly employed in 
asymmetric halolactonisation reactions, where the substrate carboxylic acid is an 
excellent H-bond donor.  As discussed in the section 1.2.5 on racemic Lewis base 
catalysis, tertiary amines, amidines and guanidines have been used as catalysts for this 
transformation.  Several chiral catalysts containing these functional groups have 
recently been reported.  In particular, cinchona alkaloids, possessing a basic tertiary 
quinuclidine amine are considered privileged organocatalytic structures, due to their 
wealth of stereochemical complexity and ready availability in both pseudo-
enantiomeric forms.64 A fuller review of their applications in organocatalysis is given 
in section 1.5. 
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Within the past three years, they have been used extensively in asymmetric 
halolactonisation reactions, and routinely give excellent enantioselectivities (>95:5 
e.r.) albeit for a limited substrate set.34  The parent alkaloids can also be easily 
functionalised to install desired functional groups within the chiral scaffold.  
However, their mechanism of stereoinduction in asymmetric halogenation reactions is 
unclear, and there is insufficient data in the current literature to decide.  The debate 
rests on whether the tertiary amine of the quinuclidine ring acts as a Lewis base- 
coordinating X+ (type I catalysis) or as a Bronsted base (type III), activating the 
carboxylic acid towards lactonisation (figure 1.9). 
 
Figure 1.9: Possible modes of stereoinduction for cinchona alkaloid catalysts. 
 
1.4.1 Aminothiocarbamate Catalysts 
In some cases, this can be resolved by the inclusion of a strong Lewis basic functional 
group within the cinchona alkaloid catalyst such that the halogen may be assumed to 
bind here preferentially, leaving the tertiary amine free to bind the carboxylic acid.  
Yeung and co-workers have developed a remarkably effective quinidine catalyst 
containing a Lewis basic thiocarbamate moiety.  In their initial paper,65 the 
combination of bifunctional catalyst 67, NBS and 4-nitrobenzenesulfonamide (71) 
gave excellent enantioselectivities for bromolactonisation of 1,1-disubstituted 
alkenoic acids, 68 (scheme 1.33). 
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Scheme 1.33: Amino-thiocarbamate catalysed bromolactonisation.65 
An exhaustive catalyst screening showed that the system was very finely balanced, 
particularly with respect to modification of the thiocarbamate moiety, as thioureas, 
thiocarbonates, carbonates and carbamates all gave racemic products.  Interestingly, 
control of electron density on the thiocarbamate was also vital.  Increasing the acidity 
of the thiocarbamate proton using catalyst 72, which would be expected to increase its 
H-bond donor ability, gave the opposite sense of asymmetric induction. 
Furthermore, the exact role of additive 71 is unclear.  The authors reasoned that the 
acidic sulfonamide group would alter the H-bonding capabilities of basic sites within 
the catalyst and strengthen association to the substrate and NBS.  However, in the 
presence of 50 mol% 71, the reaction time doubled (from 17 to 40 h) with only a 
small increase in e.r. (93.5:6.5 to 95:5 e.r. for substrate 68a).  It is possible that 71 acts 
as a bromine sink, due to the irreversible generation of NsNHBr,65 which is less 
reactive than NBS but gives higher e.r. (scheme 1.33). 
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The authors propose a transition state model for the enantiodetermining step.  This 
involves a ternary complex between the catalyst 67, substrate and NBS, where NBS is 
activated by bromine association to the thiocarbamate group, and the carboxylic acid 
by H-bonding to quinuclidine.  However, as Denmark points out,45 partial dissociation 
of NBS is required for orbital overlap between the alkene -system and S-Br * 
(figure 1.10).  The dependence of enantioselectivity on the Bronsted acidity of this 
functional group may be due to the partial/complete dissociation of succinimide by 
deprotonation of the thiocarbamate. 
 
Figure 1.10: Possible interactions between amino-thiocarbamate catalyst 67, NBS 
and alkenoic acid substrate. 
Yeung has extended this methodology to bromolactonisation and 
bromoaminocyclisation of several other substrate classes.  Catalyst 67 allowed the 
bromolactonisation of 1,2-disubstituted alkenes 73 to proceed with excellent 
enantioselectivities for substrates with a range of aromatic substituents (scheme 
1.34).66  The reaction was also regioselective for the 6-endo-product. 
 
Scheme 1.34: Bromolactonisation of (E)-1,2-disubstituted olefins.66 
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Conversely, (Z)-alkenes exclusively afforded the 5-exo butyrolactones 77 with 
modified catalyst 75.12  The single exception was for electron rich alkene 76b which 
was regioselective for the endo-product with reduced e.r. (65:35) (scheme 1.35). 
 
Scheme 1.35: Bromolactonisation of (Z)-1,2-disubstituted olefins and screening of 
Br+ sources.12 
A screen of various bromine sources with a wide range of reactivities had negligible 
effect on product enantioselectivity, suggesting that association of the conjugate base 
to the catalyst in the transition state may not be essential.   
In a subsequent paper,9 Yeung and co-workers found that the dihydroisocoumarin 
core, a common fragment of natural products67 could be accessed enantioselectively 
by bromolactonisation.  Cyclisation of 2-stilbene carboxylic acids, 78, with catalytic 
67 and NBS gave mixtures of 5-exo and 6-endo bromolactone products (table 1.2).  
The regioselectivity was strongly substrate dependent: electron rich aromatic 
substituents (R = OMe) primarily gave the 6-endo benzopyranone product, whereas 
electron deficient groups favoured 5-exo cyclisation.  In general 6-endo 
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bromolactones were isolated with greater e.r., mirroring the results of Denmark’s 
phosphate catalysed bromocycloetherification reaction (scheme 1.27).59   
Table 1.2: Regioselectivity for bromolactonisation of 2-stilbene carboxylic acids.9 
 
Entry R group endo:exo ratio e.r. (endo) e.r.(exo) 
1 Ph 5.5:1 96:4 ND 
2 4-CH3O-C6H4 40:1 62:38 ND 
3 4-CF3-C6H4 1:2 94:6 72:28 
4 2-Cl-C6H4 1:15.4 65.5:34.5 66:34 
5 H 0:1 NA 67:33 
Olefin containing sulfonamides could also be cyclised with analogous catalysts 80 
and 81.68,69 It was found that 1,1-disubstituted alkenes, 82, required a bulky iso-amyl 
quinoline substituent (80) for optimal results, whereas an unsubstituted cinchonine 
scaffold (81) was preferred for (E)-alkenes (scheme 1.36).  The results follow a 
similar trend to the bromolactonisation reactions with respect to the electronic 
properties of the aryl alkene substituent, and a similar mechanism can be assumed. 
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Entry Solvent e.r. 
1 PhMe 65:35 
2 PhMeCHCl3 (3:1) 74:26 
3 PhMeCHCl3 (1:1) 93:7 
4 n-hexaneCHCl3 (1:1) 95:5 
Scheme 1.36: Catalytic enantioselective bromoaminocyclisation.68,69 
However, in contrast to the bromolactonisation reactions, the enantioselectivity was 
strongly dependent on solvent, with toluene being particularly detrimental to e.r.  
Independent dilution experiments have shown that aminothiocarbamate catalysts 
dimerise in solution via -stacking of quinoline rings and intermolecular hydrogen 
bonds between thiourea groups.70 Although this phenomenon is not explored by 
Yeung, the disruption of  interactions in toluene may account for the reduced 
enantioselectivity. 
In conclusion, Yeung and his group have shown that by tuning the steric and 
electronic properties of the aminothiocarbamate catalysts, a wide range of 
bromocyclisation reactions can be performed with excellent asymmetric induction.  
The necessity of the Lewis basic sulfur atom has been proven by structural 
modification of the catalyst; therefore this system contains elements of type I and type 
III catalysis.  However, uncertainties remain as to the role of the succinimide anion in 
asymmetric induction, analogous to Denmark and Shi’s conflicting hypotheses for 
phosphate catalysed bromocycloetherification. 
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1.4.2 Jacobsen’s Catalyst System For Iodolactonisation 
Jacobsen and Veitch reported a highly functionalised catalyst system for the 
iodolactonisation of 5-hexenoic acids.71  Catalyst 86 has many structural features 
similar to the aminothiocarbamate catalyst 67.  The incorporation of a Lewis basis 
group, a urea, is maintained in 86, but the researchers found that a simpler 
cyclohexane-diamine chiral scaffold is sufficient to provide high enantiomer ratios 
(scheme 1.37).  As with bromolactonisation using catalyst 67, electron deficient 
alkenes (87b) underwent iodolactonisation with greater asymmetric induction than 
electron rich olefins (87c).  The best results were obtained using N-iodo-2-
fluorophthalimide 89 and molecular iodine as a co-catalyst (15 mol%), perhaps due to 
the formation of the tri-iodide 90.72 It was not possible to account for the interesting 
observation that iodolactonisation of 4-phenyl-4-pentenoic acid gave the 
butyrolactone 91 with the opposite sense of asymmetric induction compared to 88a. 
Scheme 1.37: Substrate scope and proposed mechanism for enantioselective 
iodolactonisation catalysed by amino-urea catalyst.71 
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Mechanistically, the reaction is thought to proceed via transfer of electrophilic iodine 
to the tertiary amine of the catalyst, and stabilisation of the phthalimide anion by 
hydrogen-bonding to urea, as shown by intermediate 92.  Upon formation of the 
iodonium ion, the carboxylic acid group of the substrate is activated towards 
cyclisation by H-bonding to phthalimide.  This hypothesis invokes all three 
mechanisms of stereoinduction: Lewis base stabilisation of the iodonium ion (type I), 
electrostatic interactions between catalyst:phthalimide complex and iodonium ion 
(type II), and H-bonding between the catalyst, substrate and NBS (type III).  Overall, 
Denmark places this system in type II.45 Evidence for iodine transfer was obtained 
from the observation that the free secondary amine (C5H11)2NH was isolated upon 
quenching a solution of 86 and N-iodophthalimide with sodium sulphite.  This 
resulted from elimination of HI and subsequent imine hydrolysis from intermediate 92 
(scheme 1.38).  However, it is not known whether this pathway proceeds under 
reaction conditions. 
 
Scheme 1.38: Decomposition of iodinated catalyst under reducing conditions. 
Hansen73 showed that the urea functional group of 86 can be interchanged with a 
vinylogous urea (squaramide catalyst 93) without loss of enantioselectivity (scheme 
1.39).  However, further structural modification showed that the electron withdrawing 
aryl substituent is essential. 
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Scheme 1.39: Asymmetric iodolactonisation using squaramide catalyst 93.73 
1.4.3 Amino-Urea Catalyst for Bromolactonisation of (Z)-Enynes 
Tang et al. developed a similar urea-containing catalyst for bromolactonisation of (Z)-
enynes.74 In this case a chiral quinine scaffold was selected for the tertiary amine 
functionality, catalyst 94.  (Z)-enynes, 95 and 97a,c were transformed 
diastereoselectively to syn-allenes 96 and 98a,c with generally excellent e.r. (scheme 
1.40).  However, increasing the electron density on the carboxylic acid group, as in 
enyne 97b, suppressed the rate of cyclisation, and only 1,2-addition products across 
the alkyne were observed.      
 
Scheme 1.40: Enantioselective bromolactonisation of (Z)-enynes.74 
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In a follow up publication,75 it was found that the degree of asymmetric induction was 
also strongly dependent on the source of electrophilic bromine (figure 1.11).  This 
informed their subsequent discussion of possible modes of activation: either direct 
transfer of the bromine atom to quinuclidine (intermediate A, similar to Jacobsen’s 
proposal71) or alternatively hydrogen bonding between quinuclidine and the 
carboxylic acid with concurrent NBS activation by the urea group (mechanism B).   
 
Entry Br+ source Yield (%) e.r. 
1 NBS 72 94.5:5.5 
2 TBCO 60 67.5:32.5 
3 DBDMH 37 91.5:8.5 
4 NBSa 34 52:48 
 
Figure 1.11: Influence of bromine source on the enantioselectivity of the 
bromolactonisation of enynes, and possible mechanisms of catalysis.75 
Mechanism A was disfavoured on the basis that the structure of the bromine source 
should not influence enantioselectivity if full Br+ transfer occurred, and A was the 
active catalyst.  In addition, premixing 94 and NBS before the addition of substrate  
95a returned allene 96a with much reduced 63:37 e.r. suggesting that N-bromination 
only occurs in the absence of carboxylic acid, and is a less selective pathway.  
However, no direct evidence for intermediate B was obtained. 
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1.4.4 Tris-Amidine Catalyst for Bromolactonisation 
This mechanistic dichotomy is confronted again in Fujioka’s bromolactonisation 
system employing C3-symmetric tris-amidine catalyst 99.
76  Hexenoic acids 101 
underwent bromolactonisation mediated by dibromodimethylhydantoin (DBDMH) 
with excellent enantioselectivities (scheme 1.41).  Unusually, the selectivity was 
maintained even for electron rich alkenes 101c.    In two subsequent publications, the 
substrate scope was successfully extended to kinetic resolution of -substituted 
hexenoic acids,77 103 and a range of tri- and tetra-substituted alkenes.15 However, 
lower e.r. was obtained for butyrolactones. 
 
Scheme 1.41: Substrate scope of C3-symmetric tris-imidazoline catalyst system for 
enantioselective bromolactonisation.76,77 
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1H NMR studies showed that mixtures of the substrate 101a and 99a would form a 
3:1 complex 105 at equilibrium (figure 1.12, left).  The authors suggest that reversible 
bromonium ion formation can occur on both faces of the olefin, and asymmetry is 
induced by diastereoselective cyclisation of the activated carboxylic acid (type III).  
In support, it was found that bis- and mono-amidine catalysts returned much poorer 
e.r.’s.  However, Denmark points out45 that the 1:3 complex may not be kinetically 
competitive with dual activation of the carboxylic acid by one amidine ring and NBS 
by another (figure 1.12, right). 
 
Figure 1.12: Formation of 3:1 substrate:catalyst complex (left) and Denmark’s 
proposed mechanism.45 
 
1.4.5 Axially Chiral Amidine-Phenol Catalyst for Halolactonisation 
On this basis, Martin rationally designed a bifunctional chiral catalyst 106 containing 
basic amidine and acidic phenol moieties to allow association of both NBS and the 
substrate carboxylic acid group.78 A range of di- and tri-substituted alkenoic acids 
underwent bromolactonisation mediated by TBCO within 14 h (scheme 1.42).  In 
common with Yeung’s system,12,66 (Z)-alkenes exclusively formed -butyrolactones 
whereas the 6-endo cyclisation product was isolated using (E)-olefins.  Tri-alkyl 
substituted alkenoic acids cyclised with moderate e.r.’s (108).  The reaction of 
dihydrobenzoic acid was the first example of desymmetrisation and -lactone 
formation under catalytic asymmetric bromolactonisation conditions, although 107 
was isolated with poor e.r. 
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Scheme 1.42: Substrate scope of bromolactonisation catalysed by bifunctional 
amidine-phenol catalyst.78   
Unusually, the system is also directly applicable to iodolactonisation reactions 
mediated by NIS.79 Excellent enantioselectivities were obtained from 5-substituted-4-
(Z)-pentenoic acids (109) with high exo-selectivity (scheme 1.43).  The 
regioselectivities of the (E)-isomers were dependent on the alkene substituent: 
electron rich aromatic substituents (e.g. R = 4-OMe-C6H4) gave high yields of the -
lactone, and this trend was reversed with electron withdrawing groups (e.g. R = 4-
CN-C6H4).  The intermediate case where R = Ph gave a 1:1 mixture of constitutional 
isomers, but as previously9, 59 e.r.(endo) is much greater than e.r.(exo). 
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Entry R group endo:exo ratio e.r. (endo) e.r.(exo) 
1 Ph 1.3:1 95:5 52:48 
2 4-CH3O-C6H4 endo only 86.5:13.5 - 
3 4-CN-C6H4 exo only - 58:42 
Scheme 1.43: Substrate scope and endo:exo selectivity of iodolactonisation catalysed 
by bifunctional amidine-phenol catalyst.79   
The authors rationalise the results for bromolactonisation by invoking a transition 
state model in which the bromonium ion is stabilised by the amidine nitrogen, while 
the phenol H-bonds to the carboxylic acid which has been deprotonated by the TBCO 
anion (figure 1.13, A).78  However, the reverse situation where the amidine activates -
CO2H and phenol H-bonds to the brominating reagent appears equally possible 
(figure 12 B).  In addition, it is acknowledged78 that the catalyst could rest as a 
zwitterion depending on the relative pKa of amidine and phenol groups in a 
CH2Cl2/toluene solvent mixture (C). 
 
Figure 1.13: Possible mechanisms of substrate and bromine activation. 
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1.4.6 Additive Effects 
Instead of installing complementary H-bond donor and acceptor functional groups 
within the chiral catalyst scaffold (e.g. Martin, Tang and Yeung), several groups have 
attempted an alternative strategy where the catalyst’s acid/base properties are altered 
by the use of reaction additives.  A common example is the addition of non-reacting 
acids to a catalyst containing multiple basic sites.  The clearest example of this 
strategy was reported by Johnston for iodolactonisation of 1,1-disubstituted alkenoic 
acids.80 Pre-addition of co-catalytic triflimide to C2-symmetric 1,2-diphenyldiamine 
catalyst 109 significantly increased enantioselectivity of -lactone 111a from 
78.5:21.5 e.r. to >99:1 e.r. (scheme 1.44).  Screening a range of acids showed that 
asymmetric induction increased with additive acidity.  The substrate scope is 
relatively limited, as -lactones are formed with moderate e.r., although 
enantioselectivity is unusually independent of the electronic properties of the R group, 
except for R = H (111d). 
 
Scheme 1.44: Asymmetric iodolactonisation catalysed by complex of 109 and 
triflimide.80 
The major problem with the additive strategy is the mechanistic complexity. The 
correlation between acid strength and e.r. certainly suggests that irreversible catalyst 
protonation is required for high enantioselectivity, but there is insufficient data to 
ascertain the role of the counterion, which of the six basic groups is protonated or the 
operative site(s) of asymmetric induction. 
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1.5 (DHQD)2PHAL Catalysed Halocyclisations 
The phthalazine linked bis(dihydroquinidine) catalyst, (DHQD)2PHAL 112 (figure 
1.14) has recently been developed as an excellent catalyst for halolactonisation, 
bromoesterification, halonium ion induced semi-pinacol and dichlorination reactions.  
It was first synthesised in the 1990’s by Sharpless and co-workers81 as a chiral ligand 
for the OsO4 catalysed dihydroxylation of olefins.  It is now commercially available 
and considered the optimal ligand for this reaction. 
 
Figure 1.14: Structure of (DHQD)2PHAL. 
A detailed study of the mechanism of asymmetric induction in bromolactonisation 
reactions will be discussed in later sections.  However, at first glance it displays many 
similarities to Johnston’s catalyst 109: it is C2-symmetric and contains six basic amine 
sites which will compete for association to halogen sources and H-bond donors.  As 
such, both systems share the same mechanistic ambiguities. 
 
1.5.1 (DHQD)2PHAL Catalysed Chlorocyclisation Reactions 
Borhan and co-workers3 first used (DHQD)2PHAL to promote the asymmetric 
chlorolactonisation of 4-substituted pentenoic acids (114) with generally high 
enantioselectivities (scheme 1.45).  Electron rich alkenes with aliphatic (114d) and 
electron-donating aromatic (114c) substituents led to lower selectivity.  Unusually, the 
reaction was very fast at – 40 ◦C and e.r. was maintained even at 1 mol% catalyst 
loading.  Benzoic acid was used as an additive, but this only resulted in a slight 
increase in enantioselectivity of 115a (91.5:8.5 to 93:7). 
 
  
59 
 
Scheme 1.45: Enantioselective chlorolactonisation catalyst by (DHQD)2PHAL 
(112).3 
Significant evidence was obtained for association between the catalyst and hydantoin 
chlorinating source in the stereo-determining step: when chiral hydantoins (R)- and 
(S)-116 were used separately for the cyclisation of 114a, (S)-116  returned 
chlorolactone 115a with higher e.r. than its enantiomer (R)-116 (91.5:8.5 e.r. and 
84.5:15.5 e.r, respectively).82 
In addition, the 1H NMR spectrum of an equilibrium mixture of (DHQD)2PHAL, 
hydantoin and benzoic acid suggested the formation of a catalyst:hydantoin complex 
(figure 1.16).  The dichlorohydantoin (DCH) protons became diastereotopic upon 
association and their NMR signals split from a singlet into an AB quartet.3   
 
Figure 1.16: Proposed (DHQD)2PHAL:dichlorohydantoin adducts.
3 
  
60 
This may result either through direct catalyst N-chlorination (B) or a H-bonded 
association between DCH and the protonated quinuclidine ring (A).  In the latter case, 
the role of benzoic acid may be to maintain this interaction towards the end of the 
reaction when substrate acid concentration is low.  However, the location and 
importance of the carboxylate anion is not discussed, nor Tang’s observation with a 
similar catalyst75 that pre-mixing the halogen source and catalyst is detrimental to e.r.  
Furthermore, the possibility of dual activation of DCH and substrate on separate 
quinuclidine rings of the dimeric catalysts is not discussed. 
In an elegant subsequent publication, Borhan and co-workers set out to resolve 
several mechanistic questions concerning the stereoselectivity of chlorolactonisation 
of substrate 114a;83 specifically the stereochemical relationship between the 
individual chlorination and cyclisation steps, and the nature of the reactive 
intermediate, i.e. a chloronium ion or a -chlorocarbocation stabilised by the adjacent 
aromatic ring.83 
Chlorolactonisation of the deuterium-labelled isotope 114a-D was performed and the 
ratios of all four possible stereoisomers analysed by 1H NMR and chiral HPLC 
(scheme 1.46).  The facial selectivity of chlorination and lactonisation could be 
determined by the absolute configuration at C6 and C5, respectively. 
 
Scheme 1.46: Bromolactonisation of deuterium-labelled substrate 114a-D catalysed 
by (DHQD)2PHAL, showing the distribution of four possible stereoisomers.
83 
The major chlorolactone, deduced to be (5R, 6R)-115a-D, which is the product of syn-
addition of chlorine and the carboxylic acid group was isolated in 89%, followed by 
its (5S, 6R)-115a-D anti-diastereomer (8.4%).  Isomers with a 6S configuration were 
only 2.6% of the total mixture. 
  
61 
These results suggest that chlorination is highly stereoselective for the pro-R 
enantiotopic face of the alkene which sets the stereochemistry at C6.  The 
intermediate must be a carbenium ion as otherwise cyclisation would necessarily be 
anti-selective.  However, although stereochemical memory at C5 is lost, cyclisation is 
also selective for the pro-R face to give (5R, 6R)-115a-D predominantly.  Similar 
experiments with the t-butyl ester analogue of 114a-D, which can not associate to the 
catalyst via hydrogen bonding gave a much more even mixture of C5 epimers.  This 
suggests that the facial selectivity of cyclisation is determined by the interactions 
between the carboxylic acid and catalyst. 
Borhan has extended this catalyst system to the chlorocyclisation of unsaturated 
amides (figure 1.17).84 Both 5- and 6-membered oxazolines (119 and 117, 
respectively) could be synthesised in high enantioselectivity.  The best results were 
obtained with p-substituted aryl groups on the amide and electron deficient aromatic 
substituents on the alkenes.  
 
Entry R1 R2 Yield (%) e.r. 
1 Ph H 91 99.5:0.5 
2 4-CF3-C6H4 H 94 97.5:2.5 
3 4-CH3O-C6H4 H 84 60:40 
4 Ph Ph 92 93:7 
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Figure 1.17: Substrate scope of enantioselective chlorocyclisation reactions catalysed 
by 112.84 
 
1.5.2 Intermolecular Bromoesterification Catalysed by 
(DHQD)2PHAL 
The same catalyst was employed by Tang and co-workers85 in a highly 
enantioselective intermolecular bromoesterification of allylic sulfonamides with 
benzoic acid and NBS.  Cinnamyl substrates 120 reacted regioselectively, suggesting 
minimal anchimeric assistance by the triflyl amide (scheme 1.47).  Addition of 
stoichiometric (+)-camphor sulfonic acid was found to be mildly beneficial, 
increasing e.r. of 121a from 85:15 to 90:10.  Aliphatic substituents favoured 
formation of the opposite regioisomer 122 with reduced enantioselectivity.   
 
Scheme 1.47: Asymmetric bromoesterification catalysed by (DHQD)2PHAL.
85 
The phthalazine spacer of 112 was found to be crucial for enantioselectivity.  
Structurally related catalysts, (DHQD)2AQN (124) and (DHQD)2PYR (125), 
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possessing anthraquinone and diphenylpyrimidine linkers, respectively, gave 
considerably reduced e.r. (figure 1.18). 
 
 
Figure 1.18: Structures of dimeric quinidine catalysts (DHQD)2AQN and 
(DHQD)2PYR, and results of asymmetric bromoesterification with these catalysts. 
Initial 1H NMR studies of equilibrium mixtures of 112 with reaction components 
resulted in a tentative mechanistic proposal.  It was found that the -styrene proton of 
the substrate H was shielded upon association to the catalyst, from 6.63 to 6.22 ppm 
(figure 1.19).85 Addition of excess (+)-CSA decreased this effect such that in a 1:1:2 
mixture of cat:SM:CSA the chemical shift of H almost returns to its initial value.  
Finally, addition of benzoic acid did not alter the chemical shift.  Separately, NBS 
signals were also found to be shielded in the presence of benzoic acid and 112.  These 
results do not disagree with a working hypothesis that one quinidine unit of the 
dimeric catalyst activates NBS while the other H-bonds to a carboxylic acid, either 
BzOH or (+)-CSA.  The substrate triflimide is proposed to bind with the central 
phthalazine on the basis that other linking groups gave lower e.r.’s, as represented in 
structure 126. 
An alternative mechanistic possibility, not discussed in the paper is that NBS, the 
substrate and CSA bind competitively and reversibly to all catalyst sites.  Each 
permutation may give different enantioselectivity.  The NMR signals reflect relative 
binding strengths of each component.  Weakly acidic benzoic acid can not displace 
the other acids and so does not alter the substrate’s chemical shift.  This mechanism 
will be discussed in detail in chapter 5. 
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Figure 1.19: 1H NMR studies of asymmetric bromoesterification.85 
 
1.5.3 Desymmetrisation by Bromolactonisation Catalysed by 
(DHQD)2PHAL 
The substrate scope of bromolactonisation reactions catalysed by 112 has recently 
been extended to desymmetrisation of dihydrobenzoic acids and alkynoic acids.  In 
early 2013, Hennecke and co-workers86 reported the first example of enantioselective 
bromolactonisation of prochiral alkynoic acids to generate bromo-enol lactones 128 
(scheme 1.48).  Possessing an alkyne, vinyl bromide and quaternary stereocentre, 
these novel products are versatile fragments for synthetic chemistry.  High 
enantioselectivities were maintained for a range of substituents at the alkyne group 
and - to the carboxylic acid. 
 
Scheme 1.48: Desymmetrisation of achiral alkynoic acids with (DHQD)2PHAL.
86 
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A possible stereo-determining transition state consistent with Tang’s63 hypothesis was 
proposed, involving direct bromine transfer from NBS to the catalyst and a hydrogen-
bonding association between the carboxylic acid and the phthalazine nitrogens 
(scheme 1.49).  Evidence for the latter interaction was obtained from a control 
experiment.  Subjection of the potassium carboxylate salt of the substrate 127c to 
reaction conditions returned lactone 128c as a racemate, indicating that H-bonding 
interactions from the acid proton are essential in the enantio-determining step. 
 
Scheme 1.49: Bromolactonisation of potassium salt of 127c catalysed by 
(DHQD)2PHAL; schematic of possible transition state.
86  
Kan et al.16 reported that prochiral cyclohexadienes derivatives undergo regioselective 
bromolactonisation mediated by NBS to generate -lactone products with high 
enantioselectivities dependent on the size and stereochemistry of substituents (scheme 
1.50).   
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Scheme 1.50: Desymmetrisation of dihydrobenzoic acids and alkynoic acids by 
bromolactonisation catalysed by (DHQD)2PHAL.
16 
The authors do not offer a speculative transition state model for asymmetric induction 
but observe many mechanistic similarities with the Tang63 and Hennecke86 systems, 
particularly with respect to the importance of the phthalazine spacer for high e.r.’s.  
Interestingly, the pyrimidine-linked catalyst, (DHQD)2PYR (125), proved superior to 
112 for the single kinetic resolution reported in this paper, despite the structural 
similarities of substrates 130 and 129 (scheme 1.51). 
 
Scheme 1.51: Kinetic resolution of 130 by asymmetric bromolactonisation catalysed 
by (DHQD)2PYR.  The substrate is returned with greater enantio-enrichment than 
product.16 
 
1.5.4 Halonium-Induced Semipinacol Rearrangements Catalysed 
by (DHQD)2PYR 
Tu et al.87 also found that the pyrimidine-linked catalyst 125 was optimal for the 
halonium-ion induced semipinacol rearrangements of tertiary allylic alcohols 132 to 
give -haloketones 133 (scheme 1.52).  As for the catalyst systems described by 
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Yeung, Borhan and Tang, a small enhancement of enantioselectivity was observed in 
the presence of an additive, in this case co-catalytic (D)-N-Boc-phenylglycine.  The 
reaction was optimised in toluene at high concentrations (200 mM), suggesting that 
halonium-ion exchange must not be competitive with migration.  This system offered 
the opportunity to study how the stereo-electronic properties of the nucleophilic 
trapping group, the migrating aryl ring, affects enantioselectivity; the electron density 
of the alkene is varied in most other reactions.  However, very similar trends were 
observed.  Electron-poor aromatics in general gave poor yields presumably to a slow 
rate of migration, whereas electron-donating groups gave near quantitative yields at 
the expense of some enantioselectivity.   
 
Scheme 1.52: Bromonium ion-induced semipinacol rearrangement.87 
 
1.5.5 Enantioselective Dichlorination Catalysed by (DHQ)2PHAL 
Recently, Nicolaou and co-workers reported the first successful system for the 
enantioselective dichlorination of allylic alcohols88 catalysed by (DHQ)2PHAL, the 
pseudo-enantiomer of (DHQD)2PHAL.  This has been a long-sought reaction due to 
its applicability towards the synthesis of poly-chlorinated, bioactive natural products 
such as chlorosulfolipids.89  The particular challenge of this reaction is that even if 
initial alkene chlorination is stereospecific, the regioselectivity of chloride attack must 
also be controlled for high enantioselectivities.90  In the event moderate 
enantioselectivities were obtained for dichlorination of cinnamyl alcohols 135 using 
the hypervalent iodine species 134 as the source of electrophilic chlorine (scheme 
1.53).  The dichlorination reactions were diastereospecific for the anti-isomer, 
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proving the formation of a chloronium ion intermediate.  The authors speculate that 
the hypervalent iodine species coordinates to a quinuclidine ring of the catalyst, 
promoting face-selective alkene chlorination.  The orientation of the olefin is 
determined by  interactions between the aromatic rings of the substrate and 
catalyst, and hydrogen-bonding between the alcohol and phthalazine to afford an 
enantiopure chloronium ion.  This undergoes regioselective, stereospecific 
nucleophilic attack by free chloride to generate products 136.   
 
 
Scheme 1.53: Catalytic asymmetric dichlorination of allylic alcohols.88 
 
1.5.6 Discussion of Dimeric Cinchona Alkaloids as Broadly 
Applicable Catalysts for Halofunctionalisation 
The dimeric cinchona alkaloid (DHQD)2PHAL (112) has emerged as a powerful 
catalyst for enantioselective halofunctionalisation reactions.  It has been used with 
success for bromolactonisation of dihydrobenzoic and alkynoic acids; bromo-
esterification of cinnamyl triflimides; chlorocyclisation of alkene containing 
carboxylic acids and amines; and dichlorination of allylic alcohols.  The catalyst’s 
close relative, (DHQD)2PYR (125), which possesses a di-phenyl pyrimidine spacer 
has proven to efficiently catalyse the kinetic resolution by bromolactonisation of 
dihydronaphthoic acids and the halonium induced semipinacol rearrangement. 
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Although these dimeric cinchona alkaloids are certainly versatile catalysts, their 
mechanism of asymmetric induction is still not fully understood, particularly for 
bromination reactions, which is slowing their further development in new 
applications.  The mechanistic uncertainties can be expressed as follows: firstly, the 
interactions between the catalyst, source of electrophilic halogen and substrate have 
not been well characterised.  Borhan has shown that both DCDMH (113) and the 
carboxylic acid 114a associate to (DHQD)2PHAL in the enantio-determining steps for 
chlorolactonisation (figure 1.16).  Similarly, Hennecke has proven that H-bonding 
between the substrate acid and 112 is essential for enantioselectivity (scheme 1.49).  
However, the site and strength of binding is not known, although several possibilities 
have been proposed.  Borhan suggests that DCDMH may coordinate either by direct 
N-chlorination or by H-bonding to quinuclidine protonated by a carboxylic acid.  For 
bromo-esterification, Tang suggests direct N-bromination at quinuclidine and 
substrate association at phthalazine.  However, the limited supporting evidence is 
based on: 1H NMR analysis of equilibrium mixtures which show that substrate 
chemical shifts are perturbed in the presence of the catalyst; and the influence of the 
linker structure on enantioselectivity.   
Elucidation of these interactions appears complicated by several structural features of 
the catalyst.  (DHQD)2PHAL possesses six basic sites which could all function as 
Lewis or Bronsted bases.  The propensity of each site towards association of 
carboxylic acids or halogens is presumably influenced by its pKaH, the catalyst’s 
conformation – quinidine catalysts have several accessible conformational states (see 
chapter 5) – and its binding cooperativity. This factor is a general property of poly-
topic molecules, where association of the first ‘guest’ can alter subsequent binding 
constants, similar to allosteric binding in proteins (see section 5.10). 
The second mechanistic ambiguity relates to the mechanism and stereoselectivity of 
halogen transfer from the original source to the alkene.  Borhan has proven that 
alkene chlorination is highly face selective, but the relative stereoselectivities of 
bromination and nucleophilic attack are not known for bromo-functionalisation 
reactions.  The role of the succinimide anion in the enantio-determining step, and the 
reversibility of the halogenation step have also not been resolved.  Similarly, it is 
unclear whether bromonium ion exchange is competitive with nucleophilic trapping. 
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Several groups have explored the use of acidic additives in asymmetric halogenation 
reactions catalysed by (DHQD)2PHAL.  In most cases there is a modest enhancement 
of enantioselectivity.  Borhan proposed that additives alter the H-bonding properties 
of the catalyst, allowing it to function as a H-bond donor, although the exact 
mechanism is currently unclear.  However, additives represent an interesting strategy 
for tuning the catalyst’s properties without the necessity for synthetic modification.  
All these points will be discussed in more detail later in this thesis. 
 
1.6 Conclusion 
The recent organocatalytic systems for enantioselective halofunctionalisation build on 
over a century of research on halogenation reactions, which have highlighted the 
complex chemical properties of halonium ions and potential challenges towards 
development of the asymmetric variant.  An important early milestone was Olah and 
Bollinger’s analysis of the propensity of each halogen towards halonium ion 
formation, relative to the carbenium ion resonance form.  This research demonstrated 
that chlorine and fluorine do not generally form halonium ions, suggesting that high 
stereoselectivity in chlorination/fluorination reactions could be hampered by poor 
diastereoselectivity and side-reactions caused by carbocations.  Indeed, chlorination 
reactions commonly give lower yields or require lower temperatures compared to 
bromination and iodination. 
The major challenge towards successful asymmetric bromo- and iodo-
functionalisation reactions is suppression of halonium ion transfer between alkenes.  
Brown and Fraser-Reid discovered that bromonium and iodonium ions undergo 
degenerate exchange between alkenes at a rate often competitive with nucleophilic 
capture.  This implied that enantiopure halonium ions would be configurationally 
unstable, as was later confirmed by Denmark.   
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In this review, current asymmetric methods for alkene halogenation have been 
categorised according to their strategy for overcoming these challenges.  Many 
catalysts possess a Lewis basic or anionic functional group which coordinates the 
halogen atom, preventing close approach of other alkenes.  In other examples, the 
primary objective of catalyst design has been to control the facial selectivity of the 
nucleophilic trapping step.  However, most systems combine elements of both 
strategies using bi-functional organocatalysts.    
In conclusion, the field of asymmetric olefin halofunctionalisation is a vibrant and 
rapidly expanding field.  The reaction can now be achieved with a wide range of 
nucleophiles and all four halogens.  Promising catalyst systems have emerged based 
on privileged scaffolds such as cinchona alkaloids and axially chiral binaphthyl 
phosphoric acids.  These achievements are only beginning to be applied by the 
synthetic community to a diverse range of novel structures and halogenated natural 
products.  However, there is still significant potential for improvement.  Many 
catalysts are applicable to a narrow substrate range and novel catalyst design still 
appears to be based on trial and error.  This is undoubtedly due to lack of mechanistic 
data, although at the current rate of publications, it is likely that this will be resolved 
soon. 
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1.7 Project Aims 
 
The objective of this project has been to elucidate the mechanisms of organocatalytic 
asymmetric halofunctionalisation systems.  This work was considered necessary for 
determining the limitations of current methods, and for the rational development of 
broadly applicable, highly enantioselective catalysts. 
Initially, Borhan’s (DHQD)2PHAL:benzoic acid system was chosen for study for 
several reasons: the catalyst is commercially available, and so the system may be 
considered an ‘off-the-shelf’ method for enantioselective halofunctionalisation.  In 
addition, there is extensive literature on general cinchona alkaloid catalysis, providing 
an existing framework in which to build our research. 
At the start of the project, the substrate scope for this catalyst was limited to 
chlorolactonisation of 114 and dichlorination of allylic alcohols, which left significant 
potential for development to other substrate classes and halogens.  Furthermore, 
Borhan3 observed that bromolactonisation of 114 using NBS and catalysed by 
(DHQD)2PHAL returned bromolactone 135 with only 67.5:32.5 e.r. (scheme 54). 
 
Scheme 1.54: Bromolactonisation of 114 catalysed by 112 proceeds with poor 
enantioselectivity. 
We therefore decided that a pertinent research approach was to optimise this 
bromolactonisation reaction through a detailed mechanistic study, and subsequently to 
extend the scope of this system to several novel substrate classes.  This thesis 
describes the efforts towards these goals. 
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1.8 Thesis Outline 
Initially, experimental results towards optimisation of enantioselectivity in the 
bromolactonisation of 114 will be discussed.  These experiments involve analysis of 
the influence of reaction variables such as solvent, temperature, catalyst loading and 
halogen source on product e.r.  Furthermore, the ability of carboxylic acid additives to 
alter the hydrogen-bonding properties and catalytic performance of (DHQD)2PHAL is 
explored.  A broad substrate screen including several novel substrate classes will also 
be performed, determining the applicability of the catalyst system. 
The mechanistic uncertainties to be addressed are as follows:  
a) Are bromination and cyclisation steps stereoselective, and which is enantio-
determining? This point may be answered from the results of the substrate screen; by 
comparing the absolute configurations of the products, analysis of the 
diastereoselectivity of bromolactonisation and comparison with Borhan’s 
chlorolactonisation. 
b) Does the intermediate bromonium ion racemise due to exchange between alkenes?  
This can be clarified by competition experiments analogous to those performed by 
Rodebaugh and Fraser-Reid 32 (section 1.2.3). 
c) How do substrates/NBS interact with the catalyst? The association of carboxylic 
acids to (DHQD)2PHAL are studied by crystallographic and equilibrium 
1H NMR 
analysis, giving detailed conformational information of catalyst:acid complexes and 
quantitative measurement of binding constants.  The conclusions drawn from this 
work lead to the design, synthesis and testing of conformationally constrained catalyst 
derivatives which are proposed to catalyse bromolactonisation with greater 
enantioselectivity than (DHQD)2PHAL.  Ternary mixtures of non-reacting carboxylic 
acids, NBS and the catalyst are also studied at equilibrium using 1H NMR. 
d) What role do carboxylic acid additives play in halofunctionalisation systems? The 
influence of additive pKa and concentration on asymmetric induction and rate is 
examined.  Since both substrates and additives are carboxylic acids, the 1H NMR 
analysis outlined above also provides detailed information on additive effects. 
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2 Results and Discussion 
2.1 Investigation of Borhan’s Asymmetric Halolactonisation 
Reaction 
 
As discussed in the previous section, the initial objective of this project was to 
optimise the enantioselectivity of bromolactonisation catalysed by (DHQD)2PHAL. 
Several strategies were considered: to assess the ability of different solvents to 
increase product e.r. by optimisation of intermolecular interactions between the 
substrate and catalyst; to determine the influence of carboxylic acid additives; and to 
suppress possible bromonium ion stereorandomisation via alkene-alkene exchange. 
 
This work was performed using Borhan’s original substrate, 4-phenyl-4-pentenoic 
acid (114).3  This has been frequently used as a model substrate for 
halofunctionalisation reactions because it cyclises regioselectively for the 5-exo 
product 135, which is also UV active, facilitating chiral HPLC analysis.  114 was 
synthesised in two steps from commercially available methyl 4-oxo-4-phenyl butyrate 
(136) via Wittig olefination and ester hydrolysis in high yields (scheme 2.1).38 
 
 
Scheme 2.1: Synthesis of 4-phenyl-4-pentenoic acid (114). 
 
Initially, several chlorolactonisation reactions of 114 were performed at variable 
temperatures using dichlorodimethyl hydantoin (113) and 10 mol% (DHQD)2PHAL, 
in order to determine the effect of temperature on product yield and e.r., and to 
confirm the reproducibility of this reaction (table 2.1).    
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Table 2.1: Results of initial chlorolactonisation experiments. 
 
Entry T (◦C) Time (min.)a Yield (%)b e.r. c 
1 40 180 88 93:7 
2 0 70 82 90.5:9.5 
3 25 30 71 82:18 
a Reaction time judged by TLC. a Isolated yield after column 
chromatography. c As judged by chiral HPLC analysis. 
 
The reaction at 40 ◦C (entry 1) gave identical results to those published by Borhan.3  
Increasing the temperature (entries 2-3) accelerated the reaction rate but was 
detrimental to enantioselectivity.  Analysis of the crude reaction mixture at reaction 
completion by 1H NMR spectroscopy showed that despite complete substrate 
conversion, the chlorolactonisation reactions proceeded with formation of several side 
products, accounting for ~7-10% of the mass balance.  It was not possible to fully 
characterise these by-products due to the low concentration of each, and the 
complexity of the spectra.  However, the presence of singlet resonances at 5.3 and 6.3 
ppm suggested the formation of allyl and vinyl chlorides shown in figure 2.1 which 
are consistent with a carbocation intermediate. 
 
 
Figure 2.1: Side products in chlorolactonisation reaction. 
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2.2 The Additive Effect of Benzoic Acid on Asymmetric 
Halolactonisation 
 
Acidic additives have been used in several halogenation reactions with varying effects 
on enantioselectivity and rate (see introduction).  In particular, Borhan found that 
stoichiometric benzoic acid is mildly beneficial to the enantioselectivity of 
chlorolactonisation of 114 using (DHQD)2PHAL.
3  Its effect on bromolactonisation 
was not explored.  Johnston also showed that the asymmetric induction of 
iodolactonisation using dimeric poly-basic catalyst 109 could be significantly 
improved in the presence of co-catalytic strong acid (scheme 1.44).80 Consequently, 
the effect of benzoic acid on bromo- and iodolactonisation reactions of 114 catalysed 
by (DHQD)2PHAL was determined.  N-bromosuccinimide (NBS) and N-
iodosuccinimide (NBS) were used as the respective electrophilic halogen sources.    
Borhan’s original chlorolactonisation reaction was also repeated in the presence of 
one equivalent benzoic acid for direct comparison to literature results.3  The results 
are shown in table 2.2.   
 
Table 2.2: Additive effect with electrophilic halogen sources 
 
Entry X+ source Additive Product Yield (%)b e.r.c 
1 DCDMH - 115 85 92.5:7.5 
2 DCDMH benzoic acid 115 86 94.5:5.5 
3 NIS - 135 94 57:43 
4 NIS benzoic acid 135 94 50:50 
5 NBS - 137 92 63:37 
6 NBS benzoic acid 137 95 80:20 
 a  Isolated yields after chromatography.  b e.r. determined by 
chiral HPLC analysis.   
 
As previously observed, benzoic acid had little effect on the enantioselectivity of 
chlorolactonisation (entries 1-2).3  The additive was also detrimental to the 
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iodolactonisation reaction returning essentially racemic products (entries 3-4).  
However, benzoic acid significantly increased the enantioselectivity of 
bromolactonisation from 64:36 to 80:20 e.r. (entries 5-6).  Higher yields were also 
obtained relative to the analogous chlorolactonisation reactions with no by-product 
formation. 
 
The absolute stereochemistry of bromolactone 135 was determined by radical de-
bromination using AIBN and Bu3SnH, and comparison of the optical rotation of 
known compound 138 to literature data (scheme 2.2).3  This confirmed the C5 
configuration to be (S)-135.  Curiously, this is the opposite enantiomer to the 
chlorolactone 115 produced with the same catalyst and DCDMH (113) as the source 
of electrophilic chlorine.3 
 
 
 
Scheme 2.2: Determination of absolute configuration of bromolactone 135. 
 
These experiments highlight the difference in reactivity of the halogens.  The unique 
effects of benzoic acid on the rate and selectivity of bromolactonisation are unknown 
to the best of our knowledge, and the majority of this report describes our efforts to 
understand this effect and further optimise the reaction. 
 
 
2.3 Optimisation of Asymmetric Bromolactonisation 
Reaction Conditions 
 
The discovery of this additive enhancement prompted a mechanistic investigation 
with the aim of maximising enantioselectivity.  The parameters examined were the 
reaction temperature, solvent, dilution and catalyst concentration.  A screening of 
commonly used quinidine organocatalysts was also performed (section 2.3.6).  
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However, the most relevant approach towards elucidation of the additive effect was to 
examine how the stereoelectronic properties and concentration of carboxylic acid 
additives influenced enantioselectivity. 
 
 
2.3.1 Influence of Additive Concentration on Enantioselectivity of 
Bromolactonisation 
 
The correlation between additive concentration and enantioselectivity was first 
examined.  Six bromolactonisation reactions of 114 with different concentrations of 
benzoic acid were carried out in 1:1 CHCl3:hexane (figure 2.2).   
 
 
Entry Benzoic acid (mol%) e.r. 135b 
1 0 64:36 
2 23.9 74:26 
3 55.2 77:23 
4 83.1 79:21 
5 108.5 79:21 
6 243 80:20 
b e.r. determined by chiral HPLC analysis.   
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Figure 2.2: Effect of benzoic acid concentration on enantioselectivity.  Data 
represented in graph is given in table. 
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Without benzoic acid (entry 1), 135 was isolated with an enantiomer ratio of 64:46 
which increases to 80:20 at ~100 mol%, or ten equivalents relative to the catalyst 
(entries 2-5).  Above this point a saturation value (80:20 e.r.) is maintained.   It is 
important to note that the total concentration of acid in the reaction mixture is not 
constant, but decreases as the reaction progresses, and the substrate acid is consumed.  
These experiments suggest two interpretations: that there is a correlation between 
total acid concentration and enantioselectivity, and specifically that below a certain 
saturation concentration asymmetric induction is diminished.  Another possibility is 
that the additive’s stereoelectronic properties enhance the catalyst’s performance 
through intermolecular interactions; thus conferring greater enantioinduction relative 
to the reaction with only substrate.   
 
The most direct test of the former hypothesis was to measure the change in e.r. with 
conversion for a bromolactonisation reaction in the absence of additive.  Under these 
conditions, acid concentration decreases towards zero towards the end of the reaction, 
and should therefore fall well below the saturation concentration. 
 
2.3.2 Monitoring Change in Enantioselectivity with Conversion 
 
In order to determine whether enantioselectivity varied with substrate conversion, 
bromolactonisation reactions of 114 were performed in the presence and absence of 
benzoic acid.  Samples were withdrawn regularly from each experiment, quenched 
with aqueous sodium sulphite and submitted for HPLC analysis to measure how 
product e.r. varied with time (figure 2.3).   
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a For each data point, reaction aliquot was withdrawn and quenched with sat. aq. Na2SO3; b e.r. 
determined by chiral HPLC analysis; b as determined by 1H NMR analysis of crude mixture. 
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Figure 2.3: Enantiomer ratio of 135 decreases over time in the absence of benzoic 
acid.  
 
The graph shows that in the absence of benzoic acid (blue points), enantioselectivity 
decreases over the course of the reaction (70:30 to 64:36) as the substrate is 
consumed.  It provides good supporting evidence for the interpretation that e.r. 
changes with total acid concentration.  An alternative explanation was also 
considered: that the reaction adopts thermodynamic control such that product 
formation becomes reversible and e.r. converges toward a racemic mixture at 
equilibrium.  However, resubmission of enantio-enriched bromolactone 135 (80:20 
e.r.) to the reaction conditions showed no change in e.r. within 2 hours, so this 
interpretation could be ruled out. 
 
A similar sampling experiment was performed in the presence of 100 mol% benzoic 
acid (yellow points, figure 2.3).  Samples were withdrawn after 2, 3, 5 and 8 minutes, 
Experiment 1: 100 mol% benzoic acid 
Entry Time (min)a e.r.b 
1 2 81.5:18.5 
2 3 82:18 
3 5 81.5:18.5 
4 8 (92% conversion)c 81:19 
Experiment 2: no benzoic acid 
Entrya Time (min)a e.r.b 
1 2 70:30 
2 5 66:34 
3 8 63:37 
4 15 (97% conversion) c 63:37 
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at which point conversion was measured by 1H NMR analysis of the quenched 
mixture to be 92%.  In this case enantioselectivity is maintained at around 80:20 e.r. 
throughout the reaction and total acid concentration never decreases below 100 mol%.   
 
It is also notable that poorer enantioselectivity is obtained in the absence of an 
additive, even towards the beginning of the reaction when substrate concentration is 
large: at two minutes product e.r. in experiment 1 was 81.5:18.5 but only 70:30 for 
experiment 2.  This observation suggests that the structure (in the general sense of 
stereoelectronic properties) of the carboxylic acid additive is also important in 
determining the degree of asymmetric induction. 
 
In conclusion, these initial experiments offered several insights to the origin of 
enantioselectivity in the presence of acid additives.  It was inferred that the degree of 
asymmetric induction is dependent on both the structure of the additive and the total 
concentration of acid in the medium; at large excesses of carboxylic acid (relative to 
the catalyst) a constant e.r. is maintained over the course of the reaction, but its 
magnitude is dependent on the acid’s structure.   
 
Our next step was to determine how the electronic properties of additives (i.e. pKa) 
influenced enantioselectivity. 
 
 
2.3.3 Acid Additive Screening 
 
The bromolactonisation reaction was performed separately with 17 protic additives 
over an aqueous pKa range of 0 to 14, as shown in figure 2.4. 
 
 
Entry Additive a pKaa Yield (%) 135b e.r. 135c 
1 -  92 63:37 
2 H2O 15.7  64.5:35.5 
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3 4-bromophenol 9.4  65:35 
4 CH3CO2H 4.76 96 67:33 
5d  Substrate 114 4.63 93 72:28 
6 2,6-naphthalene dicarboxylic acid 4.51  68.5:31.5 
7 4-MeOC6H4CO2H 4.47 94 70:30 
8 C6H5CO2H 4.20 95 80:20 
9 1-Naphthoic acid  4.17  75:25 
10 2-Naphthoic acid  4.14  77:23 
11 3-PhC6H4CO2H  4.14  78:22 
12 4-FC6H4CO2H 4.14 94 79:21 
13 4-CF3C6H4CO2H  3.69 96 83:17 
14 9-Anthroic acid 3.65 78 84:16 
15 4-NO2C6H4CO2H  3.44 93 80:20 
16 4-NCC6H4CO2H  3.55 93 83:17 
17 CH2(CO2H)2  2.83 86 0 
18 CF3CO2H 0.23 92 0 
19 HNTf2 (10 mol%) 10.4 89 64:36 
 a Aqueous pKa values. 
b Isolated yield after chromatography; where blank, yield not 
measured. c e.r. determined by chiral HPLC analysis. d 2 equivalents of substrate were 
used. 
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Figure 2.4: Influence of additive pKa on the enantioselectivity of 
bromolactonisation. 
 
Several important trends are visible.  Weak acid additives such as water (64.5:35.5 
e.r., entry 2) and bromophenol (65:35 e.r., entry 3) have little effect on e.r. relative to 
the reaction with no additive (63:37 e.r., entry 1).  Acetic acid returned a slightly 
improved e.r. of 67:33 (entry 4), and the use of excess substrate 114 (entry 5) 
increased e.r. to 70:30 e.r.   However, aromatic carboxylic acids resulted in the most 
significant and beneficial increases in e.r.91  Within the narrow pKa range between 3.4 
and 4.5, there is a general increase in enantioselectivity with stronger acids, although 
this correlation is not perfect (e.g. 4-trifluoromethyl- and 4-nitro- benzoic acids, 
  
83 
entries 13 and 15).  The highest enantioselectivity was produced by anthroic acid 
(84:16 e.r., entry 14), but small quantities of 9-bromoanthracene generated in the 
reaction mixture via ipso-bromination and decarboxylation decreased isolated yields 
and often co-eluted with the product in subsequent chiral HPLC analysis.  
Consequently, benzoic acid was maintained as the additive of choice in future 
reactions as it offers high asymmetric induction, it is readily available and there are no 
practical complications. 
 
Strong acids, such as malonic acid and TFA (entries 17 and 18) suppressed all 
enantioselectivity and returned bromolactone 135 as a racemate.  Donohoe et al. 
observed a similar effect in the presence of TFA for an asymmetric dihydroxylation 
reaction catalysed by OsO4 and (DHQD)2PHAL.
92 The strong acid had originally 
been added to trigger a proton-induced cyclisation after dihydroxylation (scheme 2.3).  
The suppression of asymmetric induction was suggested to be due to irreversible 
binding of TFA to the quinuclidine nitrogens, preventing coordination of OsO4. 
 
 
Scheme 2.3: Presence of strong acids such as TFA also prevent (DHQD)2PHAL 
binding to osmium tetroxide.92 
 
Similarly, association of the substrate carboxylic acid to the catalyst may likewise be 
prevented, such that only the unselective background reaction takes place.  Some 
enantioselectivity can be restored by lowering the concentration of strong acid, as in 
entry 19 where 10 mol% of triflimide (pKa = 10.4) returned 135 in 64:36 e.r.  This 
suggests that exchange processes between carboxylic acids and the catalyst are 
essential for enantioselectivity. 
 
Comparison of additive pKa’s to pKaH values for quinuclidine, quinoline and 
phthalazine basic sites in (DHQD)2PHAL
93 (figure 2.5) certainly suggest that acids 
will H-bond most strongly to quinuclidine.  However, (DHQD)2PHAL is a poly-basic 
compound and it is possible that association of the first acid significantly changes 
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binding affinity at the other sites, due to conformational changes or in order to prevent 
build-up of positive charges on the catalyst.94 It is indicative that the pKaH of free 
quinuclidine (10.9) is two orders of magnitude greater than quinidine. 
 
 
Figure 2.5: pKaH of quinidine; the given pKaH values of quinoline and phthalazine are 
those of the free heterocycle. 
 
Replotting the data with acetonitrile pKa values which are more representative of the 
actual dissociation constants in the non-polar chloroform:hexane solvent mixture gave 
the same trend (figure 2.6).  However, it is noteworthy that the difference in pKa 
between quinuclidine (pKa = 23.6) and benzoic acid (pKa = 20.6) is much lower in 
acetonitrile relative to water, suggesting that acid-base association is actually much 
weaker in non-polar aprotic solvents.   
 
Entry Additive a pKa (MeCN)a Yield (%) 135b e.r. 135c 
1 -  92 63:37 
3 CH3CO2H 22.3 96 67:33 
6 4-MeOC6H4CO2H 21.1 94 70:30 
7 C6H5CO2H 20.6 95 80:20 
10 3-PhC6H4CO2H  20.2  78:22 
11 4-FC6H4CO2H 20.4 94 79:21 
12 4-CF3C6H4CO2H  19.5 96 83:17 
14 4-NO2C6H4CO2H  19.1 93 80:20 
15 4-NCC6H4CO2H  19.3 93 83:17 
17 CF3CO2H 12.7 92 0 
a Acetonitrile pKa values. 
b Isolated yield after chromatography; where blank, 
yield not measured. c e.r. determined by chiral HPLC analysis. d 2 equivalents of 
substrate were used. 
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Figure 2.6: Influence of acetonitrile pKa values on enantioselectivity of 
bromolactonisation. 
 
The additive screening results suggest that H-bonding association between the catalyst 
and carboxylic acid groups is essential for enantioselectivity.  Asymmetric induction 
can be enhanced further when there is fast exchange between substrate and additive 
molecules bound to catalyst, as shown in figure 2.7. 
 
 
 
Figure 2.7: Complexes formed by competitive association of carboxylic acids to 
(DHQD)2PHAL may catalyse bromolactonisation with different enantioselectivity; 
SM = substrate 114, BzOH = benzoic acid. 
 
Assuming a prevalent 1:2 (DHQD)2PHAL:acid stoichiometry, it is possible that each 
complex A and B catalyses the reaction with a different enantioselectivity.  In this 
hypothesis, the presence of additive increases the proportion of complex B, 
particularly towards the end of the reaction when substrate concentration is 
diminished.  Further evidence for this proposal and an explanation of why type B 
complexes may be more enantioselective than type A are discussed in chapter 5. 
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2.3.4 Influence of Temperature on Enantioselectivity 
 
Many catalytic asymmetric reactions show an inverse temperature dependence of 
enantioselectivity because proportionately fewer molecules have sufficient energy to 
overcome the higher energy barrier towards the minor enantiomer.95  Therefore the 
bromolactonisation of 114 using benzoic acid was performed at five different 
temperatures between rt and 78 ◦C (table 2.3).  In the event the original reaction 
conditions (20 ◦C, entry 3) proved to be optimal, as lowering the temperature further 
was detrimental to e.r.  At 78 ◦C, 135 was isolated with only 63:37 e.r. (entry 5).   
This is due to the insolubility of benzoic acid at low temperatures, as separate 
solubility experiments indicated that benzoic acid is insoluble in 1:1 CHCl3:hexane 
below 30 ◦C.  Other factors in this conclusion can be ruled out as the value of e.r. 
never falls below that obtained in the absence of benzoic acid (63:37 e.r.).  Therefore 
it appears that a balance is struck at 20 ◦C between improved selectivity and 
decreasing additive solubility. 
   
Table 2.3: Effect of temperature on enantioselectivity. 
 
Entry 
T 
(˚C) 
Yield 
(%)a 
e.r.b 
1 20 96 78:22 
2 0 96 78:22 
3 -20 95 80:20 
4 -40 95 75:25 
 5c -78 96 67:33 
a Isolated yield after chromatography. b e.r. 
determined by chiral HPLC analysis. c Reaction 
time is 2.5 h. 
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2.3.5 Influence of Catalyst Loading On Enantioselectivity 
 
Organocatalytic reactions typically require 1 to 20 mol% catalyst loading, generally 
greater than organometallic catalysts.96 Catalyst concentration directly influences 
reaction rate, but can also affect enantioselectivity in a number of ways: a) greater 
applied amounts of catalyst may increase e.r. by enhancement of the rate of catalysed 
reaction relative to the unselective background reaction when the two are otherwise 
competitive; b) catalyst aggregation is strongly dependent on concentration and the 
formation of dimers or oligomers is known to alter selectivity in several cinchona-
alkaloid catalysed reactions;64, 97 c) Gröger et al.98 have shown that high catalyst 
concentrations can induce a switch from initial kinetic control to thermodynamic 
control whereby product formation becomes reversible.  In this situation, the product 
e.r. is observed to diminish with conversion, as there can be no asymmetric induction 
when the system reaches equilibrium. 
 
Accordingly, several bromolactonisation reactions were conducted at catalyst 
loadings between 0.01 and 20 mol% (table 2.4).  Enantioselectivity and reaction 
conversion after one hour were constant within the range 5 to 20 mol% (entries 1-3) 
suggesting that catalyst aggregation is not relevant to this system (see section 5.4), 
and that the reaction remains under kinetic control.  However, enantioselectivity 
began to erode below 5 mol% loading and at 0.01% equivalent to 100 ppm, 64:36 e.r. 
was obtained and full conversion took 2.5 hours instead of one hour.  In practice, the 
most efficient catalyst loading is a balance between the preference for short reaction 
times and high enantioselectivity.  Therefore, future experiments were conducted with 
10 mol% catalyst as the reaction was complete in only 15 minutes (as determined by 
1H NMR analysis of crude mixture at this time). 
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Table 2.4: Enantioselectivity of bromolactonisation at various catalyst loadings. 
 
Entry mol% cat.  
Yield 
(%)a 
e.r.b 
1 20 95 80:20 
 2 10 96 80:20 
3 5 - 80:20 
4 1 92 76:24 
5c 0.1 94 72:28 
6c 0.01 94 64:36 
a Isolated yield after chromatography. c e.r. 
determined by chiral HPLC analysis. d Reaction time 
is 2.5 h. 
 
2.3.6 Screening Catalysts for Bromolactonisation of 114 
 
A range of commercially available cinchona alkaloid catalysts were screened in the 
bromolactonisation of 114 (table 2.5).  At this stage, the structural features of the 
catalyst essential for asymmetric induction were unclear.  We were interested in 
determining the importance of the linker and the dimeric motif.  Accordingly, the 
commercially available anthraquinone-linked bis-dihydroquinidine catalyst 
(DHQD)2AQN
99 (124, entry 1) was screened and returned lactone 135 in a much 
reduced 58:42 e.r.  The pseudoenantiomeric catalyst, (DHQ)2PHAL, based on a 
dihydroquinine scaffold was less enantioselective than (DHQ)2PHAL, giving 67:33 
e.r.  Monomeric O9-phenanthryl (139, entry 3) and quinoline (140, entry 4) ethers 
gave identical enantioselectivity (58:42 e.r.), whereas the parent alkaloid 
dihydroquinidine (141, entry 5) gave a racemic mixture.  From these initial results, it 
can be tentatively concluded that the free O9-hydroxyl group is significantly 
detrimental to e.r., and that the dimeric structure is not intrinsically beneficial, but in 
particular the phthalazine linker is essential for high asymmetric induction.   
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Table 2.5: Results of catalyst screening experiments. 
 
 
 
Entry Catalyst e.r.a  
1 124 58:42 
2 139 58:42 
3 140 58:42 
4 141 50:50 
5 (DHQ)2PHAL 67:33 
a e.r. determined by chiral HPLC analysis. 
 
2.3.7 Influence of Reaction Solvent 
 
It is possible to identify some of the optimal solvent properties for enantioselective 
organocatalytic halogenation reactions from literature reports.  Most commonly, 
chlorinated solvents have been used e.g. dichloromethane,9 chloroform,85 carbon 
tetrachloride87 as well as their mixtures with other non-polar solvents such as hexane 
and toluene.66, 78  Fujioka observed the highest e.r. for bromolactonisation with tris-
amidine catalyst 99 in pure toluene (scheme 1.41).76  In addition to having a low 
dielectric constant, all these solvents are also poor H-bond acceptors and donors 
(except chloroform), perhaps so that they do not interfere with acid-base equilibria 
between catalyst and substrate.100  It is also essential that the solvents have 
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sufficiently low melting point to allow reaction at – 20 ◦C (precluding the use of 
benzene and 1,4-dioxane), and of course that the solvent does not react with any 
reaction component.   
 
A screen of nine solvent systems was performed to ascertain the optimal solvent 
conditions for the (DHQD)2PHAL-benzoic acid catalyst system (figure 2.8).  No 
conversion was observed in methanol (entry 1), as the solvent was competitively 
oxidised by NBS.101  For this reason the reaction was also not attempted with ethereal 
solvents e.g. THF or diethyl ether.  It was found that solvents with a low dielectric 
constant gave higher enantioselectivity (entries 2-5), which was maximised in toluene 
with 91:9 e.r. (entry 6), as shown in the graph in figure 2.8.     It was not possible to 
decrease solvent polarity further to e.g. hexane as all the reaction components were 
insoluble, and a 1:1 mixture of toluene:cyclohexane (entry 7) gave an identical value 
to pure toluene.  The lower enantioselectivity obtained in 1:1 toluene:chloroform 
(entry 8) suggested that chloroform may in fact disrupt some of the catalyst:substrate 
intermolecular interactions maximised in toluene. 
The optimised enantiomer ratio (91:9 e.r.) is now comparable to values obtained for 
this substrate with other organocatalytic bromolactonisation systems, such as those 
reported by Yeung65 (95:5) and Martin78 (86:14).  Consequently, toluene was selected 
as the solvent of choice for subsequent reactions. 
 
Entry Solvent System Dielectric constanta  Yield (%) 135b e.r. 135c 
1 MeOH 33 0 n/a 
2 ClCH2CH2Cl 10.4 91 65:35 
3 PhCl 5.6 86 78:22 
4 CHCl3 4.8 94 80:20 
5 CHCl3:hexane (1:1) - 95 80:20 
6 Toluene 2.4 95 91:9 
7 Toluene:cyclohexane (1:1) - 93 91:9 
8 Toluene:CHCl3 (1:1) - 89 85:15 
a Ref. for dielectric; b Isolated yield after chromatography; e e.r. determined by chiral HPLC analysis. 
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Figure 2.8: Enantioselectivity for bromolactonisation of 114 in different solvent 
mixtures. 
 
2.3.8 Additive Effect in Toluene 
 
The bromolactonisation of 114 in toluene in the absence of benzoic acid returned -
lactone 135 in 87:13 e.r. (figure 2.9, entry 1), a much smaller decrease compared to 
the reaction in 1:1 CHCl3:hexane (80:20 e.r. with benzoic acid and 64:36 e.r. without).  
Initially this suggested that the optimal pKa range had not been found.  It was known 
from the analogous experiments in CHCl3/hexane that after maximum e.r. has been 
obtained, enantioselectivity decreases rapidly with stronger acids due to non-
competitive binding between carboxylic acids to the catalyst (section 2.3.3). Twelve 
aromatic carboxylic acids and acetic acids were accordingly screened within the 
narrow pKa range from acetic acid (4.8), where the e.r. (88:12, entry 2) was almost 
identical to the reaction with no additive, to 2-nitrobenzoic acid (2.2) which returned 
135 as a racemate (entry 13).  In order to achieve this, several ortho-substituted 
benzoic acids were required.  In order of decreasing pKa, 4-methoxybenzoic acid 
(87:13 e.r., entry 3) gave similar enantioselectivity to acetic acid, whereas there was a 
slight increase with benzoic and 2-naphthoic acids (entries 4 and 5, respectively).  The 
optimal additive was 4-trifluoromethyl benzoic acid (93:7 e.r., entry 7), whereas 2-Me 
BzOH with an identical pKa only gave 90:10 e.r. (entry 6).  This suggests that the 
steric bulk of the ortho-substituents may be detrimental to e.r.  Inductively 
withdrawing 2-halosubstituted benzoic acids also reduced enantioselectivity (entries 
9-11) and below pKa 2.3 (entry 12) asymmetric induction began to fall rapidly.  
Although it appears initially that the correlation between e.r. and pKa is much weaker 
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in toluene, this is probably due to a balance between the steric effects of ortho-
substituents and pKa.  The beneficial effect of stronger acids is still noticeable.  For 
example, sterically similar 2-methyl (entry 6) and 2-trifluoromethyl (entry 9) benzoic 
acids with  pKa = 0.5 give markedly different enantioselectivities (82:18 and 90:10, 
respectively).   
 
Entrya Additive b pKac e.r. 135e 
1 - - 87:13 
2 CH3CO2H 4.76 88.5:11.5 
3 4-MeOC6H4CO2H 4.47 87:13 
4 C6H5CO2H 4.20 91:9 
5 2-Naphthoic acid  4.14 89:11 
6 2-MeC6H4CO2H  3.70 90:10 
7 4-CF3C6H4CO2H 3.69 93:7 
8 2-CF3C6H4CO2H 3.20 82:18 
9 2-FC6H4CO2H 3.14 85:15 
10 2-ClC6H4CO2H 2.92 87:13 
11 2,4-Cl2C6H4CO2H 2.65 87:13 
12 2,6-F2C6H4CO2H 2.30 61:39 
13 2-NO2C6H4CO2H 2.16 50:50 
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Figure 2.9: Influence of additive pKa on the enantioselectivity of 
bromolactonisation in toluene. 
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2.4 Does Bromonium Ion Racemise Due to Alkene-Alkene 
Exchange? 
 
In the introduction it was outlined that bromonium and iodonium ions are 
prone to exchange between alkenes in a fast, bimolecular reaction (section 
1.2.3).  Denmark demonstrated36 that when this process is competitive with 
nucleophilic capture, the enantiomer ratio of a scalemic bromonium ion may 
be significantly eroded (section 1.2.4). 
 
We considered that the imperfect enantioinduction of 
(DHQD)2PHALcatalysed bromolactonisation may be due to this effect.  On 
the other hand, it must be noted that a racemic bromonium ion (the 
consequence of reversible bromination) may not be detrimental to e.r. if the 
subsequent lactonisation step is highly stereoselective.  We believed that this 
point required clarification in order to gain further mechanistic understanding 
of this reaction.   
 
Fraser-Reid and Rodebaugh32-33 devised an elegant experiment for measuring 
the extent of bromonium ion-alkene exchange: two substrate alkenes 
possessing an intramolecular nucleophile, which react individually with NBS 
at similar rates, are subjected together to reaction conditions with insufficient 
NBS (scheme 1.13).  Whereas it may be expected that the product ratio 
reflects the individual rate constants, it is found that the ratio is significantly 
skewed towards the product of the slightly faster reacting substrate.  The 
reason for this is that upon alkene bromination, an equilibrium is quickly 
reached whereby the bromonium ion is transferred between substrates via 
exchange before nucleophilic trapping can occur (scheme 2.4).  The unequal 
rate of irreversible cyclisation for each substrate (A and B) drives the 
equilibrium towards production of the faster-reacting bromonium ion (A-Br+), 
regenerating the slow reacting substrate (B) and further skewing the product 
ratio. 
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Scheme 2.4: Fast alkene-alkene bromonium ion exchange can lead to skewed 
product ratios. 
 
In the extreme case where cyclisation of one substrate becomes faster than 
bromonium ion exchange, near perfect selectivities for this product may be 
achieved. 
 
The substrate requirements for these competition experiments are that both 
alkenes must have similar electronic properties to ensure a comparable rate of 
initial bromination.  However, the nucleophilic group on each substrate must 
cyclise at a different rate, such as to generate five vs. six membered rings.  It 
is observed that the product ratio is concentration dependent, as bimolecular 
bromonium ion transfer decreases at high dilutions.33 In addition, the ratio 
may change with reaction conversion as the concentration of fast-reacting 
substrate is disproportionately depleted. 
 
Accordingly, the substrates selected for our experiments were 4-pentenoic 
(142) and 5-hexenoic (144) acids which are both commercially available.  
Initially, their individual rates of bromolactonisation catalysed by 
(DHQD)2PHAL-benzoic acid were measured (table 2.6).  Each reaction was 
performed in toluene at the same substrate concentration (28 mM) as previous 
bromolactonisations.  After six minutes, each reaction was quenched and the 
substrate conversion determined by 1H NMR analysis of the crude mixture. 
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Table 2.6: Substrate conversion after 6 minutes for individual 
bromolactonisation reactions of 142 and 144. 
 
 
 
Entry Substrate Conversion (%) 
1 142 81 
2 144 40 
 
It was found that 81% of 142 and 40% of 144 had reacted, giving a relative rate, krel = 
k142/k144 = 2.0.  Both substrates were then subjected together to reaction conditions 
with limiting NBS (1 eq.) (scheme 2.5). 
 
 
Scheme 2.5: competition of 142 and 144 for insufficient NBS. 
 
The product ratio, 143:145 = 1.9, demonstrating unambiguously that 
bromonium ion exchange is not competitive with lactonisation for either 
substrate in this system.   
 
The reaction was repeated in the absence of benzoic acid (scheme 2.6) in 
order to determine whether the additive exerted an influence in suppression of 
this process. 
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Scheme 2.6: Competition of 142 and 144 for insufficient NBS in the absence 
of benzoic acid. 
 
The very similar product distribution obtained, 143:145 = 1.9, was good 
evidence that benzoic acid is not involved in preventing bromonium ion 
transfer.  As a control experiment, the competition experiment (with benzoic 
acid) was repeated in the absence of catalyst.  In this case several side 
products were formed.  Overlap of peaks made characterisation difficult from 
the 1H NMR spectrum of the crude material, and quantitative analysis was not 
possible.  However, signals characteristic of diastereotopic protons and 
indicative of intermolecular bromonium ion capture were observed.  
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2.5 Kinetic Experiments To Determine Effect Of Benzoic 
Acid on Rate of Bromolactonisation 
 
On the basis of the experimental results obtained in this chapter, a possible catalytic 
cycle for (DHQD)2PHAL catalysed bromolactonisation is shown in figure 2.10. 
 
 
Figure 2.10: Proposed catalytic cycle for (DHQD)2PHAL catalysed 
bromolactonisation. 
 
It was shown in section 2.3.2 that resubjection of bromolactone 135 (80:20 e.r.) to 
reaction conditions did not alter the enantiomer ratio over time, suggesting that the 
lactonisation step (k3) is irreversible.  Similarly, it has been demonstrated in section 
2.4 that the bromonium ions generated in this system are stable to 
stereorandomisation by alkene-alkene exchange.  Therefore, the only mechanism for 
reversible bromination is via bromonium ion transfer between the alkene and NBS or 
a N-brominated catalyst.  Evidence for this will be discussed in chapter 5.  
The dependence of enantioselectivity on the steric and electronic properties of 
additive suggests that carboxylic acids pre-associate to the catalyst via hydrogen 
bonding (K1) although it is not clear whether this equilibrium is maintained 
throughout the reaction. 
Kinetic experiments were performed in order to find evidence for the rate-determining 
step, and to determine the influence of excess acid on the reaction rate.  Initially, the 
bromolactonisation of substrate 142 was monitored by 1H NMR at 20 ◦C in toluene 
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with two different excesses of the acid ([142]0 – [NBS]0).  For each experiment, one 
scan was recorded every 30 seconds, and there was a lag time of ~7 minutes between 
sample preparation and the first spectrum (figure 2.11).   
 
Experiment [NBS]0 (mM) [142]0 (mM) Excess (mM) Time at 50% conversion (min) 
1 15.0 15.0 0 15.5 
2 13.4 17.5 4.1 6.5 
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Figure 2.11: Influence of excess substrate on reaction rate. 
It is clearly observed that the presence of excess substrate 142 increases the rate of 
reaction: 50% conversion is reached after 6.5 minutes for experiment 2, and after 15.5 
minutes when NBS and 142 are equimolar.   
Separate experiments were also performed to measure the influence of initial benzoic 
acid concentration on the rate of the background reaction of 4-phenyl-4-pentenoic 
acid (114).  This data was simply obtained by quenching the reaction after 30 minutes 
(with sodium thiosulphate) and submitting the crude material for 1H NMR analysis 
(table 2.7). 
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Table 2.7: Rates of background bromolactonisation in the presence and absence of 
benzoic acid. 
 
Experiment [BzOH]0 (mM) [114]0 (mM) Conversion after 30 minutes (%) 
1 0 25.0 2 
2 25 25.0 31 
In the absence of benzoic acid, only 2% substrate conversion was observed after 30 
minutes, whereas this increased to 31% upon addition of one equivalent of benzoic 
acid.  (DHQD)2PHAL is considered a type III catalyst for halofunctionalisation  
(section 1.3).45  The associated mode of catalysis is by H-bonding activation of the 
nucleophilic functional group of the substrate.  Therefore, it is expected that the rate 
acceleration observed in the presence of (DHQD)2PHAL is due to deprotonation of 
the carboxylic acid, which increases the rate of cyclisation.  Intuitively, the presence 
of excess acid will increase the rate of alkene bromination by H-bonding activation of 
NBS.   
Therefore, it may be tentatively concluded that in the uncatalysed reaction, both 
bromination and cyclisation steps are competitive.  In contrast, bromination becomes 
the rate determining step in the presence of the catalyst.  In this scenario, hydrogen-
bonded (DHQD)2PHAL:carboxylic acid complexes are the resting state of the 
catalyst, suggesting that a pre-equilibrium approximation may be assumed to simplify 
further kinetic studies.  Evidence for this is discussed in chapter 5. 
In the following chapters, the applicability of the (DHQD)2PHAL-benzoic acid 
catalyst system is investigated through a substrate screening. 
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3 Substrate Synthesis 
 
A vast array of structurally diverse alkenoic acids have been used as substrates for 
non-enantioselective bromolactonisation.  This shows the general utility and 
reliability of this reaction in organic synthesis and was reviewed recently by 
Jayaraman et al.102 As discussed in the introduction, the mechanism proceeds via 
initial nucleophilic attack on Br+ by the alkene, followed by intramolecular cyclisation 
from the carboxylate anion.  As such, the substrate scope of this reaction usually 
excludes only very electron poor alkenes and extremely short or long chain lengths 
which disfavour cyclisation on enthalpic and entropic grounds, respectively.103 Where 
relevant, the regio-, diastereo- and enantioselectivity of bromolactonisation depend 
strongly on the reaction conditions i.e. the source of electrophilic bromine, solvent 
and catalyst, and this has been discussed in detail in the introduction.  The range of 
bromolactones synthesised with high enantioselectivity by this reaction thus far is 
understandably limited considering the age of the field and the poor understanding of 
the mechanisms of asymmetric induction.  A list of reported substrates for asymmetric 
bromolactonisation by substrate class (e.g. chain length between acid and alkene 
groups, and alkene substitution pattern) and reaction type (e.g. kinetic resolution and 
desymmetrisation) is given in appendix 2.   
 
3.1 Reasons for Substrate Selection 
 
In order to determine the general applicability of the (DHQD)2PHAL-benzoic acid 
system, we elected to test the reaction on fifteen substrates.  Specifically, we aimed to 
answer the following questions: a) can high enantioselectivity be achieved with other 
known and novel substrate classes? b) is there an optimal substrate type which 
maximises enantioselectivity and can mechanistic information be discerned from this? 
c) is an additive effect observed with other substrates?  
 
4-Phenyl-4-pentenoic acid is commonly used as a model substrate for asymmetric 
bromolactonisation,3 but of its homologues (with varying chain length) only 5-phenyl-
5-hexenoic acid 101 has been tested by Fujioka et al. (scheme 1.41).104  We therefore 
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decided to synthesise three other substrates in this series with the intention of 
comparing the enantiomer ratios of four to seven membered rings (table 3.1, entry 1).  
To explore the effect of alkene substitution on enantioselectivity, substrates with a 
terminal, tri- and tetra- substituted alkene were also prepared (entries 2-4).  Di-
substituted alkenoic acids are considered a separate class.  Bromolactonisation of (Z)- 
and (E)-5-phenyl-4-pentenoic acids have previously been reported by Yeung,12, 66 
where it was found that the regioselectivity of lactonisation was strongly influenced 
by the alkene geometry.  Lactone 74 generated via 6-endo-trig cyclisation was formed 
exclusively from (E)-73 whereas only 5-exo-trig cyclisation occurred with (Z)-76 to 
give -lactone 77 (entries 5 and 6).  In a separate publication, Yeung9 disclosed that 
(E)-stilbene-2-carboxylic acid (78) underwent bromolactonisation with poor 
regioselectivity giving a 2:1 mixture of exo:endo isomers (entry 7).  Consequently, 
these compounds were also synthesised to study the regioselectivity of the 
(DHQD)2PHAL-benzoic acid system.  Structurally related benzoic acid derivatives 
146 and 147 were also prepared (entry 8). 
(DHQD)2PHAL has already proven to be an excellent catalyst for desymmetrisation 
of ipso-substituted dihydrobenzoic acids16 (related to substrate 148, entry 9), but not 
for kinetic resolution.  Therefore novel substrates 149 and 150 were synthesised in an 
attempt to perform the first successful kinetic resolution with this catalyst system 
(entry 10).   
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Table 3.1: Substrates selected for synthesis and bromolactonisation using 
(DHQD)2PHAL-benzoicid catalyst system. 
Entry Substrate Class Substrate Expected Product(s) 
1 
Different ring 
sizes 
 
114 
 
135 
 
 
 
151 
 
152 
 
101 
 
102 
 
153 
 
154 
2 
Terminal 
alkene 
 
 
155 
 
156 
3 
Tri-substituted 
alkene  
157 
 
158 
4 
Tetra-
substituted 
alkene 
 
159 
 
160 
5 
(Z)-5-Phenyl-
4-pentenoic 
acid 
 
(Z)-76 
 
exo-77 endo-77 
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6 
(E)-5-Phenyl-
4-pentenoic 
acid 
 
(E)-73 
  
exo-74 endo-74 
7 
(E)-stilbene-2-
carboxylic acid  
78 
 
exo-79   endo-79 
8 
Allyl and vinyl 
benzoic acids  
146            147 
 
161             162 
9 
Desymmetrisa-
tion reaction  
148 
 
107 
10 
Kinetic 
Resolution  
149         150 
 
163         164 
 
The synthesis of each substrate is described in the next section, according to the types 
described in the table above.  Within a substrate class, many of the alkenoic acids 
were prepared by the same general route and these will be discussed together.  
Substrates 149 and 155 are commercially available. The bromolactonisation results 
are reported in chapter 4.   
 
3.2 Synthesis of 1,1-Disubstituted Alkenoic Acid Substrates 
 
Substrates 101 and 153 were synthesised by the same general route as model substrate 
114,38 namely by Wittig olefination of a (or ) ketoester with methyl 
(triphenylphosphonium)bromide followed by hydrolysis of the methyl ester (scheme 
3.1).   
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Scheme 3.1: Retrosynthetic analysis for substrates 114, 101 and 153. 
 
3.2.1 Synthesis of 5-phenyl-5-Hexenoic Acid (101) 
 
For the case 5-phenyl-5-hexenoic acid 101 (n = 2) the route began with the 5-oxo 
carboxylic acid (165) which is commercially available.  Initial esterification with 
methyl iodide and potassium carbonate in acetone proceeded in near quantitative 
yield.  The subsequent Wittig reaction with methyl (triphenylphosphonium) bromide 
also proceeded in good yields with potassium butoxide and metal HMDS bases (table 
3.2). 
 
Table 3.2: Influence of base on yield of Wittig olefination. 
 
 
 
 
 
 
 
 
Although the initial esterification step is not strictly necessary as the Wittig reaction 
can be performed directly with the carboxylic acid and two equivalents of base, it was 
found that higher yields were obtained and purification was simpler when the ester 
substrate was used.  The final product, 101 could be simply accessed by ester 
hydrolysis in a mixture of aqueous LiOH and THF (scheme 3.2). 
 
Entry Base Yield (%) 
1 NaHMDS 40% 
2 KHMDS 62% 
3 KOtBu 42% 
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Scheme 3.2: Final hydrolysis reaction to form 5-phenyl-5-hexenoic acid 101. 
 
3.2.2 Synthesis of 6-Phenyl-6-hexenoic Acid 
 
The 6-oxo-6-phenylheptenoic acid precursor necessary for substrate 153 (n = 3) was 
not commercially available but could be obtained in one step from 1-phenyl-1-
cyclohexene (167) by a dihydroxylation/oxidative cleavage procedure developed by 
Weinreb et al (scheme 3.3).105 
 
 
 
Scheme 3.3: Oxidative Cleavage of 1-phenyl-1-cyclohexene (167) with Jones 
reagent/Osmium tetroxide 
 
Catalytic potassium osmate and the Jones reagent were sequentially added to a 
solution of the substrate in acetone.  The end point of the reaction could be easily 
observed from the red to green colour change corresponding to formation of Cr(III), 
and excess oxidants were quenched by addition of isopropanol.  After 
chromatography, the pure product could be isolated in 71% yield.  However, in 
subsequent repeats around 7-15% of the de-homologated 5-oxo-5-phenylhexenoic 
acid 166 was observed in the 1H NMR of the crude mixture.  This impurity may have 
been formed from further oxidative cleavage of the enol tautomer of the product with 
concurrent production of carbonic acid (scheme 3.4).   
 
  
106 
 
 
Scheme 3.4: Mechanism of de-homologation of 6-phenyl-6-hexenoic acid 168 by 
oxidative cleavage of enol tautomer.  
 
This impurity was not separable from the major product by column chromatography 
or re-crystallisation and so was taken on as a mixture.  The rest of the synthesis was 
exactly analogous to the route described previously for substrate 101 (n = 2): 
methylation of the carboxylic acid, Wittig reaction and ester hydrolysis all proceeded 
with similar yields (based on 1H NMR analysis of the mixture isolated after column 
chromatography) (scheme 3.5). 
  
 
 
Scheme 3.5: Synthetic route to substrate 153 involving sequential methylation, Wittig 
olefination and ester hydrolysis reactions. 
 
Throughout this synthesis, the shorter chain homologue was inseparable.  However, it 
was expected that 153 (n = 3) would undergo bromolactonisation at a slower rate than 
101 (n = 2) due to the greater entropic barrier towards cyclisation.  This would 
possibly offer a method of separation.  Consequently, a test racemic 
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bromolactonisation was performed with NBS and quinuclidine as a tertiary amine 
catalyst (scheme 3.6).  Under these conditions 101 cyclised quantitatively, but no 
reaction of 153 was observed.  Substrate 153 could be re-isolated after column 
chromatography in good yield. 
 
 
Scheme 3.6: Removal of impurity 101 by bromolactonisation. 
 
3.2.3 Synthesis of 3-Phenyl-3-Butenoic Acid (151) 
 
The synthesis of 3-phenyl-3-butenoic acid 151, the substrate for an expected 
bromolactone proved to be more challenging.  It was not possible to follow a route 
analogous to the related alkenoic acids described above because the -keto carboxylic 
acid precursor (n = 0, scheme 3.1) is neither commercially available, nor readily 
accessible.  Literature methods for 151 involve the ring-opening of diketene with 
Grignard reagents106 or palladium catalysed cross-coupling to a vinyl iodide.107 Three 
possible routes were considered, avoiding the use of volatile and hazardous diketene 
(scheme 3.7): direct carboxylation of methylstyrene (169) or 
bromomethylstyrene (170) with CO2 (route A); conjugate addition of diphenyl 
cuprate into allene 172; and Negishi and Suzuki coupling of phenyl boronic acid or 
zinc bromide to vinyl iodide 171, which is accessible in a single step from 172 (route 
C).  Route C is known in the literature107 using Negishi reaction conditions.  
However, the other routes are novel and shorter.  In addition, route A is a useful 
assessment of the relative rates of metallation and anionic polymerisation for 
methylstyrenes; and route B would show the robustness of cuprate addition in the 
presence of copper-coordinating groups such as the carboxylate of substrate 151. 
 
  
108 
 
 
Scheme 3.7: Possible synthetic routes to substrate 151. 
 
3.2.3.1 Direct Carboxylation Procedure – Route A 
 
Initially, the direct carboxylation of methylstyrene was attempted. n-Butyllithium 
was added dropwise to a dilute solution of starting material 169 (80 mM) in THF.  
The clear solution turned a deep red colour indicative of deprotonation.  After half an 
hour at 78 ◦C dry ice was added, immediately quenching the reaction.  Attempted 
extraction of the product with successive base and acid washes yielded none of the 
desired product, but only valeric acid (n-BuLi + CO2), identified by smell and the 
1H 
NMR spectrum of the crude material.  Evaporation of the organic phase after the 
initial base wash yielded a white polymeric material, presumably poly(-
methylstyrene).  It was evident that the rate of chain propagation was faster than 
deprotonation of the monomer by nBuLi.  Reversing the order of addition such that a 
low concentration of 169 was maintained, increasing the temperature to 20 ◦C, and 
bubbling CO2 through the solution did not improve yield.  In the latter case there was 
little dissolution of the gas at 20 ◦C.  We consequently decided to move from the 
organolithium to the Grignard or organozinc reagents as these are generally less 
reactive.  The substrate, bromomethylstyrene, was metallated with either 
magnesium powder or anhydrous zinc bromide at room temperature in THF.  After all 
the Mg/ZnBr2 had visibly been consumed, anion formation was assumed to be 
complete and dry ice was added.  As before, no product was isolated but 
polymerisation had been suppressed and all the substrate had been converted to 2,5-
diphenyl-1,5-hexadiene (173) in both reactions (scheme 3.8).  This is presumably 
formed via a radical Wurtz coupling mechanism.108  
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Scheme 3.8: Attempts at Direct Carboxylation of -bromomethyl styrene gave homo-
coupled product. 
 
It was clear that an alternative route was required; the cross-coupling to vinyl iodide 
171 (route C) and the direct conjugate addition of diphenyl cuprate to buta-2,3-
dienoic acid (172) (route B)  were explored.  Both of these substrates are obtained 
from the same literature route starting from oxidation of butynol (scheme 3.9).109   
 
 
Scheme 3.9: Synthesis of 3-iodo-3-butenoic acid. 
 
The product of the first reaction, a Jones oxidation was not purified.  The crude 
product was extracted into a 2 M aqueous NaOH solution and stirred for two hours.  
Upon re-acidification and isolation all the butynoic acid had tautomerised to the allene 
172 in 55% overall yield from butynol.  Subsequently, the conjugate addition of 
sodium iodide gave 171 in 64% yield.110  
 
3.2.3.2 Direct Conjugate Addition to Allene 172 – Route B 
 
Initially, we attempted the direct conjugate addition of lithium diphenylcuprate to 
allene carboxylic acid 172.  Organocuprates are commonly used soft nucleophiles for 
conjugate addition into -unsaturated ketones and esters.111  Carboxylic acids are 
unusual substrates for 1,4-addition with organometallic reagents.  Aside from the 
requirement of two equivalents of the cuprate, the carboxylate anion may disrupt the 
required mechanism by coordination to copper.112  However, there is literature 
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precedent for reaction between Grignard, organolithium and alkyl copper complexes 
and simple -unsaturated acids.  Aryl Grignard reagents preferentially give the 
conjugate addition product with small quantities of direct addition (scheme 3.10).113  
Alkynyl substrates give the opposite trend; 1,2-addition is observed exclusively with 
methyl propiolic acid.114   
 
 
Scheme 3.10: Grignard reagent addition to -unsaturated carboxylic acids.113,114 
 
Attack of alkyl lithium reagents (e.g. nBuLi) to unsubstituted cinnamic acids gives a 
mixtures of 1,4- and radical 1,3- addition.115  Phenyllithium undergoes conjugate 
addition exclusively, but in low yield (scheme 3.11).115  
 
 
Scheme 3.11: Organolithium addition to -unsaturated carboxylic acids.115 
 
In the 1970’s Yamamoto et al. showed that organocopper reagents are by far the most 
regioselective.116  The authors demonstrated that the n-butyl copper boron trifluoride 
complex reacts with simple acrylic acid derivatives to give the Michael addition 
product in good yields (scheme 3.12a).  Recent theoretical models suggest that BF3 
coordinates to the intermediate Cu(III) complex and enhances the rate determining 
reductive elimination step (scheme 3.12b).117  Gilman type reagents e.g. n-Bu2CuLi 
can also be used, and are even regeoselective in favour of the 1,6-adduct in dienoic 
acids (scheme 3.12c).112 
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Figure 3.12: Organocuprate addition to -unsaturated carboxylic acids.  The role of 
BF3 is to enhance rate of reductive elimination. 
 
Consequently, the Gilman reagent, Ph2CuLi, was selected for the attempted synthesis 
of 151 via a 1,4-addition to allene carboxylic acid 172.  Ph2CuLi was prepared by 
initial lithiation of iodobenzene with nBuLi in THF followed by addition of half an 
equivalent of copper iodide; the soluble cuprate was transferred by cannula to a 
solution of allene 172 in THF at78 ◦C (scheme 3.13).  After allowing the mixture to 
warm to 40 ◦C over two hours, the 1H NMR spectrum of the crude mixture showed 
no alkene protons and the presence of an aldehyde peak.  Upon repetition with one 
equivalent of Lewis acid BF3•OEt2, general decomposition and poor mass return were 
observed again.  It was assumed that the carboxylate anion was disrupting the reaction 
perhaps by coordination to copper, leading to an unknown reductive pathway.  In 
order to test this hypothesis, the synthesis of methyl ester 175 was required.  
However, very low yields of 175 were obtained (< 10%) using methyl iodide and 
potassium carbonate, possibly due to the volatility of the product (bottom of scheme 
3.13).  Therefore further experiments were not conducted and we moved to the final 
strategy of palladium catalysed cross-coupling with vinyl iodide 171.   
 
Scheme 3.13: Attempted Michael addition of lithium diphenylcuprate to allene 172, 
and methylation of 172 
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3.2.3.3 Cross-Coupling Strategy for Synthesis of Substrate 151 – 
Route C 
 
Initially a Suzuki reaction between phenyl boronic acid and 171 was performed with 
catalytic Pd(PPh3)4.  In the event, no alkene was re-isolated and the major product was 
biphenyl in 42% yield (scheme 3.14a).  It is possible that the loss of mass balance was 
due to formation of diketene by coordination of the carboxylate anion to the 
palladium(II) complex 176, followed by reductive elimination (scheme 3.14b).  
Evidence for this proposal was obtained upon repeating the reaction with the methyl 
ester of the carboxylic acid, where the desired product was now isolated in 30% yield 
although with inseparable impurities (scheme 3.14c), which could not be fully 
characterised. 
 
 
 
Scheme 3.14: a Synthesis of substrate 151 via a Suzuki reaction with phenyl boronic 
acid returned mostly biphenyl; b the poor mass return may be due to formation of 
diketene; c the yield of the desired product could be increased by carboxylic acid 
protection as the methyl ester. 
 
In order to improve the reaction yield and product purity, the experiment was 
performed with phenyl zinc bromide instead of the boronic acid.  It was expected that 
diketene formation would be suppressed as organozinc compounds are more 
nucleophilic than boronic acids and undergo faster transmetallation,118 but are still 
tolerant of protons (Negishi reactions can be performed in biphasic aqueous-organic 
solvent mixtures in the presence of amine ligands),119 meaning that separate 
carboxylic acids protection/deprotection steps could still be avoided.  In addition, we 
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decided to change the catalyst to PdCl2(MeCN)2, frequently used in similar reactions 
as a soluble source of PdCl2 which is reduced in situ.
120  To our delight the product 
could be isolated cleanly in 33% yield, with biphenyl the major by-product (44%).  
No de-halogenated substrate was observed.  The homo-coupling of organometallic 
reagents in palladium catalysis has been studied in detail for the Negishi reaction.  
The accepted mechanism,121 shown in scheme 3.15, proceeds via two consecutive 
transmetallation steps, generating diphenyl palladium, which undergoes reductive 
elimination to reform the initial catalyst, Pd(0). 
 
 
Scheme 3.15: Synthesis of substrate 151 via Negishi cross-coupling, and mechanism 
of formation of biphenyl.121 
 
3.3 Synthesis of Kinetic Resolution Substrate 150 
 
The literature synthesis122 of 3-methylidenebicyclo[2.2.1]hept-5-ene-2-carboxylic 
acid (150) involves a Diels-Alder reaction between cyclopentadiene and allene 172.  
Surplus 172 had been prepared during the synthesis of substrate 151.  We therefore 
embarked on the synthesis of 150 in order to test it as a substrate for kinetic resolution 
using the (DHQD)2PHAL system.  Freshly cracked cyclopentadiene and 172 were 
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stirred in an ethereal solution overnight, generating methylene bridged-150 in 80% 
yield as a 9:1 mixture of inseparable endo:exo diastereomers (scheme 3.16).    
 
 
Scheme 3.16: Synthesis of bicyclic substrate 150 for kinetic resolution. 
 
3.4 Synthesis of Dihydrobenzoic acid (148) 
 
As discussed in the introduction, Martin et al. have reported the desymmetrisation of 
dihydrobenzoic acid (148) by bromolactonisation to form -lactone 107 with 
moderate e.r. (73:27).78  Kan et al. found that the enantioselectivity of this reaction 
could be optimised using related cyclohexadienes and (DHQD)2PHAL as a catalyst 
(section 3.17).16  Both groups prepared these substrates by Birch reduction of benzoic 
acid.123  However, the Kan group substrates, e.g. 177, were prepared by quenching the 
reaction with pivaloyloxymethyl chloride and subsequent silyl protection of the free 
hydroxyl group (scheme 3.17a).  Following Martin’s procedure, we elected to prepare 
unsubstituted cyclohexadiene 148 as this was a novel substrate with (DHQD)2PHAL, 
and in order to determine the effect of ipso-substituents on enantioselectivity.  In the 
event, the reaction proceeded in excellent yield (scheme 3.17b). 
 
 
Scheme 3.17: a Literature synthesis of dihydrobenzoic acid derivative 177;16 b Birch 
reduction of benzoic acid. 
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3.5 Synthesis of Tri-substituted Alkene 157 
 
We returned to the Wittig reaction for the synthesis of the 1,1,2- and tetrasubstituted 
alkenoic acids 157 and 159.  Substrate (Z)-157 was prepared from 4-oxo-4-
phenylpentenoic acid methyl ester (136) and the homoallyl phosphonium bromide 
(scheme 3.18).  The product was isolated in 53% yield as a 13:1 inseparable mixture 
of Z:E isomers.  The (Z) configuration was identified from the 2D-NOESY NMR by 
observation of cross peaks between the vinyl proton and the adjacent methylene 
group. 
 
 
Scheme 3.18: Synthesis of (Z)-157 via a Wittig reaction. 
 
For completeness, the synthesis of (E)-157 was attempted using Schlosser’s Wittig 
modification:124 the basis of this reaction is that (E)-alkene selectivity can be obtained 
for non-stabilised ylids by inducing reversibility in oxaphosphatane formation.124a 
This is achieved by addition of a second equivalent of a strong lithium base after 
initial oxaphosphatane formation has already occurred. The mechanism (scheme 3.19) 
is dependent on the ability of lithium salts (the by-product of ylid generation) to 
coordinate to the oxygen atom of the oxaphosphatane, re-forming the syn-betaine 
precursor which is deprotonated by the excess base to give a configurationally 
unstable oxido ylid.  Upon quenching with one equivalent of acid the betaine is 
protonated and cyclises preferentially to the thermodynamic trans-oxaphosphatane 
product and consequently the E-alkene. 
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Scheme 3.19: Mechanism of oxaphosphatane equilibration using Schlosser’s 
conditions.124 
. 
In the event, the second equivalent of phenyl lithium simply reacted with the substrate 
ester group, as perhaps should have been expected (scheme 3.20).  In future attempts, 
direct addition may be suppressed by using bulky ester substituents. 
 
 
Scheme 3.20: Attempted synthesis of (E)-157 using Schlosser’s Wittig modification 
resulted in direct 1,2-addition of phenyllithium to the ester functional group of 136. 
 
3.6 Synthesis of Tetra-substituted Alkene 159 
 
Several procedures were attempted for the synthesis of tetra-substituted alkene 159.  
There was literature precedent for a Wittig reaction between isopropyl phosphonium 
bromide and a keto-ester, although poor yields were obtained;15 the Horner-
Wadsworth-Emmons (HWE) reaction has also been used for synthesis of tetra-
substituted olefins;125 Grignard reagent addition to the ketone 136 and elimination of 
water under acidic conditions; and finally Wirth et al. have described an elegant four 
step procedure for this substrate from bromostyrene using a Johnson-Claisen 
rearrangement.126    
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We initially attempted the Wittig reaction using literature conditions (nBuLi in THF) 
but in our hands no product was obtained.  The major compound isolated was the 
butyl ketone 180 formed from direct nucleophilic attack of nBuLi onto the substrate 
in 31% yield (scheme 3.21), despite the observation of ylid formation from a colour 
change of the solution from clear to dark-red prior to the addition of ketoester 136.  In 
a subsequent attempt, a superbasic 1:1 mixture of tBuLi and tBuOK (Schlosser’s 
base)127 was used to ensure complete conversion to the ylid.  To our surprise none of 
the desired product was isolated and the substrate was returned as the tbutyl ester 
(scheme 3.21).  Similarly the reaction between HWE reagent isopropyl 
diethylphosphate (181) (which has a lower pKa than the corresponding 
triphenylphosphonium salt)128 and nBuLi returned the substrate as the ethyl ester in 
18% yield.  These combined results suggested that the rate of deprotonation (i.e. ylid 
formation) is slow, despite being thermodynamically favourable (from pKa between 
base and salt), and that the nucleophilicity of the isopropyl ylids are insufficient to 
react with the substrate ketone.  In the absence of other reactivity, the base prefers to 
attack the substrate ester. 
 
 
Scheme 3.21: Unsuccessful attempts at formation of a tetra-substituted alkene using 
the Wittig reaction. 
 
An alternative procedure, the consecutive addition of isopropyl Grignard to the ketone 
136 and dehydration with conc. HCl had several possible drawbacks, such as poor 
regeoselectivity in the elimination step and attack at the ester instead of the ketone as 
had been observed previously.  In the event mainly substrate was recovered but also 
25% of the acid-induced lactonisation product 182 (scheme 3.22).    
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Scheme 3.22: Grignard addition/dehydration strategy:  starting material and acid-
induced lactonisation product were isolated. 
 
Wirth’s route126 proceeds in four steps via formation of -styryl Grignard which is 
quenched with acetone.  Subsequent Johnson-Claisen rearrangement with 
methylorthoacetate and ester hydrolysis give the tetra-substituted alkene substrate 
159.  This route was not initially tried because it was low yielding overall (22%) 
(scheme 3.23).   
 
Scheme 3.23: Wirth’s route to tetra-substituted alkene 159. 
 
However, due to the difficulties encountered in more direct routes, this procedure was 
followed.  In our hands, an extra step was performed to access -bromostyrene.  The 
synthesis began with bromination and dehydration of acetophenone to give the vinyl 
bromide with elemental bromine and triphenyl phosphite129 on a 10 mmol scale in 
good yields (50-60%) (scheme 3.24).  Unfortunately, it was not possible to purify the 
product completely from bromoacetophenone (20%) at this stage but the impurity 
could be removed after the next step.  The Grignard reaction was initially found to be 
low yielding (15%) despite rigorous purification of acetone by extraction from the 
NaI•(acetone)3 adduct.  The remainder of the mass balance was returned 
bromoacetophenone (20%), 4-hydroxy-4-methylpentan-2-one (184), the self-aldol 
product, and more polar compounds which were not characterised.  However, 
switching the solvent from diethyl ether to THF and using powdered magnesium 
ribbon increased product yield to 35%.  The Johnson-Claisen reaction proceeded in 
excellent yield (83%) with triethylorthoacetate to give the ethyl ester 185.  This yield 
is a substantial improvement of the literature (40%) and is perhaps due to the use of o-
xylene as the solvent rather than neat, which provides better mixing and more 
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homogeneous heating, or the use of the ethyl rather than methyl orthoacetate ester 
which has a higher boiling point.  Finally, hydrolysis under standard condition gave 
the desired product in 82% yield, and 14% overall from acetophenone. 
 
 
Scheme 3.24: Successful synthesis of substrate 159. 
 
3.7 Synthesis of 1,2-disubstituted Alkenes (E)-73 and (Z)-76  
 
For the synthesis of (E)- and (Z) alkenoic acids 73 and 76, respectively, the obvious 
disconnection was the Wittig reaction between benzaldehyde and carboxy-
phosphonium salt 186 (scheme 3.25).  Initially, we decided to use the carboxylic acid, 
as this would avoid the need for extra esterification/hydrolysis steps.  Condensation of 
the ylid, formed with two equivalents of NaHMDS in THF at room temperature, with 
benzaldehyde gave 71% of the product as a 4:1 mixture of E and Z isomers, 
respectively (scheme 3.25a).  Unfortunately, it was not possible to separate these 
chromatographically or by recrystallisation so the reaction was repeated using the 
ethyl ester of phosphonium salt 187 (scheme 3.25b).  In this case, the Z alkene was 
obtained exclusively in 76% yield, despite both ylids classically being considered 
non-stabilised ylids.  Further hydrolysis of the ethyl ester 188 under standard 
conditions gave the desired product, (Z)-76 in 92%.   
 
The ‘stereochemical drift’ towards the E alkene with ylids bearing anionic 
substituents was first reported by Corey130 but accounted for by Maryanoff in the 
early 1980’s.  The authors found that the greatest ‘drift’ occurred when the anion was 
5 or 6 atoms away from the phosphorus and in the order alkoxide > carboxylate > 
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amine (NMe2), the same as their relative nucleophilicity.
128  It was concluded that the 
anionic moiety ‘bites back’ onto the phosphorus atom in the oxaphosphatane 
intermediate forming a short-lived hexavalent phosphorus, initiating fragmentation of 
the oxaphosphatane back to the starting materials (scheme 3.25c).128, 131 The 
reversibility of oxaphosphatane formation is considered essential for (E)-selectivity as 
under these conditions the thermodynamically more stable trans- oxaphosphatane is 
prevalent. 
 
 
 
Scheme 3.25: Wittig reactions with to form (E)-73 and (Z)- 76, and mechanism of 
‘stereochemical drift’ with anion-bearing ylids. 
 
The difficulties in purification of (E)-76 and (Z)-73 mixtures meant that other 
strategies were required for synthesis of (E)-76.  Two other literature routes were 
attempted: Krapcho decarboxylation of cinnamyl dimethylmalonate (189),132 and a 
Johnson-Claisen rearrangement analogous to that described in the previous section, 
starting from -vinyl benzyl alcohol and triethylorthoacetate.133 
 
The first method involved mono-alkylation of dimethyl malonate with cinnamyl 
chloride, which proceeded in a moderate 51% yield.  The dialkylated product (190) 
was also isolated in 15% yield (scheme 3.26). 
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Scheme 3.26: Alkylation of dimethyl malonate. 
 
The subsequent decarboxylation was performed using Krapcho’s conditions,134 using 
sodium chloride and two equivalents of water in DMSO (scheme 3.27).  After heating 
at 180 ◦C for six hours only 62% of the initial mass was recovered, of which 26% was 
desired product and 36% of an unusual sulfur containing compound 192, generated by 
DMSO addition. To our knowledge, this is the first report of such a reaction in the 
literature, and the mechanism of its formation is unclear. Finally, ester hydrolysis of 
191 proceeded in 92% yield to give (E)-73. 
 
 
Scheme 3.27: Synthesis of (E)-alkenoic acid 73 via Krapcho decarboxylation. 
 
As a comparison, the Johnson-Claisen rearrangement route developed by Willis was 
attempted.133 A mixture of phenyl-vinyl carbinol (193) and triethylorthoacetate was 
heated in o-xylene at 140 ◦C with catalytic propionic acid for 18 hours.  To our delight 
the (E)-alkenoic ester 194 was isolated in 92% yield and similarly high yields were 
obtained in the final hydrolysis reaction (scheme 3.28), making this a much more 
efficient route to this substrate. 
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Scheme 3.28: Synthesis of (E)-alkenoic acid 73 via Johnson-Claisen rearrangement. 
 
3.8 Synthesis of o-vinyl Benzoic Acid (146) 
The most common method for synthesis of o-vinyl benzoic acid is via a Stille reaction 
between o-bromo ethyl benzoate and tributylvinyltin.135 However, in 2009 Cowley et 
al. reported a new procedure via direct carboxylation of o-bromostyrene (195) with 
dry ice.136  The authors obtained high yields (78%) in contrast to our attempt at 
carboxylation of -bromomethyl styrene using similar reaction conditions (section 
3.2.3.1).  In our hands, the synthesis began via a Wittig olefination of o-bromo 
benzaldehyde to access o-bromostyrene on a gram scale in high yields (63%).  
Subsequently, 195 was added to a suspension of activated magnesium in THF and 
heated to 70 ◦C for one hour to ensure complete conversion to the Grignard reagent.  
Upon addition of dry ice and purification, the desired product 146 as obtained in 37% 
yield.  The major by-product was styrene formed by protonation of the Grignard 
during work-up (46%), or from ice frozen on the surface of the CO2 (scheme 3.29). 
 
Scheme 3.29: Synthesis of 146 by carboxylation of bromostyrene. 
 
3.9 Synthesis of o-allyl Benzoic Acid (147) 
o-Allyl benzoic acid is a novel substrate for enantioselective bromolactonisation.  
Recent literature syntheses include a high yielding (85%) SN2 between a mixed aryl-
cyano cuprate (ArCNCuLi) and allyl bromide involving the use of stoichiometric 
copper cyanide.137  However, recent work within the Braddock group41 has shown that 
catalytic Li2CuCl4
138 mediates a similar reaction between an aryl iodide and geranyl 
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bromide (scheme 3.30) avoiding the use of toxic cyanide salts.  Consequently, this 
route was selected for synthesis of 147. 
 
Scheme 3.30: Copper catalysed coupling of aryl iodides and geranyl bromide. 
The reaction is initiated via addition of the copper catalyst to a solution of the aryl 
Grignard (formed by iodine-magnesium exchange with iso-propyl magnesium 
chloride), whereupon it is reduced in situ by the Grignard to the active catalytic 
species, CuCl.139  This salt itself is highly hygroscopic, so the use of Li2CuCl4 
represents a more convenient method. The subsequent catalytic cycle for allyl 
bromide is as follows (scheme 3.31):139 
 
Scheme 3.31: Catalytic cycle for copper(I) catalysed coupling between allyl bromide 
and aryl Grignard.139 
Initial reaction between copper chloride and the Grignard reagent generates an 
unreactive neutral aryl-copper complex.  A second transmetallation step forms the 
reactive diaryl cuprate which coordinates to the allyl bromide -bond with eventual 
displacement of bromide and formation of allyl-copper(III) complex.  The catalyst is 
regenerated by reductive elimination to give the desired coupled product.   
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In the event, the reaction between o-iodo methyl benzoate and allyl bromide catalysed 
by 4 mol% Li2CuCl4 (scheme 3.32) gave allyl benzoic acid in 94%. 
 
Scheme 3.32: Synthesis of o-allyl benzoic acid substrate 147 via copper catalysed 
cross-coupling. 
 
3.10 Synthesis of Stilbene-2-carboxylic Acid (78) 
 
Stilbene-2-carboxylic acid (78) has been used a substrate for enantioselective 
bromolactonisation by Yeung et al.9  Its synthesis9 proceeds in two steps via a Heck 
reaction between o-iodo methyl benzoate and styrene, followed by ester hydrolysis.       
This procedure was successfully reproduced, returning the desired product in 81% 
overall yield (scheme 3.33). 
 
 
Scheme 3.33: Synthesis of substrate 78 via Heck cross-coupling between styrene an 
aryl iodide. 
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4 Results of Bromolactonisation Reactions 
 
With the optimal catalytic conditions outlined for formation of (S)--lactone 135 we 
sought to examine the applicability of the (DHQD)2PHAL system to the substrates 
discussed in the previous section.  In each case the reaction was performed in toluene 
at 20 ◦C with an initial substrate concentration of 25 mM, 10 mol% catalyst loading 
and one equivalent NBS.  The experiments were also repeated in the absence of 
benzoic acid to determine the additive effect on enantioselectivity.  After 1 hour the 
reactions were worked up (see experimental section 7.15) and the crude mixture 
analysed by 1H NMR to determine conversion.  After purification by silica gel 
chromatography the products were submitted for chiral HPLC analysis to obtain 
enantiomeric ratios.  The absolute stereochemistry of the products was determined by 
direct comparison of optical rotation to the literature where available, or otherwise by 
radical dehalogenation and comparison of the optical rotation for the de-brominated 
lactones to literature values.  The de-brominated derivatives are often known 
compounds formed by enantioselective proton-induced lactonisation reactions. 
 
4.1 Bromolactonisation of 1,1-Disubstituted Alkenoic Acids 
 
Asymmetric bromolactonisation of substrate 101 gave (S)--lactone 102 with 94:6 e.r. 
and 94% yield, a remarkable improvement from 59:41 e.r. without benzoic acid and a 
similar enantioselectivity to the tris-amidine catalyst system reported by Fujioka 
(scheme 4.1).76  
 
 
Scheme 4.1: Bromolactonisation of substrate 101 and comparison of 
enantioselectivity to literature. 
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Although the (DHQD)2PHAL catalyst system could be extended to the synthesis of - 
and -lactone homologues with excellent yield and selectivity, preparation of other 
ring sizes proved more challenging.  Only 5% conversion of substrate 151 to 
lactone 152 was observed under standard conditions within 2 hours, the major 
product being bromomethyl styrene (90% from 1H NMR of crude mixture), 
evidently formed via a bromination-decarboxylation mechanism (scheme 4.2).   
 
 
 
Scheme 4.2: Substrate 151 undergoes alkene bromination-decarboxylation under 
bromolactonisation conditions. 
 
The bromolactonisation of 6-phenyl-6-heptenoic acid (153) to the 7-ring 
bromolactone 154 also did not proceed under standard conditions within 6 h and the 
substrate was recovered quantitatively (scheme 4.3).  This result was anticipated as 
the formation of medium ring (> 6) lactones is inhibited by entropic effects.  This is 
caused by the greater conformational flexibility of the acyclic substrate relative to the 
cyclic product.140 
 
 
Scheme 4.3: Bromolactonisation of 6-phenyl-6-heptenoic acid did not proceed under 
standard conditions. 
 
It was therefore decided to repeat the reaction in H2O, with the aim of inducing 
micelle formation due to the amphiphilic properties of substrate 153.  Micelle 
generation was considered a possible method of reducing the conformational freedom 
of the substrate, thereby increasing the rate of cyclisation.   
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Accordingly, bromolactonisation of 153 was initially performed in pure H2O at 
standard concentration (20 mM).  Although all reagents were poorly soluble in 
aqueous solution, 73% substrate conversion was observed by 1HNMR analysis after 
24 h at room temperature and 67% mass balance was returned after work up.  The 
1HNMR spectrum of the crude material indicated that several products had formed 
possessing diastereotopic protons (AB quartets) in the region 4.3 to 3.6 ppm, 
consistent with alkene bromofunctionalisation, and presumably including 
bromohydrins.  However, difficulties were encountered in chromatographic separation 
of the mixture, as the products appeared to be unstable on silica gel and very poor 
mass returns were obtained, insufficient for further analysis. 
 
Consequently, further exploratory reactions were analysed on the basis of 1H NMR 
spectra of crude mixtures.  In order to determine the influence of reagent solubility on 
micelle formation in aqueous solutions, the reaction was repeated in the presence of 1 
M salting-in (guanidinium chloride) and salting-out (lithium chloride) reagents (table 
4.1).141 
 
Table 4.1: Bromolactonisation of 6-phenyl-6-heptenoic acid (153) in aqueous 
solutions. 
 
Aqueous Solution NMR Conversion (%) 
1M LiCl 93 
1M Guanidinium chloride 22 
 
In 1 M LiCl, 60% of the expected mass was returned but NMR analysis indicated 
93% substrate conversion to major bromolactone product. The same product was 
formed in 1 M GnCl but the reaction was slower (22% conversion).  The product was 
tentatively assigned as exo-bromolactone 154 on the basis of the chemical shifts and 
multiplicity of protons Ha and Hb.  These results suggest that guanidinium chloride 
reduces micelle formation and consequently decreases the rate of bromolactonisation.  
However, further characterisation and a reliable purification method are required. 
 
  
128 
In future work, other halogen sources could be used.  Rousseau et al.142 reported the 
bromolactonisation of -unsaturated alkenyl benzoic acids to form bromolactones 
with ring size up to 20, using bis-(collidine)bromine(I) phosphate salts in non-polar 
CH2Cl2.  In combination with a chiral phosphate catalyst, e.g. 59 reported by Toste,
60 
(section 1.3.2) this reaction could perhaps be achieved in enantioselectively. 
 
4.2 The Influence of Alkene Substitution Pattern on 
Enantioselectivity of Bromolactonisations 
 
Terminal, tri- and tetra-substituted alkene substrates 155, 157 and 159, analogues of 
4-phenyl-pentenoic acid (114) were also investigated as substrates for 
bromolactonisation with the (DHQD)2PHAL-benzoic acid system to examine the 
effect of alkene substitution on enantioselectivity. 
 
Martin78 has reported the bromolactonisation of 4,5-dimethyl-4-pentenoic acid (196) 
to give -lactone 198 in 71:29 e.r. and Fujioka15 has prepared -lactones 199 and 200 
in 93:7 and 81:19 e.r. respectively, using tris-amidine catalyst 99 (scheme 4.4).  There 
is no known literature precedent for bromolactonisation of terminal alkenes and as 
such represent a new substrate class. 
 
 
Scheme 4.4: Literature precedent for asymmetric bromolactonisation of tri- and 
tetrasubstituted alkenes. 
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Under the standard reaction conditions with (DHQD)2PHAL, trisubstituted alkene 157 
(a 14:1 mixture of E:Z constitutional isomers) was cyclised regio- and 
diastereoselectively to bromolactone 158 in 93% yield and 86:14 e.r., a small 
improvement on the reaction without benzoic acid (scheme 4.5).   The minor isomer 
also underwent bromolactonisation, but it was not possible to determine its 
enantiopurity due to unresolved peaks in the HPLC chromatogram.   
 
 
Scheme 4.5: Bromolactonisation of substrate 157 catalysed by (DHQD)2PHAL. 
 
Product 160 with two contiguous quaternary centres was formed exclusively from 
tetrasubstituted alkene 159 with moderate enantioselectivity (69:31 e.r.) and excellent 
yield (95%).  The effect of benzoic acid was minimal in this case (scheme 4.6). 
 
Scheme 4.6: bromolactonisation of tetrasubstituted alkene 159. 
 
Both lactones 158 and 160 and their easily accessible dehalogenated derivatives are 
novel compounds.  Therefore their absolute stereochemistry was tentatively assigned 
by analogy to the other compounds in the series (135 and 102) which all have (S) 
configuration at the centre of carboxylate attack indicating cyclisation from the same 
face.  For bromolactone 158, the secondary stereocentre was also assigned (S) because 
its NMR spectrum showed perfect diastereoselectivity and this was assumed to result 
from anti ring opening of the bromonium ion.  Overall, the enantiomer ratios of 158 
and 198 (formed using Martin’s bifunctional catalyst 106) are comparable, but 
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Fujioka’s catalyst 99 gave higher asymmetric induction for both tri- and tetra-
substituted alkenes.104 
 
To complete the substitution pattern in this series, bromolactonisation of terminal 
alkene 155 was performed (scheme 4.7).  In the event, modest asymmetric induction 
was obtained in both the presence and absence of benzoic acid (68:32 and 63:37 
respectively).  The absolute configuration (S) was confirmed by comparison of optical 
rotation to an enantiopure literature sample prepared from (S)-glutamic acid.143 
 
Scheme 4.7: Bromolactonisation of terminal γ-δ unsaturated acid 155. 
4.3 Bromolactonisation of (E) and (Z)-1,2 Disubstituted 
Alkenes 
 
The bromolactonisation of (E)- and (Z)-5-phenyl-4-pentenoic acids have been 
reported by Yeung12, 66 and Martin78 with quinidine-thiocarbamate and BINOL-
amidine catalysts, respectively.  In both systems the -lactone, product of 5-exo-trig 
lactonisation, is formed regioselectively from the Z-alkene, whereas the 6-endo-trig 
product is preferred with the E-alkene substrate.  Excellent enantioselectivities are 
typically obtained, although initial catalyst 67 required modification of the aryl ether 
side chain to maintain high enantiomeric ratios with Z-olefins (scheme 4.8). 
 
The (DHQD)2PHAL-benzoic acid system gave exo-(S,S)--lactone exclusively from 
substrate (Z)-76 with high yield (88%) and e.r. (91:9), a noticeable improvement on 
the reaction with no additive (82:18 e.r.) (scheme 4.7).  The (5S,6S) stereochemistry, 
indicative of anti- attack of the carboxylate on the bromonium ion was confirmed by 
comparison of the 3J5-6 coupling constant (5.4 Hz) to literature 
1H NMR data for the 
(R, S) diastereomer (6.9 Hz).42 
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Scheme 4.8: Bromolactonisation of (Z)-76. 
 
However, cyclisation of (E)-73 gave a 43:57 mixture of 5-exo-74 and 6-endo-74 
isomers respectively, each in only moderate e.r. (scheme 4.9).  The regioselectivity 
reversed in the absence of benzoic acid giving 56% of exo-74 and 44% endo-74.  
Uniquely, the e.r. of endo-74 decreased from 79:21 to 74:26 in the presence of 
benzoic acid.  Complete conversion of the substrate and no by-products or other 
diastereomers were observed within one hour reaction time.  The two constitutional 
isomers could be distinguished spectroscopically by IR: -bromolactones consistently 
have a carbonyl stretching frequency at ~ 1770 cm-1 and -lactones at ~ 1730 cm-1, 
and by 1H NMR: the methine proton - to oxygen is significantly downfield in endo-
74 (5.60 ppm relative to 5.02 ppm for exo-74) due to deshielding by both the oxygen 
and phenyl substituents.  The (5R, 6S)-relative configuration of endo-74 could also be 
confirmed by comparison of the 3J5-6 coupling constant (6.2 Hz) to the literature 
1H 
NMR spectrum of the (5S, 6S) diastereomer, where 3J5-6 = 1.5 Hz.  
 
Scheme 4.9: Bromolactonisation of (E)-73 catalysed by (DHQD)2PHAL; distinctive 
spectroscopic markers of exo- and endo-74 product bromolactones, and comparison of 
enantioselectivity to the literature. 
 
These unusual results prompted an examination of whether regioselectivity and 
enantioselectivity varied with substrate conversion.  Asymmetric induction has 
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already been shown to decrease with conversion for the bromolactonisation of model 
substrate 114 in the absence of additive (section 2.3.2).  In order to obtain these 
results, seven bromolactonisation reactions were performed (four with one equivalent 
of benzoic acid, and three without additive), varying the initial concentration of NBS 
from ~20 – 100 mol%, as shown in figure 4.1.  It became apparent that consumption 
of the substrate acid with conversion has a significant effect on both regio- and 
enantioselectivity, and that the role of benzoic acid is relatively minor (figure 4.1). 
 
 
 
 
 
 
 
Experiment Conversion (%) exo:endo e.r. (exo-74) e.r. (endo-74) 
1 21 76:24 60:40 85:15 
2 49 73:27 62:38 73:27 
3 65 47:53 64:36 68:32 
4 100 43:57 67:33 74:26 
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Figure 4.1: Bromolactonisation of (E)-73 in the presence of benzoic acid.   Product 
enantioselectivity and exo:endo ratio are not constant with conversion: e.r.(exo) (■) 
increases from 60:40 to 67:33; e.r.(endo) (▲) decreases from 85:15 to 74:26; and 
exo:endo (♦) decreases from 76:24 to 43:57. 
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In the presence of 1 eq. benzoic acid (figure 4.2) the reaction is initially exo-selective, 
but this decreases steadily until endo-74 is preferred after ~ 50% conversion.  The e.r. 
of each product is highest when the rate of its formation is slowest, i.e. as the reaction 
approaches completion for exo-74 and vice versa for endo-74.  A similar trend is 
observed without benzoic acid although a complete reversal in regioselectivity is not 
quite observed (figure 4.2). 
 
 
Experiment Conversion (%) exo:endo e.r. (exo) e.r. (endo) 
1 28 72:28 60:40 85:15 
2 65 58:42 64:26 82:18 
3 100 56:44 61:39 79:21 
50
55
60
65
70
75
80
85
90
0 20 40 60 80 100
conversion (%)
s
e
le
c
ti
v
it
y
 Y
:(
1
0
0
-Y
)
exo:endo
e.r. (exo)
e.r. (endo)
 
Figure 4.2: Bromolactonisation of (E)-73 in the absence of benzoic acid.   e.r.(exo) 
(■) does not change; e.r.(endo) (▲) decreases from 85:15 to 79:21; and exo:endo (♦) 
decreases from 72:28 to 56:14. 
 
Yeung9 has reported that bromolactonisation of (E)-stilbene-2-carboxylic acid (78) 
catalysed by aminothiocarbamate 67 is also poorly regioselective and proceeds to give 
a 2:1 ratio of endo-79 and exo-79 with optimised enantioselectivities of 96:4 and 
58:42 e.r., respectively (scheme 4.10).  We therefore used 78 in the (DHQD)2PHAL-
benzoic acid system to determine whether the trends observed with substrate 73 were 
reproducible with other compounds.  The results are shown in figure 4.9. 
 
  
134 
 
Scheme 4.10: Bromolactonisation of (E)-stilbene-2-carboxylic acid. 
 
Overall, the enantioselectivities are much reduced compared to the literature.  At 
reaction completion, the influence of benzoic acid appears minimal.  As for substrate 
78, the reaction is exo-selective (76% in the presence of additive), and endo-79 is 
isolated with higher enantioselectivity (63:37 e.r.) than the exo-79 isomer (57:43 e.r.).   
 
Asymmetric induction was also measured as a function of reaction conversion.  The 
trends mirror those obtained with (E)-73.  In the presence of one equivalent benzoic 
acid (figure 4.3), the exo:endo ratio decreases from 81:19 at 23% conversion to 76:24 
at 100%.  This is accompanied by a decrease in e.r. (endo-79) from 72:28 to 63:37 e.r. 
whereas e.r. (endo-79) remains essentially constant. 
 
Experiment Conversion (%) exo:endo e.r. (exo) e.r. (endo) 
1 23 81:19 58:42 72:28 
2 53 77:23 58:42 65:35 
3 78 65:35 53:47 62:38 
4 100 76:24 57:43 63:37 
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Figure 4.3: Bromolactonisation of (E)-78 in the presence of benzoic acid.   e.r.(exo) 
(■) does not change; e.r.(endo) (▲) decreases from 72:28 to 63:37 e.r.; and exo:endo 
(♦) decreases from 81:19 to 76:24. 
 
In the absence of additive (figure 4.4), e.r.(exo) decreases slightly with conversion, 
whereas e.r.(endo) remains constant.  The fluctuation in exo:endo ratio may be due to 
experimental error; the reaction was often irreproducible and sensitive to reaction 
variables such as temperature, substrate and additive concentrations.  The speed of the 
reaction (~ 1 minute at room temperature) meant that the specific temperature was 
difficult to control.  
 
 
 
 
 
Experiment Conversion (%) exo:endo e.r. (exo) e.r. (endo) 
1 21 80:20 62:38 - 
2 47 66:34 60:40 64:36 
3 100 78:22 55:45 64:36 
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Figure 4.4: Bromolactonisation of (E)-78 in the absence of benzoic acid.   e.r.(exo) 
(■) and e.r.(endo) (▲) remain constant with conversion; exo:endo ratio (♦) decreases 
from 80:22 to 78:22. 
 
The absolute stereochemistry of endo-74 and 79 were confirmed by direct comparison 
of their optical rotations to the literature.  These values were not available for the exo-
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lactones, and in fact exo-74 is a novel compound in enantioenriched form.  Therefore, 
tris-(trimethylsilyl)silane mediated radical dehalogenation of these compounds and 
comparison of the optical rotation of the de-brominated lactones to the literature was 
required for stereochemical assignment (scheme 4.11).  As for compound 158, the 
configuration at the centre bearing the bromine atom in exo-74 and exo-79 was 
assigned on the basis of diastereospecificity. 
 
 
Scheme 4.11: Determination of absolute configuration of exo- bromolactones 74 and 
79. 
 
To this point, all bromolactones had the same (S)-configuration at the centre of 
cyclisation.  Uniquely exo-74 has the (R) stereochemistry at this position, suggesting 
that the lactonisation step takes place from the opposite face. 
 
In order to rationalise these findings, it was first necessary to determine whether the 
reaction was reversible, in which case the enantiomer and constitutional isomer ratios 
would reach equilibrium values over time.  A similar experiment was performed in 
section 2.3.2 to prove that catalytic bromolactonisation of model substrate 114 was 
under kinetic control.    Resubmission of the product mixture 74 to standard reaction 
conditions for two hours showed no interconversion or change in e.r. strongly 
suggesting that the reaction was not reversible.  It was concluded that the catalyst’s 
performance must change over the course of the reaction, presumably due to 
decreasing total acid concentration with conversion.  This was also observed in the 
case of substrate 114, where product e.r. decreased with time in the absence of 
benzoic acid.  All these points will be discussed in more detail in the following 
chapters. 
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4.4 Bromolactonisation of o-vinyl and o-allyl Benzoic Acids 
 
o-Vinyl (146) and o-allyl (147) benzoic acids are structurally related to 78 but were 
expected to react with perfect regioselectivity because each alkenyl position is quite 
distinct.  A single report by Yeung9 has shown that 146 undergoes bromolactonisation 
to (R)-161 in a moderate 67:33 e.r.  With (DHQD)2PHAL, exo-(S)-161 was isolated as 
a racemate (scheme 4.12).  However, upon addition of benzoic acid there was a 
remarkable improvement to 83:17 e.r. which compares positively to the literature.  
The novel bromolactone 162 showed a similarly dramatic additive effect, and was 
isolated in 80:20 e.r.  Again, its absolute configuration was confirmed by radical 
dehalogenation. 
 
Scheme 4.12: Bromolactonisation 2-vinyl and 2-allyl benzoic acids. 
 
4.5 Kinetic Resolution by Bromolactonisation 
 
Kinetic resolutions (KR) are a practical method for synthesis of enantioenriched 
molecules from a racemic mixture.144 The basis of KR is that a chiral reagent 
preferentially catalyses the reaction of one particular substrate enantiomer.145 As such, 
their particular advantage is that the enantiomer ratios of both the recovered substrate 
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and product can be controlled by varying the reaction conversion.  With highly 
efficient catalyst systems e.g. the Sharpless146 and Jacobsen147 asymmetric 
epoxidations, essentially enantiopure products and substrates can be obtained at 
appropriate conversion.  Kagan has published extensively on the theory of kinetic 
resolutions145 and derived equations for calculation of e.r. with conversion for any 
catalyst with a given relative selectivity for a particular enantiomer. 
 
Recently, Kan et al. reported that cyclic-ene carboxylic acid 130 underwent kinetic 
resolution with (DHQD)2PYR and 0.5 equivalents NBS to return the starting material 
enriched to 92:8 e.r. and a 38% yield of -lactone product 131 with 93:7 e.r., which 
were excellent results for the first report of kinetic resolution by this method (scheme 
1.51).16  However, the authors commented that no reaction was observed at all when 
related catalyst (DHQD)2PHAL was employed.  We therefore decided to attempt the 
kinetic resolutions of two other substrates to determine whether this reaction was 
possible with the (DHQD)2PHAL:benzoic acid catalyst system.   
 
Substrate 150 was previously prepared as an inseparable 9:1 mixture of endo:exo 
diastereomers.  Although many possible bromolactonisation products were 
anticipated, only the fused tri-cyclic product 164, resulting from reaction of endo-150 
was isolated in 43% yield (at 50% conversion), unfortunately as a racemic mixture 
(scheme 4.13). 
 
 
Scheme 4.13: Kinetic resolution of substrate 150 by bromolactonisation. 
 
Pleasingly, better results were obtained with cyclopentenyl acetic acid (149) (scheme 
4.14).   After 55% conversion (determined by 1H NMR of the crude mixture), bicyclic 
bromolactone 163 was isolated in 48% yield and 67:33 e.r. (selectivity factor, s = 3.0).  
Typically, the absence of additive (BzOH) was mildly detrimental to e.r. (63:37) but 
made no difference to conversion within 1 hour. 
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Scheme 4.14: Kinetic resolution of substrate 149. 
 
The selectivity factor (s) was calculated using the following equation, where c = 
conversion and ee refers to product ee:145 
)]1(1ln[
)]1(1ln[
eec
eec
s


  
 
By rearranging the above equation for ee, it is possible to calculate the theoretical 
product enantiomer ratio at any conversion,145 as shown in figure 4.5 for the reaction 
of 149.  It is observed that the maximum possible enantioselectivity is 75:25 e.r. at 
<10% conversion.  However, when product e.r. was measured experimentally at four 
different conversions (figure 4.5), it was found that the e.r. at 7% conversion was 
81:19, equivalent to a selectivity factor equal to 4.6. 
 
 
 
Entry Conversion (%) e.r. (163) 
1 7.4 81:19 
2 19 76:24 
3 55.5 67:33 
4 85 56:44 
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Figure 4.5: Comparison of calculated and experimental values for the change in 
enantioselectivity of 163 with reaction conversion. 
 
It is unusual for the selectivity factor to decrease with conversion, and this suggests 
that the preferential recognition of one enantiomer also decreases as the substrate is 
consumed.  It has already been demonstrated that the catalytic performance of 
(DHQD)2PHAL is strongly dependent on the relative concentrations of carboxylic 
acids present in the reaction mixture, and the decrease in s-factor with conversion can 
be seen as further manifestation of this effect. 
 
4.6 Desymmetrisation by Bromolactonisation 
 
Desymmetrisation reactions have many similarities with KR.  However, in the former 
case the catalyst binds and preferentially catalyses one enantiotopic face of the achiral 
substrate.  Consequently, reactions may be run to completion. 
 
The desymmetrisation of dihydrobenzoic acid by bromolactonisation using 
the(DHQD)2PHAL-benzoic acid system returned the expected lactone product with 
64:36 e.r. and 40% yield within two hours, a small improvement on the reaction 
without benzoic acid (60:40 e.r., scheme 4.15).  This reaction is slow relative to other 
substrates, indicative of the high enthalpic barrier towards cyclisation.  The -lactone 
functional group of 107 was characterised spectroscopically by an IR carbonyl 
stretching frequency at 1803 cm-1.  Martin et al. reported slightly higher e.r. (73:27) 
and yield (72%) with bifunctional catalyst 106, albeit after four days at 50 ◦C and 
Kan showed that significantly greater enantioselectivities may obtained using 
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(DHQD)2PHAL (without benzoic acid) by ipso-substitution of the dihydrobenzoic 
acid ring (scheme 4.14).  
 
Scheme 4.15: Desymmetrisation of substrate 148 by bromolactonisation. 
 
Only 48% of the substrate was recovered, suggesting that some decarboxylation may 
have occurred, presumably to benzene (scheme 4.16), although clearly at a slower rate 
than for substrate 151 which gave 90% yield of the bromination-decarboxylation 
product (scheme 4.2).  This may be a consequence of the greater carbocationic nature 
of bromonium ion-148 stabilised by the adjacent phenyl group. 
 
 
Scheme 4.16: Consecutive bromination-decarboxylation of dihydrobenzoic acid 
generates benzene. 
 
4.7 Summary and Discussion 
 
The combined results (in the presence and absence of benzoic acid) and literature 
precedent with other catalyst systems are shown in table 4.2.  
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Table 4.2: Summary of substrate scope for (DHQD)2PHAL catalysed 
bromolactonisation. 
Entrya Substrate Productb e.r.c 
Literature 
e.r. 
1d  
114 
 
135 
91:9 
(83:17) 
94:665 
2d  
101 
 
102 
(94%) 
94:6 
(59:41) 
95:576 
3  
151 
 
197 
(90%) 
- 
 
 
 
- 
 
 
 
4d  
148 
 
107 
(40%) 
64:36 
(60:40) 
68:3278 
5  
153 
 
154 
- - 
6f 
 
157 
 
158 
(93%) 
86:14 
(83:17) 
- 
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7f  
159 
 
160 
(95%) 
69:31 
(67:33) 
- 
8d  
155 
 
156 
(98%) 
68:32 
(63:37) 
- 
9d  
(Z)-76 
 
exo-77 
(88%) 
91:9 
(82:18) 
96.5:3.512 
10d,g  
(E)-73 
 
      endo-74        exo-74   
endo:exo 57:43 
(44:56) 
endo: 
74:26 
(79:21) 
exo: 
67:33 
(61:39) 
 
98:266 
(endo-74) 
11d,g,h 
 
(E)-78 
   
endo-79        exo-79     
endo:exo 24:76 
(22:78) 
endo: 
63:37 
(64:36) 
exo: 
57:43 
(55:45) 
 
 
96:4 
(endo-79) 
 
58:42 (exo-
79)9 
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12d  
146 
 
161 
(95%) 
83:17 
(50:50) 
67:339 
13e 
 
147 
 
162 
(95%) 
80:20 
(50:50) 
- 
14i 
 
150 
 
164 
(43%) 
50:50 
(50:50) 
- 
15i 
 
149 
 
163 
(48%) 
67:33 
(63:37) 
- 
a Reaction conditions: 1.0 eq. NBS, 10 mol% (DHQD)2PHAL, 100 mol% benzoic acid, toluene (25 mM), 20 ◦C, 
1 h.; b values in brackets denote isolated yield after chromatography; c e.r. was determined by chiral HPLC or GC 
analysis.  Values in brackets denote e.r. without benzoic acid.  Absolute configuration determined by: d 
comparison of bromolactone optical rotation with literature; e comparison of de-bromo derivative to literature; f 
analogy to other products; g endo:exo ratio determined at 100% conversion; h 1:1 CHCl3:toluene used as solvent; i 
with 50 mol% NBS.   
 
In summary, excellent enantioselectivities (>90:10 e.r.) were obtained for three 
bromolactones, 135, 101 and (Z)-76 (entries 1-2, 9).  Products 158, endo-74, 161 and 
162 (entries 6, 10, 12-13) were formed with moderate asymmetric induction (>80:20 
e.r.) and the remaining products were isolated with poor asymmetric induction. 
 
Where comparable, the enantioselectivities obtained with the (DHQD)2PHAL:benzoic 
acid system are similar to the best results in the literature, although 
bromolactonisation of substrates (E)-73 and (E)-78 (entries 10 and 11) are notable 
exceptions.   Six novel enantioenriched bromolactones were also synthesised. 
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The additive effect varies significantly between substrates.  The most pronounced 
improvements of enantioselectivity are observed for bromolactonisation of 5-phenyl-
5-hexenoic acid 101 (entry 2) and in particular for o-vinyl and o-allyl benzoic acids, 
146 and 147 respectively (entries 12-13), where the products were isolated as a 
racemate in the absence of benzoic acid.  The influence of benzoic acid is more 
complex for the reaction of 1,2-disubstituted alkenes (E)-73  and (E)-78  (entries 10-
11), as the e.r. of endo-74 and endo-79 actually decrease in the presence of additive.  
In most cases benzoic acid conferred a small increase in e.r.  The stereoelectronic 
properties of the substrate which determine the magnitude of the additive 
enhancement with benzoic acid are unknown.  However, the ability of readily 
available reaction additives to tune the catalyst’s performance is a major advantage of 
this system.  Furthermore, we expect that given a full additive screen, the poorer 
enantioselectivities may be enhanced and we are currently developing a high 
throughput method for this purpose. 
 
4.8 Mechanistic Insights from Substrate Screening 
Experiments 
 
In all cases where it is directly observable (entries 6, 9, 10-11, 15), the 
bromolactonisation reactions proceeded diastereospecifically to give a relative anti-
configuration between bromine and carboxylate substituents.  This is indicative of 
SN2 ring opening of an intermediate bromonium ion.  In contrast, Borhan
83 observed 
the syn-diastereomer as the major product in the chlorolactonisation of 114-D using 
the same (DHQD)2PHAL:benzoic acid system (scheme 4.17).  The syn-relative 
stereochemistry was proven by base mediated degradation of chlorolactone 115 to 
terminal epoxide 201 from which a nOe interaction was observed between proton HA 
and a methylene group of the alkyl chain. 
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Scheme 4.17: NMR assignment of the absolute stereochemistry of chlorolactone 115 
by reduction and base-mediated epoxidation.83 
 
This outcome was rationalised on the basis that chlorine addition to the alkene is 
directed with high enantioselectivity for the pro-R face (scheme 4.18).  This 
determines the R stereochemistry at C6.  However, stereochemical integrity at C5 is 
lost by ring-opening of the chloronium ion to the carbenium ion form which is 
stabilized by the adjacent aromatic ring.  The absolute configuration at C5 is thus set 
by the enantioselective cyclisation step, also favouring the pro-R face of the original 
alkene to give the major syn-(R,R) configuration.  Consequently, asymmetric 
induction relies on efficient and synergistic facial selectivities of both consecutive 
chlorination and lactonisation steps. 
Scheme 4.18: Stereochemical course of Borhan’s chlorolactonisation system. 
 
The diastereospecificity of bromolactonisation for the anti-stereochemistry strongly 
suggests that the intermediate of alkene bromination retains its bromonium ion 
character and does not rearrange to the carbocationic resonance form.  This is 
consistent with well known properties of bromonium and chloronium ions.   
 
An alternative, but less convincing interpretation is that the -bromocarbenium ion is 
prevalent but that the facial selectivity of cyclisation is reversed in the 
bromolactonisation reaction.  Indeed, bromo- and chlorolactone 135 and 115 do have 
the opposite configuration at C5.  However, in this scenario general 
diastereospecificity across all substrates would not be expected: Borhan observes 10% 
of the anti- diastereomers.   
 
  
147 
Instead, we propose that both diastereospecificity and enantioinduction are 
determined by a stereoselective, irreversible bromination step.  This overrides any 
selectivity of lactonisation, as cyclisation must proceed anti- to the bromonium ion. 
 
In order to prove this hypothesis, it is necessary to look at the absolute configurations 
of the product bromolactones obtained above.  Leaving aside substrates (Z)-76, (E)-73 
and (E)-78 which give mixtures of exo- and endo-isomeric products for the present, it 
is observed that all the bromolactones isolated in the substrate screen share the same 
facial selectivity for bromination (and therefore cyclisation) steps.  The 
stereochemical course of the bromolactonisation reaction can be represented by 
generalised transition state models which invoke a chair-shape conformation (or 
envelope for -lactones), as shown in scheme 4.19:  
 
 
Scheme 4.19: Bromination is directed towards the pro-R alkene face for all 
bromolactonisation substrates. 
 
For 1,1-disubstituted alkenes 114 and 101, the model requires that the phenyl ring 
adopts a pseudo-equatorial conformation in the TS.  There is some contrary evidence 
to this assertion.  Yeung et al. have obtained an X-ray structure of the p-
fluorophenyl14 analogue of -lactone 101, which actually shows that the aromatic ring 
is pseudo-axial (scheme 4.20).  Overall the lactone adopts a half-chair conformation.  
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In addition, combined 13C NMR148 and computational analysis149 of the 
conformations of 1-phenyl-1-methylcyclohexane also suggested an axial inclination 
for the aromatic.  The reason for this unintuitive preference is that the phenyl group 
can twist 65◦ to avoid 1,3-diaxial strain, unlike the methyl group (scheme 4.20).148  
This twist can be observed in Yeung’s X-ray structure (61◦).  However, the ring-flip 
barrier is only 0.3 kcal/mol at equilibrium.   
 
 
Scheme 4.20: a X-ray crystal structure of (S)-6-(bromomethyl)-6-p-
fluorophenyloxan-2-one obtained by Yeung et al. b Ring flip barrier for 1-phenyl-1-
methylcyclohexane. 
 
Under catalytic bromolactonisation conditions, H-bonding and other intermolecular 
interactions between the substrate bromonium ion and the catalyst will contribute to 
the conformational orientation in the transition state, so it is not possible to definitely 
assign the conformation. 
 
However, assuming an equatorial phenyl ring greatly simplifies stereochemical 
analysis.  In this way bromination is consistently directed towards the pro-R face of 
the alkene, in common with Borhan’s observation for chlorolactonisation.83  If 
cyclisation were enantiodetermining, the bromolactone 135 would be expected to 
have the same C5-configuration as chlorolactone-115 which is not the case. 
 
Furthermore, we have demonstrated that the bromonium ions generated in this system 
are configurationally stable to racemisation by alkene-alkene exchange (section 2.4).  
Therefore, the only mechanism for non stereo-determining bromonium ion formation 
is via reversible bromine exchange between the alkene and NBS or the N-brominated 
catalyst.  This will be discussed in detail in section 5.9. 
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4.9 Interpretation of Results for Bromolactonisation of 1,2-
Disubstituted Alkenes 
 
There are several observations for the bromolactonisation of (Z)-76 and (E)-73 and 
(E)-78 which need to be mechanistically resolved.  Firstly, (Z)-76 cyclises to give the 
exo-bromolactone exclusively, whereas (E)-73 and 78 generate mixtures of exo- and 
endo- products.  Secondly, the constitutional isomer and enantiomer ratio of each 
product varies with reaction conversion.  Finally, comparison of the absolute 
configuration of exo-74 and endo-74 suggests that the major enantiomer of each is 
formed by bromination on opposite alkene faces, whereas exo-79 and endo-79 share 
the same (5R,6R) bromonium ion.   
 
In Denmark’s system for bromocycloetherification of (E)-55 and (Z)-52 alkenols 
catalysed by BINOL-phosphate 47 (scheme 1.27),59 it was also observed that (Z)-52 
generated the exo-THF bromoether 53 specifically, whereas (E)-55 formed a 45:55 
mixture of exo-56:endo-56 isomers, respectively.  This was rationalised on the basis 
that the phenyl substituent can adopt a pseudo-equatorial conformation in the 
transition states leading to both exo-56 and endo-56 from (E)-55.  In contrast, 
formation of endo-53 from (Z)-52 requires an unfavourable Ph-axial conformation.  
This phenomenon has also been observed in other olefin-addition induced 
cyclisations.42, 150 
 
Analogous transition states can be proposed for (DHQD)2PHAL catalysed 
bromolactonisation, accounting for the absolute product configurations obtained 
(scheme 4.21). 
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Scheme 4.21: Proposed transition state models for the bromolactonisation of (Z)-76, 
(E)-73 and (E)-78 catalysed by (DHQD)2PHAL. 
 
The models for formation of bromo-benzofuran (exo-79) and benzopyran (endo-79) 
products from (E)-stilbene carboxylic acid (78) are more tentative, as the high levels 
of unsaturation make half-chair conformations unlikely and there are no diaxial 
protons to disfavour a Ph-pseudo axial orientation.  In future work, further 
conformational information on (E)-78 could be acquired by comparison with regio- 
and enantioselectivity results for bromolactonisation of the (Z)-alkene isomer.  In 
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contrast, endo-77 is not observed due to torsional strain in the transition state towards 
its formation from (Z)-76. 
 
Scheme 4.21 shows that bromonium ion formation takes place on the pro-R1 face of 
(Z)-76 to form (S,S)-exo-77, (E)-78 towards (5S,6R)-exo-79 and (5R,6S)-endo-79, and 
(E)-73 towards (5R,6S)-endo-74.  This is in common with all previous examples.  
Uniquely, the enantiomeric transition state is required for producing the major 
enantiomer of exo-74.  The reasons for this change are discussed in the following 
section. 
 
                                                 
1 More specifically, the (R) configuration at C5 of the bromonium ion, the centre of cyclisation, is 
maintained. 
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4.10 Discussion of Change in e.r. with Conversion for 
Bromolactonisation of (E)-73 and 78 
 
It is a striking feature of the bromolactonisation reactions of (E)-73 and 78 that the 
enantiomer ratios of exo and endo products are neither equal, nor constant with 
reaction conversion.  Yeung9 observed that endo-79 was isolated with lower e.r. than 
exo-79 in the bromolactonisation of 78 catalysed by aminothiocarbamate catalyst 75, 
and Denmark59 reported similar results for the bromocycloetherification described 
above.  Jacobsen151 studied this phenonemenon in detail for Mn/salen catalysed 
epoxidations reactions (scheme 4.22).   
 
Scheme 4.22: System used by Jacobsen et al. to study reactions where product 
enantioselectivity is controlled by two consecutive stereoselective steps.151 
 
The epoxidations of cis-1,2-disubstituted olefins resulted in mixtures of syn- and anti-
epoxides at reaction completion each with very different enantiomeric excesses.  For 
example, for R1 = Ph, R2 = CO2Et, e.r.(syn) = 96:4, e.r.(anti) = 82:18. Control 
experiments proved that (Z) to (E)- alkene isomerism was not occurring; in fact initial 
oxygen transfer from the catalyst to alkene is stereoselective and irreversible.  
Diastereomeric products arise because oxygen transfer is not concerted, and forms a 
radical intermediate at the centre best able to stabilise it, with consequent loss of 
stereochemical information at this position.151   
 
Subsequent ring closure is also diastereoselective, giving an excess of either the syn- 
or anti-isomers.  The enantiomer ratios of each diastereomer are not equal because the 
diastereoselectivity of ring closure is different for each radical intermediate, A and B.  
Accordingly, asymmetric induction is determined by two independent factors: 
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enantioselectivity of initial oxidation (termed e.r.facial) and the relative 
diastereoselectivities of cyclisation ([kR]syn/[kR]anti vs. ([kS]syn ([kS]anti).  In this way 
high enantioselectivities may be obtained even when e.r.facial is moderate.   
 
The parallels with (DHQD)2PHAL catalysed bromolactonisation are numerous.  
Initial bromination is selective for a particular alkene face; both enantiomeric 
bromonium ions are presumably bound to the chiral catalyst, so have different 
energies and therefore different regioselectivities for cyclisation.  Using experimental 
data for regioselectivity and enantiomer ratios of exo-74 and endo-74 at 21% 
conversion, the proportion of each product isomer was calculated (scheme 4.23).  
 
 
Scheme 4.23: Initial bromination of (E)-73 proceeds with formation of either (S,S) or 
(R,R) bromonium ions.  The exo:endo cyclisation selectivity is not necessarily the 
same for each bromonium ion. 
 
The results show that bromination is essentially unselective (e.r.facial = (S,S):(R,R) 
bromonium ions = 51:49).  As a result, product e.r. is generated because the (S,S)-
bromonium ion cyclises with much greater regioselectivity for exo-74 (45.6:3.6 
exo:endo) than the (R,R)-bromonium ion (30.4:20.4 exo:endo).  The same analysis 
was performed using data at 49, 65 and 100% conversion, as shown in table 4.3. 
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Table 4.3 
 
Conversio
n 
exo 
(%
) 
end
o 
(%) 
e.r.(exo) 
(5S,6R):(5R,6S
) 
e.r.(endo) 
(5R,6S):(5S,6R
) 
e.r.facial 
(for (R,R)-
bromoniu
m ion) 
exo:endo 
for (R,R) 
bromoniu
m ion 
exo:endo 
for (S,S) 
bromoniu
m ion 
21 76 24 40:60 85:15 51:49 60:40 93:7 
49 73 27 38:62 73:27 47.5:52.5 58.5:41.5 86:14 
65 47 53 36:64 68:32 53:47 32:68 64:36 
100 43 57 33:67 74:26 56.5:43.5 25:75 66:34 
The results show that bromination remains unselective.  However, both bromonium 
ions become increasingly endo-selective.  This is more pronounced for (R,R)-
bromonium ions, where regioselectivity switches to favour the formation of (5R,6S)-
endo-74 after 65% conversion.  Consequently, more of the minor (5S,6R)-exo-74 and 
more of the major (5R,6S)-endo-74 are formed, which explains why e.r.(exo) 
decreases while e.r.(endo) increases with conversion. 
A similar analysis was performed for bromolactonisation of 2-stilbene carboxylic acid 
(78) (table 4.4). 
 
Conversio
n 
exo 
(%
) 
end
o 
(%) 
e.r.(exo) 
(5S,6R):(5R,6S
) 
e.r.(endo) 
(5R,6S):(5S,6R
) 
e.r.facial 
(for (R,R)-
bromoniu
m ion)  
exo:endo 
for (R,R) 
bromoniu
m ion 
exo:endo 
for (S,S) 
bromoniu
m ion 
23 81 19 58:42 72:28 60.5:39.5 77.5:22.5 86.5:13.5 
53 77 23 58:42 65:35 59.5:40.5 75:25 80:20 
78 65 35 53:47 62:38 56:55 61:39 69.5:30.5 
100 76 24 57:43 63:37 58.5:41.5 74:26 78.5:21.5 
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In this case, there is a small but evident selectivity for bromination on the (R,R) 
alkene face.  This may explain the observation that both major products, (5S,6R)-exo-
79 and (5R,6S)-endo-79 are both generated from the same bromonium ion.   Unlike 
for substrate 73, lactonisation is overall exo selective throughout the reaction, 
although there is a small decrease with conversion.  The fact that e.r.(endo) > e.r.(exo) 
may be accounted for because the minor (S,S) bromonium ion has a greater exo 
selectivity than the (R,R) isomer.    
 
4.11 Conclusion 
 
The substrate screening experiments gave several insights into (DHQD)2PHAL 
catalysed bromolactonisation reactions.  By comparison to Borhan’s results on 
chlorolactonisation,83 a mechanism of asymmetric induction could be proposed.  It 
was concluded that for all substrates except (E)-73 and (E)-78, alkene bromination is 
the enantio-determining step, and that the intermediate scalemic bromonium ion is 
opened diastereospecifically via an SN2 reaction.   
 
For all substrates (excluding (E)-73), the bromine atom is selectively directed towards 
the pro-R alkene face.  Borhan et al. observed the same selectivity for chlorination.  It 
was found that the intermediate chloronium ion opens to the carbocation form with 
consequent loss of configurational information at the centre of cyclisation.  This 
information is recovered because hydrogen-bonding interactions between the chiral 
catalyst and the carboxylic acid determine the selectivity of lactonisation towards the 
pro-R alkene face.  However, a diastereomeric product mixture is obtained because 
the selectivities of the individual chlorination and cyclisation step are not perfect. 
 
In contrast, bromolactonisation proceeds diastereospecifically to give anti relative 
stereochemistry between bromine and carboxylate groups, confirming the presence of 
an intermediate bromonium ion.  Furthermore, the configurational stability of 
bromonium ions in the (DHQD)2PHAL system to alkene-alkene exchange has been 
demonstrated.  Therefore, despite presumably similar interactions between the 
catalyst and substrate carboxylic acids in both chloro- and bromolactonisation 
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reactions, and a natural preference for the pro-R face, the stereoselectivity of 
lactonisation is dictated by the stereochemistry of the bromonium ion, and attack 
takes place via the pro-S alkene face. 
 
These results also provide evidence that bromination is irreversible, and agree with 
indications from the kinetic investigation in section 2.5 that this step is rate-
determining: if bromine addition occurred reversibly and unselectively e.g. by 
exchange with NBS, enantioselectivity would be dictated by the natural bias of the 
cyclisation step for the pro-R face.  However, all products (except exo-74) possess the 
S-configuration at the centre of nucleophilic attack. 
 
Asymmetric induction in the bromolactonisation of (E)-alkene containing substrates 
73 and 78 is more complex.  In these examples, enantioselectivity is determined by 
the initial bromination step and by the requirement that the regioselectivity of 
lactonisation is different for each of the diastereomeric bromonium ions.  This effect 
is most pronounced for (E)-73, where bromination is completely unselective.  Despite 
this, (5R,6S)-endo-74 is isolated with high e.r. because formation of the enantiomeric 
(5S,6R)-endo-74 generated from the (S,S)-bromonium ion is disfavoured, perhaps due 
to repulsive interactions between the catalyst and 6-phenyl substituent.  By this 
rationalisation, it is theoretically possible to obtain the major product in near 
enantiopurity if the disparity in regioselectivity is maximised.  In future work, we plan 
to test this hypothesis with substrate 201, possessing a bulky anthracenyl substituent 
which should maximise repulsive interactions, suppressing the formation of the 
(5S,6R) enantiomer. 
 
 The magnitude of the additive effect on enantioselectivity was found to be strongly 
substrate dependent.  For substrates 101, 146, 147, product ee diminished by over 
60% in the absence of benzoic acid.  However, in most cases the influence of excess 
benzoic acid was less marked.  Although evidence suggests that bromination is stereo-
determining, it is likely that the face selectivity of this step is determined by strong 
hydrogen-bonding interactions between the substrate carboxylic acid and the catalyst, 
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which control the conformation of both components.  In the following chapter, the 
structures of (DHQD)2PHAL:carboxylic acid complexes are studied with the aim of 
rationalising the additive effect. 
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5 Conformational Studies of 
(DHQD)2PHAL:Carboxylic Acid H-bonded Complexes 
 
In the previous chapters, it was established that the enantioselectivity of 
bromolactonisation is strongly influenced by the total acid concentration in solution.  
This effect is manifested by a deterioration of product e.r. with substrate conversion.  
Addition of excess benzoic acid can recover and often enhance enantioselectivity.  
For bromolactonisation of (E)-alkenoic acids 73 and 78, acid concentration also 
affects the regioselectivity of lactonisation towards 5-exo or 6-endo bromolactones.   
 
In order to rationalise these observations, we considered that a pertinent strategy was 
to obtain detailed structural information on the hydrogen-bonded complexes between 
(DHQD)2PHAL and carboxylic acids, with particular emphasis on catalyst and 
substrate conformations, the basic site(s) of association, binding cooperativity and 
stoichiometry at different acid concentrations. 
 
A simple yet informative method of gathering this data is to study isolated 
(DHQD)2PHAL:carboxylic acid equilibria by 
1H NMR spectroscopy.  This strategy 
has been used by Hennecke86 and Tang63 to provide evidence for 
substrate:(DHQD)2PHAL interactions in bromofunctionalisation reactions, as detailed 
in the introduction.  However, the precise nature of association was not examined. 
 
The validity of this approach depends on whether equilibrium is reached and 
maintained under reaction conditions, despite substrate depletion. The kinetic 
investigation described in section 2.5 provided some evidence that alkene bromination 
is rate-determining, such that (DHQD)2PHAL:carboxylic acid complexes are the 
catalyst resting state.  However, it is not known whether the pre-equilibrium 
approximation may be assumed throughout the reaction.  In addition, the presence of 
other reaction components may disrupt catalyst:carboxylic acid equilibrium constants, 
for example via irreversible catalyst N-bromination.  This point will be addressed by 
study of ternary mixtures of NBS, carboxylic acids and (DHQD)2PHAL. However, 
initial work was directed towards the elucidation of catalyst conformations in the 
presence of carboxylic acids. 
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5.1 Conformations of Cinchona Alkaloids 
 
The torsion angles which determine the conformational space of cinchona alkaloids 
are shown in figure 5.1 (for dihydroquinidine p-chlorobenzoyl ester) (202) and are 
labelled as follows, using Sharpless’ numbering:152  (< H8-C9-C8-H9),  (< C3’-
C4’-C9-C8),  (< C8-C9-O9-C1’’),  (< C9-O9-C1’’-C2’’) and e (< H9-C8-C7-H11).   
 
Figure 5.1: Torsion angles of p-chloro benzoyl dihydroquinidine (202) relevant to 
asymmetric catalysis. 
 
When cinchona alkaloids are used in Lewis or Brønsted base catalysis, e.g. in 
asymmetric dihydroxylation153 or conjugate addition154 reactions, the primary 
interaction with the substrate involves a dative bond or hydrogen bonding to the 
quinuclidine nitrogen.  As a result, the torsion angles  and  are crucial for 
enantioselectivity, as they determine the spatial relationship between quinuclidine and 
the adjacent quinoline and O9-substituents.   
 
The torsion angle  describes rotation around the C8-C9 bond.  Detailed studies by 
Sharpless152 and Wynberg155 (for dihydroquinidine derivatives) and Baiker and 
Bürgi156 (for cinchonidine) have shown that there are two potential energy minima 
(figure 5.2): at = 180◦ where H8-H9 are anti and the quinuclidine N is directed 
towards the quinoline ring; and = 60◦, resulting from a 120◦ rotation around the C8-
C9 bond such that H8 and H9 are gauche and quinuclidine N is now oriented away 
from the quinoline moiety  
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Figure 5.2: Staggered conformations described by torsion angle Q = 6-methoxy 
quinoline. 
 
The remaining staggered conformation, = 300◦ (H8 and H9 are gauche) is 
disfavoured due to steric clashing between the quinoline ring and the ethyl substituent 
at C3. 
 
The dihedral angle  describes rotation around the C4’-C9 bond, and consequently the 
direction of the quinoline ring vector.  Sharpless152 and Baiker156 have identified 
minima at  = 90 ± 10◦ where the aryl methoxy (OCH3) group of the quinoline ring 
faces towards the quinuclidine N, and  =+ 90 ± 10◦, where OCH3 points in the 
opposite direction.  The two  rotamers are shown in figure 5.3 for benzoyl 
dihydroquinidine 202 in the anti conformation.  In both cases, the orthogonality of 
C4’-C9 and C8-C7 bonds minimises steric clashes between quinoline and 
quinuclidine ring hydrogens.  However, Baiker et al.157 recently discovered a low 
energy rotamer of cinchonidine with  =+ 17◦, allowing an intramolecular hydrogen 
bond between O9-H and N1. 
 
Figure 5.3: Energetically favoured values of torsion angle 

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The angles  and  are determined by the nature of the O9-substituent.152  For 
example, the X-ray crystal structure of (p-chloro-benzoyl) dihydroquinidine 202152 
indicates that = 172◦ to ensure conjugation of O9 lone pair into the benzoyl -
system, and  = 240◦ such that the benzoyl group and quinoline are anti (figure 5.4).
9
8
3’
O9
4’
1’’
2’’
 
Figure 5.4: Crystal structure of (p-chloro-benzoyl) dihydroquinidine 202, showing 
torsion angles and 
 
It is generally observed that the quinuclidine ring twists in order to relieve 1,3-diaxial 
strain caused by eclipsed vicinal ring hydrogens and also the C3-ethyl substituent 
(figure 5.5).152  The twist may occur in two directions, forming either a right-handed 
or left-handed screw (when viewed along the pseudo-C3 axis from N1 to C4).  
Pseudo-enantiomeric cinchona alkaloid pairs are distinguished by a quinuclidine twist 
in opposite in opposite directions: quinidine forms a right-handed screw and quinine 
forms a left-handed screw.  This has been posited as an explanation for the small, but 
constant difference in enantioselectivity observed with pseudo-enantiomeric 
catalysts.158  
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Figure 5.5: Schematic of quinuclidine ring twist caused by 1,3-diaxial strain to form 
either a right-handed or left-handed screw.152 
 
The magnitude of this twist (e) is described by the sum of the three component torsion 
angles torsion angles, and varies from 26◦ to 65◦.152  However, e can be modified by 
varying the steric bulk (A-value) of the C3 substituent.  The torsion angle decreases in 
the order dihydroquinidine >quinidine>de-hydroquinidine (203),158 which highlights 
that torsional strain between C2 and C3 substituents is the dominant contribution 
towards the quinuclidine twist.   
 
In general, conformational analyses of cinchona alkaloids relevant to catalysis focus 
on the conformers with different combinations of  and  (figure 5.6).  The relative 
energies of the four possible conformations defined by minimum energy values of 
torsion angles  and  have been calculated by Sharpless and Wynberg152 for a range 
of dihydroquinidine derivatives using a molecular mechanics approach, and by Baiker 
et al.156 for cinchonidine at the Hartree-Fock level.  The results showed that three 
conformers, anti(1), anti(2) and gauche(1) are accessible at room temperature.  The 
reason why gauche(2) ( = 60◦,  = +90◦) is disfavoured has not been discussed, but 
steric repulsion between the quinoline methoxy group and C3-ethyl substituent may 
be invoked.  For the pseudo-enantiomeric alkaloids, dihydroquinine and 
dihydrocinchonidine, which retain C3 stereochemistry but have opposite 
configurations at C8 and C9 relative to dihydroquinidine, the inaccessible gauche(2) 
conformation is characterised by the torsion angles,  = 60◦,  = 90◦.156 
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Figure 5.6: Conformations described by minimum energy values of torsion angles  
and  of dihydroquinidine derivatives.  
 
The populations of the three remaining conformations depend on several parameters, 
such as the O9-substituent,152 solvent,156,159 interacting co-solutes152,160 and the 
presence of metal surfaces.161   
 
Sharpless and Dijkstra found that large and electron withdrawing O9 substituents 
favour adoption of the anti conformers.  For example, (p-chloro-benzoyl) 
dihydroquinidine 202 prefers the anti rotamer (which of the two was not determined), 
whereas the methyl ether (204) and the parent alkaloid dihydroquinidine both adopt 
the gauche(1) conformation in chloroform solution (figure 5.7).152  A possible 
explanation for this effect is that steric clashing between the large benzoyl substituent 
(in 202) and quinuclidine ring are minimised in the anti conformations. 
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Figure 5.7: The effect of O9-substituent on catalyst conformation.152 
 
In their respective studies, Sharpless152 and Baiker156 also found a striking difference 
in dipole moments between anti and gauche conformers, as shown in figure 5.8 for 
acetyl dihydroquinidine 205.   
 
Figure 5.8: Dipole moments of anti and gauche conformations of acetyl 
dihydroquinidine 205.152 
 
The gauche conformations of dihydroquinidine derivatives can have dipole moments 
up to ~2 Debye lower than anti, although the exact values depend on the O9-
substituent.  Although it has not been discussed in the literature, this is perhaps 
because the co-directional alignment of quinoline and quinuclidine N lone pairs 
reinforces the net dipole in the anti conformation.  A consequence of this disparity is 
that the gauche conformations are stabilised in apolar solvents e.g. CH2Cl2 and 
toluene, and vice versa in polar media.152, 156 
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It has also been shown experimentally that coordination of benzoyl ester 202 to a 
Lewis (OsO4) or Brønsted acid (TFA) caused a transition from anti to gauche 
conformations in solution.152  This was revealed using a combination of NMR 
techniques, which are described in the following section.  Similarly, Zaera et al.160 
found that protonation of cinchonidine with HCl or HF leads to restriction of rotation 
around the C8-C9 and C4’-C9 bonds, constraining the alkaloid in the gauche(1) 
conformation (figure 5.9a).  This is upheld by steric and coulombic repulsion between 
the conjugate base and quinoline ring, as confirmed by heteronuclear nOe’s between 
fluoride, H5 and H8.  The conformational rigidity of protonated cinchonidine can also 
be observed from published X-ray crystal structures of salts with mandelic acid162 
(figure 5.9b) and citronellic acid163 (figure 5.9c), where the gauche(1) rotamer is 
observed in each case. 
 
 
  
 
 
 
 
Figure 5.9: Protonated cinchonidine is constrained by conjugate base in the 
gauche(1) conformation, as demonstrated by a heteronuclear nOe’s between fluoride 
anion, benzylic H8 and quinoline H5; b X-ray crystal of cinchonidine salt with 
mandelic acid; c salt with citronellic acid.  
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5.2 Experimental Determination of Cinchona Alkaloid 
Conformations 
 
The populations of cinchona alkaloid conformational isomers are determined by many 
competing factors.  In addition to ab initio calculations,157 several experimental 
techniques have been developed to identify and quantify particular conformers in 
complex solution environments.159, 164 
 
The most direct indication of torsion angle  is obtained using 1H NMR spectroscopy, 
from the 3J8-9 coupling constant via application of the Karplus
165 or related Altona166 
equations.  Baiker et al. have extended this method to the quantification of conformer 
populations for cinchonidine, as shown in figure 5.10. 
 
Figure 5.10: Major conformations and associated 3J8-9 coupling constants for 
cinchonidine. 
 
When the rate of interconversion between rotamers is fast on the NMR timescale,156 
the observed coupling constant, 3J8-9(obs), is an average of the couplings for individual 
isomers weighted by the population (or mole fraction, f) of each, as represented in 
equation 5.1.   
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The  torsion angles, and therefore coupling constants of the conformational 
extremes, 3J8-9(i), are determined by ab initio calculations.  The gauche(2) state is not 
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considered as it is not accessible at room temperature.  Provided that both anti(1) and 
anti(2) rotamers have essentially the same torsion angle, it is assumed that they also 
have the same 3J8-9 value (
3Janti(1) = 
3Janti(2)) as the sign of  should not influence the 
coupling constant.  In this way, the sum of anti conformers and gauche(1) populations 
are calculated.156 
In conjunction, inter-ring nOe cross-peaks between quinuclidine and quinoline 
protons can be used for identification of individual  rotamers and independent 
validation of torsion angle , as shown in figure 5.11 for dihydroquinidine 
derivatives.  For each conformation the expected cross-peaks are listed, and those 
unique to a particular rotamer highlighted in bold.   
 
Figure 5.11: NOESY cross-peaks can be used to identify individual conformations. 
 
For example, Sharpless152 confirmed the preference of benzoyl ester 202 (R = p-Cl 
benzoyl) towards the anti(1) conformation by this method.  Irradiation of proton H5 
enhanced H8, indicating 90◦ (anti(1) or gauche(1)).  An additional inter-ring nOe 
between H9 and H1 confirmed the anti(1) orientation.  Conversely, the gauche 
preference of methyl quinidine152 (204, R = Me) was assigned on the basis of cross 
peaks from H8 and H9, and a further nOe between H1 and H10 confirmed gauche(1), 
90◦.  In principle, anti(2) and gauche(2) could be detected by cross peaks from 
H1 to H8 and H18, and from H5 to H10, respectively.  Calculation of populations is 
not generally possible using NOESY, as accurate integration of cross-peaks requires 
knowledge of interatomic distances and rotamer lifetimes.  However, an elegant 
example of the power of this technique in combination with DFT calculations has 
been published recently.157 
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5.3 Conformations Of Bis-Cinchona Alkaloid Catalysts 
5.3.1 Literature Precedent 
 
There have been relatively few conformational studies of dimeric cinchona alkaloid 
catalysts.  Sharpless81 has published the X-ray crystal structure of (DHQD)2PHAL 
from EtOAc-toluene (figure 5.12).  In this structure, each quinidine is H-bonded to a 
molecule of water and adopts the gauche(1) conformation, where  = 80◦  and  = 
78◦.  The torsion angle  = 165◦ such that the phthalazine ring is anti to 
quinuclidine, and  = 2.5◦ to allow conjugation of the O9 p-orbital into the phthalazine 
-system.  Overall the ligand is C2 symmetric with the axis of rotation through the 
centre of the phthalazine spacer. 
8
9
3’
4’
O9
N1
2’’
N1’’



 = 80◦,  = 78◦,  = 165◦,  = 2.5◦  
Figure 5.12: X-ray crystal structure of (DHQD)2PHAL.
81 
 
The conformations of (DHQD)2PHAL were also studied in chloroform solution using 
NOESY NMR.167  Cross peaks between H8, H10 and H18 indicated that the anti 
conformations are preferred, in contrast to the solid state, but  = ±90◦ rotamers could 
not be distinguished (figure 5.13). 
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Figure 5.13: NOESY cross-peaks observed by Sharpless et al. for (DHQD)2PHAL in 
CDCl3.  Cross-peaks highlighted in red were observed, and those in bold are unique to 
a particular conformation. 
 
Lin and co-workers168 have reported the crystal structure of a phthalazine linked bis-
(de-methyl dihydroquinine) catalyst for conjugate addition of malonates to nitro-
olefins (figure 5.14).  Each unit cell contains two catalyst molecules and three of 
methanol.  The preferred structure is unusual, as in one catalyst molecule individual 
alkaloid units adopt opposite anti(1) and gauche(1) conformations, whereas in the 
other both favour gauche(1).  This is to allow an intermolecular hydrogen-bond 
between donor quinoline OH of one catalyst molecule and acceptor N1’ of the other 
(1.9 Å, figure 5.14).  Uniquely, the monomeric unit in the anti(1) rotamer is not H-
bonded to methanol, suggesting that the gauche(1) state is required for guest binding. 
 
3’
4’
9
8
OH
1.9 Å
O99
8
N1’
= 176◦,  = 68◦,  = 156◦,  = 6.0◦
anti(1)
= 80◦,  = 102◦,  = 136◦,  = 18◦
gauche(1)
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Figure 5.14: X-ray crystal structure of bis-(de-methyl quinine) phthalazine, 
synthesised by demethylation of the quinoline aryl ether.168 
 
Sharpless167 and Corey169 have also examined the conformational properties of bis-
cinchona alkaloids in the context of the Sharpless asymmetric dihydroxylation (SAD) 
reaction.  It was found that association of OsO4 to (DHQD)2PHAL constrained both 
quinidine units in the gauche(1) conformation, identified by a decrease in the 3J8-9 
coupling constant and by characteristic NOESY cross peaks from H5 to H8, and from 
phthalazine proton H1’ to H1 and H18 (figure 5.15).167 
 
 
Figure 5.15: nOe interactions observed in 1:2 (DHQD)2PHAL:OsO4 complex 
indicate the gauche(1) conformation.167 
 
This conformational rigidity sets up formation of a binding pocket in which aromatic 
alkene substrates associate through  interactions with the quinoline and 
phthalazine rings, as represented by Corey for dihydroxylation of styrene using 
(DHQD)2PYDZ as the chiral ligand (figure 5.16).
169b 
 
 
Figure 5.16: Representation of binding pocket of (DHQD)2PYDZ (206) for 
asymmetric dihydroxylation of styrene.169b 
 
Kinetic investigations revealed that each quinidine of the (DHQD)2PHAL dimer 
functions as an independent catalyst, such that the effective catalyst concentration 
may be considered double that of a monomeric catalyst.167  Under reaction conditions, 
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Corey and Noe169a, 170 proposed that the substrate alkene and OsO4 pre-associate to the 
catalyst with a 1:1:1 stoichiometry prior to osmate ester formation.  The 
conformational rigidity of the unbound quinidine in the gauche(1) conformation is 
maintained by hydrogen bonding to the protic medium (t-BuOHH2O). 
 
 
5.3.2 Conformational Studies of (DHQD)2PHAL:Carboxylic Acid H-
Bonded Complexes 
 
From the outset, the objective of our investigation was to elucidate the structures of 
H-bonding complexes between (DHQD)2PHAL and carboxylic acids (pKa = 0-5), 
such as the additives and substrates used in the bromolactonisation reaction, using a 
combination of NMR and crystallographic techniques. 
 
On the basis of pKa differences between relevant carboxylic acids and the three 
distinct basic catalyst sites,2 it is expected that H-bonding interactions to quinuclidine 
will dominate.  It may therefore be assumed that (DHQD)2PHAL has three possible 
binding stoichiometries, depending on the degree of protonation: the free catalyst, 1:1 
and 1:2 complexes (scheme 5.1).  Within each complex, quinidine may adopt anti ( 
= 180◦) or gauche ( = 60◦) conformers with  = 90◦ (1) or  = 90◦ (2), giving in 
principle a total of 36 conformational combinations. Of course, literature precedent 
suggests that many of these are inaccessible, such as gauche(2) and anti when 
quinuclidine is bound. 
 
 
Scheme 5.1: Structures of free catalyst, 1:1 and 1:2 (DHQD)2PHAL:carboxylic acid 
complexes. 
 
                                                 
2 The aqueous pKaH of quinuclidine (within quinidine) = 8.6, pKaH (quinoline) = 4.9, pKaH(phthalazine) 
= 3.4 (section 2.3.3). 
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Initially, we aimed to determine the available conformations of free (DHQD)2PHAL 
in solution, and to address whether carboxylic acids promote an overall transition 
from anti to gauche conformations upon association.  Building on this, we aimed to 
establish how the prevalent stoichiometry changes with acid concentration, to 
quantify any resultant conformational changes, and ultimately to determine whether 
the acid concentration dependence of enantioselectivity in the bromolactonisation 
reaction can be correlated to these changes. 
 
5.3.3 Assignment of 1H NMR Spectrum of (DHQD)2PHAL 
 
In order to understand the conformational changes in the presence of carboxylic acids, 
it was first necessary to fully assign the 1H NMR spectrum of free (DHQD)2PHAL.  
The assignments and spectrum in CDCl3 are shown in figure 5.17.   
 
 
 
H2
H1’
H3 H2’’
H5
H1 H4
H8
OCH3
H9
H15,16,18,19
H10
H12
H21H13,17,20H11,14
 
Figure 5.17: 1H NMR spectrum of (DHQD)2PHAL in CDCl3. 
 
Only one set of resonances are observed, indicating that interconversion between 
conformations is fast on the NMR timescale.  The assignment of quinoline and 
phthalazine ring signals is relatively straightforward. Protons H2 and H1 are observed 
as doublets at 8.67 and 7.48 ppm, respectively, with coupling of 4.6 Hz.  H3 (meta to 
  
173 
the quinoline methoxy group) is also a doublet at 8.01 ppm, with an ortho coupling of 
9.2 Hz to H4 at 7.40 ppm.  This proton (H4) also shows W-coupling to H5 at 7.59 (4J 
= 3.2 Hz).  The magnetic inequivalence of the phthalazine protons is manifested in 
their dd multiplicity.  H1’ and H2’ are located at 8.34 and 7.95 ppm, respectively.  
The quinoline OCH3 group is observed as a singlet at 3.93 ppm.   
Assignment of the quinuclidine resonances is more complex, due to overlap of peaks, 
and assistance from a 2D-COSY spectrum of the catalyst, and Sharpless’ assignments 
of p-chloro-benzoyl dihydroquinidine (202)152 was required.  The benzylic proton, 
H8, appears as a doublet at 6.99 ppm, which is remarkably deshielded.  The coupling 
constant to H9 is 6.5 Hz, higher than the literature values for 202 (3J8-9 = 3.2 Hz) and 
the 1:2 (DHQD)2PHAL:OsO4 complex (
3J8-9 < 1 Hz),
167 indicating that the catalyst 
has a higher anti population, although the prevalent anti conformation is retained.  At 
this stage it was not possible to calculate exact populations as the torsion angles 
corresponding to pure gauche and anti conformations for (DHQD)2PHAL were not 
known.  The 2D-COSY NMR spectrum indicates that the H9 signal, which appears as 
an apparent quartet is at 3.43 ppm.  This is turn couples to H10 and H11 at 1.98 and 
1.57 ppm, respectively.  The remaining -protons (H15-16 and H18-19) to 
quinuclidine N1could not be resolved as the peaks overlapped to a complex multiplet 
at 2.88-2.63 ppm.   
 
The bridgehead proton at H12 appears as a broad singlet at 1.72 ppm.  The methyl 
group (H21) of the C3 ethyl substituent is clearly seen as a triplet at 0.83 ppm, 
coupling to H20 at 1.44 ppm.  This multiplet at 1.44 ppm contains signals for two 
other protons, which could not be easily assigned.  However, comparison to 
Sharpless’ 1H NMR spectrum of benzoyl ester 202 suggested that H14 is located 
slightly more downfield to H13 and H17, so corresponds to the multiplet at 1.57 ppm, 
whereas the latter protons overlap with H20 at 1.44 ppm. 
 
In the 2D-NOESY spectrum of (DHQD)2PHAL, Sharpless reported cross-peaks 
indicative of the anti conformation (section 5.2).167  However,  = ± 90◦ rotamers 
were not distinguished, and the spectrum was not fully assigned.  Consequently, we 
repeated this experiment in CDCl3 ([cat]0 = 26 mM).  Figure 5.18 shows an expansion 
of the spectrum showing inter-ring nOe’s between phthalazine, quinoline and 
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quinuclidine protons.  In the accompanying diagrams, the observed cross-peaks are 
highlighted in red, and nOe’s unique to a particular conformation are in bold.  The 
fully assigned spectrum is included in section 7.20. 
 
 
 
 
Figure 5.18: Expansion of 2D-NOESY spectrum of free (DHQD)2PHAL in CDCl3. 
 
Through space interactions were observed between H8 and H9, and between H1 and 
H10, distinctive of the gauche(1) rotamer.  All expected enhancements were 
observed, except for H1 to H11, and phthalazine H1’ to H18 and H20.  Cross peaks 
from H8 to H10 and H18 are diagnostic of the anti conformations, and evidence for 
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both  = ± 90◦ isomers was observed from irradiation of H1: enhancement of H9 
suggests  = 90◦ (anti(1)), and this enhancement of H8 supports  = 90◦ (anti(2)).  
To the best of our knowledge, is the first experimental observation of the anti(2) 
conformation for quinidine derivatives. 
 
The results suggest that free (DHQD)2PHAL is highly conformationally flexible in 
CDCl3 solution. 
 
5.4 1H NMR Spectra of (DHQD)2PHAL:Carboxylic Acid 
Mixtures 
 
In order to characterise the conformational changes in the presence of carboxylic 
acids, the 1H NMR spectrum of a 1:4.2 mixture of (DHQD)2PHAL:anthranoic acid 
(207) in CDCl3 was recorded ([cat]0 = 25.7 mM) (figure 5.19). 
 
 
7.07.27.47.67.88.08.28.48.68.8 0.00.20.40.60.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.0
H2
H1’
H3
H2’
H5
H1
H4
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H9
H10
H12
H21
H15,16,
18,19
H11,14
H13,17,20
H2
H1’
He
H3,2’Ha
Hd
H5
H1
H4
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H8
H9
H16,18,19
H15
OMe
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H10
H13,1417,20
H12
H11
H21
 
 
H Free Species (ppm) 1:4.2 112:207  (ppm) 
1 7.47 7.37 -0.1 
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2 8.68 8.33 -0.35 
3 8.01 8.02 0.01 
4 7.39 7.26 -0.13 
5 7.60 7.64 0.04 
1’ 8.35 8.50 0.15 
2’ 7.95 8.02 0.07 
8 6.99 8.02 1.03 
9 3.44 3.70 0.26 
10 1.99 2.53 0.54 
11 1.57 1.25 -0.32 
12 1.72 1.99 0.27 
13-14, 17, 20 1.41 1.76 0.35 
15 2.76 3.31 0.55 
16, 18-19 2.76 3.57 0.81 
21 0.83 1.20 0.37 
OCH3 3.93 3.03 -0.90 
a 8.36 8.02 -0.34 
b,c 7.61 7.16 -0.45 
d 8.09 7.86 -0.23 
e 8.63 8.34 -0.29 
 
Figure 5.19: 1H NMR spectra of free (DHQD)2PHAL (top) and a 1:4.2 mixture of 
(DHQD)2PHAL:anthranoic acid (bottom); table of proton assignments for each 
spectrum. 
 
Anthranoic acid (205) was initially selected in order to maximise the perturbation of 
chemical shifts, due to its large size and the expected anisotropic effect of the 
aromatic ring system.  Excess acid was added to ensure that only the putative 1:2 
complex would be present.  The concentration of (DHQD)2PHAL in this experiment 
is ten times greater than under bromolactonisation conditions, and the possibility of 
self-associative interactions at high concentrations was considered.  However, the 
spectrum of an equivalent mixture at 8mM was identical, ruling out any concentration 
effects. 
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Only one set of catalyst and anthranoic acid peaks was observed, despite excess 207, 
suggesting that association-dissociation of 207 is fast on the NMR timescale.  The 
spectrum did not change with time (over 24 h), and equilibrium was reached quickly 
(within the time taken to record the initial spectrum, ~ 1 minute). 
 
There were several indications that a conformational change had taken place.  
Whereas the 3J8-9 coupling constant of free (DHQD)2PHAL, measured at H8 is 6.5 
Hz, in the presence of anthranoic acid H8 now appeared as a broad singlet.  H9 is 
observed as a sharp triplet, showing coupling solely to H10 and H11.  This decrease 
in 3J8-9 coupling is indicative of a conformational switch from anti to gauche 
rotamers.152 
 
Several chemical shift changes are associated with this transition.  Upon addition of 
anthranoic acid, the benzylic H8 proton is significantly deshielded to 8.02 ppm ( = 
1.03 ppm); the H11 resonance becomes strongly shielded ( = 0.32 ppm) due to its 
proximity to the shielding cone of the quinoline ring in the gauche conformation.169b  
A similar effect is observed for the quinoline OCH3 group ( = 0.90 ppm) although 
this is perhaps due to its orientation towards the -system of anthranoic acid (section 
5.5).  Tight binding between the catalyst and 207 is also suggested by the fact that all 
anthranoic acid signals are shielded (e.g.  =  ppm for Ha).  The right-handed 
screw twist of quinuclidine does not change considerably: 3J9-11 = 8.7 Hz for free 
(DHQD)2PHAL and 
3J9-11 = 9.4 Hz in the complex. 
 
In order to independently identify accessible conformations, the 2D-NOESY spectrum 
of a 1:2 (DHQD)2PHAL:anthranoic acid mixture was recorded in CDCl3 ([cat]0 = 
25.7 mM) (figure 5.20).  All the observed cross-peaks were consistent with the 
gauche(1) conformation.  This was deduced as follows: in the gauche rotamer 
irradiation of H8 enhances H9, as the torsion angle  = 60◦.  No cross-peaks 
diagnostic of  = 180◦ (anti), e.g. H8 to H10 and H18 were observed.  The  = 90◦ 
was discerned by nOe interactions from H1’ to H1 and H5 to H8.   
 
In the 2D-NOESY of a 1:2 (DHQD)2PHAL:OsO4 complex, Sharpless used the cross-
peaks between H1’ to H1 and H18 to assign both the gauche(1) conformation at each 
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quinidine and the global catalyst structure.167  These were also observed in the 
anthranoic acid complex, which suggests that a similar binding pocket is formed.  In 
addition, the nOe between the quinoline methoxy group (OMe) and the peri-
hydrogens of the acid (Ha) provided further evidence of close ion-pair binding, but 
was insufficient to determine the orientation of anthranoic acid within the catalyst 
binding pocket.  However, we hoped to obtain this information from an X-ray crystal 
structure of a (DHQD)2PHAL:acid complex (section 5.5). 
 
 
Figure 5.20: Expansion of 2D-NOESY spectrum of 1:2 (DHQD)2PHAL:anthranoic 
acid mixture in CDCl3.  In the accompanying scheme, observed cross-peaks are 
highlighted in red, and those unique to a specific conformation in bold. 
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These initial NMR experiments were invaluable in highlighting the significant 
decrease in conformational flexibility as (DHQD)2PHAL is constrained in the 
gauche(1) conformational upon association of anthranoic acid.  Furthermore, the 
observation of fast carboxylic acid exchange on the NMR timescale is in agreement 
with the hypothesis that the acid:base pre-equilibrium is maintained prior to an 
irreversible, stereoselective bromination step.  In future kinetic studies, it may be 
possible to calculate the precise rate of exchange from 2 relaxation times.171 
 
5.5 X-ray Crystal Structure of (DHQD)2PHAL:Anthranoic 
Acid Complex 
 
An X-ray crystal structure of a catalyst:anthranoic acid salt was required to 
complement solution phase conformational studies, to compare with Sharpless’ 
structure of the free catalyst,81 and to elucidate how anthranoic acid modifies the 
structure of the binding pocket, particularly  and  torsion angles which are difficult 
to determine using NMR. 
 
After an extensive solvent and acid screening, an X-ray structure of a 1:2 
(DHQD)2PHAL:anthranoic acid H-bonded complex was obtained from a 1:4 mixture 
of (DHQD)2PHAL and 207 in toluene (figure 5.21).   
 
C2 axis
quinuclidine
quinoline
anthranoic acid
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Figure 5.21: X-ray crystal structure of 1:2 (DHQD)2PHAL:anthranoic acid hydrogen-
bond complex. 
 
Each unit cell also contains one residual water and four toluene molecules (which 
have been omitted for clarity).  There is a small uncertainty (~0.1 Å) in the exact 
position of each atom in the spacer, one quinoline ring and one toluene molecule.  The 
complex is essentially C2 symmetric, with the axis of rotation through the centre of 
the phthalazine linker.  This means that the conformation-defining torsion angles at 
each quinidine half of (DHQD)2PHAL are very similar. 
 
The X-ray structure allows us to visualise each of the angles e and make direct 
comparison to NMR data. 
 
5.5.1 Torsion Angle  
 
In figure 5.15, the torsion angle  = 65.9◦ at the quinidine shown and  = 69.6◦ at the 
other, confirming the gauche conformation at each.  The associated shielding of H11 
in the NMR spectra due its proximity to the quinoline -orbitals can also be seen.  In 
Sharpless’ X-ray structure of the free catalyst (figure 5.22), each quinidine is H-
bonded to H2O and also adopts the gauche conformation ( = 65.9◦). 
 
H8
H9
H11
N1
OCH3 
3’
4’
9
8

 
Figure 5.22: Close-up of X-ray crystal structure indicating torsion angles and . 
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5.5.2 Torsion Angle  
 
The C3’-C4’-C9-C8 torsion angle, , which describes how the quinoline ring is 
oriented relative to quinuclidine is exactly 90.0◦ (figure 5.22), in agreement with the 
NOESY data and an assignment of the gauche(1) conformation.  Consequently, the 
aryl ether protons (OCH3) are directed towards the anthracenyl -system, which 
causes their significant shielding in the CDCl3 spectrum.  
 
5.5.3 Torsion Angles and and Position of Anthranoic Acid 
Within Binding Pocket 
 
When the crystal structure is viewed along the C2 rotation axis, as in figure 5.23, it is 
clearly observed that the N1’’-C2’’-O9-C9 torsion angle  is close to zero (7◦ and 14◦) 
to allow conjugation of the oxygen p-orbital with the phthalazine -system.  A 180◦ 
rotation is not permitted due to steric clashing between phthalazine and anthranoic 
acid.  The phthalazine ring is also anti to quinuclidine (C2’’-O9-C9-C8,  = 166◦ and 
170◦).  This torsion angle sets up the observed C2 symmetry of the complex, as the 
pairs of quinuclidine and quinoline rings are positioned on opposite sides of the 
central spacer.  Similar values are obtained for the free catalyst ( = 165◦ and = 
2.5◦).81  The structure of the binding pocket described by Corey169b and Sharpless167 
can be clearly observed: for association at N1 in figure 5.23, the rotational flexibility 
of a substrate alkenoic acid (or alkene for SAD) is restricted by the adjacent quinoline 
ring (N1’), phthalazine and the methoxy group of the other quinoline.  Overall, the 
dimensions of the pocket are approximately: 8.6 Å (N1-C9) x 6.6 Å (O9-OCH3) x 4.4 
Å (C9-N1’). 
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Figure 5.23: X-ray crystal structure viewed along C2 rotation axis, with torsion angles 
 and  indicated. 
The crystal structure also allows the clear visualisation of how anthranoic acid fits 
into the binding pocket of the catalyst.  For free anthranoic acid, it is known that the 
carboxyl group makes a dihedral angle of 55◦ to the anthracene core, due to steric 
repulsion with the peri-hydrogens (Ha).
172  This increases to 88◦ (and 78◦) once 
associated to (DHQD)2PHAL, presumably to minimise steric clashing.  The 
internuclear displacements between the carboxylate oxygen atoms and the acidic 
quinuclidine proton are 1.8 and 2.3 Å, suggesting that H-bonding is not equally 
bifurcated.   
 
Aside from the strong H-bond and Van der Waals’ interactions, attractive forces 
within the binding pocket may also comprise several C-H-interactions: between 
OCH3 and anthracene (2.7 Å) and between Hc and the quinoline OCH3 p-orbital (3 Å) 
(figure 5.23). 
 
Overall, the crystal structure shows excellent correlation with the solution phase 
conformation studied in CDCl3.  Corey
169b, 170 predicted that a similar catalyst 
conformation was required for (DHQD)2PYDZ (206) in order to maximise non-
covalent interactions with an alkene substrate and impart high enantioselectivities in 
the SAD reaction.  However, this data was based on molecular mechanics calculations 
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and an X-ray crystal structure of 206 bis-methylated at quinuclidine (using MeI).169b  
To our knowledge, the structure obtained in our laboratory is the first reported co-
crystal between a dimeric cinchona alkaloid and an interacting solute. 
 
5.6 The Influence of Other Carboxylic Acids on 
(DHQD)2PHAL Conformations 
 
It was observed for the bromolactonisation of 4-phenyl-4-pentenoic acid 114 that 
product e.r. was strongly influenced by additive pKa.  Consequently, 
1H NMR spectra 
of (DHQD)2PHAL mixtures were recorded with other carboxylic acids used as 
reaction additives.  The aromatic additives p-trifluoromethyl benzoic acid (pKa = 3.7) 
and benzoic acid (pKa = 4.2) increase enantioselectivity to a similar extent as 
anthranoic acid, suggesting that the conformation of (DHQD)2PHAL is modified in 
the same way.  Conversely, TFA generates a racemic mixture of bromolactones.  This 
acid displayed unique binding behaviour and will be discussed separately.   
 
The NMR analysis was also repeated with substrates 114 and o-allyl benzoic acid 
(147).  These substrates are more conformationally flexible that the aromatic additives 
and distinct interactions to the catalyst were anticipated.  
 
The alkaloid:acid ratios used and the results are shown in figure 5.24.  The data, 
expressed as changes in chemical shift () relative to free (DHQD)PHAL was used 
qualitatively to highlight general trends and unique interactions between the catalyst 
and various acids.  In some cases, overlap of peaks prevented accurate determination 
of as indicated in the table 
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Anthranoic acid
4-phenyl-4-pentenoic acid (114)
4-CF3 Benzoic acid
Benzoic acid
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Anthranoic acid 
(207) 
Substrate 
114 
Benzoic 
acid 
p-CF3 
BzOH 
o-allyl 
BzOH 
(147) 
[DHQD]2PHAL: 
acid 
1:4.2 1:3.8 1:4.0 1:4.2 1:4.0 
pKa (aq.) 3.6 ~4.7 4.2 3.7 ~4.2 
H1 0.11 -0.11 0.06 0.06 -0.08 
H2 -0.36 0.07 0.05 0.00 0.07 
H3 0.01 0.01 0.11 0.09 0.14 
H4 0.14 N/D 0.01 0.02 0.04 
H5 0.04 0.03 0.06 0.02 0.04 
H1’ 0.15 0.04 0.08 0.14 0.09 
H2’ 0.08 0.07 0.07 0.09 0.10 
H8 1.03 N/D 0.69 N/D 0.80 
H9 0.26 0.04 0.19 0.32 0.14 
H10 0.54 0.39 0.53 0.64 0.61 
H11 0.32 0.23 0.12 0.07 0.18 
H12 0.27 0.18 0.26 0.35 0.29 
H13,17,20 0.35 0.26 0.32 0.42 0.36 
H15 0.55 0.13 0.53 0.48 0.42 
H16,18,19 0.81 0.41 0.53 0.75 0.63 
H21 0.19 N/D 0.13 0.17 0.18 
OCH3 0.90 0.13 0.1 0.14 0.25 
 
Figure 5.24: Graph and associated data showing the change in chemical shifts of 
(DHQD)2PHAL:carboxylic acid mixtures relative to free catalyst in CDCl3.   
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Overall, it was found that the substrates 114 and 147 induced the same trends in  as 
aromatic carboxylic acids, although the magnitude of perturbations is generally 
smaller for 4-phenyl-4-pentenoic acid (114).  The quinuclidine protons are deshielded 
due to N-protonation, except H11 where the familiar upfield shift in the gauche 
conformation is observed.  The quinoline aryl ether (OCH3) is also shielded due to 
proximity to the additive aromatic rings.  Consequently, the greatest upfield shift of 
these protons is caused by anthranoic acid.   
 
The perturbations in quinoline ring signals (H1-H5) are smaller, suggesting that 
association of carboxylic acids to N1’ is weak.  In general H3 and H5 are shifted 
downfield while H1 and H2 are shielded, although this is not easily rationalised by 
examination of the X-ray crystal structure.   
 
Using NOESY NMR as a complementary approach for identification of specific 
catalyst conformations, mixtures of (DHQD)2PHAL with structurally distinct 
substrate 114 and benzoic acid were also examined in CDCl3.  Accordingly, the 2D-
ROESY spectrum of a 1:2 (DHQD)2PHAL:114 mixture was recorded ([cat]0 = 26 
mM).  This technique compensates for the quenching effect of slow tumbling of large 
molecules on nOe enhancements.173    Through space interactions were observed from 
H5 to H9, from H1 to H10 and from H1’ to H18 and H20.  These were sufficient to 
assign the gauche(1) conformation despite the absence of H8 to H9 (figure 5.25). 
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Figure 5.25: 2D-NOESY of a 1:2 (DHQD)2PHAL:4-phenyl-4-pentenoic acid 
mixture. 
 
A 1D-NOESY experiment gave direct evidence of a close ion-pair interaction 
between a carboxylic acid and (DHQD)2PHAL in solution.  Selective irradiation of 
the o-protons of benzoic acid (Ha) in a 1:2 alkaloid:acid mixture in CDCl3 at 253 K 
caused enhancement of the quinoline methoxy protons (OCH3) at 3.90 ppm and the 
m-protons of benzoic acid (Hb) at 7.10 ppm (figure 5.26). 
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Ha
Hb
OCH3
 
Figure 5.26: 1D-NOESY spectrum of a 1:2 (DHQD)2PHAL:benzoic acid mixture in 
CDCl3.  Irradiation of signal at 7.75 ppm enhances peaks at 7.10 and 3.90 ppm. 
 
These results support the assertion that carboxylic acids relevant to the 
bromolactonisation reaction constrain (DHQD)2PHAL in the gauche(1) conformation 
and enforce the global structure observed in the crystal structure.  Comparison of 
chemical shifts for mixtures with different acids is an informative qualitative method 
of measuring relative binding strengths and rigidity of the binding pocket.   is 
greatest for aromatic acids, although there is not a perfect correlation with pKa.  This 
suggests that other factors e.g. conformational flexibility of the acid (in the case of 4-
phenyl-4-pentenoic acid), and size of the aromatic ring system also contribute to the 
binding strength.  This is in agreement with Sharpless’ hypothesis that aromatic rings 
are stabilised within the binding pocket of (DHQD)2PHAL via  interactions. 167 
 
In an experiment using TFA as the acid, the unique effect of TFA on the 1H NMR 
spectrum of (DHQD)2PHAL was immediately apparent.  Line broadening of all the 
catalyst resonances (except H21) suggested that association-dissociation of TFA is 
approaching the slow exchange region174 of NMR (figure 5.27).  Sharpless has 
reported that broadening of the quinoline ring signals, H1-H5, is indicative of N1’ 
protonation (for p-chlorobenzoyl dihydroquinidine (202)).152 This was not observed 
for (DHQD)2PHAL mixtures with weaker acids. 
 
  
188 
H2’
H2’
H3’
H3’
H9
H9
H10
H10
H11
H10
 
Figure 5.27: 1H NMR spectrum of 1:2 (DHQD)2PHAL:TFA mixture in CDCl3 (top), 
and free catalyst (bottom). 
 
5.7 Influence of Solvent on Conformations of (DHQD)2PHAL  
 
Up to this point all conformational studies had been conducted in CDCl3, due to its 
ready availability.  Bromolactonisation reactions in CHCl3 proceed with moderate 
enantioselectivity relative to toluene.  In order to study the formation of catalyst:acid 
complexes under the optimal reaction solvent, several of NMR experiments described 
above were repeated in toluene-d8.  CHCl3 and toluene are both poor H-bond 
acceptors and have similar polarizabilities.  They differ mainly in their dielectric 
constants and the ability of chloroform to act as a weak H-bond donor.175  Both of 
these factors are known to influence the stabilisation of cinchonidine gauche(1) 
conformation.152, 156 Initially, the 1H NMR spectrum of free (DHQD)2PHAL was 
recorded in toluene-d8 and compared to the analogous spectrum in CDCl3 (in both 
cases [cat]0 = 30 mM).  Most proton signals have similar chemical shifts, except H8 
which is more deshielded (= 0.4 ppm), and H11 which is more shielded (= 
0.49 ppm) in toluene.  The 3J8-9 coupling constant is also slightly lower in this 
solvent (6.0 Hz relative to 6.6 Hz in CDCl3). All these results suggest that the mole 
fraction of catalyst in the gauche conformation is greater in toluene (see section 5.8.1 
for more detailed discussion). 
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1.1 equivalents of benzoic acid ([cat] = 30 mM) were then added, and the 1H NMR 
spectrum recorded.  The changes in chemical shifts relative to the free species were 
compared to analogous  values for an equivalent mixture in CDCl3 ([cat] = 35 mM, 
[BzOH] = 38 mM), as shown in figure 5.28. 
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Figure 5.28: Changes in chemical shifts for 1:1.1 (DHQD)2PHAL:benzoic acid in 
CDCl3 and toluene-d8 relative to free (DHQD)2PHAL in each solvent. 
 
Protons H8 and H10 were deshielded and H11 shifted upfield in both solvents.  These 
chemical shift changes are indicative of the gauche(1) conformation.  However, there 
were several differences between the spectra in each solvent (e.g. H5, H9 and H12) 
which are difficult to rationalise.  The influence of toluene anisotropy may be the 
dominant factor in determining chemical shift for some signals. 
 
In future work, a 2D NOESY spectrum of a (DHQD)2PHAL:carboxylic acid complex 
in toluene-d8 is required to confirm the preferred conformer; however, considering 
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that the X-ray crystal structure was obtained from toluene, the gauche(1) 
conformation is most likely. 
 
5.8 Influence of Acid Concentration on Conformation of 
(DHQD)2PHAL 
 
It has been established that (DHQD)2PHAL favours the gauche(1) conformation 
under solvent and acidic conditions relevant to the bromolactonisation reaction.  It 
may therefore be assumed that under reaction conditions with added benzoic acid, 
both quinidine units of the dimer are bound and adopt this conformation throughout 
the reaction.  However, in the absence of additives the depletion of acid:catalyst 
interactions with substrate conversion means that the catalyst will no longer remain  
coordinatively saturated.  Under this scenario, the unbound quinidine of the 1:1 
(DHQD)2PHAL:substrate complex is unconstrained, and may rotate freely.  This was 
identified as a possible explanation for the decay of product e.r. with time for 
bromolactonisation of 114 (section 2.3.2).   
 
It was therefore considered necessary to quantify the concentration of acid at which 
point (DHQD)2PHAL becomes saturated, and to establish whether this is dependent 
on the structure and pKa of the acid. 
 
A wealth of information can be obtained from NMR titrations of carboxylic acids 
against (DHQD)2PHAL, and estimates of the saturation concentration may be 
extracted from analysis of changes in 3J8-9 coupling constants, chemical shift () and 
by calculation of the relevant equilibrium constants for association.  All these 
methods are described below. 
 
5.8.1 Coupling Constant Analysis 
 
A 1H NMR titration of (DHQD)2PHAL against benzoic acid was performed in CDCl3.  
The catalyst concentration was kept constant throughout (30 mM), and twenty 
different concentrations of benzoic acid were used, ranging from [BzOH]0/[cat]0 = 0 
to 11.  At all concentrations of acid, a single, averaged set of signals was observed for 
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each component, indicating that benzoic acid exchange processes are fast on the NMR 
timescale.  At each data point, the 3J8-9 coupling was measured at both H8 and H9.  
However, above [BzOH]0/[cat]0 = 2, broadening of the H8 signal made accurate 
evaluation difficult.  Above [BzOH]0/[cat]0 = 3.2, H8-H9 coupling could not be 
observed at all, as H9 appeared as a sharp apparent triplet (due to coupling to adjacent 
H10 and H11).  At each point, it was possible to calculate the mole fraction of the 
catalyst in the gauche(1) conformation using the method developed by Baiker156 
which is based on application of the Karplus equation: in the same way that coalesced 
chemical shifts are observed when exchange processes between distinct species are 
fast on the NMR timescale, the observed 3J8-9 constant can be expressed in terms of 
the contributions from each individual conformation weighted by its associated mole 
fraction, f: 
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As discussed in section 5.2, it is approximated that anti(1) and anti(2) conformations 
have the same coupling constant, such that the sum of anti rotamers is in fact 
measured.  This equation can be simplified further by assuming that gauche(2) is 
inaccessible, and no evidence for this conformer has been observed from NMR data.  
Therefore, equation 5.2 to be used in this analysis is: 
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   (eq. 5.2) 
Determination of the coupling constants for the conformational extremes, 3Jgauche(1) 
and 3Janti requires knowledge of the  torsion angle for (DHQD)2PHAL for each 
rotamer.  For gauche(1), the torsion angle  65.9◦ was obtained from the previously 
determined crystal structure; for pure anti,  was estimated to be 180◦, as this is the 
average of calculated values for related dihydroquinidine derivatives152 and 
cinchonidine.156   
 
In their influential publication, Baiker et al.156 suggested that the Karplus equation 
applied176 should take into account the electronegativities of substituent chemical 
groups, and recommended the Diez-Altona-Donders equation.177  This equation can 
be solved using the Mestre-J program178 which also contains a database of 
Huggins’179 electronegativities for common substituent groups.  Accordingly, the 
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above values of torsion angle  were converted to the corresponding coupling 
constants, 3Jgauche(1) = 9.8 Hz and 
3Jgauche(1) = 1.2 Hz.  The associated error in the 
calculated 3J8-9 values, introduced by the substituent correction is 0.18 Hz (rms)
180 
which translates to an error of fgauche(1) = 0.02.  This systematic uncertainty should 
affect all experimental data for (DHQD)2PHAL in the same way
156 provided that the 
torsion angles for anti and gauche do not change significantly for mixtures with 
different carboxylic acids. 
 
Application of equation 5.2 to each data point in the titration generated a plot of 
fgauche(1) against benzoic acid concentration, shown in figure 5.29. 
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Figure 5.29: Titration of benzoic acid vs. (DHQD)2PHAL; the mole fraction of the 
catalyst in the gauche(1) conformation (fgauche(1))   is indicated for each data point. 
 
The mole fraction of gauche(1) is 0.38 for the free catalyst in CDCl3.  As anticipated, 
this conformation is stabilised with increasing acid concentration and at 
[BzOH]0/[cat]0 = 3.1, 94% of the catalyst has adopted this rotamer, suggesting that 
catalyst saturation occurs near this value. 
 
Two further titrations were also performed with (DHQD)2PHAL against anthranoic 
acid and o-allyl benzoic acid (figure 5.30).  In each case, the same initial catalyst 
concentration was used (30 mM) and acid concentrations were varied between 
[acid]0/[cat]0 = 02.  However, it was not possible to measure coupling constants 
above [acid]0/[cat]0 = 1 due to line broadening of both H8 and H9.   
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Figure 5.30: Mole fraction of gauche(1) conformation vs. acid concentration for 
anthranoic (pKa = 3.6), benzoic (pKa = 4.2) and o-allyl benzoic (pKa = 4.1) acids. 
 
The fraction of the catalyst in the gauche(1) conformation increases more rapidly for 
the anthranoic acid titration relative to the weaker acids.  It may be assumed that 
catalyst saturation will also be reached at a lower acid concentration.  Due to its lower 
pKa, anthranoic acid will have a higher binding constant to (DHQD)2PHAL than 
benzoic acid and 114, driving the conformational equilibrium towards the gauche(1) 
state. 
 
The use of toluene as the solvent gives higher enantioselectivity for 
bromolactonisation of alkenoic acid 114 relative to CHCl3 (83:17 and 63:37 e.r., 
respectively, without benzoic acid) and it was considered that this may be due to a n 
inherently higher population of (DHQD)2PHAL in the gauche(1) state.  Accordingly, 
a titration of (DHQD)2PHAL against benzoic acid was also performed in toluene-d8 
([cat]0 = 30 mM).  The 
3J8-9 coupling constant was measured at four benzoic acid 
concentrations between [BzOH]0/[cat]0 = 02.1. 
 
As shown in figure 5.31, fgauche(1) = 0.44 for the free catalyst in toluene is greater than 
in CDCl3 (fgauche(1) = 0.38).  However, the increase upon addition of benzoic acid is 
slower, and above 0.5 equivalents the mole fractions of gauche(1) are essentially 
identical in both solvents: at [BzOH]0/[cat]0 = 2.2, fgauche(1) = 0.82 in CDCl3 and 0.78 
in toluene-d8. 
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Figure 5.31: Mole fraction of gauche(1) conformation vs. benzoic acid concentration 
in toluene-d8 and CDCl3. 
 
A complementary approach for quantifying the acid concentration at which 
(DHQD)2PHAL becomes coordinatively saturated which can be obtained from the 
same NMR titration data sets, is the measurement of the change in chemical shifts 
() relative to the unbound catalyst in CDCl3.  Figure 5.32 charts  for protons H8 
and H10, which show the greatest perturbation at saturation.  By visual inspection, 
sat ~ 0.78 ppm for H8 and 0.58 for H10.  In contrast to the coupling constant 
analysis these values are only reached above [BzOH]0/[cat]0 = 8. 
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Figure 5.32: Change in chemical shift of catalyst protons H8 and H10 at increasing 
concentrations of benzoic acid. 
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5.8.2 Discussion 
 
The coupling constant analysis has provided a quantitative measure of the mole 
fraction of (DHQD)2PHAL in the gauche(1) conformation at different acid 
concentrations and in both solvents relevant to bromolactonisation; toluene and 
CHCl3.  However, there is a disparity between the 
3J8-9 and  estimates of catalyst 
saturation.  This is because the chemical shift perturbations primarily result from acid 
association, whereas the coupling constant method directly measures fgauche(1) which is 
already significantly populated for the free catalyst.   
 
It was initially tempting to relate the enantioselectivity of bromolactonisation with 
conversion directly to the proportion of (DHQD)2PHAL adopting gauche(1), but this 
appears too simplistic.  This hypothesis can not explain: the difference in asymmetric 
induction between toluene and CHCl3; the poor enantioselectivities obtained with 
monomeric catalysts relative to (DHQD)2PHAL (section 2.3.6); nor, the influence of 
additive structure and pKa on product e.r., even though catalyst saturation is assured in 
the presence of additives. 
 
Instead, the gauche(1) conformation should simply be considered the consequence of 
acid binding.  From the anti state, rotation of the quinoline ring away from the 
quinuclidine N lone pair minimises steric clashing with the H-bond donor (figure 
5.33).  Furthermore, upon protonation of quinuclidine N1, the gauche(1) rotamer may 
be stabilised by hyperconjugation as the low energy C-N+ * orbital is antiperiplanar 
to the C-C  bond, which offers better energy overlap than the C-O  bond. 
 
Figure 5.33: Protonated quinidine derivatives adopt the gauche(1) conformation to 
minimise steric clashing and maximise hyperconjugation. 
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In their respective studies on asymmetric dihydroxylation, Sharpless167 and Corey169a 
both proposed that dimeric cinchona alkaloids maximise enantioselectivity through 
formation of an enzyme-like binding pocket, which optimises non-covalent 
interactions with the substrate alkene.  The structure of the pocket was elucidated by 
X-ray and NMR analysis, and is essentially identical to that observed in the 
(DHQD)2PHAL:anthranoic acid complex (section 5.5).  In the SAD reaction, this 
global structure does not change with substrate conversion as only one alkene is 
bound and OsO4 is regenerated within a single turnover.
169a, 170 
 
In contrast, for the bromolactonisation reaction, the diminishing interactions between 
substrate carboxylic acids and (DHQD)2PHAL with reaction conversion will alter the 
stoichiometry and identity of bound carboxylic acids, depending on whether the 
reaction is performed with additives. 
 
As was discussed in section 5.3.2, (DHQD)2PHAL has three available binding 
stoichiometries: the unbound catalyst, 1:1 and 1:2 (DHQD)2PHAL:carboxylic acid 
complexes (figure 5.34).  The free catalyst may adopt anti(1), anti(2) and gauche(1) 
conformations with populations dictated by the solvent, but is necessarily inactive as 
no substrate is associated.  The unbound quinidine of the 1:1 complex is also 
conformationally flexible, although the extent to which the protonated quinidine and 
counter ion influence the rotational freedom at the unbound site is not known at this 
stage.   
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Figure 5.34: Conformational flexibility of the 1:1 (DHQD)2PHAL:substrate 114  
complex. Association of a second carboxylic acid (e.g. benzoic acid) constrains the 
catalyst in global gauche(1) conformation. 
 
Both monomeric units are constrained in the gauche(1) conformation in the 1:2 
complex.  However, in the presence of benzoic acid, it may be envisaged that the 
binding pocket structure is also influenced by the identity of acids bound (complex 
A). 
 
We propose that each species is catalytically distinct and that overall asymmetric 
induction is determined by the mole fractions and the rate of catalysis of each 
complex.   
 
Evidence for this hypothesis will be examined in the following sections.  Firstly, the 
population of each complex stoichiometry may be calculated at any concentration of 
acid by elucidation of the equilibrium constants for association.  This analysis will 
also reveal the binding cooperativity of this system: it can not be necessarily assumed 
that the 1:2 complex is prevalent because catalysts with two binding sites often show 
cooperative binding, where association of the first ‘guest’ molecule results in 
conformational or electronic changes which may favour/disfavour binding at another 
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site.  The degree of cooperativity is represented by the parameter  = K2/K1, which is 
simply the ratio of equilibrium constants for consecutive binding.  A well known 
example of positive cooperativity ( >1) is the binding of oxygen to haemoglobin 
where the binding of successive O2 molecules increases the protein’s affinity at its 
other binding sites.181  Conversely, many poly-basic molecules e.g. peptides display 
strong negative cooperativity because formation of a di- or tri- cation is much less 
favourable than formation of the mono-protonated species, particularly in non-
aqueous solvents which can not stabilise cations.182 
  
In the case of (DHQD)2PHAL complexation, positive/negative cooperativity would 
significantly affect the proportion of each complex at a particular acid concentration, 
and may also suggest that the conformations at each monomeric unit are not 
conformationally independent.  Our efforts towards calculation of binding constants 
are described in section 5.10. 
 
Secondly, the effect of the loss of binding pocket rigidity in the 1:1 complex on 
enantioselectivity will be explored by the synthesis and testing of (DHQD)2PHAL 
analogues constrained in the gauche(1) conformation (section 5.13). 
 
However, the accuracy of this mechanistic hypothesis under bromolactonisation 
reaction conditions rests on the supposition that (DHQD)2PHAL-carboxylic acid 
association reaches an equilibrium state prior to irreversible, stereoselective 
bromination.  The validity of this assumption will be discussed in the following 
section, by investigation of (DHQD)2PHAL-NBS-carboxylic acid interactions. 
 
 
5.9 Catalyst Interactions with NBS 
 
Until this point, considerable structural analysis has been performed on 
catalyst:carboxylic acid complexes.  According to our mechanistic model (section 
5.8.2), association of the substrate to the catalyst is the first step of the catalytic cycle, 
reaching an equilibrium which is maintained throughout the bromolactonisation 
reaction.  The proceeding steps are olefin bromination and lactonisation.  Under this 
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proposed mechanism, there is no direct interaction between NBS and 
(DHQD)2PHAL.  However, it is possible to envisage initial bromination of the 
catalyst which may disrupt catalyst:carboxylic acid equilibrium constants, but also 
explain why bromine is directed selectively to one alkene enantiotopic face. 
 
Borhan et al.3 found strong evidence for association of dichlorohydantoin to 
(DHQD)2PHAL in chlorolactonisation reactions (section 1.4).  Two possible 
associative complexes were proposed in the presence of benzoic acid (figure 5.35).  
Complex 208a invokes a hydrogen bond between the protonated (DHQD)2PHAL and 
dichlorohydantoin, whereas 208b depicts direct N-chlorination with a 
chlorohydantoin counterion. 
 
 
Figure 5.35: (DHQD)2PHAL:dichlorohydantoin adducts proposed by Borhan. 
 
N-halogenated tertiary amines have been well studied and invoked as reactive 
electrophilic hydrogen sources in other halogenation reactions.  N-Cl quinuclidine and 
N-Cl triethylamine have been used to mediate the chlorination of aniline in TFA with 
para:ortho selectivity ratios of > 99:1.50  These quaternary ammonium salts were 
prepared from reaction of Cl2 and the tertiary amine in CCl4 at 78 ◦C.50  The chloride 
counterion can be exchanged for TFA, perchlorate or acetate in good yields.  All 
yields were measured from 1H NMR spectra with an internal standard.  These salts are 
rarely isolated due to their thermal instability.  1:1 N-Br ammonium salts are even 
more unstable because they quickly reverse back to the free amine and bromine 
source, and only N-bromoquinuclidine perchlorate has been isolated.50 However, 2:1 
amine:bromine complexes are much more stable and well known, for example 
bis(collidine)bromine(I) triflate (which Brown has shown to have an equilibrium 
constant for dissociation of Kd = 6 x 10
-5),62 and bis(DABCO)bromine(I) 
tetrafluoroborate derivative reported by Toste in 2012 60 (figure 5.36). 
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Figure 5.36: a) Dissociation constant of bis(collidine)bromine(I) triflate; b) 
bis(DABCO)bromine(I) tetrafluoroborate. 
 
Our aims were therefore to study intermolecular interactions between 
(DHQD)2PHAL, NBS and carboxylic acids in ternary mixtures, with particular 
emphasis on the site(s), strength and reversibility of binding, and on changes in 
catalyst conformations. 
 
Several possible structures were considered, and NMR experiments devised to 
distinguish them (figure 5.37). 
 
Figure 5.37: a) Proposed (DHQD)2PHAL:NBS complexes; b) Transition state model 
for desymmetrisation of alkynoic acid proposed by Hennecke.86 
 
Complex 209 is analogous to structure 208a proposed by Borhan,3 and invokes a H-
bonding between NBS and protonated quinuclidine.  A solvent-separated benzoate 
anion will be disfavoured in non-polar solvents e.g. hexane:CHCl3 and toluene,
183 but 
it is possible that the three components share a bifurcated H-bond.  Alternatively, 
structure 210 represents direct N-bromination at quinuclidine.  This complex has 
similarities to the stable 3-centre-4-electron bis(amine) bromine(I) complexes studied 
by Brown and Toste.  The formation of this complex depends on the relative binding 
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constants of NBS and carboxylic acids.  It can also be envisaged that under acidic 
reaction conditions, succinimide is protonated and replaced by a benzoate anion.  This 
would make N-bromination effectively irreversible (as benzoate will not deprotonate 
succinimide, pKa ~5).  The release of succinimide could perhaps be observed by 
time-dependent NMR monitoring of (DHQD)2PHAL:benzoic acid:NBS mixtures. 
 
It is also possible that NBS and carboxylic acids bind at different basic sites of the 
catalyst.  Tang85 and Hennecke86 have proposed that NBS and acidic substrates 
associate at quinuclidine and phthalazine sites, respectively (complex 212). 
 
Initially, a simplified model system containing only NBS and (DHQD)2PHAL was 
studied.  The 1H NMR spectrum of a 1:1.2 [cat]0:[NBS]0 mixture ([cat]0 = 12.9 mM) 
was recorded in CDCl3.  It was apparent from chemical shift changes () that 
association had taken place.  In addition, a single set of peaks was observed for the 
catalyst and NBS, and the chemical shifts remained constant over time (2 h at room 
temperature in the dark), indicating that equilibrium had been reached.  However, the 
line width of catalyst signals was found to vary with the batch of NBS used, 
suggesting that minor impurities in NBS e.g. molecular bromine influence the rate of 
Br+ exchange (figure 5.38). 
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Figure 5.38: 1H NMR spectra of 1:1.2 (DHQD)2PHAL:NBS mixtures in CDCl3 with 
different batches of NBS (middle and lower); and comparison to 1H NMR spectrum 
of free catalyst (top). 
 
The changes in chemical shift () were similar to (DHQD)2PHAL:carboxylic acid 
mixtures.  The graph in figure 5.39 compares  values for 1:1.2 catalyst:NBS and 
1:1 catalyst:benzoic acid mixtures. 
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Figure 5.39: Changes in chemical shifts of 1:1.2 (DHQD)2PHAL:NBS (blue) and 1:1 
(DHQD)2PHAL:benzoic acid (yellow) mixtures relative to the free catalyst. 
 
The deshielding of benzylic proton H8, accompanied by a decrease in 3J8-9 coupling 
constant (6.5 Hz → 1.5 Hz), and the upfield shift of H11 are indicative of a 
conformational transition from anti to gauche(1) rotamers.  This conformational 
change is usually induced by intermolecular interactions at quinuclidine, suggesting 
that NBS associates to the catalyst via direct N1-bromination.  However, there are 
several differences between the spectra.  In particular, H5 and H9 are shielded in the 
NBS complex, but deshielded in the presence of acid.  Conversely, the quinoline 
methyl ether which is usually shielded in the presence of aromatic carboxylic acids 
because of proximity to the aromatic ring, moves downfield with NBS. 
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The conformations of (DHQD)2PHAL was confirmed unambiguously by a 2D-
NOESY NMR spectrum of a 1:1.4 (DHQD)2PHAL:NBS ([cat]0 = 15 mM) in CDCl3 
(figure 5.40).  Cross peaks were observed from H8 to H9, from H1 to H10 and from 
H1’ to H18 and H20 which are unique to the gauche(1) conformation.  Additional 
nOe’s from H1’ to H10, H20 and H21 support this assignment but have not been 
previously observed, suggesting a closer proximity between the phthalazine and 
quinuclidine rings in the binding pocket.  The anti(1) conformation was also 
identified through cross-peaks from H1 to H9 and from H8 to H18. 
 
 
 
Figure 5.40: Expansion of a 2D-NOESY spectrum of a 1:1.4 (DHQD)2PHAL:NBS 
mixture in CDCl3. 
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Overall, NBS and carboxylic acids associate to (DHQD)2PHAL via the same 
mechanism and induce the same conformational changes in isolated systems.  
However, the observation of the anti(1) rotamer suggests that (DHQD)2PHAL  
binding to NBS is weaker than to carboxylic acids, and that the global catalyst 
structure is less constrained.    
 
Ternary mixtures are more complex and several interactions are possible, as discussed 
above.  Initially, the 1H NMR spectrum of a 1:1.1:2.7 mixture of 
(DHQD)2PHAL:NBS:benzoic acid ([cat]0 = 10 mM) was recorded.  A single set of 
peaks was observed for each component, indicating that exchange of both NBS and 
BzOH is fast on the NMR timescale.  It was also found that the order of reagent 
addition did not alter the spectrum, proving that association is reversible for NBS and 
benzoic acid individually.  Furthermore, the spectrum did not change over two hours 
at room temperature, suggesting that equilibrium had been reached. 
 
Figure 5.41 compares chemical shift changes for this ternary complex to 1:1.1 
(DHQD)2PHAL:NBS and 1:2.7 (DHQD)2PHAL:benzoic acid mixtures.  The  
values do not match those for component binary equilibria, indicating that both NBS 
and benzoic acid are associated.  The chemical shift changes of protons H8 and H10 
suggested that (DHQD)2PHAL approaches saturation in the gauche(1) conformation.  
However, the increased shielding of H11 which usually accompanies this transition 
was not observed (NBS = 0.39, BzOH = 0.12, NBS+BzOH = 0.23 ppm).  
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Figure 5.41: Change in chemical shifts of 1:1.1 (DHQD)2PHAL:NBS, 1:2.7 
(DHQD)2PHAL:NBS:benzoic acid mixtures in CDCl3 relative to free catalyst. 
 
It was not possible to deduce the structures of the associative complexes from the 
NMR data.  However, several insights can be obtained from the observation that the 
system reaches equilibrium.  Initially, N-bromination followed by irreversible 
succinimide protonation leading to complex 211 may be ruled out.  A putative 
quinuclidine N-brominated complex therefore requires that succinimide remains 
closely associated to the bromine atom, as in complex 210 which is structurally 
related to the 2:1 amine:bromine complexes developed by Toste60 and Brown62 
(figure 5.36).  In this scenario, NBS and benzoic acid necessarily compete for 
association to (DHQD)2PHAL.  NMR titrations were performed in an effort to 
calculate the equilibrium constants for NBS binding, but it was not possible to fit the 
data to a 1:2 binding isotherm (section 5.10). 
 
An alternative possibility is that both components hydrogen bond cooperatively to 
quinuclidine (figure 5.42).  This interaction is feasible because the crystal structure of 
1:2 (DHQD)2PHAL:anthranoic acid indicates that H-bonding is not equally bifurcated 
between the carboxylate oxygen atoms (section 5.5). 
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Figure 5.42: Bifurcated H-bonding between protonated quinuclidine, NBS and 
benzoic acid. 
 
It was anticipated that N-bromination or N-protonation at quinoline or phthalazine 
basic sites (complex 212) would result in line broadening of adjacent proton signals 
and significant perturbations in chemical shift, as was observed for TFA binding 
(section 5.6).  However, no evidence for binding at independent sites was obtained. 
 
In conclusion, these experiments have shown that NBS does associate to 
(DHQD)2PHAL in the presence of carboxylic acids, although the NMR data was 
insufficient to characterise the resulting ternary complexes.  The observation that 
equilibrium is reached is important validation of the pre-equilibrium approximation 
assumed throughout this project, whereby (DHQD)2PHAL:carboxylic acid 
interactions reach equilibrium prior to irreversible alkene bromination.  Our 
mechanistic hypothesis, that enantioselectivity is determined by the stoichiometry and 
identity of bound acids, relies on this approximation for quantitative calculation of 
changes in catalyst conformation and complex stoichiometry with acid concentration.  
In the following section, elucidation of the association constants for (DHQD)2PHAL 
binding to benzoic acid is described. 
 
 
5.10 Calculation of Binding Constants 
 
5.10.1 Introduction 
 
Binding constants describe the affinity between two or more molecules at equilibrium.  
The best known subset of these is acid-base equilibria for pKa determination.  Binding 
constants are frequently studied in supramolecular chemistry: to measure the 
thermodynamic stability of self-assembled structures; and to predict the amplification 
of particular complexes in dynamic combinatorial libraries upon addition of template 
molecules.184  Biochemists also regularly use these methods to determine the strength 
of protein-ligand interactions.185   
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The facility with which binding constants can be obtained and the best analytical 
method for the measurement depends on two major properties of the system: the 
number of reaction components and possible stoichiometries, and the rate of exchange 
or interconversion between complexed and free species.  When exchange processes 
are fast relative to the timescale of an analytical technique, individual species can not 
be observed directly and an average signal is measured.  However, species 
concentrations can be calculated from titration experiments.  Common techniques 
used are NMR, UV-Vis and isothermal titration calorimetry for small chemical 
systems; in biochemistry UV-vis and fluorescence spectroscopy are used for studying 
biomolecule-drug interactions; electrophoresis and filter binding assays for e.g. 
protein-protein association where dissociation is very slow.174, 185-186  
 
In the present system, the association of ditopic (DHQD)2PHAL (abbreviated for the 
following discussion to ‘host’ H) to a single type of carboxylic acid (guest G) may 
lead to the formation of three complex stoichiometries: H, HG, and HG2.  The 
concentration of each is described by the following equilibrium constants, K1 and K2: 
 
H + G  HG HG2 
 
]][[
][
2 1
GH
HG
K   , 
]][[
][
2
1 2
2
GHG
HG
K  . 
 
The numerical coefficients are statistical factors required because each binding site in 
(DHQD)2PHAL is chemically equivalent, so the total concentration of HG is actually 
comprised of two degenerate and indistinguishable complexes, depending on which 
site the first guest binds.94  Initially UV-vis spectroscopy was attempted for the 
titration, although this proved unfeasible due to the large difference in extinction 
coefficient between (DHQD)2PHAL (e = 11457, 0.18 mM) and benzoic acid (e = 250, 
7.1 mM) in toluene, such that changes is max could not be detected.  Therefore, NMR 
was used as the technique of choice.     
 
The basis of the NMR titration method is that the change in chemical shift of a host 
proton is measured at several different [G]0:[H]0 ratios.  In each case the observed 
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shift can be expressed as a sum of the chemical shifts of the individual species 
present, weighted by the mole fraction of each,174 similar to equation 5.2 for coupling 
constant analysis. 
 
22 HGHGHGHGHHobs
fff    
 
The chemical shift of the free guest, G, may be ignored because a host resonance is 
being monitored.  Therefore, the observed change in chemical shift, at a certain point 
in the titration relative to free H, obs, is directly proportional to the mole 
fraction of the two complexes HG and HG2. 
 
22 HGHGHGHG
ff   , where e.g. HG = HG  H. 
 
Simultaneous equations linking  to the equilibrium constants may be derived based 
on this relationship.174  These equations are usually solved numerically, and require 
initial estimates of K1, K2, HG and HG2 to give the best fit to observed data for 
From these results, the mole fraction of each species present in a 1:2 binding 
system (i.e. Hf , HGf , 2HGf ) can be calculated: 
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Additionally, the parameter A = 
2
1
HGf  + 2HGf is commonly used to represent the 
proportion of bound catalyst sites, or the degree of saturation:94 
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A 1:1 binding isotherm with a monotopic host and where there is only one complex 
HG, is described by the simpler equation:
][1
][
][
][
0 GK
GK
H
HG
fHG

 .  This is a 
hyperbolic function of the general form y = x/(1 + x) and similar to the equation for 
A.  A simulated 1:1 binding curve (K = 100) is shown in figure 5.43.  
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Figure 5.43: Simulated 1:1 binding isotherm (K = 100) showing mole fraction of 
complex HG at different guest concentrations. 
 
The relative concentrations of each species in the 1:2 binding isotherm are strongly 
dependent on the cooperativity of the system,  = K2/K1.  Three plots of species 
population against free guest concentration with decreasing cooperativity are shown 
in figure 5.44.  Figure 5.44a shows a general example of non-cooperative binding 
system ( = 1).  It is observed that HG (magenta) rapidly increases to a maximum at 
low guest concentration, before being diminished as the second guest binds and HG2 
(yellow) becomes prevalent.  It is notable that the curves for A (purple) and 1:1 
binding (light-blue) overlay under these conditions.94, 187  For a system displaying 
positive cooperativity (figure 5.44b), the mole fraction of HG2 increases rapidly and 
therefore host saturation is reached at lower guest concentration.  Conversely, much 
higher concentrations are required for association of the second guest in negative 
cooperativity systems (figure 5.44c). 
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b)  = 10 
 
c)  = 0.01 
 
 
 
 
 
 
Figure 5.44: Species populations for binding systems with different cooperativity: a) 
 = 1; b)  = 10; c)  = 0.01.   Mole fractions of H (dark blue), HG (magenta), HG2 
(yellow) and A (purple) are shown for a 1:2 binding model and fHG for 1:1 binding 
(light blue line) vs. free guest concentration. 
 
An alternative presentation of titration data is the Hill plot.188  This is a curve of 
logA/(1-A)) versus log K’[G].  The normalisation factor K’ = √ K1K2 ensures that 
the plot goes through the origin.  The Hill coefficient nH which characterises the 
cooperativity of the system is the gradient of the curve at 50% saturation (A = 0.5) 
such that log (A/(1-A)) = 0.  Non-cooperative systems give a straight line (nH = 1) 
while negative cooperativity (green line) gives a slope of less than one and (nH > 1) 
for positive cooperativity (pink line) as shown in figure 5.45.  Again, identical curves 
are obtained for 1:1 and non-cooperative 1:2 binding.94 
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Figure 5.45: Hill plots for systems with different degrees of cooperativity: no 
cooperativity, nH, = 1,  =1 (blue line); negative cooperativity, nH, = 0.2,  =0.01 
(green line), positive cooperativity; nH, = 2,  =10 (pink line).  The grey diamonds 
represent the reference 1:1 binding system, nH, = 1.  
 
Elucidation of binding constants is a powerful method of studying equilibrium 
systems because it allows calculation of both cooperativity and the concentration of 
each possible reaction component in the system from the same data set.  The data can 
be represented in several ways, depending on which point is to be emphasised. 
 
 
5.10.2 Fitting the Association of Benzoic Acid and 
(DHQD)2PHAL to a 1:2 Binding Isotherm 
 
In order to calculate the equilibrium constants for association of benzoic acid (guest) 
to (DHQD)2PHAL (host), a 
1H-NMR titration in CDCl3 was performed.  The 
concentration of (DHQD)2PHAL was kept constant throughout, and 30 different 
concentrations of benzoic acid were used ranging from [G]0/[H]0 = 0 to 11 ([H]0 = 30 
mM).  Calculated values of were fitted to experimental data using a MATLAB 
program created by Thordarson.174  This program allows global analysis of the data 
sets for up to four proton resonances simultaneously.  However, association of 
benzoic acid results in a noticeable change in chemical shift of almost all host 
protons.  Therefore the fitting process was attempted with several combinations of 
host protons.  All gave similar results, but the lowest error was obtained using protons 
H3’, H9, H 10 and H21 (figure 5.46). 
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Figure 5.46: Structure of (DHQD)2PHAL with protons relevant to the titration 
labelled. 
 
Initially, the NMR shift data were fitted to a 1:1 binding model, resulting in a value of 
K = 31.9 Lmol-1.  The standard error (SEy) in the chemical shifts was 0.0189 ppm 
which translated to an error in K of ±7.2%.  Therefore, K = 31.9 ±2.3 Lmol-1.  A plot 
of the mole fraction of the complex HG (fHG) versus free [G] gave the hyperbolic 
curve indicative of 1:1 binding, as shown in figure 5.47. 
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Figure 5.47:  Plot of mole fraction of bound catalyst vs. free benzoic acid 
concentration. 
 
Next, the data was fitted to the more complex 1:2 binding model, also using the 
MATLAB program.  This resulted in values of K1 = 43.6 ± 20 Lmol-1 and K2 = 42.8 
± 1.8 Lmol-1.  The cooperativity of the system,  = K2/K1 = 0.98.  Within error, this 
suggests that binding to (DHQD)2PHAL is non-cooperative.  Graphically, this result 
should be represented by: a Hill plot with coefficient equal to one; and by overlaying 
curves for A and 1:1 binding in a plot of species population against guest 
concentration.   This is shown in figure 5.48. 
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Figure 5.48: Degree of (DHQD)2PHAL saturation vs. benzoic acid concentration 
calculated by fitting experimental data to 1:1 (dark blue) and 1:2 (light blue) binding 
isotherms. 
 
The curves also indicate that (DHQD)2PHAL does not reach saturation within the 
limits of this titration: A = 0.92 at [G]0/[H]0 = 11. 
 
A graph was also plotted of mole fraction of each complex (H (blue-grey), HG (red) 
and HG2 (green)) at increasing benzoic acid concentrations (figure 5.49).  Complex 
HG reaches a maximum population (50%) at [G]0/[H]0 = 2.0.  Its concentration then 
diminishes, but 18% population is maintained even at [G]0/[H]0 = 9.1.  The 1:2 
complex (HG2) becomes prevalent above [G]0/[H]0 = 3.8.   
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Figure 5.49: Relative populations of free (DHQD)2PHAL H, 1:1 (HG) and 1:2 (HG2) 
(DHQD)2PHAL:benzoic acid  complexes vs. [G]0/[H]0. 
 
The Hill plot (figure 5.50) perfectly fit the linear trendline y = x (R2 = 1) and overlay 
was observed with the Hill plot generated from 1:1 binding data.  Both these points 
indicate that the coefficient, nH = 1, and that association is non-cooperative. 
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Figure 5.50: Hill plot of experimental data.   
 
The experimental data could also be validated by comparison to a computational 
model using Copasi software which simulates the kinetic and thermodynamic 
behaviour of complex dynamic and equilibrium systems.189 It is often used in 
biochemistry and systems biology to predict the behaviour of signalling pathways 
[ref]; and in chemistry as a means of fitting experimental results to rate equations.99, 
190  
 
The experimental system was modelled under steady-state conditions at ten different 
concentrations of guest G.  Figure 5.51 shows the relevant parameters used in the 
simulation, and a comparison of calculated values for fHG (purple line) and
2HG
f  
(orange line) to empirical results. 
 
         H + G  HG, HG + G HG2;   
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2K1 = 43.6, ½K2 = 42.8; [H]0 = 30 mM 
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Figure 5.51: Comparison of experimental and simulated results for fHG and fHG2. 
 
The overlay of the theoretical and experimental results confirmed the accuracy of the 
NMR titration method. 
 
 
5.11 Discussion of Mechanistic Insights into 
Bromolactonisation Reaction without Benzoic Acid 
 
The results of the binding constant analysis indicate that each quinuclidine hydrogen 
bonds to benzoic acid independently.  The equilibrium constants (K1 = 44, K2 = 43                                
) are lower than those expected from pKa differences between quinuclidine and 
benzoic acid in water (pKa = 4.4) and acetonitrile (pKa ~ 3), suggesting that other 
intermolecular forces contribute significantly to the binding strength.
 
The concentration of benzoic acid required for catalyst saturation (A = 1) is reached 
at [G]0/[H]0 > 10, which agrees more closely with the value obtained from chemical 
shift changes ([G]0/[H]0 > 8) compared to the coupling constant analysis (fgauche(1) = 1 
at ([G]0/[H]0 ~3.5) (figure 5.22). 
 
The disparity in these results is because the coupling constant method measures the 
proportion of catalyst sites in the gauche conformation: 
  
216 
fgauche(1) =
2
1
)1(/)1()1(/ gauchegauchegaucheanti ff   
where fanti/gauche represents the mole fraction of (DHQD)2PHAL molecules with one 
quinuclidine in the anti conformation and the other in the gauche(1) state etc.  This is 
not the same as the fraction of bound sites, as 39% of catalyst sites are already in the 
gauche(1) conformation for free (DHQD)2PHAL in CDCl3.  Consequently, saturation 
is reached at much lower acid concentration by the coupling constant method. 
 
This inequality has important implications in the bromolactonisation reaction without 
additive.  In the discussion of section 5.8.2, it was proposed that the conversion-
dependent decrease in asymmetric induction for bromolactonisation of substrate 114 
with no benzoic acid (from >73:27 to 63:37 e.r.) could be attributed to changes in 
catalyst:substrate stoichiometry.  This is because (DHQD)2PHALsubstrate 
interactions fall away with conversion, diminishing catalyst saturation. 
 
Binding constant analysis indicated that the mole fraction of the 1:2 complex HG2 
decreases logarithmically with acid concentration, showing that the 1:2 complex HG2 
(where G = substrate) is more enantioselective than HG.   We propose that this is due 
to changes in the rigidity of the binding pocket, which diminish the stereoselectivity 
of bromination. 
 
In the transition from HG2 to HG which occurs due to product release or substrate 
dissociation, the rigidity of the binding pocket decreases due to loss of H-bonding 
interactions with the substrate.   The non-cooperativity of (DHQD)2PHAL binding 
indicates that each quinidine unit is coordinatively and conformationally independent.  
Therefore, it is expected that the unbound quinidine of HG rapidly interconverts 
between the gauche(1), anti(1) and anti(2) rotamers with populations elucidated by 
the coupling constant analysis: fgauche(1) = 0.39, fanti(1) + fanti(2) = 0.61.  The 
conformationally flexible catalyst structure of HG also increases the rotational 
freedom of the bound substrate, which reduces the facial selectivity of alkene 
bromination.   
 
One strategy for validating this hypothesis is to perform the bromolactonisation 
reaction with a catalyst analogue constrained in the gauche(1) conformation.  By 
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suppressing the adoption of the anti rotamers in the free catalyst, it is expected that 
this analogue will return higher product enantiomer ratios in the reaction without 
additive.  Work towards the synthesis and testing of conformationally constrained 
analogues of (DHQD)2PHAL is described in section 5.13.  However, the binding 
constant analysis also gave several insights into bromolactonisation reactions with 
added benzoic acid, which will be discussed in the following section. 
 
 
5.12 Discussion of Mechanistic Insights into 
Bromolactonisation Reaction with Excess Acid 
 
Strong evidence has been obtained that 1:2 (DHQD)2PHAL:carboxylic acid 
complexes catalyse bromolactonisation with greater enantioselectivity than the 1:1 
catalyst:substrate complex.  Therefore, it seems clear that the additive’s role is to 
suppress the formation of this 1:1 complex towards the end of the reaction when 
substrate concentration is diminished.  However, mechanistic ambiguities remain as to 
why enantioselectivity varies with additive pKa and why the enantiomer ratio of exo-
74 and endo-74 bromolactones changes with conversion (60:40 to 67:33 e.r. and 
85:15 to 74:26 e.r., respectively) although a constant e.r. (80:20) is maintained with 
original substrate 114.   
 
Under reaction conditions with benzoic acid (100 mol% BzOH, 10 mol% 
(DHQD)2PHAL) the total acid concentration decreases to a minimum of [G]0/[H]0 = 
10.  According to binding constant measurements, 
2HG
f = 0.83 and fHG = 0.16 at this 
point i.e. the catalyst is not completely coordinatively saturated towards the end of the 
reaction.  Therefore, the beneficial effect of additives with a lower pKa than benzoic 
acid (scheme 2.3.3) may in part be due to an increase in catalyst saturation, A.  This 
suppresses the formation of 1:1 complexes, and the consequent deterioration of 
enantioselectivity.  However, it may envisaged that there is a further 
enantiodifferentiation between symmetric complexes: HSS (where two substrates (S) 
are bound) and non-symmetric HSA ((DHQD)2PHAL is bound to one additive (A) 
and one substrate (S)), as shown in figure 5.52.   
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Figure 5.52: Enantiodivergent complexes between (DHQD)2PHAL (H), substrate 114 
(S) and benzoic acid additive (A). 
 
The population of HAA (two additives bound) could also determine how much of the 
substrate reacts via the uncatalysed pathway.  Kinetic experiments (section2.5) 
indicated that the background reaction of substrate 114 is a competitive process, with 
30% conversion after 0.5 h at 20 ◦C in the presence of benzoic acid. 
 
The additive may influence the structure of the binding pocket through both steric and 
electronic effects.  In the additive screening experiments described in chapter 2, both 
factors were shown to influence enantioselectivity.  In principle it is possible to 
characterise the relative binding pocket structures of HSS, HSA and HAA by 
crystallography, although this was not attempted due to the difficulty in obtaining 
single crystals of sufficient quality.  Instead, the specific influence of additive pKa (i.e. 
binding constant) on enantioselectivity was investigated computationally.   
 
Using Copasi software,189 it is possible to model an equilibrium system where two 
carboxylic acids e.g. a substrate and additive compete with different affinities for 
association to a ditopic host e.g. (DHQD)2PHAL.
184  If the relative population of each 
complex changes with acid concentration, and each complex is catalytically distinct, it 
may be expected that overall asymmetric induction changes with substrate 
conversion.  It should be noted that this analysis does not take into account the steric 
properties of additives, which were also shown to affect enantioselectivity (section 
2.3.8). 
 
The influence of additive binding constant on the mole fractions of HSS, HSA and 
HAA was modelled at six substrate concentrations, chosen to follow reaction 
conversion.  The association of substrate to catalyst was assumed to have KS = 40 
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Lmol-1 (similar to that for benzoic acid).  For ternary mixtures of (DHQD)2PHAL 
(H), substrate (S) and additive (A), the relevant equilibria and statistical factors are:  
 
 
H + S  HS 
H + A  HA 
 
HS + A  HSA 
HA + S  HSA 
 
HS + S  HSS 
HA + A  HAA. 
 
Five simulations were performed with KA = 10, 40, 80, 200 and 400 Lmol
-1, and 
initial concentrations, [H]0 = 30 mM, [A]0  = 300 mM, concentrations ten times 
greater than reaction conditions. [S]0 was varied between 30 and 300 mM.  For each 
data point, the mole fraction (f) of HSS, HSA and HAA was generated by the 
software (figure 5.53). 
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Figure 5.53: Mole fractions of complexes HSS (top), HSA (middle) and HAA 
(bottom) vs. initial substrate concentration, [S]0 for additive binding constants KA = 
10, 40, 80, 200 and 400 Lmol-1. 
 
The proportion of each complex is strongly dependent on the additive binding 
constant.  The reactive symmetric complex HSS (top graph of figure 5.53) only 
reaches a significant population (fHSS > 0.2) for KA ≤ 40.  This is in agreement with 
the supposition   Similarly, the concentration of mixed complex HSA (middle) is 
diminished at high additive binding constants.  As anticipated, the populations of HSS 
and HSA both decrease with substrate concentration.  With strongly acidic additives, 
most of the catalyst rests as the spectator complex HAA (lower graph of figure 5.53).  
In extreme cases, e.g. additive is TFA (pKa ~ 4), it is clear that formation of reactive 
complexes will be completely suppressed, such that racemic products are returned.   
 
Figure 5.53 reveals that the rate of complex HSS depletion with substrate 
concentration is much faster relative to HSA at all additive binding constants.  For 
example, at KA = 80, [HSA]0/[HSS]0 = 3.8 at [S]0/[H]0 = 10, but [HSA]0/[HSS]0 = 37 
at [S]0/[H]0 = 1.   If each complex catalyses the reaction with different asymmetric 
induction, it would be expected that product e.r. changes with reaction conversion.  
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Although this is observed for endo- and exo-(74), enantioselectivity remains constant 
at 80:20 e.r. for bromolactonisation of 4-phenyl-4-pentenoic acid (114).  Without 
knowledge of the influence of additive steric properties on enantioselectivity, it is not 
possible to fully rationalise these results.  However, it may be tentatively concluded 
that complexes with different acid identities and stoichiometry do influence the 
stereoselectivity of bromolactonisation. 
 
In the following section, further evidence for both of this hypothesis will be obtained 
by performing the bromolactonisation reaction with catalyst analogues constrained in 
the gauche(1) conformation.  It is anticipated that these catalysts will restrict the 
conformational flexibility of the 1:1 catalyst:substrate complex, and thus perform the 
role of the additive in the (DHQD)2PHAL system.  Consequently, higher 
enantioselectivities are expected for the reaction without benzoic acid. In the presence 
of benzoic acid, the constrained catalysts should give similar asymmetric induction to 
(DHQD)2PHAL. 
 
 
5.13 Design and Synthesis of Conformationally Biased 
Catalysts 
5.13.1 Introduction 
 
Mechanistically inspired rigid cinchona alkaloid catalysts have been used by several 
groups to probe the effect of catalyst conformation on enantioselectivity and rate.  
Several of these have been discussed in the introduction such as -isocupreidine 213, 
an excellent catalyst for the Morita-Baylis-Hillman reaction reported by Hatekayama 
(scheme 5.1).191   
 
Scheme 5.2: Highly enantioselective Morita-Baylis-Hillman reaction catalysed by 
constrained -isocupreidine 213.191 
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This catalyst was specifically designed to maximise the nucleophilicity of the 
quinuclidine nitrogen by locking the catalyst in the gauche conformation which 
restricts rotation of the sterically hindering quinoline ring.  Excellent 
enantioselectivities were observed for the reaction between hexafluoroisopropyl 
acrylates and aromatic and aliphatic aldehydes.  Unconstrained catalysts such as 
quinidine gave much lower yields and racemic products. 
 
Corey and Noe published several important reports on the mechanism of the Sharpless 
asymmetric dihydroxylation reaction in the early 1990’s.169-170  They proposed that 
dimeric quinidine catalysts form a chiral binding pocket which maximises attractive 
intramolecular interactions with the substrate olefin (figure 5.10).  In order to test this, 
the catalyst 215 (figure 5.54) an adipate-bridged derivative of (DHQD)2PYDZ was 
designed to constrain the catalyst in this conformation.  It was synthesised in five 
steps from quinidine.192 
 
 
 
Figure 5.54: Mechanistically inspired catalyst for the Sharpless dihydroxylation 
reaction which is constrained in the gauche(1) conformation.192 
 
NMR studies of 214 showed that the 3J8-9 coupling constant was 1.5 Hz and nOe 
cross-peaks between protons H5, H8 and H9 were all indicative of the gauche(1) 
conformation with  =  90◦.  The 1H NMR spectrum of a catalyst:OsO4 complex 
showed very similar geometry.  A space filling (CPK) model also shows how the 
adipate bridge forces and constrains the two quinoline rings on the same face of the 
pyridazine linker (compare with the crystal structure of (DHQD)2PHAL and 
anthranoic acid where the quinolines are on opposite faces of PHAL).  As a catalyst in 
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the SAD reaction, this locked catalyst gave essentially identical enantioselectivities as 
the unbridged catalyst for dihydroxylation of several alkenes.  This was taken as good 
evidence that both catalysts have the same mode of action and that their model was an 
accurate representation of the binding pocket of the catalyst.  Further SAR studies 
confirmed this and the later design of catalysts tailored to specific substrate classes 
results from this work.193 
 
More recently, Deng et al. designed the first catalyst locked in the anti conformation 
(216),194 achieved by connecting the quinoline ring and quinuclidine side chain via 
ring-closing metathesis (scheme 5.3).  NOESY NMR cross-peaks from H5 to H19 and 
from H1 to H9 confirmed this conformation. 
 
 
Scheme 5.3: Synthesis and enantioselectivity of constrained catalyst 216 in the 
asymmetric methanolysis of meso-anhydrides.194 
 
The constrained alkaloid 216 proved to be an efficient catalyst in the asymmetric 
methanolysis of meso-succinic anhydrides giving similar results to the initial catalyst 
(97:3 and 98:2 e.r., respectively).  These results compared favourably with the rigid 
gauche catalyst -isoquinidine 213 which gave much lower asymmetric induction 
(60:40 e.r.).  The authors concluded that this was strong evidence that the anti 
conformation was required for maximum enantioselectivity for this reaction and 
stressed that these conclusions were not just based on ground state considerations of 
isolated systems.   
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However, a recent computational study by Wong et al. disputes this analysis and 
claims that the usually inaccessible gauche(2) conformation (with  = +90◦) gives the 
lowest energy transition state.195  This suggests that Deng’s locked catalyst 216 must 
be able to adopt the gauche conformation under reaction conditions (although  = 
+90◦ seems unlikely).  This could perhaps be determined from the 1H NMR spectrum 
of a catalyst:alcohol mixture.  Furthermore, the locked -isoquinidine 213 catalyst is 
structurally very different to the phenanthryl ethers examined, and overall this 
example highlights the caution required in drawing conclusions from this kind of 
experimental data. 
 
For our bromolactonisation reactions, two dimeric catalysts conformationally biased 
towards the gauche(1) rotamer at each quinidine were designed.  Molecular models 
suggested that the preferred anti(1) conformation of (DHQD)2PHAL could be 
suppressed by the presence of bulky substituents on the quinuclidine C3-ethyl side 
chain.  Steric hindrance between this group and the quinoline C6’-methyl ether could 
be relieved by C8-C9 bond rotation towards the gauche(1) conformation, as shown in 
scheme 5.4.  It is also possible that steric crowding may instead induce a switch in 
torsion angle  from anti(1) ( = 90◦)  to anti(2) ( = 90◦) conformations.  However 
this can be identified from characteristic 2D-NOESY cross-peaks. 
 
In the event, bulky trityl and tri-isopropyl silyl ether groups were selected for 
modified catalysts, 215 and 216, respectively.     
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Scheme 5.4: 1,4-Bis-(9-O-11-tri-isopropoxy dihydroquinidine) phthalazine (217) and 
1,4-bis-(9-O-11-triphenylmethoxy dihydroquinidine) phthalazine (218); catalysts for 
bromolactonisation which stabilise the gauche(1) conformation. 
5.13.2 Catalyst Synthesis 
 
The retrosynthesis of both catalysts (scheme 5.5) was adopted from Corey’s 
preparation of (QD-OTIPS)2PYDZ, an intermediate towards the adipate-bridged bis-
cinchona alkaloid 213.192   
Scheme 5.5: Retrosynthesis of novel catalysts. 
 
The dimerisation step, involving nucleophilic aromatic substitution of chloride from 
1,4-dichloropyridazine, was to be performed last.  The silyl ether functional group of 
the monomer 219 was to be pre-installed by hydroboration and silylation of quinidine.  
Our proposed synthetic route differed only in the use of 1,4-dichlorophthalazine, and 
trityl ether protection for catalyst 219. 
 
Corey’s procedure for the first step involved hydroboration of quinidine in THF with 
borane, followed by oxidation using lithium hydroxide and hydrogen peroxide 
(scheme 5.6).  The resulting N-borane adducts (at quinuclidine and quinoline) were 
cleaved by heating the crude material to 80 ◦C in a mixture of methanol and acetone 
acidified to pH 2 with concentrated HCl, to give the C11-hydroxylated quinidine 221 
as an impure mixture. 
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Scheme 5.6: Hydroboration-oxidation procedure reported by Corey et al. for the 
synthesis of C11-hydroxylated dihydroquinidine 221. 
 
Initially, this procedure was followed for the synthesis of catalysts 217 and 218.  In 
accordance with Corey’s observations, it was found that the acidic cleavage of N-
borane adducts led to significant decomposition products inseparable from C11-
alcohol 219 by both column chromatography and recrystallisation.  An alternative 
method developed by Sanders et al. was thereafter attempted.196  This involved the 
use of trimethylamine N-oxide in diglyme to mediate both organoborane oxidation 
and N-borane cleavage steps concurrently (scheme 5.7). 
 
 
Scheme 5.7: Procedure developed by Sanders et al. for one-pot organoborane 
oxidation and N-borane bond cleavage of O9-TBS quinidine 222. 
 
In order to avoid the use of high boiling diglyme, we elected to perform this reaction 
with quinidine in with the original hydroboration solvent, THF.  The required high 
temperatures could be obtained using a microwave reactor.  The major advantage of 
microwave heating is that solutions can be heated rapidly and uniformly;197 the sealed 
reaction flask means that solvents can be heated above their atmospheric boiling 
point.  In the event (scheme 5.8), the desired product alcohol 221 could be isolated 
pure in up to 78% yield after heating the hydroborated mixture to 130 ◦C twice 
sequentially for ten minutes each time.  An important practical issue with this reaction 
was the avoidance of pressure runaway (> 20 bar), which occasionally occurred due to 
the inhomogeneity of Me3NO in the reaction mixture and gave lower product yields. 
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Scheme 5.8: Quinidine C11 oxidation mediated by Me3NO in a microwave reactor. 
 
The following step in the synthesis of 217 was selective triisopropylsilyl protection of 
the primary C11 alcohol.  This was simply achieved using triisopropylsilyl chloride 
and imidazole in CH2Cl2.
192  The product 219 was isolated as a yellow oil in 86% 
yield (scheme 5.9). 
 
 
Scheme 5.9: Silyl ether protection of primary alcohol 221. 
 
The trityl group towards catalyst 218 was installed using trityl chloride and excess 
triethylamine.  Dimethylaminopyridine (DMAP) could also be added as a 
nucleophilic catalyst without any loss of selectivity for the primary alcohol (scheme 
5.10). 
 
 
Scheme 5.9: Trityl ether protection of primary alcohol 221. 
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The stage was now set for the two SNAr reactions required to generate the dimeric 
catalysts.  Corey’s original procedure involved heating a mixture of QD-OTIPS (219), 
1,4-dichloropyridazine and potassium hydroxide in toluene to 120 ◦C.192  In our hands, 
repetition of this experiment with 1,4-dichlorophthalazine gave none of the desired 
product.  Instead, it was found that reaction would stall after the first addition-
elimination event to give the 1-quinidyl-4-chlorophthalazine 223 (scheme 5.11).  The 
same result was obtained with stronger bases e.g. potassium t-butoxide and sodium 
hydride (this reaction was performed in THF).   
 
 
 
Scheme 5.11: Reaction of triisopropylsilyl ether 219 and 1,4-dichlorophthalazine 
stalled after nucleophilic aromatic substitution step.  The product was independent of 
the base used. 
 
It was therefore concluded that the product of the first nucleophilic aromatic 
substitution step, 223, increased the electron density of the phthalazine ring, 
deactivating it towards the subsequent reaction.  Several solutions were considered, 
such as increasing the lability of the phthalazine leaving groups by replacement of 
chloride for triflate; or using higher boiling solvents to overcome the thermal barrier 
for this reaction.  This was a similar problem to that encountered in the hydroboration 
step, as Sanders et al. used diglyme instead of THF for C11-oxidation of quinidine.196   
 
Consequently, it was decided to attempt the reaction in a microwave reactor.  
Accordingly, the triisopropylsilyl ether 219 was deprotonated using sodium hydride in 
THF, 1,4-dichlorophthalazine was added and the reaction mixture was heated to 130 
◦C for five minutes.  To our delight a peak corresponding to the desired bis-cinchona 
alkaloid 217 was observed by LC-MS.  After heating for a further ten minutes, 217 
could be isolated cleanly in 74% yield (scheme 5.12). 
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Scheme 5.12: Synthesis of (QD-OTIPS)2PHAL in a microwave reactor. 
 
Synthesis of the dimeric trityl ether 216 required even more forcing conditions, as the 
second SNAr step did not proceed at 130 
◦C in THF.  However, by exchanging the 
solvent to DMF, the reaction temperature could be increased further and the polar 
aprotic properties of DMF are known to increase the reactivity of anionic 
nucleophiles.198  In the event, the optimal temperature and reaction time had to be 
closely monitored to prevent substrate decomposition, but 32% yield of the desired 
product could be isolated after heating the mixture to 190 ◦C for 15 minutes (scheme 
5.13). 
 
Scheme 5.13: Synthesis of (QD-OTr)2PHAL in a microwave reactor. 
 
 
5.13.3 Conformations of Modified Catalysts 
The conformations of the mechanistically designed catalysts 217 and 218 were 
examined using the 1H NMR techniques described in previous sections.  Initially, the 
proportion of each catalyst in the gauche(1) conformation was determined from the 
3J8-9 coupling constants.  These were measured from 
1H NMR spectra of 217 and 218 
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in CDCl3 ([cat]0 = 20 mM) and compared to the values obtained for (DHQD)2PHAL 
in section 5.8.1.  The results are shown in table 5.1. 
 
Table 5.1: Conformational analysis of modified catalysts. 
Catalyst 3J8-9 (Hz) fgauche(1) 
(DHQD)2PHAL (112) 6.6 0.39 
(QD-OTIPS)2PHAL (217) 5.7 0.49 
(QD-OTr)2PHAL (218) 4.6 0.61 
Both novel catalysts stabilise the gauche(1) conformation relative to (DHQD)2PHAL.  
The effect is more pronounced for trityl ether 218, where fgauche(1) = 0.61, suggesting 
that the trityl group induces greater steric repulsion with the adjacent quinoline methyl 
ether in the original anti(1) conformation. 
 
The 2D-NOESY spectrum of the trityl ether 218 was also recorded in CDCl3 in order 
to identify the conformations adopted by this catalyst.  In addition to a transition to 
the gauche(1) rotamer, molecular models suggested that steric strain induced in the 
anti(1) conformation between the trityl and quinoline rings could be relieved by 
adoption of the anti(2) conformer (figure 5.55). 
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Figure 5.55: Expansion of 2D-NOESY spectrum of (QD-OTr)2PHAL (218) in 
CDCl3. 
In the actual spectrum, the only relevant nOe observed was from H5 to H8, which is 
characteristic of both the anti(1) and gauche(1) conformations.  No evidence of 
anti(2) e.g. H1’ to H5 was observed.  In conjunction with the 3J8-9 coupling constant 
data, this was important validation of the original design behind catalysts 217 and 
218, and suggested that the results of subsequent bromolactonisation reactions 
performed with these catalysts could be rationalised in terms of the mole fraction of 
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the gauche(1) conformation.  These experiments are described in the following 
section. 
 
5.13.4 Bromolactonisation Reactions Catalysed by 
Conformationally Biased Catalysts 
 
The initial objective behind the synthesis of catalyst analogues 217 and 218 was to 
establish whether the conformational flexibility of the 1:1 catalyst:substrate complex 
diminished enantioselectivity.  By increasing the gauche(1) population of the free 
catalyst, the additive would no longer be required to maximise asymmetric induction. 
 
The novel catalysts were accordingly used in the bromolactonisation of substrate 147 
without additive.  This substrate was chosen because in the absence of benzoic acid 
the product is isolated as a racemic mixture, whereas 80:20 e.r. was obtained with 
benzoic acid, suggesting that the 1:1 complex formed when the catalyst is unsaturated 
is significantly detrimental to asymmetric induction.  The results are shown in table 
5.2. 
 
Table 5.2: Bromolactonisation of o-allyl benzoic acid using gauche(1)-stabilising 
catalysts. 
 
Catalyst fgauche(1) e.r.(162) 
(DHQD)2PHAL (112) 0.39 50:50 
(QD-OTIPS)2PHAL (217) 0.49 69:31 
(QD-OTr)2PHAL (218) 0.61 63:37 
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Both catalysts are more enantioselective than (DHQD)2PHAL.  Bromolactone 162 is 
obtained in 69:31 e.r. using TIPS-ether 215, and 63:37 e.r. with (QD-OTr)2PHAL 
(216).   Although the trityl-ether 216 has a greater population in the gauche 
conformation, it is less enantioselective than TIPS-ether 215.  These results appear 
contradictory.  If the magnitude of asymmetric induction is correlated to the 
proportion of unbound quinidine in the gauche(1) conformation, (QD-OTr)2PHAL 
should be the most effective catalyst. 
 
It is possible that the large size of the trityl group disrupts other intermolecular 
interactions, which override the beneficial conformational preference.  However, 
further work is required to establish unambiguously the enantiodifferentiation of rigid 
and flexible catalyst:substrate complexes.  This will involve measurement of the 
change in product e.r. with conversion, and repeating the reaction with other 
substrates.  Both novel catalysts should decrease the rate of e.r. deterioration with 
substrate depletion, and their influence should be reproducible to other alkenoic acids.  
In addition, it is necessary to quantify the binding constants between the novel 
catalysts and carboxylic acids.  The steric bulk or conformational bias towards 
gauche(1) may alter the strength of these interactions, and consequently the relative 
mole fractions of 1:1 and 1:2 complexes. 
 
The reaction was also carried out in the presence of one equivalent benzoic acid.  It 
was anticipated that the novel catalysts would give the same enantioselectivity as 
(DHQD)2PHAL, as association of benzoic acid only reinforces the inherent 
conformational preference of these catalysts (table 5.3). 
 
 
Table 5.2: Bromolactonisation of o-allyl benzoic acid using conformationally biased 
catalysts with benzoic acid. 
 
Catalyst fgauche(1) e.r.(162) 
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(DHQD)2PHAL (112) 0.39 80:20 
(QD-OTIPS)2PHAL (217) 0.49 76:24 
(QD-OTr)2PHAL (218) 0.61 74:26 
 
 
In the event, both (QD-OTIPS)2PHAL (76:24 e.r.) and (QD-OTr)2PHAL (74:26 e.r.) 
returned essentially the same product e.r.’s but were less efficient than the original 
catalyst (80:20 e.r.).  In addition to the uncharacterised steric interactions between 
benzoic acid, substrate and the bulky ether substituents of 217 and 218, a possible 
explanation for this disparity an increase in the catalyst:carboxylic acid association 
constants favours the formation of the spectator 1:2 benzoic acid complex, such that 
more of the substrate reacts via the uncatalysed background reaction.  Evidence for 
this supposition was obtained from the 1H NMR spectrum of a 1:2 (QD-
OTIPS)2PHAL:benzoic acid mixture in CDCl3 (figure 5.56). 
 
Figure 5.56: 1H NMR spectra of (QD-OTIPS)2PHAL in CDCl3 (top), and 1:2 (QD-
OTIPS)2PHAL:benzoic acid (bottom) in CDCl3. 
 
Significant line broadening of catalyst signal was observed, suggesting that benzoic 
acid association-dissociation approaches the slow exchange regime within the NMR 
timescale. 
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In conclusion, these results broadly support our mechanistic hypothesis that 
constraining both quinidine units of the bis-cinchona alkaloid catalyst in the 
gauche(1) conformation is essential for high enantioselectivity.  This may be achieved 
through addition of excess acid in the reaction mixture or by use of catalysts with an 
inherent bias for this conformation.  In the following section, a unifying model for 
asymmetric induction will be proposed to account for the absolute product 
configurations observed. 
 
 
5.14 Model for Asymmetric Induction 
 
In chapter 4, transition state models were posited in order to account for the 
observations that enantio-determining alkene bromination consistently takes place on 
the pro-R alkene face for all substrates, except exo-74.  However, at the time, 
insufficient understanding of catalyst:substrate interactions made a proposal of 
absolute substrate conformation and vector of NBS attack impossible.   
 
The conformational analyses of the preceding sections gave several insights into these 
ambiguities.  Figure 5.57 shows four possible transition state representations (224-
227) for reaction of 5-phenyl-5-hexenoic acid (101), which gave bromolactones 102 
in 94:6 e.r.  These are distinguished by the alkene group facing towards or away from 
the binding pocket, and by a pseudo-axial or equatorial phenyl substituent.  We 
propose that the alkene will be oriented away from the catalyst binding pocket, into 
solution, and furthermore that the phenyl ring will adopt the equatorial position (227).  
This is because no evidence has been obtained for association of NBS and carboxylic 
acids at independent catalyst basic sites; and it is likely that the rigidity of the binding 
pocket will hinder approach of NBS from within the pocket (224 and 225).  It can also 
be clearly seen that transition state 226, with an axial phenyl group, causes significant 
steric clashing with the quinuclidine ring of (DHQD)2PHAL.  Structure 227 facilitates 
approach of NBS from the solution, and minimises non-hydrogen bonding 
interactions with quinuclidine.  This is reflected in the significant preference for the 
(S)-bromolactone 101.  
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Figure 5.57: Transition state models for bromolactonisation of 5-phenyl-5-hexenoic 
acid (101). 
 
This model also explains the observed pro-R face selectivity of bromination for -
lactones (figure 5.58).  Intuitively, an envelope structure with staggered methylene 
groups is likely to be favoured.  The large substituent (RL) takes a pseudo-equatorial 
position in this case to avoid steric clashes with quinuclidine. 
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Figure 5.58: Transition state models for bromolactonisation of 4-phenyl-4-pentenoic 
acid (114) and other -unsaturated alkenoic acids. 
 
Furthermore, it may be envisioned that upon alkene bromination, the forming 
succinimide anion may be stabilised by hydrogen-bonding to the acidic quinuclidine 
proton (figure 5.59).  This is possible because H-bonding to the carboxylate oxygen 
atoms is not fully bifurcated, as was indicated by the previously determined crystal 
structure (section 2.5).   
 
Figure 5.59: Lactonisation step proceeds with concomitant protonation of 
succinimide. 
 
The principle of this mechanistic model is also applicable to benzoic acid based 
derivatives.  However, it was not possible to rationalise the observed 
enantioselectivity for (E)-5-phenyl-4-pentenoic acid (73).  In chapter 4, it was shown 
that alkene bromination is non-selective for this substrate and that asymmetry is 
induced because formation of (5S,6R)-endo-74 is significantly disfavoured.  This may 
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be rationalised because the chair conformation transition state towards this enantiomer 
(figure 5.60) directs the phenyl substituent directly towards quinuclidine.  However, 
this is also the case in the transition state for the major enantiomer, which also 
requires adoption of a boat conformation.   
 
Figure 5.60: Transition state models for bromolactonisation of substrate (E)-73 
towards endo-74. 
 
In future work, it should be possible to test this model by performing the 
bromolactonisation reaction with substrates designed to enhance or minimise 
unfavourable steric interactions with the quinuclidine ring (figure 5.61).  Substrate 
228 is expected to give low enantioselectivity as both isopropyl and alkene groups are 
of similar size, resulting in poor differentiation.  In contrast, the large mesityl group of 
substrate 229 should be constrained in the pseudo-axial position giving high 
selectivity.  
 
Figure 5.61: Possible substrates to test proposed model for asymmetric induction. 
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6 Conclusion  
 
In summary, this thesis describes the development of an asymmetric 
bromolactonisation reaction catalysed by (DHQD)2PHAL-benzoic acid combinations.  
Initial experiments with 4-phenyl-4-pentenoic acid indicated that added benzoic acid 
significantly enhanced the enantioselectivity of bromolactonisation from 63:37 to 
80:20 e.r. in a CHCl3:hexane solvent mixture.  Other aromatic carboxylic acids had a 
similar beneficial effect, and product e.r. was optimised at 93:7 e.r. using p-
trifluoromethyl benzoic acid in toluene. 
 
The applicability of the catalyst system was determined by a substrate screen of 
fifteen alkenoic acids.  Several substrate classes were investigated, distinguished by 
chain length between alkene and carboxylic acid functional groups, olefin 
nucleophilicity and geometry.  The enantiomer ratios obtained were comparable with 
the best results in the literature, which often require the use of bespoke catalysts 
optimised for a particular substrate class.  Six novel enantioenriched bromolactones 
were also synthesised. 
 
For all substrates, bromolactonisation proceeded diastereospecifically to give anti 
relative stereochemistry between bromine and carboxylate groups, confirming the 
presence of an intermediate bromonium ion.  Furthermore, it was established that 
bromonium ion racemisation via alkene-alkene transfer, which is frequently cited as 
the major challenge towards enantioselective bromo- and iodo-functionalisation 
reactions, is suppressed in the (DHQD)2PHAL system.  In conjunction with analysis 
of the absolute product configurations, these results strongly suggested that alkene 
bromination is the enantiodetermining step of the catalytic cycle.  The face selectivity 
of lactonisation is thus dictated by the stereochemistry of the intermediate bromonium 
ion. 
 
Two exceptions to this hypothesis were observed.  For bromolactonisation of (E)-
containing alkenoic acids, (E)-5-phenyl-4-pentenoic acid and 2-stilbene benzoic acid, 
enantioselectivity is determined by the initial bromination step and by the requirement 
that the regioselectivity of lactonisation towards 5-exo or 6-endo bromolactones is 
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different for each diastereomeric bromonium ion.  This unusual mechanism of 
stereocontrol was not observed with the other substrates, as these cyclised 
regiospecifically. 
 
Further investigation of the additive effect showed that the enantioselectivity of 
bromolactonisation is strongly influenced by the total acid concentration in solution.  
In the absence of an additive, diminishing H-bonding interactions between the 
substrate and catalyst cause the deterioration of product e.r. with conversion.  
Enantioselectivity is recovered and often enhanced by the presence of excess benzoic 
acid. 
 
These observations were rationalised by studying the conformations adopted by 
(DHQD)2PHAL at different concentrations of carboxylic acids.  This was achieved 
using combined 1H NMR and crystallographic analyses.  Free (DHQD)2PHAL is 
rotationally flexible in CDCl3 solution, adopting the anti(1), anti(2) and gauche(1) 
conformations.  Carboxylic acids bind at the quinuclidine nitrogen atom.  This 
association rigidifies the catalyst structure, enforcing the gauche(1) conformation at 
each quinidine.   
 
During the development of the eponymous asymmetric dihydroxylation reaction, 
Sharpless proposed that dimeric cinchona alkaloid catalysts maximise 
enantioselectivity by formation of a chiral binding pocket which enforces a specific 
substrate conformation.  This structure is also relevant to asymmetric 
bromolactonisation, as monomeric catalysts gave significantly reduced 
enantioselectivity.  The structure of the binding pocket enforced by carboxylic acids 
was characterised by a crystal structure of a 1:2 (DHQD)2PHAL:anthranoic acid 
complex.  This is the first reported co-crystal between a dimeric cinchona alkaloid and 
an interacting co-solute.   
 
The equilibrium constants for association of benzoic acid to (DHQD)2PHAL were 
elucidated by NMR titrations.  These results indicate the binding stoichiometry of 
catalyst:carboxylic acid complexes varies significantly with acid concentration.  The 
1:1 complex becomes prevalent as acid concentration decreases.  This trend mirrors 
the deterioration of enantioselectivity with substrate conversion.   
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The 1:1 complex recovers rotational flexibility at the unbound quinidine, decreasing 
the rigidity of the binding pocket.  On this basis, we proposed that the 1:1 
(DHQD)2PHAL:substrate complex is less enantioselective than the 1:2 complex.  The 
role of carboxylic acid additives is to ensure that both quinidine units of the catalyst 
are protonated throughout the reaction, suppressing formation of the 1:1 complex.   
 
Two novel analogues of (DHQD)2PHAL, inherently biased towards the gauche(1) 
conformation, were designed and synthesised in order to test this hypothesis.  Both 
catalysts give greater enantioselectivity than the original catalyst in the absence of 
additive, showing that the conformational rigidity of the catalyst is essential for 
optimal asymmetric induction.  The structural information obtained during this 
investigation allowed the proposal for a unifying model to account for the absolute 
product configurations observed. 
 
In conclusion, the (DHQD)2PHAL-carboxylic acid system has several advantages 
over other methods for asymmetric bromolactonisation.  All the reagents are 
commercially available, and the system is broadly applicable to a wide range of 
substrates without structural modification of the catalyst.  Instead, catalyst properties 
can be tuned using different added carboxylic acids.  Ultimately, the utility of this 
reaction should be tested in natural product synthesis.   
 
In this project, we have been the first group to apply a conformational analysis of 
cinchona alkaloids to asymmetric halogenation, which has shed light on several 
unusual mechanistic features.  In future work, further studies are required on reaction 
kinetics and catalyst interactions with NBS in order to finally resolve the mechanism 
of bromine transfer. 
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7 Experimental Section 
7.1 General Experimental 
 
Reagents: Bis(acetonitrile) palladium chloride was prepared according to the method 
of Welton.199 N-bromosuccinimide was purified by prior to use by recrystallisation 
from water.  Triethylamine was distilled from CaH2 onto activated 4Å molecular 
sieves.  Anthracene-9-carboxylic acid was purified by recrystallisation from ethanol.  
Commercially obtained solutions of n-butyl lithium and iso-propyl magnesium 
chloride were titrated prior to use using diphenylacetic acid and menthol/1,10-
phenanthroline, respectively.  All other reagents were obtained from commercial 
suppliers and used as received.   
 
Solvents: Bromolactonisation reactions were performed in HiPerSolv grade 
chloroform, n-hexane and toluene.  All other reactions were carried out in anhydrous 
solvents unless explicitly stated.  CH2Cl2, Et2O, THF and toluene were dried by 
passing through a column of alumina.  Extraction solvents and chromatography 
eluents were used as received.  CH2Cl2, MeOH, n-hexane and ethyl acetate were 
HiPerSolv grade.  Petroleum ether 40-60 and Et2O were GPR grade.  n-Hexane and i-
PrOH for analytical HPLC were HPLC grade and used as received.   
 
Experimental Techniques:  Bromolactonisation reactions were carried out in oven-
dried, sealed, screw-top vials in the dark.  All other reactions were carried out in 
oven-dried glassware under a nitrogen atmosphere.  Air and moisture sensitive 
reagents were transferred by syringe or cannula.  Reaction temperatures other than 
room temperature were recorded as aluminium alloy heating block or bath 
temperatures.  The phrase, concentrated under reduced pressure, refers to rotary 
evaporation.  Brine refers to a saturated aqueous solution of NaCl.  Column 
chromatography was performed on silica gel, particle size 40-63 m.  Analytical thin 
layer chromatography (TLC) was performed on Kieselgel 60 F254 pre-coated plastic-
backed plates and visualised with UV light (265 nm) or staining with potassium 
permanganate or vanillin solutions.  
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HPLC and GC: Chiral analytical HPLC was performed on 25 cm x 4.6 mm 
CHIRACEL OD, OD-H, AD or OJ columns.  Chiral analytical GC was carried out 
using a g-DEX 225 30 m x 0.25 mm column.  Retention times (tR) are reported in 
minutes 
 
Calorimetry: Isothermal reaction calorimetry was performed in an Omnical Insight 
Reaction Calorimeter in a glass septum-capped vial equipped with a magnetic stirrer.  
The reaction temperature was controlled using a Julabo F25 cooling bath. 
 
Characterisation: Melting points are uncorrected.  Optical rotations were recorded on 
a polarimeter with a path length of 0.5 dm, using the D-line of sodium.  
Concentrations (c) are quoted in g/100mL.  Fourier transform infra-red (IR) spectra 
were recorded neat using an ATR-IR spectrometer.  1H, 13C and 19F NMR spectra 
were recorded on Bruker DRX-400, Bruker AV-400 or AV-500 spectrometers.  
Chemical shifts (d) are expressed in parts per million (ppm) relative to the residual 
solvent peak.  Abbreviations are: s, singlet; d, doublet; t, triplet; q, quartet; m, 
multiplet.  Low resolution MS (ESI, CI, EI), HRMS and GCMS were recorded by 
Imperial College Department of Chemistry Mass Spectrometry Service or the EPSRC 
National Mass Spectrometry Service.   
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7.2 Synthesis of 4-Phenyl-4-pentenoic acid (114) 
7.2.1 Methyl 4-Phenyl-4-pentenoate (136)38  
 
According to the procedure of Braddock et al.,38 methyl triphenylphosphonium 
bromide (980 mg, 2.80 mmol, 1.1 eq.) was suspended in toluene (15 mL) at 5 ◦C.  
NaHMDS (1 M in toluene, 2.7 mL, 2.80 mmol, 1.1 eq.) was added, and after 90 
minutes the temperature of the ylid solution was lowered to 78 ◦C.  Methyl 4-oxo-4-
phenylbutyrate (500 mg, 2.60 mmol) was added and the reaction mixture allowed to 
warm to room temperature, and then heated to reflux for 40 hours.  After cooling to rt, 
the reaction was quenched with saturated NH4Cl (20 mL) and extracted with EtOAc 
(2 x 50 mL).  The combined extracts were washed with water (30 mL), brine (30 mL), 
dried over sodium sulphate and concentrated under reduced pressure.  The dark-red 
crude material was purified by flash chromatography (80:20 petrol:Et2O) to give the 
title compound (440 mg, 2.32 mmol,  83 %).  
 
Yellow oil; IR (neat) 3060, 3030, 2990, 1736, 1670, 1605, 1495, 1435, 1280, 900, 
780 cm-1; 1H NMR (400 MHz, CDCl3)  7.42-7.26 (m, 5H, ArH), 5.31 (s, 1H, 
CH2=C), 5.10 (s, 1H, CH2=C), 3.67 (s, 3H, OCH3), 2.83 (t, J = 7.8 Hz, 2H, H2), 2.56 
(t, J = 7.8 Hz, 2H, H3) ppm; 13C NMR (100 MHz)  173.6, 146.9, 140.6, 128.5, 
127.7, 126.2, 112.9, 51.7, 33.1, 30.5; MS (EI+) m/z 190 (M)•+.  All spectroscopic data 
are in accordance with the literature.38 
7.2.2 4-Phenyl-4-pentenoic acid (114)38  
 
According to the procedure of Braddock et al.,38 an aqueous solution of LiOH (105 
mg, 4.30 mmol, 0.82 M) was added to a stirred solution of methyl 4-phenyl-4-
pentenoate (136) (95 mg, 0.500 mmol) in THF (5 mL) at 0 ◦C.  The reaction mixture 
was warmed to 50 ◦C and stirred for a further 18 hours.  The solution was acidified to 
pH≤ 4 with HCl (1M), and extracted with Et2O (2 × 10 mL).  The combined organic 
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phases were washed with water (10 mL), brine (10 mL), dried over Na2SO4 and 
concentrated under vacuum.  The residue was chromatographed over silica gel (90:10 
CH2Cl2:MeOH) to give the title compound (74.5 mg, 0.423 mmol 92 %). 
 
White crystalline solid; m.p. 93-94 ◦C (lit.38 m.p. = 92-93 ◦C); IR (neat) 3400-2600 
(br), 1691, 1624, 1426, 1331, 1314, 1219, 1267, 922, 898, 777 cm-1; 1H NMR (400 
MHz, CDCl3)  7.42-7.27 (m, 5H, ArH), 5.32 (d, J = 1.2 Hz, CH2=C, 1H), 5.11 (q, J 
= 1.2 Hz, CH2=C, 1H), 2.83 (t, J = 7.8 Hz, 2H, H2) 2.56 (t, J = 7.8 Hz, 2H, H3); 
13C 
NMR (100 MHz, CDCl3)  178.6, 146.6, 140.4, 128.5, 127.7, 126.1, 113.0, 32.8, 
30.2; MS (CI+, NH3) m/z 194 (M+NH4)
+; HRMS (CI+, NH3) m/z calcd for C11H16NO2 
(M+NH4)
+
 194.0288, found 194.0286.  All spectroscopic data obtained are in 
accordance with the literature.38 
 
7.3 Synthesis of 5-Phenylhexen-5-oic acid (101)  
7.3.1 Methyl 5-oxo-5-phenylpentanoate (165)200 
 
To a solution of 5-oxo-5-phenylpentanoic acid (1.67 g, 8.70 mmol) in acetone (20 
mL) was added K2CO3 (2.40 g, 17.4 mmol, 2 eq.) and methyl iodide (0.81 mL, 13.0 
mmol, 1.5 eq.).  The mixture was stirred at room temperature for 24 h.  The solvent 
was evaporated and the residue dissolved in Et2O (40 mL) and washed with water (20 
mL).  The organic layer was dried (Na2SO4), evaporated and the residue was 
chromatographed (80:20 petroleum ether:EtOAc) to give the title compound (1.70 g, 
8.25 mmol, 95%).  
 
Colourless oil; IR (neat) 2968, 1738, 1686, 1599, 1585, 1449, 1216, 747, 695 cm-1; 1H 
NMR (400 MHz, CDCl3)  7.95 (d, J = 7.3 Hz, 2H, Ha), 7.55 (dt, J = 7.3, 1.7 Hz, 1H, 
Hc), 7.45 (t, J = 7.3 Hz, 2H, Hb), 3.67 (s, 3H, OCH3), 3.04 (t, J = 7.0 Hz, 2H, H4), 
2.44 (t, J = 7.0 Hz, 2H, H2), 2.06 (quintet, J = 7.0 Hz, 2H, H3); 13C NMR (100 MHz) 
199.3, 173.7, 136.8, 132.9, 128.6, 128.0, 51.4, 37.2, 33.1, 19.2.  All spectroscopic 
data obtained are in accordance with the literature.200  
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7.3.2 Methyl 5-phenylhexenoate (166)104
 
 
Using a modified procedure of Fujioka et al.,104 methyl triphenylphosphonium 
bromide (2.70 g, 7.55 mmol, 1.1 eq.) was suspended in toluene (60 mL) at 5 ◦C.  
KHMDS (1.51 g, 7.55 mmol, 1.1 eq.) was added, and after 2 h the temperature of the 
ylid solution was lowered to 78 ◦C.  Methyl 5-oxo-5-phenylpentanoate (1.40 g, 6.79 
mmol) was added and the reaction mixture allowed to warm to room temperature, and 
then heated to reflux for 40 hours.  After cooling to rt, the reaction was quenched with 
saturated NH4Cl (30 mL) and extracted with EtOAc (2 × 30 mL).  The combined 
extracts were washed with water (30 mL), brine (30 mL), dried over sodium sulphate 
and concentrated under reduced pressure.  The pale yellow/orange crude mixture was 
purified by flash chromatography (80:20 petrol: Et2O ether) to give the title ester 
(0.86 g, 4.22 mmol, 62%). 
 
Colourless oil; 1H NMR (400 MHz, CDCl3) 7.44 (dd, J = 8.3, 1.4 Hz, 2H, Ha), 
7.39-7.27 (m, 3H, ArH), 5.33 (s, 1H, CH2=C), 5.10 (s, 1H, CH2=C), 3.69 (s, 3H, 
OCH3), 2.58 (t, J = 7.0 Hz, 2H, H4), 2.37 (t, J = 7.0 Hz, 2H, H2), 1.92 (quintet, J = 
7.0 Hz, 2H, H3); 13C NMR (100 MHz) 174.0, 147.2, 140.7, 128.4, 127.4, 126.0, 
113.0, 51.4, 34.6, 33.3, 23.2.  All spectroscopic data obtained are in accordance with 
the literature.104 
 
7.3.3 5-Phenylhexen-5-oic acid (101)104  
 
 
According to a modified method of Braddock et al.,38 an aqueous solution of LiOH 
(411 mg, 17.2 mmol, 1.72 M) was added to a stirred solution of ester 166 (350 mg, 
1.72 mmol) in THF (10 mL) at 0 ◦C.  The reaction mixture was warmed to 50 ◦C and 
stirred for a further 18 hours.  The solution was acidified to pH≤ 4 with HCl (1M), 
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and extracted with Et2O (2 × 20 mL).  The combined organic phases were washed 
with water (10 mL), brine (10 mL), dried over Na2SO4 and concentrated under 
vacuum.  The residue was chromatographed over silica gel (90:10 CH2Cl2:MeOH) to 
give the title product (258 mg, 1.36 mmol, 79%). 
 
White solid; m.p. 42-43 ◦C (lit. m.p.201 = 44 ◦C); IR (neat) 3700-3200 (br), 2943, 
1699, 1402, 1294, 1196, 887, 778, 752, 700 cm-1; 1H NMR (400 MHz, CDCl3)  12.5-
9.5 (br s, 1H, COOH) 7.43 (d, J = 8.3 Hz, 2H, Ha), 7.39-7.28 (m, 3H, ArH), 5.35 (s, 
1H, CH2=C), 5.12 (s, 1H, CH2=C), 2.63 (t, J = 7.0 Hz, 2H, H2), 2.42 (t, J = 7.0 Hz, 
2H, H4), 1.64 (quintet, J = 7.0 Hz, 2H, H3); 13C NMR (100 MHz, CDCl3) 179.7, 
147.4, 140.8, 128.5, 127.5, 126.1, 113.1, 34.5, 33.2, 23.0; MS (ESI) m/z 189 (M – H)-; 
HRMS (ESI) m/z calcd for C12H13O2 (M – H)- 189.0921, found 189.0924.  All 
spectroscopic data obtained are in accordance with the literature.104 
 
7.4 Synthesis of 6-Phenylhepten-6-oic acid (153)  
7.4.1 6-Oxo-6-phenylhexanoic acid (168)105 
 
 
According to the procedure of Weinreb et al.,105 to a solution of 1-phenyl cyclohexene 
(1.50 g, 9.50 mmol) in acetone (40 mL) at 0 ◦C was added a solution of K2OsO4 (63 
mg, 0.19 mmol, 0.02 eq.) in water (2 mL) followed by a solution of CrO3 (3.28 g, 
32.8 mmol, 3.5 eq.) and H2SO4 (5.70 mL, 8% v/v) in H2O (22 mL).  The reaction 
mixture was allowed to warm to room temperature and stirred for 12 h.   The dark 
green solution was quenched with iPrOH (4.8 mL) and NaHSO3 and diluted with H2O 
(20 mL).  The mixture was extracted with Et2O (4 × 30 mL).  The combined organic 
layers were dried (Na2SO4), evaporated and chromatographed (95:5 CH2Cl2:MeOH) 
to give the title compound (168) as a 6.5:1 mixture with minor 5-oxo-5-
phenylhexanoic acid (1.40 g, 71%).   
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168: IR (neat) 3300-2600 (br), 2944, 2874, 1696, 1679, 1414, 1283, 1196, 914, 730, 
688 cm-1; 1H NMR (400 MHz, CDCl3)  8.01-7.97 (m, 2H, Ha), 7.59 (tt, 1H, J = 7.4, 
1.5 Hz, Hc), 7.49 (t, 2H, J = 7.4 Hz, Hb), 3.04 (t, 2H, J = 6.9 Hz, H2), 2.46 (t, 2H, J = 
6.9 Hz, H5), 1.89-1.72 (m, 4H, H3 and H4); 13C NMR (100 MHz, CDCl3) 200.0, 
179.4, 136.9, 133.2, 128.6, 128.1, 38.1, 33.8, 24.3, 23.6.  All spectroscopic data 
obtained are in agreement with the literature.105 
 
5-oxo-5-phenylhexanoic acid: 1H NMR (400 MHz, CDCl3)  8.01-7.97 (m, 2H, Ha), 
7.62-7.57 (m, 2H, Hc), 7.53-7.46 (m, 2H, Hb), 3.11 (t, J = 7.1 Hz, H2), 2.86 (t, J = 7.1 
Hz, H4), 2.12 (quintet, J = 7.1 Hz, H3); 13C NMR (100 MHz, CDCl3) 199.4, 179.2, 
136.8, 133.2, 128.6, 128.1, 37.3, 33.0, 18.9.  NMR spectra obtained are in agreement 
with the literature.202 
 
7.4.2 Methyl 6-phenyl-6-heptenoate  
 
 
To a 6.5:1 mixture of 6-oxo-6-phenylhexanoic acid (168) (525 mg, 2.55 mmol) and 5-
oxo-5-phenylhexanoic acid (75 mg, 0.39 mmol) in acetone (20 mL) were added 
K2CO3 (873 mg, 6.32 mmol, 2.5 eq.) and methyl iodide (0.30 mL, 4.74 mmol, 1.9 
eq.).  The mixture was stirred at room temperature for 24 h.  The solvent was 
evaporated and the residue was dissolved in Et2O (20 mL) and washed with water (20 
mL).  The organic layer was dried (Na2SO4) and evaporated to give methyl 6-oxo-6-
phenylhexanoate as a 6.5:1 mixture with minor methyl 5-oxo-5-phenylhexanoate (520 
mg, 83%).  The crude material was used directly for subsequent Wittig olefination 
without further purification.  
 
Methyl triphenylphosphonium bromide (811 mg, 2.27 mmol, 1.1 eq.) was suspended 
in toluene (20 mL) at 5 ◦C. A solution of NaHMDS (416 mg, 2.27 mmol, 1.1 eq.) 
was added, and after 3 h the ylid solution was lowered to 78 ◦C.  A 6.5:1 mixture of 
methyl 6-oxo-6-phenylhexanoate (437 mg, 2.00 mmol) and minor methyl 5-oxo-5-
phenylhexanoate (63 mg, 0.31 mmol) was added and the reaction mixture allowed to 
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warm to room temperature, and then heated to reflux for 40 hours.  After cooling, the 
reaction was quenched with saturated NH4Cl (15 mL) and extracted with EtOAc (2 x 
20 mL).  The combined extracts were washed with water (30 mL), brine (30 mL), 
dried over sodium sulphate and concentrated under reduced pressure.  The dark 
red/brown crude mixture was purified by flash chromatography (85:15 petroleum 
ether:EtOAc) to give the title compound as a 7.9:1 mixture with minor methyl 5-oxo-
5-phenylpentanoate (165) (263 mg, 53%). 
 
Methyl 6-phenyl-6-heptenoate: colourless oil; IR (neat) 2958, 1734, 1686, 1599, 
1581, 1452, 1442, 1216, 1008, 751 cm-1; 1H NMR (400 MHz, CDCl3)  7.44-7.25 (m, 
5H, ArH), 5.30 (s, 1H, CH2=C), 5.09 (s, 1H, CH2=C), 3.67 (s, 3H, OCH3), 2.55 (t, J = 
7.5 Hz, 2H, H2), 2.33 (t, J = 7.5 Hz, 2H, H5), 1.69 (quintet, J = 7.5 Hz, 2H, H3), 1.54 
(quintet, J = 7.5 Hz, 2H, H4); 13C NMR (100 MHz, CDCl3) 174.0, 148.1, 141.2, 
128.2, 127.3, 126.1, 112.5, 51.5, 35.0, 33.9, 27.6, 24.6; ; MS (CI+, NH3) m/z 236 
(M+NH4)
+; HRMS (CI+, NH3) m/z calcd for C14H22NO2 (M+NH4)
+
 236.1651, found 
236.1659. 
 
Methyl 5-oxo-5-phenylpentanoate: NMR spectra could not be resolved due to overlap 
with signals for major product; the product ratio was calculated from relative integrals 
of –OCH3 peaks. 
 
7.4.3 6-Phenylhepten-6-oic acid (153)201 
 
 
An aqueous solution of LiOH (220 mg, 9.17 mmol, 0.92 M) was added to a stirred 
7.9:1 mixture of methyl 6-phenyl-6-heptenoate (179 mg, 0.82 mmol) and minor 
methyl 5-oxo-5-phenylpentanoate (21 mg, 0.10 mmol) in THF (10 mL) at 0 ◦C.  The 
reaction mixture was warmed to 50 ◦C and stirred for a further 18 hours.  The solution 
was acidified to pH≤ 4 with HCl (1M), and extracted with Et2O (2 ×20 mL).  The 
combined organic phases were washed with water (10 mL), brine (10 mL), dried over 
Na2SO4 and concentrated under vacuum.  The residue was chromatographed over 
  
250 
silica gel (90:10 CH2Cl2:MeOH) to give the title compound as a 8:1 mixture with 
minor 5-phenylhexen-5-oic acid (101) (124 mg, 66%).   
 
The 8:1 mixture of 6-phenylhepten-6-oic acid (153) (89 mg, 0.44 mmol) and minor 5-
phenylhexen-5-oic acid (101) (11 mg, 0.06 mmol) was added to a solution of 
quinuclidine (4.4 mg, 0.04 mmol, 0.1 eq.) and NBS (39 mg, 0.22 mmol, 0.5 eq.) in 
toluene (10 mL) at room temperature.  The reaction mixture was stirred for 1 hour and 
quenched by addition of sodium thiosulfate (5 mL).  The organic layer was washed 
with 1M HCl (5 mL) and brine (10 mL) then dried (Na2SO4) and concentrated under 
reduced pressure.  The residue was chromatographed over silica gel (90:10 
CH2Cl2:MeOH) to give bromolactone 102 (14 mg, 95%) and recovered 6-
phenylhepten-6-oic acid (153) (71 mg, 0.348 mmol, 80%). 
 
153: white solid; m.p. 38-39 ◦C (lit.201 m.p. = 37.5 ◦C); IR (neat) 3200-2500 (br), 
2931, 1694, 1624, 1412, 1284, 889, 786, 736, 654 cm-1; 1H NMR (400 MHz, CDCl3) 
 7.45-7.28 (m, 5H, ArH), 5.32 (s, 1H, CH2=C), 5.10 (s, 1H, CH2=C), 2.57 (t, J = 7.4 
Hz, 2H, H2), 2.38 (t, J = 7.4 Hz, 2H, H5), 1.64 (quintet, J = 7.4 Hz, 2H, H3), 1.55 
(quintet, J = 7.4 Hz, 2H, H4); 13C NMR (100 MHz, CDCl3) 179.5, 148.0, 141.1, 
128.3, 127.4, 126.1, 112.6, 35.0, 33.4, 27.6, 24.3; MS (ESI) m/z 203 (M – H)-; HRMS 
(ESI) m/z calcd for C12H15O2 (M – H)- 203.1078, found 203.1078.  All spectroscopic 
data obtained are in accordance with the literature.201 
 
102: see section 7.15.2 for full spectroscopic characterisation. 
 
7.5 Synthesis of 3-Phenylbut-3-enoic acid (151)107 
7.5.1.1 Route A: Direct Carboxylation of -Methyl styrene (170) 
 
A solution of-methyl styrene (170) (236 mg, 2 mmol) in THF (10 mL) was added 
dropwise with a syringe pump (0.1 mL/min) to a solution of n-BuLi (0.88 mL, 2.5 M 
in hexanes, 2.2 mmol, 1.1 eq.) in THF (5 mL) at – 20 ◦C.  The deep red solution was 
stirred for 0.5 h at – 20 ◦C before quenching with dry ice.  The mixture was diluted 
with Et2O (10 mL) and warmed to room temperature.  The solution was extracted 
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with 1M NaOH (10 mL) and the aqueous layer acidified to pH ≤ 2 with 1M HCl (15 
mL) to give valeric acid as the major product (86 mg, 0.843 mmol, 38%). 
 
Valeric acid was identified by comparison of the 1H NMR spectrum of the crude 
material to literature data.203 1H NMR (400 MHz, CDCl3)  2.42-2.38 (m, 1H), 1.69-
1.23 (m, 5H), 0.99-0.90 (m, 3H).
 
 
7.5.1.2 Direct Carboxylation of -Bromomethyl Styrene (169) 
 
-Bromomethyl styrene (169) (250 mg, 1.27 mmol) was dissolved in dry THF at rt 
under and N2 atmosphere.  Magnesium flakes (37.1 mg, 1.53 mmol, 1.2 eq.) were 
added, and the metal surface was activated with 1,2-dibromoethane (2 drops).  The 
mixture was heated incrementally to up 70 ◦C until all the magnesium had reacted.  
After cooling to room temperature, the Grignard reagent was quenched with dry ice.  
Upon sublimation of the dry ice, the solution was diluted with EtOAc (10 mL), 
washed with water (10 mL) and brine (10 mL).  The organic layer was dried 
(Na2SO4), filtered and concentrated under reduced pressure.  
1H NMR analysis of the 
crude mixture indicated no conversion to desired 3-phenylbut-3-enoic acid (151), and 
two major products, 2,5-diphenyl-1,5-hexadiene and -methyl styrene (170), were 
assigned by comparison to literature 1H NMR data. 
 
2,5-Diphenyl-1,5-hexadiene204 (89 mg, 0.380 mmol, 60%): Colourless oil; 1H NMR 
(400 MHz, CDCl3)  7.45-7.25 (m, 10H), 5.32 (s, 2H), 5.09 (s, 2H), 2.69 (s, 4H). 

-Methyl styrene (170)205 (15 mg, 0.127 mmol, 11%): Colourless oil; 1H NMR (400 
MHz, CDCl3)  7.57-7.48 (m, 5H), 5.33 (s, 1H), 5.06 (s, 1H), 2.31 (s, 3H). 
  
252 
7.5.2 Route B: Conjugate Addition of Diphenyl Cuprate to Buta-
2,3-dienoic acid (172) 
7.5.2.1 Buta-2,3-dienoic acid (172)109  
 
 
According to the procedure of Wipf et. al.,109 a cold (0 ◦C) solution of CrO3 (8.57 g, 
85.7 mmol, 2 eq.) and conc. H2SO4 (57.6 mL) in distilled H2O (216 mL) was added 
dropwise to a stirred solution of butyn-1-ol (3.00 g, 42.9 mmol) in acetone (40 mL) at 
0 ◦C.  The reaction mixture was stirred for 3 h before warming to room temperature 
and stirring for a further 8 h.  The dark green mixture was transferred to a separating 
funnel and extracted with Et2O (6 × 40 mL).  The combined organic extracts were 
washed with 1M NaOH (2 × 60 mL).  The aqueous layer was stirred for 2 h at room 
temperature, while the organic layer was discarded.  1M HCl was added until pH ~ 3.  
The suspension was extracted with Et2O (2 × 50 mL or until aqueous layer becomes 
clear).  The organic extracts were dried (Na2SO4), evaporated and the residue was 
chromatographed (95:5 CH2Cl2:MeOH) to give the title compound (1.80 g, 21.4 
mmol, 55%). 
 
White solid: m.p. 64-65 ◦C (lit.109 m.p. = 65-66 ◦C); IR (neat) 3400-2400 (br), 2985, 
1961, 1656, 1291, 1221, 857, 703 cm-1; 1H NMR (400 MHz, CDCl3) 11.2-10.0 (br 
s, 1H, COOH), 5.68 (t,  J  = 6.9 Hz, 1H, H2), 5.32, (d, J  = 6.9 Hz, 2H, H4);  
13C NMR (100 MHz CDCl3) 217.0, 172.0, 87.7, 79.7.  All spectroscopic and 
physical data obtained are in accordance with the literature.109 
 
7.5.2.2 Procedure for Conjugate Addition 
 
According to a modified method of Tamura et al.,206 to a solution of bromobenzene 
(1.44 g, 9.20 mmol) in dry THF (5 mL) at 78 ◦C under N2, was added n-BuLi (3.70 
mL, 2.5 M in hexanes, 9.25 mmol).  The mixture was stirred at this temperature for 1 
hour.  At this point the clear solution was transferred by cannula to a solution of 
copper iodide in THF at 40 ◦C.  After 2 h, buta-2,3-dienoic acid (172) (260 mg, 3.0 
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mmol) was added as 2 mL solution in THF, and the mixture was warmed to 20 ◦C 
over a further 3 h.  Upon complete substrate conversion as indicated by TLC, the 
reaction was quenched with NH4Cl (aq.) (10 mL) and extracted with Et2O (20 mL).  
The organic layer was washed sequentially with HCl (1M, 10 mL) which turned the 
aqueous layer a red-brown colour, and brine (10 mL), dried (Na2SO4), filtered and 
concentrated under reduced pressure.  The crude material was chromatographed over 
silica gel (95:5 CH2Cl2:MeOH) to give three major fractions, and overall 10% of mass 
recovery.  Fraction 1 contained iodine, and it was not possible to characterise the 
remaining fractions by 1H NMR analysis. 
 
7.5.3 Route C: Negishi Cross-Coupling Reaction Between Phenyl 
Zinc Bromide and Allene 172 
7.5.3.1 3-Iodo-3-butenoic acid (171)110 
 
A solution of buta-2,3-dienoic acid (172) (1.00 g, 11.9 mmol)  and NaI (2.14 g, 14.3 
mmol, 1.2 equiv.) in acetic acid (15 mL) was stirred at 70 ◦C for 8 h.  The dark red 
reaction mixture was diluted with Et2O (10 mL), transferred to a separating funnel, 
washed with brine (20 mL) and extracted with Et2O (2 × 20 mL).  The combined 
organic extracts were dried (Na2SO4), evaporated and the residue was 
chromatographed (98:2 CH2Cl2:MeOH to 90:10 CH2Cl2:MeOH) to give 3-iodobut-3-
enoic acid (171) (1.63 g, 7.689 mmol, 64%).   
 
White solid: m.p. 52-53 ◦C (lit.110 m.p. = 52-53 ◦C); IR (neat) 3400-2500 (br), 2913, 
2726, 1685, 1621, 1414, 1229, 1202, 918, 725, 654; 1H NMR (400 MHz, CDCl3) 
11.7-9.1 (br s, 1H, COOH), 6.29 (m, 1H, CH2=C), 6.00 (d, J  = 1.5 Hz, 
1H, CH2=C), 3.67 (d, J  = 1.5 Hz, 2H, H2); 
13C NMR (100 MHz CDCl3) 
174.4, 131.0, 96.3, 50.1 cm-1.  All spectroscopic data obtained are in accordance 
with the literature.110 
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7.5.3.2 Procedure for Negishi Reaction 
 
A mixture of bromobenzene (590 mg, 3.77 mmol, 4eq.), magnesium turnings (92 mg, 
3.77 mmol, 4 eq.) and 1,2-dibromoethane (one drop) in Et2O (7 mL) was stirred at 
room temperature until all the magnesium was consumed (5 h).  Anhydrous ZnBr2 
(0.85 g, 3.77 mmol, 4 eq.) was added and the heterogeneous mixture was stirred for a 
further 6 h.  The mixture was diluted with DMF (6 mL).  3-iodobut-3-enoic acid (200 
mg, 0.94 mmol) was dissolved in DMF (1 mL) and added dropwise to the organozinc 
solution.  Lastly, PdCl2(MeCN)2 (20 mg, 0.09 mmol, 10 mol%) was added and the 
dark grey suspension was stirred at room temperature for 12 h.  The reaction was 
quenched with saturated NH4Cl (10 mL) and extracted with Et2O (2 × 20 mL).  The 
combined organic extracts were washed with 1M NaOH (15 mL).  The aqueous layer 
was acidified to pH ~ 3 with 1M HCl, and re-extracted with Et2O.  The organic layer 
was dried (Na2SO4), evaporated and the residue chromatographed (95:5 
CH2Cl2:MeOH) to give the target molecule 3-phenylbut-3-enoic acid (151) (51 mg, 
0.315 mmol, 33%) and biphenyl (244 mg, 1.58 mmol, 44%). 
 
 
 
White solid: m.p. 47 ◦C (lit. m.p.207 = 46-47 ◦C); IR (neat), 3300-2700 (br) 2620, 
1696, 1637, 1498, 1422, 1349, 1307, 1226, 911, 782, 703 cm-1; 1H NMR (400 MHz, 
CDCl3) 12.5-9.0 (br s, 1H, COOH), 7.49-7.45 (m, 2H, Ha), 7.40-7.29 (m, 3H, ArH), 
5.62 (s, 1H, CH2=C), 5.30 (s, 1H, CH2=C)  3.58 (d, J = 1.0 Hz, 2H, H2); 
13C NMR 
(100 MHz CDCl3) 177.0, 140.2, 139.4, 128.5, 128.0, 125.8, 116.9, 40.8; MS (ESI) 
m/z 161 (M – H)-; HRMS (ESI) m/z calcd for C10H9O2 (M – H)- 161.0611, found 
161.0608.  All spectroscopic data obtained are in accordance with the literature.107 
 
Biphenyl: White solid; 1H NMR (400 MHz, CDCl3) 7.64 (m, 4H, Ar o-H),  
7.49 (t, J  = 7.4 Hz, 2H, Ar p-H), 7.39 (tt,  J  = 7.4, 1.3 Hz, 4H, Ar m-H); 
13C NMR (100 MHz CDCl3) 141.3, 128.9, 127.3, 127.2.  The NMR data obtained 
are in accordance with the literature.208 
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7.6 (±)-endo-3-Methylidenebicyclo[2.2.1]hept-5-ene-2-
carboxylic acid (150)122  
 
 
According to the literature procedure,122 freshly cracked cyclopentadiene (0.61 mL, 
7.20 mmol, 2.6 eq.) was added to a solution of buta-2,3-dienoic acid (172) (300 mg, 
3.60 mmol) in Et2O.  The reaction mixture was stirred for 16 h at room temperature, 
concentrated under reduced pressure and chromatographed directly (gradient 80:20  to 
50:50 petroleum ether:Et2O) to give the title compound as a 9:1 mixture with minor 
exo-150 (432 mg,  80 %).  
 
Major isomer (endo-150): White solid; IR (neat) 3400-2500 (br), 1780, 1665, 1338, 
1293, 1224, 1109, 1066, 980, 941, 889, 760, 710 cm-1; 1H NMR (400 MHz, CDCl3) 
11.8-10.6 (br s, 1H, COOH), 6.26-6.20m, 2H, H5 and H6), 5.18 (d, J = 2.3 Hz, 
1H, CH2=C), 5.07 (d, J = 2.3 Hz, 1H, CH2=C), 3.53-3.49 (m, 1H, H2), 3.31, (app s, 
1H, H7), 3.28 (app s, 1H, H4), 1.68 (td, J = 8.5, 1.8 Hz, 1H, H8), 1.53 (d, J = 8.5 Hz, 
1H, H8); 13C NMR (100 MHz CDCl3) 179.1, 147.9, 135.6, 135.1, 106.8, 51.5, 49.8, 
49.4, 45.5; MS (ESI) m/z 151 (M + H)+; HRMS (ESI) m/z calcd for C9H11O2 (M + H)
+ 
151.0754, found 151.0752.  All spectroscopic data obtained are in agreement with the 
literature.122 
 
Minor isomer  (exo-150): 1H NMR (400 MHz, CDCl3) t, J = 1.6 Hz, 2H, H5 
and H6), 5.19 (d, J = 2.3 Hz, 1H, CH2=C), 5.09 (d, J = 2.3 Hz, 1H, CH2=C), 3.28 (app 
s, 1H, H2), 3.20 (app s, 1H,  H7), 2.87 (app q, J = 2.0 Hz, 1H, H4), 1.91 (d, J = 8.3 
Hz, 1H, H8), 1.68 (d, J = 8.3 Hz, 1H, H8); 13C NMR (100 MHz CDCl3) 
11111.  All spectroscopic data 
obtained are in accordance with the literature.122 
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7.7 Dihydrobenzoic Acid (148)123 
 
 
According to the literature procedure,123 benzoic acid (2.00 g, 16.4 mmol) was added 
to absolute ethanol (20 mL) in a 500 mL 3-necked flask fitted with a cold-finger 
condenser at the central neck, an ammonia gas inlet and a safety outlet at the side 
necks.  The outlet of the condenser was connected to a gas bubbler.  The mixture was 
cooled to 78 ◦C and liquid ammonia (120 mL) was condensed in the flask.  The cold 
bath was removed and sodium (1.40 g, 58 mmol) was added in small pieces.  After 
the blue colour had disappeared, ammonium chloride (2.92 g, 54 mmol) was added 
carefully and the reaction mixture was left stirring until all the ammonia had 
evaporated.  The residue was dissolved in water (100 mL), poured into ice (50 g) and 
acidified to pH ~ 3 with 1M HCl.  The resulting suspension was extracted with Et2O 
(4 ×50 mL), and the combined extracts washed with brine (100 mL), dried over 
sodium sulphate, filtered and concentrated under vacuum.  The crude product was 
chromatographed (95:5 CH2Cl2:MeOH) to remove mineral oil, giving the title 
compound containing 2% benzoic acid contamination (1.83 g, 14.8 mmol, 90%). 
 
Colourless oil; IR (neat) 3058, 1679, 1453, 1279, 1196, 1119, 1071, 713, 688 cm-1;  
1H NMR (400 MHz, CDCl3) 12.0-8.5 (br s, 1H, COOH), 5.99-5.93 (m, 2H, H3), 
5.89-5.84 (m, 2H, H4), 3.85-3.78 (m, 1H, H5), 2.77-2.71 (m, 2H, H2); 13C NMR (100 
MHz, CDCl3) 178.8, 226.9, 121.5, 41.4, 25.8; MS (EI+) m/z 124 (M)•+; HRMS (EI+) 
m/z calcd for C7H8O2 (M)
•+ 124.0524, found 124.0528.  All spectroscopic data 
obtained are in accordance with the literature.209 
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7.8 Synthesis of (4Z)-4-phenylocta-4,7-dienoic Acid (157)  
7.8.1 Methyl (4Z)-4-phenyl-4,7-dienoate (156) 
 
 
NaHMDS (1.88 mL, 1.88 mmol, 1M solution in THF, 1 eq.) was added dropwise to a 
solution of but-3-en-1-yltriphenylphosphonium bromide (0.596 g, 1.88 mmol, 1 eq.) 
in THF (10 mL) at 0 ◦C under a nitrogen atmosphere.  After stirring at this 
temperature for 2 h, the reaction mixture was cooled to 78 ◦C for the dropwise 
addition of methyl 4-oxo-4-phenylbutanoate (0.360 g, 1.88 mmol).  The mixture was 
warmed to 30 ◦C and stirred for 12 h.  The reaction was quenched with saturated 
NH4Cl (15 mL) and extracted with Et2O (2 x 20 mL).  The combined organic extracts 
were washed with water (30 mL), brine (30 mL), dried over sodium sulphate and 
concentrated under reduced pressure.  The dark red/brown crude mixture was purified 
by flash chromatography (95:5 petroleum ether:EtOAc) to give the product ester as a 
colourless oil (194 mg, 0.843 mmol, 53 %, Z:E = 13.3:1). 
 
Colourless oil; IR (neat) 2954, 1738, 1498, 1446, 1359, 1161, 910, 702 cm-1; 1H NMR 
(400 MHz, CDCl3)  7.39-7.33 (m, 2H, Ar o-H), 7.31-7.26 (m, 1H, Ar p-H), 7.20-
7.15 (m, 2H, Ar m-H), 5.81 (ddt, J = 16.0, 10.0, 5.9 Hz, 1H, H7), 5.56 (t, 1H, J =  7.6 
Hz, H5), 5.03 (dq, J = 16.0, 1.8 Hz, 1H, H8), 5.00 (dq, J = 10.0, 1.8 Hz, 1H, H8), 3.66 
(s, 3H, OCH3), 2.71 (m, 4H, H2 and H6), 2.38 (t, 2H, J = 7.4 Hz, H3); 
13C NMR 100 
MHz, CDCl3)  173.6, 140.5, 139.9, 137.3, 128.4, 128.3, 126.9, 125.1, 114.6, 51.5, 
34.5, 33.2, 33.2; MS (EI+) m/z 230 (M)•+; HRMS (EI+) m/z calcd for C15H18O2 (M)
•+ 
230.1307, found 230.1303. 
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7.8.2 (4Z)-4-Phenylocta-4,7-dienoic acid (157)  
 
 
An aqueous solution of LiOH (177 mg, 7.40 mmol, 1.85 M) was added to a solution 
of methyl (4Z)-4-phenylocta-4,7-dienoate (170 mg, 0.74 mmol) in THF (4 mL) at 
room temperature.  The reaction mixture was heated to 50 ◦C and stirred at this 
temperature for 24 h.  The dark yellow solution was acidified to pH≤ 4 with HCl 
(1M), and extracted with Et2O (2 × 20 mL).  The combined organic phases were 
washed with water (10 mL), brine (10 mL), dried over Na2SO4 and concentrated 
under vacuum.  The residue was chromatographed over silica gel (95:5 
CH2Cl2:MeOH) to give the title compound (141 mg, 0.653 mmol, 88%). 
 
Colourless oil (120 mg, 75%, Z:E = 13.3:1): IR (neat) 3400-2600 (br), 2978, 1706, 
1495, 1415, 1300, 1213, 979 cm-1; 1H NMR (400 MHz, CDCl3)  11.8-9.2 (br s, 1H, 
COOH), 7.39-7.34 (m, 2H, Ar o-H), 7.32-7.26 (dt, 1H, J = 7.3, 1.5 Hz, Ar p-H), 7.20-
7.15 (m, 2H, Ar m-H), 5.82 (ddt, 1H, J = 16.2, 10.1, 5.9 Hz, H7), 5.58 (t, 1H, J = 7.7 
Hz, H5), 5.03 (d, J = 16.2 Hz, 1H, H8), 5.00 (d, J = 10.1 Hz, 1H, H8), 2.77-2.67 (m, 
4H, H2 and H6), 2.41 (t, J = 7.6 Hz, 2H, H3); 13C NMR 100 MHz, CDCl3)  179.4, 
140.1, 139.7, 137.2, 128.3, 128.2,  127.0, 125.3, 114.8, 34.2, 33.1, 33.0; MS (EI+) m/z 
216 (M)•+; HRMS (EI+) m/z calcd for C14H16O2 (M)
•+ 216.1150, found 216.1151. 
 
7.8.3 Schlosser Modification Procedure Towards Synthesis of 
Methyl (4E)-4-Phenylocta-4,7-dienoate 
 
According to the method of Schlosser,124a a freshly prepared solution of phenyllithium 
(1.88 mmol, 0.63 M, 1 eq.) in dry Et2O (3 mL) was cooled to 78 ◦C.  Methyl 4-
phenyl-4-oxobutyrate (360 mg, 1.88 mmol) was added as a 1M solution in Et2O (1.9 
mL).  The reaction mixture was warmed over the course of 2 h to 40 ◦C, at which 
point a further equivalent of phenyllithium (1.88 mmol, 0.63 M) in Et2O was added 
dropwise.  After 45 minutes, ethereal HCl (1.88 mmol, 1M in Et2O) was added 
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followed by excess solid potassium t-butoxide (316 mg, 2.82 mmol, 1.5 eq.).  The 
reaction was warmed slowly to room temperature over 6 h, quenched with H2O (5 
mL) and extracted with Et2O (2 × 10 mL).  The combined organic layers were washed 
with brine (10 mL), dried (Na2SO4) and concentrated under reduced pressure.  The 
crude material was chromatographed (80:20 petroleum ether:EtOAc) to give 1,4-
diphenylocta-4,7-dien-1-one (179) (138 mg, 27%, Z:E 3:1), tentatively assigned from 
1H NMR spectrum. 
(4Z)-1,4-Diphenylocta-4,7-dien-1-one (179)   
 
Colourless oil; 7.46-7.15 (m, 10 H, ArH), 5.94-5.73 (m, 1H, H7), 5.52 (t, 2H, J = 7.5 
Hz, H5), 5.11-4.99 (m, 2H, H8), 2.87 (t, 2H, J = 6.8 Hz, H2), 2.58-2.51 (m, 2H, H3). 
 
7.9 Synthetic Routes Towards 5-Methyl-4-phenylhex-4-enoic 
Acid (159)126 
7.9.1 Route A: Wittig Olefination of methyl 4-oxo-4-phenylbutyrate 
(136) with Triphenyl(iso-propyl)phosphonium Iodide and n-Butyl 
Lithium 
 
A solution of n-BuLi (1.2 mmol, 2.5 M in hexanes, 1.1 eq.) was added dropwise to a 
suspension of isopropyl triphenylphosphonium iodide (520 mg, 1.2 mmol, 1.1 eq.) in 
THF (5 mL) at 40 ◦C.   After 2 h, methyl 4-phenyl-4-oxobutyrate (136) (210 mg, 1.1 
mmol) was added to the deep red solution, which turned yellow upon complete 
addition.  The reaction mixture was warmed to room temperature overnight, quenched 
with saturated NH4Cl (aq.) and extracted with Et2O (2 × 10 mL).  The combined 
organic layers were washed with brine (10 mL), dried (Na2SO4) and concentrated 
under reduced pressure.  The crude material was chromatographed (gradient 98:2 to 
90:10 petroleum ether:EtOAc) to give butyl 4-oxo-4-phenylbutanoate (84 mg, 0.360 
mmol, 33%) and recovered substrate (254 mg, 1.33 mmol, 60%). 
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Butyl 4-oxo-4-phenylbutanoate (180)210 
 
Yellow oil; 1H NMR (400 MHz, CDCl3) 8.04-8.01 (m, 2H, Ha), 7.61 (tt, J = 7.4, 1.3 
Hz, 1H, Hc), 7.50 (t, J = 7.4 Hz, 2H, Hb), 4.14 (t, J = 7.4 Hz, 2H, H1’), 3.35 (t, J = 
6.7 Hz, 2H, H2), 2.80 (t, J = 6.7 Hz, 2H, H3), 1.69-1.59 (m, 2H, H2’), 1.41 (sextet, J 
= 7.4 Hz, 2H, H3’), 0.96 (t, J = 7.4 Hz, H4’); 13C NMR (100 MHz, CDCl3) 198.2, 
173.0, 136.6, 133.2, 128.6, 128.1, 64.6, 33.4, 30.7, 28.3, 19.1, 13.7.  NMR spectra 
obtained are in accordance with literature data.210 
 
7.9.2 Route B: Wittig Olefination of methyl 4-oxo-4-phenylbyrate 
(136) with Triphenyl(iso-propyl)phosphonium Iodide and 
Schlosser’s Superbase 
 
A THF solution (3 mL) containing t-BuLi (0.69 mL, 1.1 mmol, 1.6 M in pentane) and 
t-BuOK (123 mg, 1.1 mmol) was carefully added to a suspension of isopropyl 
triphenylphosphonium iodide (520 mg, 1.2 mmol) in THF (2 mL) at 30 ◦C.  After 3 
h, methyl 4-phenyl-4-oxobutyrate (136) (210 mg, 1.1 mmol) was added to the deep 
red solution, which turned yellow upon complete addition.  The reaction mixture was 
warmed to room temperature overnight, quenched with saturated NH4Cl (aq.) and 
extracted with Et2O (2 × 10 mL).  The combined organic layers were washed with 
brine (10 mL), dried (Na2SO4) and concentrated under reduced pressure.  The crude 
material was chromatographed (gradient 98:2 to 90:10 petroleum ether:EtOAc) to 
give t-butyl 4-oxo-4-phenylbutanoate (30 mg, 0.128 mmol, 12%) and recovered 
substrate (48 mg, 0.250 mmol, 23%). 
  
261 
t-Butyl 4-oxo-4-phenylbutanoate121 
 
 
Yellow oil; 1H NMR (400 MHz, CDCl3) 8.04-8.00 (m, 2H, Ha), 7.59 (tt, J = 7.4, 1.2 
Hz, 1H, Hc), 7.49 (t, J = 7.4 Hz, 2H, Hb), 3.29 (t, J = 6.9 Hz, 2H, H2), 2.71 (t, J = 6.9 
Hz, 2H, H3), 1.48 (s, 9H, (CH3) 3); 
13C NMR (100 MHz, CDCl3) 198.4, 272.2, 
136.7, 133.3, 128.6, 128.0, 80.6, 33.5, 29.5, 28.1.  The NMR spectra obtained are in 
accordance with literature data.121 
 
7.9.3 Route C: Horner-Wadsworth-Emmons Olefination of methyl 
4-oxo-4-phenylbutyrate (136) with Diethyl(iso-propyl)phosphonate 
and n-Butyl Lithium 
7.9.3.1 Diethyl(iso-propyl)phosphonate (181)211 
 
 
According to the literature procedure,211 isopropyl magnesium chloride (4 mL, 1.6 M 
in THF, 6.4 mmol, 1.1 eq.) was added dropwise to a solution of chlorodiethyl 
phosphonate (1.00 g, 5.8 mmol) in Et2O (20 mL) at 20 ◦C.  The mixture was warmed 
to room temperature over 12 h.  The reaction was quenched by addition of H2O (20 
mL) which dissolved precipitated salts and extracted with Et2O (2 × 20 mL).  The 
combined organic layers were washed with brine (20 mL), dried (Na2SO4), filtered 
and concentrated under reduced pressure.  The crude material was purified by flash 
column chromatography (gradient 90:10 to 50:50 petroleum ether:EtOAc) to give the 
title compound (284 mg, 1.58 mmol, 27%). 
 
Colourless oil; 1H NMR (400 MHz, CDCl3) 4.67 (app octet, J = 6.2 Hz, 1H,  
CH(CH3)3), 4.12 (quintet, J = 7.0 Hz, 4H, OCH2), 1.39-1.33 (m, 12H, CH3); 
13C NMR 
(100 MHz, CDCl3) 72.4 (d, J = 5.8 Hz, 1C), 63.5 (d, J = 6.8 Hz, 2C), 23.7 (d, J = 
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5.1 Hz, 2C), 16.2 (d, J = 5.1 Hz, 2C).  The NMR spectra obtained are in accordance 
with literature data.211 
 
 
7.9.3.2 Procedure for Horner-Wadsworth-Emmons Reaction 
 
n-BuLi (0.52 mL, 0.78 mmol, 1.5 M in hexane) was added dropwise to a solution of 
isopropyldiethyl phosphonate in THF (6 mL) at 20 ◦C.  After 2 h, the reaction was 
cooled to 78 ◦C for dropwise addition of methyl 4-phenyl-4-oxobutyrate (150 mg, 
0.70 mmol).  The dark yellow solution was warmed to room temperature overnight 
and then quenched with H2O (5 mL).  The product was extracted with Et2O (2 × 20 
mL).  The combined organic layers were washed with brine (20 mL), dried (Na2SO4), 
filtered and concentrated under reduced pressure.  The crude material was purified by 
flash column chromatography (gradient 90:10 to 50:50 petroleum ether:EtOAc) to 
give ethyl 4-oxo-4-phenylbutanoate (34 mg, 0.165 mmol, 24%).   
 
Ethyl 4-oxo-4-Phenylbutanoate212 
 
 
Yellow oil; 1H NMR (400 MHz, CDCl3)  8.04-8.00 (m, 2H, Ha), 7.60 (tt, J = 7.4, 1.2 
Hz, 1H, Hc), 7.50 (t, J = 7.4 Hz, 2H, Hb), 4.19 (q, J = 7.3 Hz, 2H, H1’), 3.35 (t, J = 
6.9 Hz, 2H, H2), 2.79 (t, J  = 6.9 Hz, 2H, H3), 1.30 (t, J = 7.3 Hz, 3H, H2’); 13C NMR 
(100 MHz, CDCl3) 198.2, 172.9, 135.7, 133.2, 128.6, 128.1, 60.7, 33.4, 28.3, 14.2.  
The NMR spectra obtained are in accordance with literature data.212 
   
7.9.4 Route D: Grignard Addition of iso-Propyl Magnesium 
Chloride to Methyl 4-oxo-4-phenylbutyrate (136) 
 
According to a modified undergraduate experiment using isophorone,213 isopropyl 
magnesium chloride (1.85 mL, 1.6  M in THF, 2.95 mmol, 2.1 eq.) was added to 4-
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phenyl-4-oxobutyric acid (250 mg, 1.4 mmol) in dry Et2O (10 mL) at   ◦C.  The 
reaction mixture was allowed to warm to room temperature (3 h) before addition of 
concentrated HCl (aq.) (0.5 mL, 4 eq.).  The solution was extracted with EtOAc (20 
mL).  The combined organic layers were washed with brine (20 mL), dried (Na2SO4), 
filtered and concentrated under reduced pressure.  The crude material was purified by 
flash column chromatography (gradient 99:1 to 95:5 CH2Cl2:MeOH) to give 5-
phenyl-5-(propan-2-yl)oxolan-2-one (182) (74 mg, 0.363 mmol, 26%) and recovered 
starting material (122 mg, 0.635 mmol, 45%). 
 
5-Phenyl-5-(propan-2-yl)oxolan-2-one (182)214 
 
White solid; 1H NMR (400 MHz, CDCl3) 7.40-7.29 (m, 5H, ArH), 2.61-2.37 (m, 
4H, H3 and H4), 2.17 (septet, J = 6.8 Hz, 1H, CH(CH3)2), 0.94 (d, J = 6.8 Hz, 3H, 
CH3), 0.88 (d, J = 6.8 Hz, 3H, CH3).  The 
1H NMR spectrum obtained is in 
accordance with literature data.214  
 
 
7.9.5 Route E: Successful Synthesis of 159 via Johnson-Claisen 
Rearrangement of 2-methyl-3-phenylbut-3-en-2-ol (183) 
 
7.9.5.1 2-Methyl-3-phenylbut-3-en-2-ol (183)215 
 
 
According to the literature procedure,215 magnesium ribbon (66 mg, 2.7 mmol, 1.2 
eq.) was cut in small pieces and added to a rbf containing THF (6 mL) and a crystal of 
iodine under N2.  After 1 h, -bromostyrene (420 mg, 2.3 mmol) was added and the 
reaction mixture heated to 50 ◦C for 6 h until all the magnesium was consumed.  
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Anhydrous acetone (268 mg, 4.6 mmol, 2 eq.) was added dropwise at 0 ◦C, and the 
mixture was heated to 50 ◦C for 24 h.  The reaction was quenched with saturated 
aqueous NH4Cl (10 mL), extracted with Et2O (2 × 20 mL) and the combined organic 
layers were dried over Na2SO4 and concentrated under vacuum.  The residue was 
chromatographed (gradient 90:10 to 80:20 petroleum ether:EtOAc) to give the title 
compound (183) (138 mg, 0.0.851 mmol, 37%) and 4-hydroxy-4-methylpentan-2-one 
(184) (56 mg, 0.483 mmol, 21%). 
 
183: Colourless oil; IR (neat) 3500-3100 (br), 2978, 1495, 1366, 1138, 1074, 913, 
774, 703 cm-1; 1H NMR (400 MHz, CDCl3)  7.36-7.31 (m, 5H, ArH), 5.46 (d, J = 
1.4 Hz, 1H, CH2=C), 5.00 (d, J = 1.4 Hz, 1H, CH2=C), 1.45 (s, 6H, CH3); 
13C NMR 
(100 MHz, CDCl3) 157.1, 141.4, 128.8, 127.8, 127.1, 112.6, 73.1, 29.7; MS (EI+) 
m/z 162 (M)•+; HRMS (EI+) m/z calcd for C11H14O (M)
•+ 162.1045, found 162.1040.  
All spectroscopic data obtained are in accordance with the literature.215 
 
4-Hydroxy-4-methylpentan-2-one (184)216 
 
Colourless oil; 1H NMR (400 MHz, CDCl3)  6.06 (s, 1H, OH), 2.62 (s, 2H, H3), 2.20 
(s, 3H, H1), 1.29 (s, 6H, (CH3)2).  The 
1H NMR spectrum obtained is in accordance 
with literature data.216 
 
 
7.9.5.2 5-Methyl-4-phenylhex-4-enoic Acid (159)126 
 
According to the procedure of Wirth et al.,126 2-methyl-3-phenylbut-3-en-2-ol (183) 
(110 mg, 0.68 mmol) and triethylorthoacetate (551 mg, 3.4 mmol) in o-xylene (2 mL) 
were stirred at room temperature under N2.  Catalytic propionic acid (5 drops) was 
added and the mixture was refluxed at 140 ◦C for 18 h. The solution was transferred 
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directly to a flash column and the product was purified by flash column 
chromatography (98:2 petroleum ether:EtOAc) to yield ethyl 5-methyl-4-phenylhex-
4-enoate colourless oil (104 mg, 0.462 mmol, 68%) which was hydrolysed directly. 
 
An aqueous solution of LiOH (77 mg, 3.2 mmol, 1.6 M) was added to a solution of 
methyl 5-methyl-4-phenylhex-4-enoate (70 mg, 0.32 mmol) in THF (2 mL) at room 
temperature.  The reaction mixture was heated to 50 ◦C and stirred at this temperature 
for 24 h.  The dark yellow solution was acidified to pH≤ 4 with HCl (1M), and 
extracted with Et2O (2 ×10 mL).  The combined organic phases were washed with 
water (15 mL), brine (15 mL), dried over Na2SO4 and concentrated under vacuum.  
The residue was chromatographed over silica gel (95:5 CH2Cl2:MeOH) to give the 
target molecule (51 mg, 0.249 mmol, 82 %). 
 
Yellow oil; IR (neat) 3400-2800 (br), 2923, 2860, 1706, 1491, 1446, 1411, 1216, 
1168, 1029, 775, 709 cm-1; 1H NMR (400 MHz, CDCl3) 12.0-9.5 (br s, 1H, COOH), 
7.34 (t, J = 7.1 Hz, 2H, Ar o-H), 7.24 (tt, J = 7.5, 1.3 Hz, 1H, Ar p-H ), 7.12-7.09 (m, 
2H, Ar m-H), 2.73 (t, J = 8.2 Hz, 2H, H2), 2.31 (t, J = 8.2 Hz, 2H, H3), 1.87 (s, 3H, 
CH3), 1.57 (s, 3H, CH3); 
13C NMR (100 MHz, CDCl3) 179.1, 142.7, 132.9, 129.2, 
129.1, 128.1, 126.2, 32.7, 29.4, 22.3, 20.1; MS (EI+) m/z 206 (M + H)+; HRMS (EI+) 
m/z calcd for C13H17O2 (M + H)
+ 205.1229, found 205.1232.  All spectroscopic data 
obtained are in accordance with the literature.217  
 
 
7.10 Synthesis of (Z)-5-Phenylpent-4-enoic Acid (76) 
 
 
To a stirred suspension of (4-ethoxy-4-oxobutyl)triphenylphosphonium bromide (186) 
(529 mg, 1.16 mmol) under N2 in THF (6 mL) at 30 ◦C was added KOtBu (143 mg, 
1.27 mmol) in one portion.  The reaction mixture was stirred for 2 h at this 
temperature before cooling to -78 ◦C.  Benzaldehyde (123 mg, 1.16 mmol) was added 
  
266 
dropwise, and the mixture was warmed to room temperature overnight.  The reaction 
was quenched by addition of saturated aqueous solution of NH4Cl (10 mL) and 
extracted with EtOAc (2 × 10 mL).  The combined organic extracts were dried 
(Na2SO4), evaporated and the residue chromatographed (90:10 petroleum ether:ethyl 
acetate) to give ethyl 4(Z)-5-phenylpent-4-enoate (137 mg, 0.673 mmol, 58%) which 
was hydrolysed directly.  
To a solution of ethyl 4(Z)-5-phenylpent-4-enoate (100 mg, 0.49 mmol) in THF (2 
mL) was added a solution of LiOH (118 mg, 4.9 mmol) in water (4 mL).  The reaction 
mixture was stirred at room temperature for 24 h.  The yellow solution was diluted 
with EtOAc, transferred to a separating funnel and extracted with EtOAc (10 mL).  
The aqueous layer was acidified by addition of 1M HCl until pH ~ 2 resulting in 
precipitation of the product which was re-extracted with EtOAc (2 × 20 mL).  The 
combined organic extracts were dried (Na2SO4), evaporated and the residue was 
chromatographed (95:5 CH2Cl2:MeOH) to give the title compound. 
 
White solid; m.p. 85-86 ◦C; (lit. m.p.65 = 86.4-88.4 ◦C) IR (neat) 3500-2750 (br), 
3019, 1704, 1495, 1411, 1214, 918, 789 cm-1; 1H NMR (400 MHz, CDCl3) 7.40-
7.35 (m, 2H, Ar o-H), 7.32-7.25 (m, 3H, ArH), 6.52 (dt, J = 11.5, 1.9 Hz, 1H, H5), 
5.67 (dt, J = 11.5, 7.7 Hz, 1H, H4), 2.71 (app dq, J = 7.7, 2.0 Hz, 2H, H2), 2.53 (t, J = 
7.7 Hz, 2H, H3); 13C NMR (100 MHz CDCl3) 178.2, 137.1, 130.4, 129.9, 128.7, 
128.3, 126.8, 34.0, 23.8; MS (ESI) m/z 175 (M – H)-; HRMS (ESI) m/z calcd for 
C11H11O2 (M – H)-175.0765, found 175.0763.  All spectroscopic data obtained are in 
accordance with the literature.12  
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7.11 Synthesis of (4E)-5-Phenylpent-4-enoic acid (73)66 
 
7.11.1 Route A: Decarboxylation of 1,3-Dimethyl 2-[(2E)-3-
phenylprop-2-en-1-yl]malonate (189)  
 
7.11.1.1 1,3-Dimethyl 2-[(2E)-3-Phenylprop-2-en-1-yl]malonate 
(189)218 
 
 
According to the literature procedure,218 dimethyl malonate (527 mg, 3.30 mmol) was 
added slowly to a suspension of NaH (132 mg, 3.30 mmol, 60% in mineral oils) in 
anhydrous THF (5 mL) at room temperature under nitrogen.  After effervescence had 
ceased and the reaction mixture became a homogeneous yellow solution (~2 h), 
cinnamyl chloride (503 mg, 3.30 mmol) was added dropwise.  The reaction was 
stirred at room temperature for 18 h.  Any unreacted NaH was quenched by dilution 
of the reaction mixture with Et2O (5 mL) and addition of H2O (5 mL).  The mixture 
was extracted with Et2O (20 mL) and the combined extracts were washed with brine 
(10 mL), dried over Na2SO4 and concentrated under vacuum.  The residue was 
purified by flash column chromatography (98:2 petroleum ether:EtOAc) to give the 
title compound (420 mg, 1.69 mmol, 51%) and 1,3-dimethyl 2,2-bis[(2E)-3-
phenylprop-2-en-1-yl]propanedioate (190) (104 mg, 0.285 mmol, 15%). 
 
189: Yellow oil; 1H NMR (400 MHz, CDCl3) 7.38-7.22 (m, 5H, ArH), 6.51 (d, J = 
15.8 Hz, 1H, H3), 6.17 (dt, J  = 15.8, 6.8 Hz, 1H, H2), 3.78 (s, 6H, OCH3), 3.57 (t, J = 
7.5 Hz, 1H, H2’), 2.84 (dt, J = 7.5, 1.4 Hz, 2H, H1); 13C NMR (100 MHz, CDCl3) 
169.3 (2C), 137.0, 133.0, 128.5, 127.5, 126.3, 125.4, 52.6 (2C), 51.8, 32.3.  All 
spectroscopic data obtained are consistent with the literature.218 
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1,3-Dimethyl 2,2-bis[(2E)-3-phenylprop-2-en-1-yl]propanedioate 
(190)218 
 
Yellow oil: IR (neat) 2923, 2857, 1734, 1442, 1255, 1203, 970, 740, 699 cm-1; 1H 
NMR (400 MHz, CDCl3) (m, 8H, ArH), 7.27 (m, 2H, ArH), 6.52 (d, J = 16.0 Hz, 
2H, H3), 6.12 (dt, J = 16.0, 7.6 Hz, 2H, H2), 3.79 (s, 6H, OCH3), 2.90 (dd, J = 7.6, 
1.0 Hz, 4H, H1); 13C NMR (100 MHz, CDCl3) 171.3, 137.1, 134.2, 128.6, 127.5, 
126.3, 123.9, 58.3, 52.6, 36.8; MS (EI+) m/z 365 (M)•+; HRMS (EI+) m/z calcd for 
C23H25O4 (M)
•+  365.1753, found 365.1771.  All spectroscopic data obtained are in 
accordance with the literature.218 
 
7.11.1.2 Methyl (4E)-5-Phenylpent-4-enoate (191)133  
 
 
Following the method of Krapcho et al.,134a 1,3-dimethyl 2-[(2E)-3-phenylprop-2-en-
1-yl]malonate (189) (300 mg, 1.21 mmol) was dissolved in a solution of DMSO (6 
mL) and water (44 mg, 2.42 mmol, 2 eq.).  The reaction mixture was heated to 180 ◦C 
for 18 h.  The mixture was allowed to cool to room temperature, diluted with water 
(10 mL) and extracted with Et2O (2 x 20 mL). The combined organic extracts were 
washed with brine (20 mL), dried over Na2SO4 and concentrated under vacuum.  The 
residue was purified by column chromatography (97:3 petrol:EtOAc) to give the title 
product (61 mg, 0.321 mmol, 27%) and 4-hydroxy-5-(methylsulfanyl)-5-
phenylpentanoate (192) (105 mg, 0.436 mmol, 36%). 
 
191: Colourless oil; IR (neat) 3030, 2958, 1720, 1602, 1434, 1251, 1081, 970, 765, 
695; 1H NMR (400 MHz, CDCl3) 7.40-7.22 (m, 5H, ArH), 6.48 (d, J = 15.8 Hz, 1H, 
H5), 6.25 (dt, J = 15.8, 6.4 Hz, 1H, H4), 3.73 (s, 3H, OCH3), 2.62-2.47 (m, 4H, H2 
and H3); 13C NMR (100 MHz, CDCl3) 173.4, 137.4, 131.0, 128.5, 128.3, 127.2, 
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126.1, 51.6, 33.8, 28.3; MS (EI+) m/z 190 (M)•+; HRMS (EI+) m/z calcd for C12H14O2 
(M)•+  190.0994, found 190.0994.   All spectroscopic data obtained are in accordance 
with the literature.133 
 
4-Hydroxy-5-(methylsulfanyl)-5-phenylpentanoate (192) 
 
White solid; 1H NMR (400 MHz, CDCl3) 7.41-7.29 (m, 5H, ArH), 4.88 (app q, J = 
6.9 Hz, 1H, H4), 3.94 (d, J = 6.3 Hz, 1H, H5), 2.55-2.35 (m, 3H, H2 and H3), 2.27-
2.17 (m, 1H, H3), 2.00 (s, 3H, SCH3); 
13C NMR (DEPT-135, 100 MHz, CDCl3) 
176.5 (C), 137.4 (C), 128.7 (2 x CH), 128.0 (CH), 82.0 (CH), 56.0 (CH), 28.6 
(CH2), 25.9 (CH2), 14.8 (CH3); MS (CI
+, NH3) m/z 241 (M+H)
+.    
 
 
7.11.2 Route B: Johnson-Claisen Rearrangement of -
Vinylbenzylalcohol  
 
7.11.2.1 Ethyl (4E)-5-Phenylpent-4-enoate (194)132 
 
 
According to the procedure of Willis et al.,133  -Vinylbenzylalcohol (475 mg, 3.73 
mmol) and triethylorthoacetate (3.50 mL, 18.6 mmol) in o-xylene (4 mL) were stirred 
at room temperature under N2.  Catalytic propionic acid (5 drops) was added and the 
mixture was refluxed at 140 ◦C for 18 h. The solution was transferred directly to a 
flash column and the product was purified by eluting with 98:2 petroleum 
ether:EtOAc to yield the title compound (710 mg, 3.48 mmol, 92%).  
 
Colourless oil; 1H NMR (400 MHz, CDCl3)  7.41-7.22 (m, 5H, ArH), 6.48 (d, J = 
16.0 Hz, 1H, H5), 6.26 (dt, J = 16.0, 6.2 Hz, 1H, H4), 4.20 (q, J = 7.2 Hz, 2H, OCH2), 
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2.58 (t, J = 6.8 Hz, 2H, H2), 2.52 (m, 2H, H3), 1.31 (t, J = 7.2 Hz, 3H, OCH2CH3); 
13C NMR (100 MHz, CDCl3)  173.0, 137.3, 131.0, 128.6, 128.5, 127.2, 126.6, 60.4, 
34.1, 28.4, 14.3; MS (EI+) m/z 204 (M)•+; HRMS (EI+) m/z calcd for C13H16O2 (M)
•+  
204.1150, found 204.1149.  All spectroscopic data obtained are in accordance with 
the literature.132 
 
7.11.2.2 (4E)-5-Phenylpent-4-enoic acid (73)66 
 
An aqueous solution of LiOH (706 mg, 29.4 mmol, 2.45 M) was added to a solution 
of ethyl (4E)-5-phenylpent-4-enoate (600 mg, 2.94 mmol) in THF (12 mL) at room 
temperature.  The reaction mixture was heated to 50 ◦C and stirred at this temperature 
for 24 h.  The dark yellow solution was acidified to pH≤ 4 with HCl (1M), and 
extracted with Et2O (2 ×20 mL).  The combined organic phases were washed with 
water (15 mL), brine (15 mL), dried over Na2SO4 and concentrated under vacuum.  
The residue was chromatographed over silica gel (95:5 CH2Cl2:MeOH) to give the 
target molecule (486 mg, 2.76 mmol, 94 %).  
 
White solid; IR (neat) 3300-2500 (br), 2930, 2624, 1692, 1498, 1408, 1292, 1213, 
977, 751 cm-1; 1H NMR (400 MHz, CDCl3)  12.8-9.2 (br s, 1H, COOH), 7.41-7.22 
(m, 5H, ArH), 6.48 (d, J = 16.0 Hz, 1H, H5), 6.26 (dt, J = 16.0, 6.2 Hz, 1H, H4), 2.59 
(m, 4H, H2 and H3); 13C NMR (100 MHz, CDCl3) 178.9, 137.2, 131.2, 128.6, 
128.0, 127.3, 126.1, 33.4, 27.9; MS (EI+) m/z 176 (M)•+; HRMS (EI+) m/z calcd for 
C11H12O2 (M)
•+ 176.0837, found 176.0838.  All spectroscopic data obtained are in 
accordance with the literature.66 
7.12 2-Vinyllbenzoic acid (146)136 
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According to the method of Cottrell et al.,136 Magnesium turnings (61 mg, 2.51 mmol, 
1 eq.) were placed in a two necked flask connected to a condenser.  After purging the 
system with nitrogen, THF (3 mL) and 1,2-dibromoethane (one drop) were added.  2-
bromostyrene (460 mg, 2.51 mmol) was dissolved in THF (3 mL) and was added 
dropwise to the magnesium solution at room temperature over 20 minutes.  The 
temperature was increased to 70 ◦C, and the mixture stirred for 2 h.  After cooling, the 
reaction was quenched by addition of dry ice.  The mixture was allowed to warm to 
room temperature before diluting with Et2O and washing with 1 M HCl (10 mL).  The 
mixture was extracted with Et2O (2 × 10 mL) and the combined organic phases were 
dried (Na2SO4), evaporated and chromatographed (70:30 petroleum ether:EtOAc) to 
give the title compound (120 mg, 0.805 mmol, 37%).  
 
White solid: m.p. 93-94 ◦C (lit.136 m.p. = 95.5 ◦C); IR (neat) 2867, 1668, 1565, 1483, 
1401, 1262, 902, 768, 756, 660 cm-1; 1H NMR (400 MHz, CDCl3) 13.0-10.0 (br s, 
1H, COOH), 8.09 (dd, J = 7.8, 1.4 Hz, 1H, H6), 7.67-7.56 (m, 3H, H3-H5), 7.41 (td, J 
= 7.8, 1.4 Hz, 1H, H1’), 5.71 (dd, J = 7.4, 1.2 Hz, 1H, CH2=C), 5.43 (dd, J = 10.8, 1.2 
Hz, 1H, CH2=C); 
13C NMR (100 MHz CDCl3) 172.4, 140.7, 136.1, 133.2, 131.3, 
127.6, 127.5, 127.1, 116.9; MS (ESI) m/z 149 (M + H)+; HRMS (ESI) m/z calcd for 
C9H9O2 (M + H)
+ 149.0597, found 149.0595.  All spectroscopic data obtained are in 
accordance with the literature.136 
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7.13 Synthesis of 2-(Prop-2-en-1-yl)benzoic acid (147)  
7.13.1 Methyl 2-(prop-2-en-1-yl)benzoate (195)137  
 
 
 
According to a modified literature method,137 to a solution of methyl 2-iodobenzoate 
(3.00 g, 11.5 mmol) in dry THF (30 mL) under N2 at -20 
◦C was added iPrMgCl (10.7 
mL, 1.82 M solution in THF, 12.94 mmol).  The bright yellow solution was stirred for 
1 h, then cooled to -40 ◦C before addition of Li2CuCl4 (4.8 mL, 0.1 M in THF, 0.48 
mmol, 4 mol%).  After 0.5 h, allyl bromide (1.09 mL, 12.94 mmol) was added to the 
red/brown reaction mixture, and the stirred solution was allowed to warm to room 
temperature overnight.  The reaction was quenched by the addition of saturated 
aqueous NH4Cl (30 mL), extracted with Et2O (2 × 20 mL), dried (Na2SO4), 
evaporated and the residue chromatographed (90:10 petroleum ether: Et2O) to give 
the title compound (1.86 g, 10.6 mmol, 92%). 
 
Yellow oil; IR (neat) 2954, 1724, 1439, 1258, 1081, 747, 713 cm-1; 1H NMR (400 
MHz, CDCl3) 7.91 (d, J = 7.6 Hz, 1H, H6), 7.47 (dt, J = 7.6, 1.4 Hz, 1H, H4), 7.33-
7.27 (m, 2H, H5 and H3), 6.05 (m, 1H, H2’), 5.09-5.02 (m, 2H, CH2=C), 3.92 (s, 3H, 
OCH3), 3.79 (dt, J = 6.4, 1.5 Hz, 2H, H1’); 13C NMR (100 MHz CDCl3) 168.1, 
141.6, 137.4, 132.1, 131.0, 130.6, 129.7, 126.2, 115.6, 52.9, 38.4. All spectroscopic 
data obtained are in accordance with the literature.137 
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7.13.2 2-(Prop-2-en-1-yl)benzoic acid (147)137  
 
 
 
To a stirred solution of methyl 2-(prop-2-en-1-yl)benzoate (1.80 g, 10.2 mmol) in 
ethanol (10 mL) was added an aqueous 2M NaOH solution (10 mL) at room 
temperature.  The reaction mixture was heated to 50 ◦C and stirred for 18 h.  The 
yellow solution was transferred to a separating funnel and extracted with EtOAc (30 
mL).  The aqueous layer was acidified by addition of 1M HCl until pH ~ 2 resulting 
in precipitation of the product which was re-extracted with EtOAc (2 × 20 mL).  The 
combined organic extracts were dried (Na2SO4), evaporated and the residue was 
chromatographed (50:50 petroleum ether: Et2O) to give the title compound (1.23 g, 
7.64 mmol, 75 %). 
 
White solid: m.p. 82-83 ◦C (lit. m.p. = 82-84 ◦C); IR (neat) 3300-2600 (br), 2974, 
2878, 1679, 15764, 1410, 1274, 903, 733 cm-1; 1H NMR (400 MHz, CDCl3) 13.5-
9.5 (br s, 1H, CO2H), 8.10 (dd, J = 7.8, 1.4 Hz, 1H, H6), 7.54 (dt, J = 7.8, 1.4 Hz, 1H, 
H4), 7.38-7.33 (m, 2H, H5 and H3), 6.09 (ddt, J = 17.0, 10.6, 6.4 Hz, 1H, H2’), 5.09 
(d, J = 17.0 Hz, 1H, CH2=C), 5.07 (d, J = 10.6 Hz, 1H, CH2=C) 3.88 (d, J = 6.4 Hz, 
2H, H1’); 13C NMR (100 MHz CDCl3) 173.0, 142.8, 137.3, 133.7, 131.2, 130.9, 
128.2, 126.4, 115.8, 38.6; MS (ESI) m/z 162 (M + H)+; HRMS (ESI) m/z calcd for 
C10H11O2 (M + H)
+ 163.0754, found 163.0753.  All spectroscopic data obtained are in 
accordance with the literature.137 
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7.14 Synthesis of 2-[(E)-2-phenylethenyl] Benzoic acid (78)  
7.14.1 Methyl 2-[(E)-2-phenylethenyl] benzoate (196)217 
 
 
 
According to the procedure of Wirth et al.,217 styrene (191 mg, 1.80 mmol), methyl o-
iodobenzoate (400 mg, 1.53 mmol, 1.2 eq.) and NEt3 (0.44 ml, 3.20 mmol, 2.1 eq.) 
were added to a round-bottom flask fitted with a magnetic stirrer and reflux condenser 
under a nitrogen atmosphere.  Pd(OAc)2 (34 mg, 0.153 mmol, 0.1 eq.) and PPh3 (100 
mg, 0.383 mmol, 0.25 eq.) were added to the reaction mixture and the mixture was 
heated to reflux at 100 ◦C for 18 h.  After cooling to room temperature, the reaction 
was quenched with HCl (10 mL, 1M) and extracted with Et2O (2 x 20 mL).  The 
organic extracts were washed with brine (20 mL), dried over sodium sulphate and 
concentrated under reduced pressure.  The product was purified by flash column 
chromatography (96:4 petroleum ether:EtOAc) to give the title compound (306 mg, 
1.29 mmol, 84%). 
 
Colourless oil: IR (neat) 3200-2750 (br), 1715, 1435, 1272, 1243, 1131, 1078, 963, 
762, 707, 691 cm-1;  1H NMR (400 MHz, CDCl3)  13.0-11.2 (br s, 1H, COOH) 8.03 
(d, 1H, J = 16.4 Hz, H1’), 7.97 (d, 1H, J = 8.2 Hz, H6), 7.76 (d, 1H, J = 8.2 Hz, H3), 
7.59 (d, 2H, J = 7.6 Hz, H1’), 7.55 (t, 1H, J = 7.6 Hz, H3’’), 7.43-7.30 (m, 4H, ArH), 
7.05 (d, 1H, J = 16.4 Hz, H2’), 3.95 (s, 3H, OCH3); 13C NMR (100 MHz, CDCl3)  
167.9, 139.3, 137.5, 132.2, 131.5, 130.7, 128.7, 128.6, 127.9, 127.5, 127.2, 127.0, 
126.9, 52.2; MS (CI+, NH3) m/z 239 (M + H)
+; HRMS (CI+, NH3) m/z calcd for 
C16H15O2 (M + H)
+ 239.1072, found 239.1084.  All spectroscopic data obtained are in 
accordance with the literature.217 
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7.14.2 2-[(E)-2-phenylethenyl] benzoic acid (78)217 
 
 
 
An aqueous solution of LiOH (546 mg, 13.0 mmol, 1.86 M) was added to a solution 
of methyl 2-[(E)-2-phenylethenyl] benzoate (310 mg, 1.30 mmol) in THF (6 mL) at 
room temperature.  The reaction mixture was heated to 50 ◦C and stirred at this 
temperature for 24 h.  The dark yellow solution was acidified to pH≤ 4 with HCl 
(1M), and extracted with Et2O (2 ×15mL).  The combined organic phases were 
washed with water (10 mL), brine (10 mL), dried over Na2SO4 and concentrated 
under vacuum.  The residue was chromatographed over silica gel (95:5 
CH2Cl2:MeOH) to give the title compound (280 mg, 1.25 mmol, 96 %). 
 
White solid: m.p. 151-153 ◦C (lit.217 m.p. = 151-152 ◦C); IR (neat) 3200-2750 (br), 
2819 (br), 1675, 1567, 1453, 1411, 1314, 1286, 1255, 973, 942, 761, 702, 674 cm-1;  
1H NMR (400 MHz, CDCl3)  13.0-10.0 (br s, 1H, COOH),  8.14 (d, J = 5.2 Hz, 1H, 
H6), 8.12 (d, J = 16.4 Hz, 1H, H1’), 7.79 (d, J = 8.2 Hz, 1H, H3), 7.64-7.59 (m, 3H, 
ArH), 7.41 (app t, J = 7.6 Hz, 3H, ArH), 7.32 (t, J = 7.6 Hz, 1H, H3’’), 7.08 (d, J = 
16.4 Hz, 1H, H2’); 13C NMR (100 MHz, CDCl3) 172.9, 140.2, 137.4, 133.2, 131.9, 
131.7, 128.8, 128.0, 127.6, 127.4, 127.3, 127.2, 127.0; MS (EI+) m/z 224 (M)•+; 
HRMS (EI+) m/z calcd for C15H12O2 (M)
•+ 224.0837, found 224.0833.  All 
spectroscopic data obtained are in accordance with the literature.217 
 
7.15 General Procedure for Bromolactonisation 
 
To a sealed screw-capped vial was added DHQD2PHAL (15.6 mg, 0.02 mmol), NBS 
(38.9 mg, 0.22 mmol) and benzoic acid (24.4 mg, 0.2 mmol).  The reagents were 
dissolved in toluene (5 mL) and the solution cooled to -20 ◦C.  The carboxylic acid 
substrate (0.2 mmol) was dissolved in toluene (1 mL), injected into the reaction vial 
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and the mixture was stirred until TLC analysis showed complete conversion of the 
substrate.  The reaction was diluted with toluene (5 mL) and quenched by addition of 
2M HCl (10 mL). The organic layer was washed with 2M NaOH (10 mL) and brine 
(10 mL), then dried (Na2SO4), evaporated and chromatographed (gradient of 90:10 to 
80:20 petroleum ether:EtOAc) to give the lactone product. 
 
 
7.15.1 (5S)-5-(Bromomethyl)-5-phenyloxolan-2-one (135)65 
 
 
 
Following the general procedure using substrate 114 gave bromolactone 135 (49 mg, 
0.192 mmol, 95%).  Colourless oil: []D20 12.5 (c 1.00, CH2Cl2); IR (neat) 1774, 
1449, 1416, 1233, 1156, 1033, 1011, 948, 927, 760, 700, 663, 608 cm-1; 1H NMR 
(400 MHz, CDCl3)  7.46-7.36 (m, 5H, ArH), 3.78 (d, J = 11.3 Hz, 1H, CH2Br), 3.72 
(d, J = 11.3 Hz, 1H, CH2Br), 2.90-2.79 (m, 2H, H3), 2.67-2.52 (m, 2H, H4); 
13C 
NMR (100 MHz, CDCl3) 11111111 
MS (CI+, NH3) m/z 272, 274 (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for 
C11H15NO2
79Br (M + NH4)
+ 272.0288, found 272.0286; HPLC (CHIRALCEL-AD; 2 
% IPA in n-hexane; 1.0 mL/min; 254 nm) tR  = 36.4 (major), 43.0 min (minor) – 91:9 
e.r. (82% e.e.). 
All spectroscopic data are consistent with the literature.65 
7.15.2 (S)-6-(Bromomethyl)-6-phenyloxan-2-one (102)104 
 
 
Following the general procedure using substrate 101 gave bromolactone 102 (51 mg, 
0.188 mmol, 94%).  Colourless oil: []D20 +35.0 (c 0.95, CH2Cl2); IR (neat) 2968, 
1734, 1734, 1501, 1449, 1234, 1178, 1039, 935, 765, 709, 674 cm-1; 1H NMR (400 
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MHz, CDCl3) m, 5H, ArH), 3.71 (d, J = 11.1 Hz, 1H, CH2Br), (d, J = 
11.1 Hz, 1H, CH2Br), 2.58-2.35 (m, 4H, H3 and H4), 1.91-1.82 (m, 1H, H5), 1.67-
1.55 (m, 1H, H5); 13C NMR (100 MHz, CDCl3) 170.5, 140.3, 129.0, 128.6, 125.4, 
85.2, 41.6, 30.1, 29.1, 16.2; MS (EI+) m/z 271, 269 (M)●+; HRMS MS (EI+) m/z calcd 
for C12H13O2
79Br (M)●+ 269.0176, found 269.0172; HPLC (CHIRALCEL-AD; 2 % 
IPA in n-hexane; 1.0 mL/min; 216 nm) tR = 29.5 (major), 32.7 min (minor) – 94:6 e.r. 
(88% e.e.).  All spectroscopic data obtained are in accordance with the literature.104 
 
7.15.3 7-(Bromomethyl)-7-phenyloxepan-2-one (154) 
 
To a sealed screw-capped vial was added (DHQD)2PHAL (15.6 mg, 0.02 mmol), 
NBS (38.9 mg, 0.22 mmol) and benzoic acid (24.4 mg, 0.2 mmol).  The reagents were 
suspended in aqueous LiCl (1M, 5 mL).  The substrate 6-phenyl-6-heptenoic acid 
(153) was added directly and the mixture was stirred in the dark for 24 hours.  The 
reaction was extracted with EtOAC (3 x 10 mL).  The organic layers were washed 
successively with 1M HCl (10 mL) and brine (10 mL), dried (Na2SO4) and 
concentrated under reduced pressure to give the title compound (93%) as a crude 
mixture with the substrate 153. 
 
1H NMR (400 MHz, CDCl3): 7.42-7.29 (m, 5H, ArH), 3.79 (AB q, J = 10.4 Hz, 2H, 
CH2Br), 2.30 (t, J = 7.5 Hz, 2H, H3), 2.02 (ddd, J = 4.7, 11.7, 13.7 Hz, 1H, H6), 1.90 
(ddd, J = 4.7, 11.7, 13.7 Hz, 1H, H6), 1.68-1.51 (m, 2H, H4), 1.14 (m, 1H, H5), 0.87 
(ddddd, J = 4.7, 6.1, 9.6, 13.7,16.4 Hz, 1H, H5). 
 
1-Bromomethyl Styrene (197)219 
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Following the general procedure using substrate 151 gave -bromomethyl styrene 
(197) (35 mg, 0.179 mmol, 90%).  Colourless oil; 1H NMR (400 MHz, CDCl3) 
m, 2H, Ha), 7.44-7.34 (m, 3H, Hb and Hc), 5.59 (s, 1H, CH2=C), 5.53 
(s, 1H, CH2=C), 4.42 (s, 2H, CH2Br);
 13C NMR (100 MHz, CDCl3) 144.2, 137.6, 
128.4, 128.2, 126.1, 117.2, 34.2.  All spectroscopic data obtained are in accordance 
with the literature.219 
  
7.15.5 (1S,5S,6S)-5-Bromo-7-oxabicyclo[4.2.0]oct-2-en-8-one 
(107)78 
 
 
 
Following the general procedure using substrate 148 gave bromolactone 107 (16 mg, 
0.080 mmol, 40%). White solid: m.p. 97 ◦C, [lit m.p.78 = 96-98 ◦C]; []D20 +20.0 (c 
0.3, CH2Cl2); IR (neat) 1803, 1438, 1339, 1362, 1335, 1264, 1211, 1118, 1068, 968, 
891, 872, 847, 738, 673 cm-1; 1H NMR (400 MHz, CDCl3)  6.09 (dt, J = 9.4, 4.7 Hz, 
1H, H3), 5.94 (dd, J = 6.4, 9.4 Hz, 1H, H2), 4.98 (dd, J = 5.7, 3.1 Hz, 1H, H6), 4.58 
(q, J = 3.1 Hz, 1H, H5), 4.32 (t, J = 6.4 Hz, 1H, H1), 2.79-2.74 (m, 2H, H4); 13C 
NMR (100 MHz CDCl3) 166.1, 128.3, 118.4, 70.7, 49.1, 41.3, 27.9; MS (CI+, NH3) 
m/z 222, 220 (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C7H7NO2
79Br (M + NH4)
+ 
219.9972, found 219.9981; HPLC (CHIRALCEL-ODH; 2 % IPA in n-hexane; 1.0 
mL/min; 212 nm) tR = 19.9 min (minor), 22.0 (major) – 64:36 e.r. (28% e.e.).  All 
spectroscopic data obtained are in accordance with literature data.78 
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7.15.6 (5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-5-phenyloxolan-2-
one (158) 
 
 
Following the general procedure using substrate 157 gave bromolactones 158 (55 mg, 
0.186 mmol, 93%). Colourless oil, 8.3:1 mixture of (S,S):(S,R) isomers: IR (neat) 
1779, 1640, 1182, 1032, 1001, 926, 740, 706 cm-1; []D20 6.6 (c 0.6, CH2Cl2); 1H 
NMR (400 MHz, CDCl3) 7.61-7.56 (m, 2H, ArH), 7.47-7.37 (m, 3H, ArH), 5.77 
(dddd, J = 17.2, 10.1, 7.2, 6.1 Hz, 1H, H3’), 5.12 (d, 1H J = 10.1 Hz, H4’), 5.08 (d, J 
= 17.2 Hz, 1H, H4’), 4.25 (dd, J = 11.0, 3.1 Hz, 1H, H1’), 2.88-2.64 (m, 4H), 2.56-
2.41 (m, 1H), 2.08 (ddd, J = 14.8, 11.0, 7.2 Hz, 1H, H2’); 13C NMR (100 MHz, 
CDCl3) 175.4, 137.3, 134.3, 128.8, 128.4, 126.9, 118.3, 89.3, 61.3, 37.9, 33.0, 29.0; 
MS (CI+, NH3) m/z 314, 312  (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for 
C14H19NO2
79Br (M + NH4)
+ 312.0599, found 312.0595; HPLC (CHIRALCEL-AD; 
4% IPA in n-hexane; 1.0 mL/min; 216 nm) tR = 10.9 min (major), 12.5 min (minor) – 
86:14 e.r. (72 % e.e.). 
 
7.15.7 (5S)-5-(2-Bromopropan-2-yl)-5-phenyloxolan-2-one 
(160) 
 
 
Following the general procedure using substrate 159 gave bromolactone 160 (56 mg, 
0.190 mmol, 95%).  Colourless oil: []D20 10.0 (c 0.4, CH2Cl2); IR (neat) 2921, 
2851, 1784, 1464, 1267, 1174, 1117, 739, 705 cm-1; 1H NMR (400 MHz, CDCl3)  
7.47-7.45 (m, 2H, ArH), 7.37-7.31 (m, 3H, ArH), 2.97-2.93 (m, 1H, H3), 2.68-2.64 
(m, 2H, H3 and H4), 2.39-2.35 (m, 1H, H4), 1.68 (s, 3H, OCH3), 1.66 (s, 3H, OCH3);
 
13C NMR (100 MHz CDCl3) 175.6, 138.4, 128.4, 127.9, 127.5, 92.3, 71.6, 32.6, 
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30.1, 29.7, 29.2; MS (CI+, NH3) m/z 302, 300 (M + NH4)
+; HRMS (CI+, NH3) m/z 
calcd for C13H19NO2
79Br (M + NH4)
+;  300.0599, found 300.0609; HPLC 
(CHIRALCEL-AD; 5% IPA in n-hexane; 1.0 mL/min; 210 nm) tR = 9.6 min (minor), 
13.0 min (major) – 69:31 e.r. (38% e.e.).  All spectroscopic data obtained is in 
accordance with literature data.126 
 
 
7.15.8 (5S)-5-(Bromomethyl)oxolan-2-one (156)143 
 
 
Following the general procedure using substrate 155 gave bromolactone 156 (35 mg, 
0.196 mmol, 98%).  Colourless oil: []D20 +4.0 (c 2.0, CH2Cl2);IR (neat) 2922, 1774, 
1464, 1342, 1118, 1022, 921, 737 cm-1; 1H NMR (400 MHz, CDCl3) 4.77 (app qd, J 
= 6.7, 4.5 Hz, 1H, H5), 3.62-3.54 (m, 2H, CH2Br), 2.74-2.54 (m, 2H, H3), 2.47 (dddd, 
J = 12.8, 9.7, 7.1, 5.4 Hz, 1H, H4), 2.15 (dddd, J = 12.8, 9.9, 7.6, 6.5 Hz, 1H, H4); 13C 
NMR (100 MHz, CDCl3) 176.2, 77.9, 34.1, 28.4, 26.2 MS (CI+, NH3) m/z 198, 196 
(M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C5H11NO2
79Br (M + NH4)
+ 195.9973, 
found 195.9964; GC (-DEX: 100 ◦C (5 min), 10 ◦C/min, 250 ◦C (20 min)) tR = 38.9 
min (major), 39.2 min (minor) – 68:32 e.r. (36% e.e.).  All spectroscopic data 
obtained is in accordance with literature data.143 
 
 
7.15.9 (5S)-5-[(S)-Bromo(phenyl)methyl]oxolan-2-one (70)12 
 
 
 
Following the general procedure using substrate (Z)-76 gave bromolactone exo-77 (45 
mg, 0.176 mmol, 88%).  White solid: m.p. 127-130 ◦C; []D20 +124.4 (c 0.45, 
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CH2Cl2); IR (neat) 2940, 1776, 1505, 1467, 1463, 1421, 1338, 1171, 1150, 1057, 918, 
706, 664 cm-1; 1H NMR (400 MHz, CDCl3) dd, J = 7.9, 1.8 Hz, 2H, ArH), 
7.41-7.33 (m, 3H, ArH), 5.02 (d,  J = 5.4 Hz, 1H, H6), 4.94 (td, J = 7.0, 5.4 Hz, 1H, 
H5),  2.55-2.36 (m, 2H, H3), 2.27 (dddd, J = 13.1, 10.2, 7.6, 5.4 Hz, 1H, H4), 2.07 
(dddd, J = 13.1, 9.8, 8.8, 6.8 Hz, 1H, H4); 13C NMR (100 MHz, CDCl3) 176.0, 
136.9, 129.2, 128.9, 128.5, 82.0, 55.2, 28.4, 25.7; MS (CI+, NH3) m/z 274, 272 (M + 
NH4)
+; HRMS (CI+, NH3) m/z calcd for C11H11O2
79BrNH4 272.0285 (M + NH4)
+, 
found 272.0281; HPLC (CHIRALCEL-ODH; 25% IPA in n-hexane; 1.0 mL/min; 216 
nm) tR 16.2 min (major), 19.0 min (minor) – 91:9 e.r. (82% e.e.).  All spectroscopic 
data obtained is in accordance with literature data.12  
 
 
7.15.10 (5R,6S)-5-Bromo-6-phenyloxan-2-one (endo-74)78  
 
 
Following the general procedure using substrate (E)-73 gave bromolactones endo-74 
(30 mg, 0.114 mmol, 57%) and exo-74 (21.9 mg, 0.086 mmol, 43%).   
 
endo-74: White solid: m.p. 120-121 ◦C, [lit m.p.78 = 132-133 ◦C]; []D20  12.5◦ (c 
0.32 CH2Cl2); IR (neat) 2958, 1727, 1505, 1460, 1352, 1286, 1206, 1060, 1029, 984, 
751, 699 cm-1; 1H NMR (400 MHz, CDCl3) 7.47-7.34 (m, 5H, ArH), 5.60 (d, J = 
6.2 Hz, 1H, H6), 4.42 (app td, J = 6.2, 4.4 Hz, 1H, H5), 2.99 (ddd, J = 18.2, 8.9, 7.4 
Hz, 1H, H3), 2.75 (app dt, J = 18.2, 6.2 Hz, 1H, H3) 2.45 (dddd, J = 14.6, 8.9, 6.2, 4.1 
Hz, 1H, H4), 2.35-2.26 (m, 1H, H4); 13C NMR (100 MHz, CDCl3) 
1111111; MS (EI+) m/z 256, 254 
(M)●+; HRMS (EI+) m/z calcd for C11H11O2
79Br (M)●+ 253.9942, found 253.9937; 
HPLC (CHIRALCEL-ODH; 8% IPA in n-hexane; 1.0 mL/min; 216 nm) tR = 16.7 min 
(major), 18.3 min (minor) – 74:26 e.r. (48% e.e.).  All spectroscopic data obtained is 
in accordance with literature data.220 
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7.15.11 (5R)-5-[(S)-bromo(phenyl)methyl]oxolan-2-one (exo-74) 
 
 
White solid: []D20 20.0 (c 0.3, CH2Cl2); IR (neat) 3037, 2370, 1766, 1463, 1338, 
1178, 1022, 918, 702, 657 cm-1; 1H NMR (400 MHz, CDCl3): 7.47-7.33 (m, 5H, 
ArH), 5.03 (d, J = 6.9 Hz, 1H, H6), 4.97-4.91 (m, 1H, H5), 2.59-249 (m, 3H, H3 and 
H4), 2.35-2.26 (m, 1H, H4); 13C NMR (100 MHz CDCl3) 176.1, 137.1, 129.1, 
128.3, 126.4, 81.7, 55.5, 28.6, 26.4 MS (EI+) m/z 256, 254 (M)●+; HRMS (EI+) m/z 
calcd for C11H11O2
79Br (M)●+ 253.9942, found 253.9939; HPLC (CHIRALCEL-OD-
H; 25% IPA in n-hexane; 1.0 mL/min; 216 nm) tR = 13.8 min (major), 16.4 min 
(minor) – 67:33 e.r. (34% e.e.).  All spectroscopic data obtained are in accordance 
with literature data.42 
 
 
 
7.15.12 (3S)-3-[(R)-Bromo(phenyl)methyl]-1,3-dihydro-2-
benzofuran-1-one (exo-79)9 
 
 
 
Following a modified general procedure using 1:1 CHCl3:toluene solvent system and 
substrate (E)-78 gave bromolactones exo-79 (46 mg, 0.152 mmol, 76%) and endo-79 
(14.5 mg, 0.048 mmol, 24%).   
 
exo-79: White solid: []D20 5.8 (c 0.35, CH2Cl2); IR (neat) 3090, 1762, 1599, 1293, 
1223, 1074, 980, 754, 723, 699, 671 cm-1; 1H NMR (400 MHz, CDCl3) 7.87 (d, J = 
7.2 Hz, 1H, Ha), 7.69-7.59 (m, 2H, Hc and Hd), 7.57 (t, J = 7.7 Hz, 1H, Hb), 7.43 (m, 
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2H, ArH), 7.38-7.32 (m, 3H, ArH), 5.97 (d, J = 6.3 Hz, 1H, H3), 5.25 (d, J = 6.3 Hz, 
1H, H4); 13C NMR (100 MHz,  CDCl3) 169.3, 146.3, 136.0, 133.9, 130.0, 129.1, 
128.7, 128.6, 126.7, 125.8, 123.8, 82.5, 53.5; MS (CI+, NH3) m/z 322, 320 (M + 
NH4)
+; HRMS (CI+, NH3) m/z calcd for C15H15NO2
79Br 320.0286, found 320.0276; 
HPLC (CHIRALCEL-OJ; 20% IPA in n-hexane; 1.0 mL/min; 216 nm) tR = 22.1 min 
(major), 28.8 min (minor) – 57:43 e.r. (14% e.e.).  All spectroscopic data obtained are 
in accordance with literature data.9 
 
 
7.15.13 3S,4R)-4-Bromo-3-phenyl-3,4-dihydro-1H-2-
benzopyran-1-one (endo-79)9 
 
 
Colourless oil: []D20 16.6 (c 0.24, CH2Cl2); IR (neat) 2925, 1732, 1607, 1269, 1241, 
1161, 1033 cm-1; 1H NMR (400 MHz, CDCl3) 8.19 (d, 1H, J = 7.7 Hz, Ha), 7.63 
(td, J = 7.7, 1.5 Hz, 1H, Hc), 7.54-7.48 (m, 2H, Hb and Hd), 7.40-7.30 (m, 5H, ArH), 
5.95 (d, 1H, J = 4.8 Hz, H3), 5.59 (d, 1H, J = 4.8 Hz, H4); 13C NMR(100 MHz 
CDCl3)11111111111
; MS (CI+, NH3) m/z 322, 320 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for 
C15H15NO2
79Br (M + NH4)
+ 320.0286, found 320.0281; HPLC (CHIRALCEL-OJ; 
20% IPA in n-hexane; 1.0 mL/min; 228 nm) tR = 24.4, 27.2 min – 63:37 e.r. (26% 
e.e.).  All spectroscopic data obtained are in accordance with literature data. 9 
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7.15.14 (3S)-3-(Bromomethyl)-1,3-dihydro-2-benzofuran-1-one 
(161)9 
 
 
Following the general procedure using substrate 146 gave bromolactone 161 (43 mg, 
0.19 mmol, 95%).  Colourless oil: []D20 +31.6 (c 0.25, CH2Cl2); IR (neat) 2971, 
1759, 1467, 1286, 1064, 984, 712 cm-1; 1H NMR (400 MHz, CDCl3) 7.96 (d, J = 
7.9 Hz, 1H, Ha), 7.75 (td, J = 7.9, 1.1 Hz, 1H, Hc), 7.67-7.60 (m, 2H, Hb and Hd), 
5.73 (t, J = 5.1 Hz, 1H, H3), 3.80 (d, J = 5.1 Hz, 2H, H4); 13C NMR (100 MHz 
CDCl3) 169.5, 147.2, 134.4, 130.1, 126.5, 126.0, 122.5, 78.6, 32.2; MS (EI+) m/z 
229, 227 (M)●+; HRMS (EI+) m/z calcd for C9H7O2
79Br (M)●+ 226.9700, found 
226.9702; HPLC (CHIRALCEL-OJ; 16 % IPA in n-hexane; 1.0 mL/min; 228 nm) tR 
22.8 min (minor), 30.9 min (major) – 83:17 e.r. (66% e.e.).  All spectroscopic data 
obtained are in accordance with literature data.9  
 
 
7.15.15 (3S)-3-(Bromomethyl)-3,4-dihydro-1H-2-benzopyran-1-
one (162) 
 
 
 
Following the general procedure using substrate 147 gave bromolactone 162 (46 mg, 
0.19 mmol, 95%).  Colourless oil; []D20 -30.0 (c 0.26, CH2Cl2); IR (neat) 2970, 
1718, 1612, 1476, 1275, 1118, 1082, 1030, 744, 693 cm-1; 1H NMR (400 MHz, 
CDCl3) 1dd, J = 7.7, 1.6 Hz, 1H, Ha) 7.61 (td, J = 7.7, 1.6 Hz, 1H, Hc), 7.45 (t, 
J = 7.7 Hz, 1H, Hb), 7.32 (d, J = 7.7 Hz, 1H, Hd), 4.78 (dtd, J = 8.4, 6.9, 4.8 Hz, 1H, 
H3), 3.72 (dd, J = 10.8, 4.8 Hz, 1H, CHHBr), 3.62 (dd, J = 10.8, 6.9 Hz, 1H, 
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CHHBr), 3.23-3.19 (m, 2H, H4); 13C NMR (100 MHz, CDCl3) 164.3, 137.9, 134.2, 
130.5, 128.0, 127.7, 124.6, 76.7, 32.4, 31.6; MS (EI+) m/z 243, 241 (M)●+; HRMS 
(EI+) m/z calcd for C10H9O2
79Br 240.9864 (M)●+, found 240.9859; HPLC 
(CHIRALCEL-OJ; 16 % IPA in n-hexane; 1.0 mL/min; 228 nm) tR = 18.1 min 
(minor), 23.0 min (major) – 80:20 e.r. (60% e.e.). 
 
 
7.15.16 2-Bromo-9-methylidene-4-oxatricyclo[4.2.1.03,7]nonan-
5-one (164) 
 
Following a modified general procedure using 50 mol% NBS and substrate 150 gave 
bromolactone 164 (20 mg, 0.086 mmol, 43%).  White solid: m.p. 77 ◦C, (lit.221 m.p. = 
77-78 ◦C); 1H NMR (400 MHz, CDCl3) 5.34, (d, J = 2.0 Hz, 1H, CH2=C), 5.28 (d, J 
= 2.0 Hz, 1H, CH2=C), 5.05 (d, J = 5.0 Hz, 1H, H3), 3.92 (dd, J = 2.2, 1.0 Hz, 1H, 
H2), 3.40 (dt, J = 5.0, 1.6 Hz, 1H, H6), 3.16 (br s, 1H, H7), 3.11-3.08 (m, 1H, H1), 
2.39 (d, J = 11.3 Hz, 1H, H8), 1.88 (d, J = 11.3 Hz, 1H, H8);13C NMR (100 MHz 
CDCl3)175.8, 144.8, 112.2, 87.5, 53.8, 52.9, 46.4, 45.9, 35.2; MS (EI+) 229, 231 
(M)●+; HRMS (EI+) m/z calcd for C9H9O2
79Br 228.9858 (M)●+, found 228.9858; 
HPLC (CHIRALCEL-AD; 2% IPA in n-hexane; 1.0 mL/min; 220 nm) tR  = 12.1, 13.5 
min – 50:50 e.r. (0% e.e.). 
 
7.15.17 (3aR,6S,6aS)-6-Bromo-hexahydro-2H-
cyclopenta[b]furan-2-one (163)38 
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Following the general procedure using substrate 149 gave bromolactone 163 (20 mg, 
0.096 mmol, 48%).  Colourless oil; []D20 12.7 (c 0.5, CH2Cl2); IR (neat) 2975, 1779, 
1467, 1321, 1162, 1025, 883 cm-1; 1H NMR (400 MHz, CDCl3): 5.10 (d, J = 6.2 Hz, 
1H, H6a), 4.48 (d, J = 4.5 Hz, 1H, H6), 3.20 (ddt, J = 18.6, 9.7, 2.5 Hz, 1H, H3), 2.91 
(dd, J = 10.3, 18.6 Hz, 1H, H3), 2.52-2.41 (dddd, J = 13.6, 11.7, 9.7, 7.4 Hz, 1H, H5), 
2.36 (dd, J = 2.5, 18.6 Hz, 1H, H5), 2.33-2.22 (dddd, J = 14.6, 11.7, 7.4, 4.6 Hz, 1H, 
H5), 2.11 (dd, J = 14.6, 7.4 Hz, 1H, H5), 1.63 (ddd, J = 13.6, 7.4, 2.5 Hz, 1H, H3a); 
13C NMR (100 MHz CDCl3) 176.5, 90.5, 52.8, 36.0, 35.9, 33.1, 31.4; MS (EI+) m/z 
205, 207 (M)●+; HRMS (EI+) m/z calcd for C7H9O2
79Br 204.9857 (M)●+, found 
204.9859; HPLC (CHIRALCEL-AD; 2% IPA in n-hexane; 1.0 mL/min; 232 nm) tR = 
17.0 min (major), 22.4 min (minor) – 67:33 e.r. (34% e.e.).  All spectroscopic data 
obtained are in accordance with literature data.38 
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7.16 Determination of Absolute Configuration of Product 
Bromolactones by Comparison to Literature 
 
The absolute configuration of bromolactones, 135, 102, exo-77, endo-74, 156, endo-
79, 161 and 107 were assigned by comparison of optical rotation to the literature.  In 
addition, the stereochemistry of compounds 102 and 107 could be independently 
confirmed by comparison of HPLC chromatograms to the literature.  
Product Optical Rotation 
(D20) in CH2Cl2 
Literature product 
and rotationa 
Absolute 
Configuration 
 
 

12.5◦ (c = 1.00), 
60% e.e.   
 
26.3◦ (c = 1.00), 
72% e.e. 
 
(S) 
 
 


◦ (c = 0.95), 
88% e.e. 
 
1◦ (c = 1.58), 
91% e.e.  
 
 
(S) 
 
 

1◦ (c = 0.45), 
82% e.e. 
 
1◦ (c = 0.80), 
93% e.e.  
 
 
(S,S) 
 
 


1◦ (c = 0.32),  
 
◦ (c = 1.00), 
96% e.e.  
 
 
(S,R) 
 
 
 

◦ (c = 2.00), 
36% e.e.  
◦ (c = 0.69), 
100% e.e.  
 
 
(S) 
 
 
 


1◦ (c = 0.24), 
 
◦ (c = 1.00), 
92% e.e.  
 
 
(S,R) 
 
 

1◦ (c = 0.26),  
66% e.e. 
 
◦ (c = 1.00), 
34% e.e.  
 
 
(S) 
  
288 
 

◦ (c = 0.50), 
28% e.e. 
 
◦ (c = 1.00), 
36% e.e.  
 
 
(S,S,S) 
a References are given in section 7.15. 
 
7.17 Determination of Absolute Configuration by Radical 
Debromination 
 
The absolute stereochemistry of products exo-74, exo-79, 162 and 163 was 
determined by radical dehalogenation, and comparison of the optical rotation of the 
de-brominated lactones to the literature. 
 
7.17.1 General Procedure for Radical Dehalogenation 
 
AIBN (4 mg, 0.024 mmol) was added to a refluxing solution of bromolactone (0.2 
mmol) and tris(trimethylsilyl)silane (98 mg, 0.4 mmol) in toluene (4 mL).  The 
resulting mixture was refluxed for 4 h.  The mixture was then purified directly by 
silica gel column chromatography (gradient 10 – 20% ethyl acetate in hexanes).   
 
7.17.2 (R)-3-Methyl-3,4-dihydro-1H-2-benzopyran-1-one222 
 
Starting from bromolactone 162 (48 mg, 0.2 mmol) of 60% e.e. gave the title 
compound (22 mg, 0.136 mmol, 68%) as a colourless oil; D + 59.0 (c 2.20, 
CH2Cl2), (lit.222 D 87.5 (c 1.41, CHCl3) for (R) enantiomer) IR (neat) IR (neat) 
1710, 1609, 1461, 1354, 1388, 1278, 1239, 1121, 1086, 1034 ,959, 744 cm-1; 1H 
NMR (400 MHz, CDCl3)  8.10 (d, J = 7.9 Hz, 1H, Ha), 7.54 (td, J = 7.6, 1.4 Hz, 1H, 
Hc), 7.39 (t, J = 7.6 Hz, 1H, Hb), 7.24 (d, J = 7.9 Hz, 1H, Hd), 4.69 (ddq, J = 10.8, 
6.4, 4.4 Hz, 1H, H3), 3.01-2.89 (m, 2H, H4), 1.53 (d, J = 6.4 Hz, 3H, CH3); 
13C NMR 
(100 MHz CDCl3) 165.6, 139.1, 133.7, 130.3, 127.6, 127.3, 125.0, 75.1, 34.9, 20.9; 
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MS (EI+) m/z 162 (M)●+; HRMS (EI+) m/z calcd for C10H10O2 162.0681 (M)
●+, found 
162.0671.  All spectroscopic data obtained are in accordance with the literature.222 
 
 
7.17.3 (3aR,6aR)-Hexahydro-2H-cyclopenta[b]furan-2-one223 
 
Starting from bromolactone 163 (41 mg, 0.2 mmol) of 34% e.e. gave the title 
compound (20 mg, 0.158 mmol, 79%) as a colourless oil: D +9.0 (c 3.30, 
CH2Cl2), (lit.223 D +59.7 (c 1.28, MeOH) for (R,R) isomer); IR (neat) 2963, 
2877, 1765, 1173, 1162, 1098, 1027, 984, 908, 806 cm-1; 1H NMR (400 MHz, 
CDCl3)  5.00 (t, J = 5.0 Hz, 1H, H6a), 2.93-2.78 (m, 2H, H3’), 2.29 (d, J = 16.0 Hz, 
1H, H3a), 2.09-2.02 (m, 1H, H4), 1.86 (app dq, J = 16.0, 8.5 Hz, 1H, H4), 1.78-1.66 
(m, 3H, H5 and H6), 1.58-1.52 (m, 1H, H5); 13C NMR (100 MHz CDCl3)  177.8, 
86.4, 38.0, 36.1, 33.6, 33.5, 23.4; MS (EI+) m/z 126 (M)●+; HRMS (EI+) m/z calcd for 
C7H10O2 126.0681 (M)
●+, found 126.0679.  All spectroscopic data obtained are in 
agreement with the literature.223 
 
 
7.17.4 (R)-5-Benzyloxolan-2-one222 
 
 
Starting from bromolactone exo-74 (51 mg, 0.2 mmol) of 26% e.e. gave the title 
compound (15 mg, 0.086 mmol, 43%) as a colourless oil: []D20 28.0◦ (c 0.50, 
CH2Cl2), (lit.
222 []D20 1◦ (c 1, CHCl3) for (S) isomer); IR (neat) 1776, 1728, 
1459, 1283, 1182, 1032, 753, 700 cm-1; 1H NMR (400 MHz, CDCl3): 7.36-7.23 (m, 
5H, ArH), 4.76 (app quin, J = 6.3 Hz, 1H, H5), 3.10 (dd, J = 14.3, 6.3 Hz, 1H, H1’), 
2.95 (dd, J = 14.3 Hz, 6.3 Hz, 1H, H1’), 2.54-2.45 (m, 2H, H3), 2.28 (dddd, J = 12.8, 
9.3, 6.3, 4.7 Hz, 1H, H4), 1.98 (dddd, J = 12.8, 9.3, 9.2, 7.2 Hz, 1H, H4); 13C NMR 
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(100 MHz CDCl3) 177.0, 135.9, 132.2, 129.4, 128.7, 127.0, 41.3, 28.6, 27.1; MS 
(EI+) m/z 176 (M)●+; HRMS (EI+) m/z calcd for C11H12O2 176.0837 (M)●
+, found 
176.0836.  All spectroscopic data obtained are in agreement with the literature.222 
7.17.5 (R)-3-Benzyl-1,3-dihydro-2-benzofuran-1-one224 
 
 
Starting from bromolactone exo-79 (61 mg, 0.2 mmol) of 16% e.e. gave the title 
compound (18 mg, 0.108 mmol, 54%); []D20  (c 0.40, CH2Cl2); (lit.224 []D20 
◦ (c 1.12, CHCl3) for (R) isomer; IR (neat)1765, 1470, 1290, 1066 cm-1; 1H 
NMR (400 MHz, CDCl3): 7.87 (d, J = 7.6 Hz, 1H, Hd), 7.62 (td, J = 7.6, 1.0 Hz, 
1H, Hb), 7.51 (t, J = 7.6 Hz, 1H, Hc), 7.34-7.22 (m, 5H, ArH), 7.18 (d, J = 7.6 Hz, 
1H, Ha), 5.72 (t, J = 6.5 Hz, 1H, H3), 3.31 (dd, J  = 13.8, 6.5 Hz, 1H, H1’), 3.17 (dd, 
J = 13.8, 6.5 Hz, H1’); 13C NMR (100 MHz CDCl3) 149.1, 135.0, 133.7, 129.7, 
129.2, 128.6, 127.2, 126.3, 125.7, 122.3, 81.2, 40.9 (the expected C=O 13C resonance 
at 170.4224 was not observed (128 scans)); MS (EI+) m/z 224 (M)●+; HRMS (EI+) m/z 
calcd for C15H12O2 224.0837 (M)●
+, found 224.0839. 
 
7.18 Determination of Absolute Configuration of Remaining 
Bromolactones 
 
The stereochemistry of products 158 (S,S) and 160 (S) were assigned by analogy to 
other bromolactones in the series 155, 135 and 102.  
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7.19 Characterising Data for Constrained Catalysts 215 and 
216 
 
7.19.1 10,11-Dihydro-11-hydroxy-quinidine (221)192 
 
 
According to a modified method of Sanders et al.,196 to a solution of quinidine (3.00 
g, 9.26 mmol) in THF (50 mL), borane (1 M in THF, 37 mL, 37 mmol, 4.0 eq.) was 
added dropwise at 0 ◦C.  The mixture was stirred for 6 h at 0 ◦C, and concentrated 
under reduced pressure to 30-40 mL.  The remaining solution was distributed evenly 
between four 20 mL microwave vials.  Trimethylamine N-oxide (1.74 g, 23 mmol, 10 
eq.) was added carefully to each vial, causing gas evolution.  When the gas evolution 
subsided, the vials were sealed and transferred to a microwave reactor.  The 
inhomogeneous reaction mixtures were each heated for 5 minutes at 130 ◦C, to form a 
pale yellow solution.  CARE: pressure run-away occurs (>25 bar) occurs if there is 
insufficient head space (< 10 mL) in vial.  The heating process was repeated, and after 
cooling to room temperature the reaction mixtures were diluted with EtOAc (10 mL), 
recombined and treated with saturated aqueous Na2CO3 (50 mL).  The solution was 
extracted with EtOAc (4 x 50 mL), and the combined organic layers washed with 
brine (150 mL), dried (Na2SO4), filtered and concentrated under reduced pressure.  
The crude material was chromatographed (88:8:4 Et2O:MeOH:Net3) to give the title 
compound (1.95 g, 5.69 mmol, 62%). 
 
White crystalline solid: m.p. = 212 ◦C, (lit.192 m.p. = 211 ◦C); []D20 1 (c 0.90, 
MeOH), (lit.192 []D20 ◦ (c 0.14, MeOH); IR (neat) 3600-2500 (br), 2931, 2870, 
1623, 1593, 1511, 1472, 1244, 1230, 1027, 831, 641 cm-1; 1H NMR (400 MHz, 
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CDCl3): 8.56 (d, J = 4.5 Hz, 1H, H2), 7.88 (d, J = 9.2 Hz, 1H, H3), 7.53 (d, J = 4.6 
Hz, 1H, H1), 7.22 (dd, J = 9.2, 2.6 Hz, 1H, H4), 7.08 (d, J = 2.6 Hz, 1H, H5), 5.59 (d, 
J = 3.0 Hz, 1H, H8), 5.06-4.23 (br s, OH), 3.74 (s, 3H, OCH3), 3.58 (t, J = 6.9 Hz, 2H, 
H21), 3.33-3.29 (m, 1H, H9), 2.96-2.75 (m, 3H, H16, H18 and H19), 2.66 (dt, J 
=13.3, 9.0 Hz, 1H, H15), 2.05 (m, 1H, H10), 1.78 (app quintet, J = 6.7 Hz, 1H, H20), 
1.71 (app quintet, J = 6.7 Hz, 1H, H20), 1.63-1.52 (m, 2H, H12 and H17), 1.46-1.34 
(m, 2H, H13 and H14), 0.95 (m, 1H, H11); 13C NMR (100 MHz CDCl3) 157.6 
(C8a’), 148.6 (C4a’), 147.2 (C2’), 143.7 (C4’), 131.1 (C8’), 126.4 (C6’), 121.5 (C7’), 
118.4 (3’), 101.1 (C5’), 71.5 (C9), 60.6 (C11), 59.2 (C8), 55.5 (OCH3), 51.0 (C2), 
50.1 (C6), 36.0 (C10), 32.1 (C3), 27.0 (C4), 26.9 (C5), 20.0 (C7) ; MS (EI+) m/z 343 
(M)●+; HRMS (EI+) m/z calcd for C20H27N2O3 343.2022 (M)●
+, found 343.2034.  All 
spectroscopic data are consistent with the literature.192 
  
7.19.2 10,11-Dihydro-11-(triisopropylsilyloxy)quinidine (219)192 
 
According to a modified literature procedure,192 10,11-dihydro-11-hydroxy-quinidine 
(425 mg, 1.24 mmol) was stirred together with triisopropylsilyl chloride (358 mg, 
1.86 mmol, 1.5 eq.) and imidazole (211 mg, 3.1 mmol, 2.5 eq.) in a CH2Cl2 solution 
(5 mL) at room temperature for 24 h.  The yellow solution was diluted with saturated 
aqueous K2CO3 (10 mL), and extracted with CH2Cl2 (2 x 10 mL).  The combined 
organic layers were washed with brine (20 mL), dried (Na2SO4), filtered, concentrated 
under reduced pressure and chromatographed (89:6:5 toluene:MeOH:NEt3) to give 
the title compound (532 mg, 1.07 mmol, 86%). 
 
Yellow oil; []D20 1 (c 0.40, MeOH), (lit.192 []D20 1 (c 0.41, MeOH); IR 
(neat) 3400-2700 (br), 2935, 2872, 1734, 1621, 1511, 1477, 1457, 1384, 1353, 1278, 
1165, 1078, 987, 846, 827, 780, 661 cm-1; 1H NMR (400 MHz, CDCl3): 8.56 (d, J = 
4.5 Hz, 1H, H2), 7.91 (d, J = 9.2 Hz, 1H, H3), 7.51 (d, J = 4.5 Hz, 1H, H1), 7.22 (dd, 
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J = 9.2, 2.8 Hz, 1H, H4), 7.19 (d, J = 2.8 Hz, 1H, H5), 5.58 (d, J = 4.0 Hz, 1H, H8), 
5.10-4.90 (br s, OH), 3.83 (s, 3H, OCH3), 3.68 (t, J = 5.9 Hz, 2H, H21), 3.21-3.10 (m, 
1H, H9), 3.02 (td, J = 8.8, 3.7 Hz, 1H, H16), 2.94-2.77 (m, 2H, H18 and H19), 2.78-
2.65 (m, 1H, H15), 2.06-1.97 (m, 1H, H10), 1.74-1.63 (m, 4H), 1.52-1.46 (m, 2H), 
1.17-0.89 (m, 22H, H11 and iPrH); 13C NMR (100 MHz CDCl3) 157.6 (C8a’), 
148.1 (C4a’), 147.4 (C2’), 144.0 (C4’), 131.3 (C8’), 126.6 (C6’), 121.4 (C7’), 118.5 
(3’), 101.3 (C5’), 71.8 (C9), 61.8 (C11), 59.8 (C8), 55.6 (OCH3), 51.0 (C2), 50.3 
(C6), 35.7 (C10), 31.2 (C3), 27.0 (C4), 26.7 (C5), 21.0 (C7), 18.05 (CH3 x 12), 11.7 
(Si-CH x 6); MS (ES+) m/z 498 (M)+.  All spectroscopic data are in consistent with the 
literature.192 
 
7.19.3 10,11-Dihydro-11-(triphenylmethoxy)quinidine (220) 
 
 
To a solution of 10,11-dihydro-11-hydroxy-quinidine (250 mg, 0.73 mmol) in CH2Cl2 
(5 mL) at room temperature were added triphenylmethyl chloride (305 mg, 1.09 
mmol, 1.5 eq.), triethylamine (184 mg, 1.83 mmol, 2.5 eq.) and 
dimethylaminopyridine (18 mg, 0.146 mmol, 0.2 eq.).  After 24 h, the crude material 
was purified directly by flash column chromatography (85:9:6 toluene:MeOH:Net3) to 
give the title compound (255 mg, 0.438 mmol, 60%). 
 
Yellow oil; []D20  (c 0.15, CH2Cl2); IR (neat) 2927, 2867, 1623, 1596, 1513, 
1449, 1230, 1242, 1114, 1032, 767, 746, 634 cm-1; 1H NMR (400 MHz, CDCl3): 
8.49 (d, J = 4.5 Hz, 1H, H2), 7.90 (dd, J = 9.2, 2.0 Hz, 1H, H3), 7.47-7.40 (m, 7H, 
o-ArH and H1), 7.33-7.12 (m, 11H, ArH, H4 and H5), 5.49 (d, J = 4.4 Hz, 1H, H8), 
5.01-4.40 (br s, OH), 3.80 (s, 3H, OCH3), 3.11-3.00 (m, 3H, H21 and H16), 2.97 (td, J 
= 8.6, 3.4 Hz, 1H, H9), 2.79 (m, 2H, H18 and H19), 2.68 (m, 1H, H15), 1.92 (app t, J 
= 11.6 Hz, 1H, H10), 1.80-1.71 (m, 2H, H13 and H17), 1.67 (m, 1H, H14), 1.55 (br s, 
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1H, H12), 1.44-1.37 (m, 2H, H20), 1.03 (app td, J = 7.7, 4.2 Hz, 1H, H11); 13C NMR 
(100 MHz CDCl3) 157.6 (C8a’), 147.4 (C4a’), 144.4 (ArC), 144.0 (C4’), 131.3 
(C8’), 128.7 (ArC), 127.8 (ArC), 126.9 (ArC), 126.6 (C6’), 121.4 (C7’), 118.5 (C3’), 
101.4 (C5’), 85.6 (C(Ph)3), 72.0 (C9), 62.0 (C11), 60.0 (C8), 55.6 (OCH3), 51.3 (C2), 
50.3 (C6), 32.9 (C10), 32.5 (C3), 27.2 (C4), 26.6 (C5), 20.9 (C7); MS (ES+) m/z 585 
(M)+; HRMS (EI+) m/z calcd for C39H41N2O3 585.3117 (M)
+, found 585.3089 
 
7.19.4 1,4-Bis-(10,11-dihydro-11-(triisopropylsilyloxy) 
quinidine) phthalazine (217) 
 
 
Sodium hydride (9.6 mg, 0.4 mmol, 2 eq.) was added to a solution of 10,11-dihydro-
11-(triisopropylsilyloxy)quinidine (217) (100 mg, 0.2 mmol) in THF (2 mL).  1,4-
Dichlorophthalazine (20 mg, 0.1 mmol, 0.5 eq.) was added and the reaction mixture 
stirred at room temperature for one hour or until TLC analysis indicated that the spot 
for 1,4-dichlorophthalazine had disappeared.  The mixture was transferred to a 
microwave reactor and heated to 130 ◦C for 2 x 5 minutes.  The pressure did not 
exceed 8 bar.  After cooling to room temperature, the mixture was diluted with 
saturated aqueous Na2CO3 (5 mL), and extracted with EtOAc (2 x 5 mL).  The 
combined organic extracts were washed with brine (10 mL), dried (Na2SO4), filtered 
and concentrated under reduced pressure.  The crude material was chromatographed 
(84:8:8 toluene:MeOH:NEt3) to give the title compound as a yellow solid (81 mg, 
0.072 mmol, 72%). 
 
Yellow solid; m.p. = XX ◦C; []D20  (c 0.2, CH2Cl2); IR (neat) 2936, 2867, 1623, 
1511, 1461, 1386, 1358, 1230, 1098, 1025, 885, 847, 664 cm-1; 1H NMR (400 MHz, 
CDCl3): 8.63 (d, J = 4.5 Hz, 2H, H2’), 8.35 (dd, J = 6.1, 3.3 Hz, 2H, H1’’), 7.98 (d, 
J = 9.3 Hz, 2H, H3’), 7.93 (dd, J = 6.1, 3.3 Hz, 2H, H2’’), 7.55 (d, J = 2.7 Hz, 2H, 
H5), 7.43 (d, J = 4.5 Hz, 2H, H1’), 7.35 (dd, J = 9.3, 2.7 Hz, 2H, H4’), 7.03 (d, J = 
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5.8 Hz, 2H, H8), 3.91 (s, 6H, OCH3), 3.61 (dt, J = 5.8, 3.0 Hz, 4H, H21), 3.44-3.36 
(m, 2H, H9), 2.89-2.62(m, 8H, H15, H16, H18 and H19), 2.06 (app t, J = 11.8 Hz, 
2H, H10), 1.72 (br s, 2H, H12), 1.70-1.60 (m, 6H), 1.59-1.41 (m, 6H), 1.12-0.89 (m, 
42H, iPrH); 13C NMR (100 MHz CDCl3) 157.7 (C8a’), 156.4 (Ca), 147.4 (C4a’), 
145.0 (Ca’), 144.7 (C4’), 132.2 (C8’), 131.6 (Cb), 127.3 (C6’), 122.9 (Cc), 122.5 
(C2’) 121.9 (C7’), 118.4 (C3’), 102.1 (C5’), 76.4 (C9), 61.7 (C11), 60.4 (C8), 55.7 
(OCH3), 51.1 (C2), 49.9 (C6), 36.0 (C10), 32.4 (C3), 27.3 (C4), 26.8 (C5), 23.2 (C7), 
18.0 (CH3 x 12), 11.9 (Si-CH x 6); MS (ES+) m/z 1124 (M)+; HRMS (ES+) m/z calcd 
for C66H94N6O6Si21123.6866 (M)
+, found 1123.6268. 
 
7.19.5 1,4-Bis-(10,11-dihydro-11-(triphenylmethoxy) quinidine) 
phthalazine (218) 
 
 
Sodium hydride (22 mg, 0.93 mmol, 2 eq.) was added to a solution of 10,11-dihydro-
11-(triphenylmethoxy)quinidine (218) (213 mg, 0.37 mmol) in DMF (4 mL).  1,4-
Dichlorophthalazine (37 mg, 0.19 mmol, 0.5 eq.) was added and the reaction mixture 
stirred at room temperature for one hour or until TLC analysis indicated that the spot 
for 1,4-dichlorophthalazine had disappeared.  The mixture was transferred to a 
microwave reactor and heated to 190 ◦C for 2 x 5 minutes.  The pressure did not 
exceed 5 bar.  After cooling to room temperature, the mixture was diluted with 15% 
LiCl (aq.) (10 mL), and extracted with EtOAc (3 x 5 mL).  The combined organic 
extracts were washed with brine (10 mL), dried (Na2SO4), filtered and concentrated 
under reduced pressure.  The crude material was chromatographed (84:8:8 
toluene:MeOH:NEt3) to give the title compound (115 mg, 0.088 mmol, 24%). 
 
Yellow oil; []D20 1 (c 0.7, CH2Cl2); IR (neat) 2938, 2870, 1623, 1511, 1472, 
1456, 1433, 1244, 1228, 1029, 1004, 833, 917, 732 cm-1; 1H NMR (400 MHz, 
CDCl3): 8.60 (d, J = 4.5 Hz, 2H, H2’), 8.32 (dd, J = 6.1, 3.3 Hz, 2H, H1’’), 7.97 (d, 
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J = 9.2 Hz, 2H, H3’), 7.97 (dd, J = 6.1, 3.3 Hz, 2H, H2’’), 7.51 (br s, 2H, H5), 7.39 
(d, J = 4.5 Hz, 2H, H1’), 7.36-7.32 (m, 14H, o-ArH and H4’), 7.24-7.19 (m, 12H, m-
ArH) 7.18-7.13 (tt, J = 7.3, 1.3 Hz, 6H, p-ArH), 3.85 (s, 6H, OCH3), 3.37 (d, J = 5.8, 
2H, H9), 3.01 (tt, J = 5.5, 2.1 Hz, 4H, H21), 2.83-2.71 (m, 4H, H15, H16) 2.70-2.60 
(m, 4H, H18 and H19), 2.01 (m, 2H, H10), 1.81-1.56 (m, 6H), 1.62 (br s, 2H, H12), 
1.57-1.39 (m, 6H); 13C NMR (100 MHz CDCl3) 157.7 (C8a’), 156.2 (Ca), 147.2 
(C4a’), 144.6 (PhC), 144.2 (C4’), 132.3 (C8’), 131.5 (Cb), 128.5 (PhC), 127.7 (PhC), 
127.2 (C6’), 126.8 (PhC), 122.7 (Cc), 122.4 (C7’), 118.1 (C3’), 101.9 (C5’), 86.5 
(CPh3) 76.0 (C9), 61.7 (C11), 60.0 (C8), 55.8 (OCH3), 50.8 (C2), 49.7 (C6), 33.0 
(C10), 32.3 (C3), 27.3 (C4), 26.6 (C5), 23.3 (C7); MS (ES+) m/z 1295 (M)+; HRMS 
(EI+) m/z calcd for C86H83N6O6 1295.6448 (M)●
+, found 1295.6374. 
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7.20 2D-NOESY Spectra  
7.2.1 Characteristic nOe’s for Each Quinidine Conformation 
(Cross peaks in bold are unique to a particular conformation). 
 
 
Sharpless’ Numbering for (DHQD)2PHAL and Numbering for Carboxylic 
Acids
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2D-NOESY Spectrum of (DHQD)2PHAL in CDCl3 (20 mM) 
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2D-NOESY Spectrum of 1:2.5 (DHQD)2PHAL:Anthranoic acid Mixture in CDCl3 (25.7 mM) 
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2D-NOESY Spectrum of 1:1.4 (DHQD)2PHAL:NBS Mixture in CDCl3 (15 mM) 
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2D-NOESY of 1,4-Bis-(10,11-dihydro-11-(triphenylmethoxy) quinidine) phthalazine 
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Appendix: Data for X-ray Crystal Structure of 1:2 
(DHQD)2PHAL:Anthranoic acid Complex 
 
Table 1. Crystal data and structure refinement for CB1103. 
 
Identification code CB1103 
Formula C48 H56 N6 O4, 2(C15 H9 O2), 4(C7 
H8), 
 0.35(H2 O) 
Formula weight 1598.27 
Temperature 173 K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 15.7434(3) Å  = 90° 
 b = 20.5682(3) Å  = 90° 
 c = 26.9760(3) Å  = 90° 
Volume, Z 8735.2(2) Å3, 4 
Density (calculated) 1.215 Mg/m3 
Absorption coefficient 0.603 mm-1 
F(000) 3406 
Crystal colour / morphology Colourless blocks 
Crystal size 0.20 x 0.14 x 0.12 mm3 
 range for data collection 2.70 to 72.42° 
Index ranges -19<=h<=18, -17<=k<=25, -
30<=l<=32 
Reflns collected / unique 22182 / 13539 [R(int) = 0.0244] 
Reflns observed [F>4(F)] 11359 
Absorption correction Analytical 
Max. and min. transmission 0.939 and 0.912 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 13539 / 338 / 1186 
Goodness-of-fit on F2 1.039 
Final R indices [F>4(F)] R1 = 0.0728, wR2 = 0.2030 
 R1+ = 0.0728, wR2+ = 0.2030 
 R1- = 0.0728, wR2- = 0.2031 
R indices (all data) R1 = 0.0821, wR2 = 0.2130 
Absolute structure parameter x+ = 0.0(3), x- = 1.2(3) 
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 Absolute structure indeterminate, 
 assigned by internal reference on 
N26, 
 C29, C32, N50, C53 and C56 
Largest diff. peak, hole 0.418, -0.347 eÅ-3 
Mean and maximum shift/error 0.000 and 0.002 
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Table 2. Bond lengths [Å] and angles [°] for CB1103. 
 
N(1)-C(10) 1.287(4) 
N(1)-N(2) 1.391(4) 
N(2)-C(3) 1.282(4) 
C(3)-O(11) 1.357(4) 
C(3)-C(4') 1.454(9) 
C(3)-C(4) 1.455(6) 
C(4)-C(9) 1.403(8) 
C(4)-C(5) 1.406(7) 
C(5)-C(6) 1.352(8) 
C(6)-C(7) 1.373(10) 
C(7)-C(8) 1.367(8) 
C(8)-C(9) 1.411(7) 
C(9)-C(10) 1.418(5) 
C(4')-C(9') 1.401(12) 
C(4')-C(5') 1.422(11) 
C(5')-C(6') 1.358(12) 
C(6')-C(7') 1.387(15) 
C(7')-C(8') 1.371(12) 
C(8')-C(9') 1.403(11) 
C(9')-C(10) 1.522(9) 
C(10)-O(35) 1.358(4) 
O(11)-C(12) 1.428(4) 
C(12)-C(13) 1.523(5) 
C(12)-C(25) 1.527(5) 
C(13)-C(14) 1.354(5) 
C(13)-C(22) 1.427(5) 
C(14)-C(15) 1.383(7) 
C(15)-N(16) 1.325(7) 
N(16)-C(17) 1.359(6) 
C(17)-C(18) 1.409(7) 
C(17)-C(22) 1.434(6) 
C(18)-C(19) 1.360(7) 
C(19)-C(20) 1.385(7) 
C(20)-O(23) 1.371(5) 
C(20)-C(21) 1.379(5) 
C(21)-C(22) 1.415(5) 
O(23)-C(24) 1.413(7) 
C(25)-N(26) 1.515(5) 
C(25)-C(30) 1.538(5) 
N(26)-C(31) 1.490(5) 
N(26)-C(27) 1.503(5) 
C(27)-C(28) 1.530(7) 
C(28)-C(29) 1.545(6) 
C(29)-C(30) 1.530(5) 
C(29)-C(32) 1.533(6) 
C(31)-C(32) 1.535(5) 
C(32)-C(33) 1.530(5) 
C(33)-C(34) 1.504(7) 
O(35)-C(36) 1.438(4) 
C(36)-C(37) 1.500(6) 
C(36)-C(49) 1.531(5) 
C(36)-C(37') 1.569(16) 
C(37)-C(38) 1.380(7) 
C(37)-C(46) 1.439(7) 
C(38)-C(39) 1.399(8) 
C(39)-N(40) 1.331(7) 
N(40)-C(41) 1.373(7) 
C(41)-C(46) 1.409(7) 
C(41)-C(42) 1.410(7) 
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C(42)-C(43) 1.366(8) 
C(43)-C(44) 1.392(8) 
C(44)-C(45) 1.365(6) 
C(44)-O(47) 1.374(8) 
C(45)-C(46) 1.418(7) 
O(47)-C(48) 1.396(9) 
C(37')-C(38') 1.386(16) 
C(37')-C(46') 1.452(15) 
C(38')-C(39') 1.399(16) 
C(39')-N(40') 1.329(16) 
N(40')-C(41') 1.379(15) 
C(41')-C(46') 1.385(15) 
C(41')-C(42') 1.411(15) 
C(42')-C(43') 1.351(17) 
C(43')-C(44') 1.386(17) 
C(44')-O(47') 1.358(16) 
C(44')-C(45') 1.385(15) 
C(45')-C(46') 1.405(16) 
O(47')-C(48') 1.388(19) 
C(49)-N(50) 1.517(5) 
C(49)-C(54) 1.535(5) 
N(50)-C(55) 1.492(5) 
N(50)-C(51) 1.496(6) 
C(51)-C(52) 1.524(8) 
C(52)-C(53) 1.536(6) 
C(53)-C(56) 1.519(6) 
C(53)-C(54) 1.534(6) 
C(55)-C(56) 1.540(6) 
C(56)-C(57) 1.532(5) 
C(57)-C(58) 1.512(7) 
O(60)-C(61) 1.233(5) 
C(61)-O(62) 1.239(5) 
C(61)-C(63) 1.496(5) 
C(63)-C(64) 1.387(6) 
C(63)-C(76) 1.412(5) 
C(64)-C(65) 1.418(7) 
C(64)-C(69) 1.458(6) 
C(65)-C(66) 1.395(8) 
C(66)-C(67) 1.432(11) 
C(67)-C(68) 1.295(10) 
C(68)-C(69) 1.421(8) 
C(69)-C(70) 1.375(7) 
C(70)-C(71) 1.381(7) 
C(71)-C(76) 1.430(5) 
C(71)-C(72) 1.450(7) 
C(72)-C(73) 1.346(8) 
C(73)-C(74) 1.374(7) 
C(74)-C(75) 1.352(6) 
C(75)-C(76) 1.417(6) 
O(80)-C(81) 1.215(5) 
C(81)-O(82) 1.273(6) 
C(81)-C(83) 1.517(5) 
C(83)-C(84) 1.405(5) 
C(83)-C(96) 1.406(5) 
C(84)-C(85) 1.422(6) 
C(84)-C(89) 1.450(6) 
C(85)-C(86) 1.365(7) 
C(86)-C(87) 1.443(10) 
C(87)-C(88) 1.358(10) 
C(88)-C(89) 1.420(7) 
C(89)-C(90) 1.368(7) 
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C(90)-C(91) 1.377(6) 
C(91)-C(96) 1.435(5) 
C(91)-C(92) 1.437(6) 
C(92)-C(93) 1.334(7) 
C(93)-C(94) 1.419(7) 
C(94)-C(95) 1.336(6) 
C(95)-C(96) 1.419(5) 
 
C(10)-N(1)-N(2) 118.8(3) 
C(3)-N(2)-N(1) 119.2(3) 
N(2)-C(3)-O(11) 121.1(3) 
N(2)-C(3)-C(4') 126.4(5) 
O(11)-C(3)-C(4') 109.9(4) 
N(2)-C(3)-C(4) 123.7(4) 
O(11)-C(3)-C(4) 114.8(3) 
C(9)-C(4)-C(5) 119.1(4) 
C(9)-C(4)-C(3) 116.9(4) 
C(5)-C(4)-C(3) 123.6(5) 
C(6)-C(5)-C(4) 118.8(5) 
C(5)-C(6)-C(7) 122.2(5) 
C(8)-C(7)-C(6) 121.4(5) 
C(7)-C(8)-C(9) 117.8(5) 
C(4)-C(9)-C(8) 120.6(4) 
C(4)-C(9)-C(10) 113.9(4) 
C(8)-C(9)-C(10) 125.4(5) 
C(9')-C(4')-C(5') 120.1(7) 
C(9')-C(4')-C(3) 112.0(6) 
C(5')-C(4')-C(3) 127.5(8) 
C(6')-C(5')-C(4') 119.4(9) 
C(5')-C(6')-C(7') 120.8(9) 
C(8')-C(7')-C(6') 120.6(9) 
C(7')-C(8')-C(9') 120.6(9) 
C(4')-C(9')-C(8') 118.4(7) 
C(4')-C(9')-C(10) 117.0(6) 
C(8')-C(9')-C(10) 123.9(7) 
N(1)-C(10)-O(35) 120.7(3) 
N(1)-C(10)-C(9) 126.7(3) 
O(35)-C(10)-C(9) 112.1(3) 
N(1)-C(10)-C(9') 121.5(5) 
O(35)-C(10)-C(9') 115.7(4) 
C(3)-O(11)-C(12) 117.9(3) 
O(11)-C(12)-C(13) 110.7(3) 
O(11)-C(12)-C(25) 107.8(3) 
C(13)-C(12)-C(25) 109.5(3) 
C(14)-C(13)-C(22) 118.0(4) 
C(14)-C(13)-C(12) 119.6(4) 
C(22)-C(13)-C(12) 122.4(3) 
C(13)-C(14)-C(15) 121.2(4) 
N(16)-C(15)-C(14) 124.0(4) 
C(15)-N(16)-C(17) 116.5(4) 
N(16)-C(17)-C(18) 118.3(4) 
N(16)-C(17)-C(22) 123.5(4) 
C(18)-C(17)-C(22) 118.2(4) 
C(19)-C(18)-C(17) 121.0(4) 
C(18)-C(19)-C(20) 120.7(4) 
O(23)-C(20)-C(21) 123.6(4) 
O(23)-C(20)-C(19) 115.2(4) 
C(21)-C(20)-C(19) 121.2(4) 
C(20)-C(21)-C(22) 119.4(3) 
C(21)-C(22)-C(13) 124.0(3) 
C(21)-C(22)-C(17) 119.4(4) 
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C(13)-C(22)-C(17) 116.7(4) 
C(20)-O(23)-C(24) 117.8(3) 
N(26)-C(25)-C(12) 113.8(3) 
N(26)-C(25)-C(30) 107.3(3) 
C(12)-C(25)-C(30) 115.5(3) 
C(31)-N(26)-C(27) 108.3(3) 
C(31)-N(26)-C(25) 113.1(3) 
C(27)-N(26)-C(25) 108.1(4) 
N(26)-C(27)-C(28) 108.6(3) 
C(27)-C(28)-C(29) 108.2(3) 
C(30)-C(29)-C(32) 110.5(3) 
C(30)-C(29)-C(28) 108.2(3) 
C(32)-C(29)-C(28) 107.3(3) 
C(29)-C(30)-C(25) 108.6(3) 
N(26)-C(31)-C(32) 109.5(3) 
C(33)-C(32)-C(29) 113.8(3) 
C(33)-C(32)-C(31) 112.2(3) 
C(29)-C(32)-C(31) 107.5(3) 
C(34)-C(33)-C(32) 114.1(4) 
C(10)-O(35)-C(36) 119.4(2) 
O(35)-C(36)-C(37) 115.4(4) 
O(35)-C(36)-C(49) 106.2(2) 
C(37)-C(36)-C(49) 106.5(3) 
O(35)-C(36)-C(37') 96.3(6) 
C(49)-C(36)-C(37') 118.2(7) 
C(38)-C(37)-C(46) 117.1(4) 
C(38)-C(37)-C(36) 117.7(4) 
C(46)-C(37)-C(36) 125.2(5) 
C(37)-C(38)-C(39) 120.8(5) 
N(40)-C(39)-C(38) 123.8(5) 
C(39)-N(40)-C(41) 116.8(4) 
N(40)-C(41)-C(46) 123.5(5) 
N(40)-C(41)-C(42) 116.4(4) 
C(46)-C(41)-C(42) 120.1(5) 
C(43)-C(42)-C(41) 120.2(4) 
C(42)-C(43)-C(44) 119.7(4) 
C(45)-C(44)-O(47) 125.5(5) 
C(45)-C(44)-C(43) 122.0(6) 
O(47)-C(44)-C(43) 112.5(4) 
C(44)-C(45)-C(46) 119.6(5) 
C(41)-C(46)-C(45) 118.5(4) 
C(41)-C(46)-C(37) 118.0(5) 
C(45)-C(46)-C(37) 123.5(4) 
C(44)-O(47)-C(48) 118.1(4) 
C(38')-C(37')-C(46') 117.7(13) 
C(38')-C(37')-C(36) 124.3(11) 
C(46')-C(37')-C(36) 117.7(11) 
C(37')-C(38')-C(39') 119.4(15) 
N(40')-C(39')-C(38') 123.6(14) 
C(39')-N(40')-C(41') 118.2(12) 
N(40')-C(41')-C(46') 122.3(12) 
N(40')-C(41')-C(42') 117.6(12) 
C(46')-C(41')-C(42') 120.0(13) 
C(43')-C(42')-C(41') 119.6(14) 
C(42')-C(43')-C(44') 122.0(15) 
O(47')-C(44')-C(45') 126.0(14) 
O(47')-C(44')-C(43') 115.3(12) 
C(45')-C(44')-C(43') 118.7(14) 
C(44')-C(45')-C(46') 120.8(14) 
C(41')-C(46')-C(45') 118.8(12) 
C(41')-C(46')-C(37') 118.5(13) 
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C(45')-C(46')-C(37') 122.7(12) 
C(44')-O(47')-C(48') 121.8(15) 
N(50)-C(49)-C(36) 113.1(3) 
N(50)-C(49)-C(54) 107.4(3) 
C(36)-C(49)-C(54) 115.7(3) 
C(55)-N(50)-C(51) 108.1(3) 
C(55)-N(50)-C(49) 112.5(3) 
C(51)-N(50)-C(49) 108.6(4) 
N(50)-C(51)-C(52) 107.7(4) 
C(51)-C(52)-C(53) 109.5(4) 
C(56)-C(53)-C(54) 110.4(3) 
C(56)-C(53)-C(52) 107.3(4) 
C(54)-C(53)-C(52) 108.8(3) 
C(53)-C(54)-C(49) 108.4(3) 
N(50)-C(55)-C(56) 110.5(3) 
C(53)-C(56)-C(57) 115.5(4) 
C(53)-C(56)-C(55) 106.4(3) 
C(57)-C(56)-C(55) 111.4(4) 
C(58)-C(57)-C(56) 114.2(4) 
O(60)-C(61)-O(62) 124.5(4) 
O(60)-C(61)-C(63) 117.8(4) 
O(62)-C(61)-C(63) 117.5(4) 
C(64)-C(63)-C(76) 120.8(3) 
C(64)-C(63)-C(61) 120.6(4) 
C(76)-C(63)-C(61) 118.5(3) 
C(63)-C(64)-C(65) 122.7(4) 
C(63)-C(64)-C(69) 118.9(4) 
C(65)-C(64)-C(69) 118.4(4) 
C(66)-C(65)-C(64) 120.5(6) 
C(65)-C(66)-C(67) 118.5(6) 
C(68)-C(67)-C(66) 122.5(6) 
C(67)-C(68)-C(69) 122.1(6) 
C(70)-C(69)-C(68) 122.7(5) 
C(70)-C(69)-C(64) 119.4(4) 
C(68)-C(69)-C(64) 117.8(5) 
C(69)-C(70)-C(71) 121.8(4) 
C(70)-C(71)-C(76) 119.7(4) 
C(70)-C(71)-C(72) 123.0(4) 
C(76)-C(71)-C(72) 117.3(4) 
C(73)-C(72)-C(71) 121.5(4) 
C(72)-C(73)-C(74) 120.3(5) 
C(75)-C(74)-C(73) 121.5(5) 
C(74)-C(75)-C(76) 121.5(4) 
C(63)-C(76)-C(75) 122.8(3) 
C(63)-C(76)-C(71) 119.2(4) 
C(75)-C(76)-C(71) 117.9(3) 
O(80)-C(81)-O(82) 124.5(4) 
O(80)-C(81)-C(83) 119.8(4) 
O(82)-C(81)-C(83) 115.7(4) 
C(84)-C(83)-C(96) 121.0(3) 
C(84)-C(83)-C(81) 119.8(3) 
C(96)-C(83)-C(81) 119.1(3) 
C(83)-C(84)-C(85) 122.6(4) 
C(83)-C(84)-C(89) 118.1(4) 
C(85)-C(84)-C(89) 119.3(4) 
C(86)-C(85)-C(84) 121.4(5) 
C(85)-C(86)-C(87) 118.8(6) 
C(88)-C(87)-C(86) 121.4(5) 
C(87)-C(88)-C(89) 121.1(6) 
C(90)-C(89)-C(88) 122.4(5) 
C(90)-C(89)-C(84) 119.8(4) 
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C(88)-C(89)-C(84) 117.9(5) 
C(89)-C(90)-C(91) 122.5(4) 
C(90)-C(91)-C(96) 119.2(4) 
C(90)-C(91)-C(92) 123.0(4) 
C(96)-C(91)-C(92) 117.8(4) 
C(93)-C(92)-C(91) 121.4(4) 
C(92)-C(93)-C(94) 120.4(4) 
C(95)-C(94)-C(93) 120.5(4) 
C(94)-C(95)-C(96) 121.8(4) 
C(83)-C(96)-C(95) 122.8(3) 
C(83)-C(96)-C(91) 119.2(3) 
C(95)-C(96)-C(91) 118.0(3) 
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